DrugA,DrugB,Interaction,Mechanism,risk_level
Mifepristone,Butalbital,The metabolism of Mifepristone can be increased when combined with Butalbital.,increase,no risk
Mifepristone,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Mifepristone.,increase,risk
Mifepristone,Gabapentin,The serum concentration of Futibatinib can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Gadobenic acid,The metabolism of Mifepristone can be increased when combined with Gabapentin.,increase,no risk
Mifepristone,Gadoxetic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Mifepristone.,increase,risk
Mifepristone,Galantamine,The excretion of Gadoxetic acid can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Ganaxolone,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Mifepristone.,increase,risk
Mifepristone,Gatifloxacin,The metabolism of Mifepristone can be increased when combined with Ganaxolone.,increase,no risk
Mifepristone,Gefapixant,The therapeutic efficacy of Mifepristone can be increased when used in combination with Gatifloxacin.,increase,no risk
Mifepristone,Gefitinib,The therapeutic efficacy of Mifepristone can be increased when used in combination with Gefapixant.,increase,no risk
Mifepristone,Gemcitabine,The metabolism of Gefitinib can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Gemifloxacin,The serum concentration of Gemcitabine can be decreased when it is combined with Mifepristone.,decrease,no risk
Mifepristone,Gepirone,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Mifepristone.,increase,risk
Mifepristone,Gestrinone,The serum concentration of Gepirone can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Gilteritinib,The metabolism of Gestrinone can be increased when combined with Mifepristone.,increase,no risk
Mifepristone,Glasdegib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Mifepristone.,increase,risk
Mifepristone,Glecaprevir,The serum concentration of Glasdegib can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Gliclazide,The serum concentration of Glecaprevir can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Glimepiride,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Mifepristone.,decrease,no risk
Mifepristone,Glipizide,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Mifepristone.,decrease,no risk
Mifepristone,Gliquidone,The therapeutic efficacy of Glipizide can be decreased when used in combination with Mifepristone.,decrease,no risk
Mifepristone,Glofitamab,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Mifepristone.,decrease,no risk
Mifepristone,Glyburide,The serum concentration of Mifepristone can be increased when it is combined with Glofitamab.,increase,no risk
Mifepristone,Glycerol phenylbutyrate,The therapeutic efficacy of Glyburide can be decreased when used in combination with Mifepristone.,decrease,no risk
Mifepristone,Glycyrrhizic acid,The metabolism of Mifepristone can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Mifepristone,Glymidine,Mifepristone may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Mifepristone,Golimumab,The risk or severity of hypoglycemia can be increased when Mifepristone is combined with Glymidine.,increase,risk
Mifepristone,Goserelin,The metabolism of Mifepristone can be increased when combined with Golimumab.,increase,no risk
Mifepristone,Granisetron,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Mifepristone.,increase,risk
Mifepristone,Grazoprevir,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Mifepristone.,increase,risk
Mifepristone,Grepafloxacin,The serum concentration of Grazoprevir can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Griseofulvin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Mifepristone.,increase,risk
Mifepristone,Halcinonide,The metabolism of Mifepristone can be increased when combined with Griseofulvin.,increase,no risk
Mifepristone,Halofantrine,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Mifepristone.,increase,risk
Mifepristone,Haloperidol,The serum concentration of Halofantrine can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Halothane,The risk or severity of QTc prolongation can be increased when Mifepristone is combined with Haloperidol.,increase,risk
Mifepristone,Heparin,The metabolism of Halothane can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Hetacillin,The risk or severity of adverse effects can be increased when Mifepristone is combined with Heparin.,increase,risk
Mifepristone,Histrelin,The therapeutic efficacy of Mifepristone can be decreased when used in combination with Hetacillin.,decrease,no risk
Mifepristone,Hydrochlorothiazide,The therapeutic efficacy of Mifepristone can be decreased when used in combination with Histrelin.,decrease,no risk
Mifepristone,Hydrocodone,The therapeutic efficacy of Mifepristone can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Mifepristone,Hydrocortamate,The metabolism of Hydrocodone can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Hydrocortisone,The metabolism of Mifepristone can be increased when combined with Hydrocortamate.,increase,no risk
Mifepristone,Hydrocortisone acetate,The serum concentration of Hydrocortisone can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Hydrocortisone butyrate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Hydrocortisone cypionate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Hydrocortisone phosphate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Hydrocortisone probutate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Mifepristone.,increase,risk
Mifepristone,Hydrocortisone valerate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Hydroflumethiazide,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Mifepristone.,increase,risk
Mifepristone,Hydromorphone,The therapeutic efficacy of Mifepristone can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Mifepristone,Hydroxychloroquine,The metabolism of Hydromorphone can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Hydroxyprogesterone caproate,The serum concentration of Hydroxychloroquine can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Hydroxyzine,The therapeutic efficacy of Mifepristone can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Mifepristone,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Mifepristone is combined with Hydroxyzine.,increase,risk
Mifepristone,Ketamine,The metabolism of Ixazomib can be increased when combined with Mifepristone.,increase,no risk
Mifepristone,Ketoconazole,The serum concentration of Ketamine can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Ketorolac,The metabolism of Mifepristone can be decreased when combined with Ketoconazole.,decrease,no risk
Mifepristone,Nabilone,The serum concentration of Mifepristone can be decreased when it is combined with Mycophenolic acid.,decrease,no risk
Mifepristone,Nabumetone,The metabolism of Nabilone can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Nadolol,The metabolism of Nabumetone can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Nadroparin,The therapeutic efficacy of Mifepristone can be increased when used in combination with Nadolol.,increase,no risk
Mifepristone,Nafcillin,The risk or severity of adverse effects can be increased when Mifepristone is combined with Nadroparin.,increase,risk
Mifepristone,Nalidixic acid,The metabolism of Mifepristone can be increased when combined with Nafcillin.,increase,no risk
Mifepristone,Naloxegol,The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Mifepristone.,increase,risk
Mifepristone,Nandrolone decanoate,The serum concentration of Naloxegol can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Nandrolone phenpropionate,Nandrolone decanoate may increase the hypoglycemic activities of Mifepristone.,increase,no risk
Mifepristone,Naproxen,Nandrolone phenpropionate may increase the hypoglycemic activities of Mifepristone.,increase,no risk
Mifepristone,Nateglinide,The serum concentration of Naproxen can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Nebivolol,The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Mifepristone.,increase,risk
Mifepristone,Nefazodone,The therapeutic efficacy of Mifepristone can be increased when used in combination with Nebivolol.,increase,no risk
Mifepristone,Nelfinavir,The metabolism of Mifepristone can be decreased when combined with Nefazodone.,decrease,no risk
Mifepristone,Neratinib,The metabolism of Mifepristone can be decreased when combined with Nelfinavir.,decrease,no risk
Mifepristone,Netupitant,The metabolism of Neratinib can be increased when combined with Mifepristone.,increase,no risk
Mifepristone,Nevirapine,The metabolism of Mifepristone can be decreased when combined with Netupitant.,decrease,no risk
Mifepristone,Niacin,The metabolism of Nevirapine can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Nialamide,The therapeutic efficacy of Mifepristone can be decreased when used in combination with Niacin.,decrease,no risk
Mifepristone,Nicardipine,Nialamide may increase the hypoglycemic activities of Mifepristone.,increase,no risk
Mifepristone,Nicergoline,The serum concentration of Nicardipine can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Niclosamide,The serum concentration of Nicergoline can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Nifedipine,The metabolism of Niclosamide can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Nilotinib,The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Mifepristone.,increase,risk
Mifepristone,Nilvadipine,The metabolism of Mifepristone can be decreased when combined with Nilotinib.,decrease,no risk
Mifepristone,Nimesulide,The risk or severity of QTc prolongation can be increased when Nilvadipine is combined with Mifepristone.,increase,risk
Mifepristone,Nimodipine,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Mifepristone.,increase,risk
Mifepristone,Nintedanib,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Mifepristone.,increase,risk
Mifepristone,Nirogacestat,The serum concentration of Nintedanib can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Nisoldipine,The metabolism of Nirogacestat can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Nitrazepam,The metabolism of Nisoldipine can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Nitrendipine,The metabolism of Mifepristone can be increased when combined with Nitrazepam.,increase,no risk
Mifepristone,Nitrofurantoin,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Mifepristone.,increase,risk
Mifepristone,Nomegestrol,Nitrofurantoin may decrease the excretion rate of Mifepristone which could result in a higher serum level.,decrease,no risk
Mifepristone,Nomegestrol acetate,The metabolism of Nomegestrol can be increased when combined with Mifepristone.,increase,no risk
Mifepristone,Norelgestromin,The metabolism of Nomegestrol acetate can be increased when combined with Mifepristone.,increase,no risk
Mifepristone,Norethisterone,The metabolism of Norelgestromin can be increased when combined with Mifepristone.,increase,no risk
Mifepristone,Norethynodrel,The therapeutic efficacy of Mifepristone can be decreased when used in combination with Norethisterone.,decrease,no risk
Mifepristone,Norfloxacin,The metabolism of Norethynodrel can be increased when combined with Mifepristone.,increase,no risk
Mifepristone,Norgestimate,The therapeutic efficacy of Mifepristone can be increased when used in combination with Norfloxacin.,increase,no risk
Mifepristone,Norgestrel,The therapeutic efficacy of Mifepristone can be decreased when used in combination with Norgestimate.,decrease,no risk
Mifepristone,Nortriptyline,The metabolism of Norgestrel can be increased when combined with Mifepristone.,increase,no risk
Mifepristone,Nylidrin,The serum concentration of Nortriptyline can be decreased when it is combined with Mifepristone.,decrease,no risk
Mifepristone,Obeticholic acid,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Mifepristone.,increase,risk
Mifepristone,Octreotide,The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Mifepristone.,decrease,no risk
Mifepristone,Ofloxacin,The therapeutic efficacy of Mifepristone can be decreased when used in combination with Octreotide.,decrease,no risk
Mifepristone,Olanzapine,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Mifepristone.,increase,risk
Mifepristone,Olaparib,The therapeutic efficacy of Mifepristone can be decreased when used in combination with Olanzapine.,decrease,no risk
Mifepristone,Oliceridine,The metabolism of Olaparib can be increased when combined with Mifepristone.,increase,no risk
Mifepristone,Olmesartan,The serum concentration of Oliceridine can be decreased when it is combined with Mifepristone.,decrease,no risk
Mifepristone,Olodaterol,Olmesartan may decrease the excretion rate of Mifepristone which could result in a higher serum level.,decrease,no risk
Mifepristone,Olsalazine,The serum concentration of Olodaterol can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Olutasidenib,Olsalazine may increase the hypoglycemic activities of Mifepristone.,increase,no risk
Mifepristone,Omadacycline,The metabolism of Mifepristone can be increased when combined with Olutasidenib.,increase,no risk
Mifepristone,Omaveloxolone,The serum concentration of Omadacycline can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Ombitasvir,The therapeutic efficacy of Mifepristone can be decreased when used in combination with Omaveloxolone.,decrease,no risk
Mifepristone,Ondansetron,The serum concentration of Ombitasvir can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Opium,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Mifepristone.,increase,risk
Mifepristone,Oritavancin,The metabolism of Opium can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Orphenadrine,The metabolism of Mifepristone can be increased when combined with Oritavancin.,increase,no risk
Mifepristone,Osilodrostat,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Mifepristone.,increase,risk
Mifepristone,Osimertinib,The metabolism of Mifepristone can be decreased when combined with Osilodrostat.,decrease,no risk
Mifepristone,Ospemifene,The serum concentration of Osimertinib can be decreased when it is combined with Mifepristone.,decrease,no risk
Mifepristone,Ouabain,The metabolism of Ospemifene can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Ox bile extract,The excretion of Ouabain can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Oxacillin,The therapeutic efficacy of Ox bile extract can be decreased when used in combination with Mifepristone.,decrease,no risk
Mifepristone,Oxaliplatin,The therapeutic efficacy of Mifepristone can be decreased when used in combination with Oxacillin.,decrease,no risk
Mifepristone,Oxandrolone,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Mifepristone.,increase,risk
Mifepristone,Oxatomide,Oxandrolone may increase the hypoglycemic activities of Mifepristone.,increase,no risk
Mifepristone,Oxcarbazepine,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Mifepristone.,increase,risk
Mifepristone,Oxprenolol,The metabolism of Mifepristone can be increased when combined with Oxcarbazepine.,increase,no risk
Mifepristone,Oxybutynin,The therapeutic efficacy of Mifepristone can be increased when used in combination with Oxprenolol.,increase,no risk
Mifepristone,Oxycodone,The metabolism of Oxybutynin can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Oxymetholone,The metabolism of Oxycodone can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Oxymorphone,Oxymetholone may increase the hypoglycemic activities of Mifepristone.,increase,no risk
Mifepristone,Oxytetracycline,The metabolism of Oxymorphone can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Oxytocin,The serum concentration of Mifepristone can be decreased when it is combined with Oxytetracycline.,decrease,no risk
Mifepristone,Ozanimod,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Mifepristone.,increase,risk
Mifepristone,Quetiapine,The therapeutic efficacy of Mifepristone can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Mifepristone,Quinethazone,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Mifepristone.,increase,risk
Mifepristone,Quinidine,The therapeutic efficacy of Mifepristone can be decreased when used in combination with Quinethazone.,decrease,no risk
Mifepristone,Quinine,The serum concentration of Quinidine can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Quinupramine,The serum concentration of Quinine can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Quizartinib,Quinupramine may decrease the hypoglycemic activities of Mifepristone.,decrease,no risk
Mifepristone,Ubidecarenone,The serum concentration of Tucatinib can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Ubrogepant,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Mifepristone.,increase,risk
Mifepristone,Udenafil,The serum concentration of Ubrogepant can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Ulipristal,The therapeutic efficacy of Mifepristone can be increased when used in combination with Udenafil.,increase,no risk
Mifepristone,Ulobetasol,The metabolism of Ulipristal can be increased when combined with Mifepristone.,increase,no risk
Mifepristone,Umeclidinium,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Mifepristone.,increase,risk
Mifepristone,Urokinase,The serum concentration of Umeclidinium can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Mifepristone is combined with Urokinase.,increase,risk
Mifepristone,Vadadustat,The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Mifepristone.,decrease,no risk
Mifepristone,Valbenazine,The serum concentration of Mifepristone can be increased when it is combined with Vadadustat.,increase,no risk
Mifepristone,Valdecoxib,The metabolism of Valbenazine can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Valproic acid,The metabolism of Valdecoxib can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Valsartan,The metabolism of Mifepristone can be increased when combined with Valproic acid.,increase,no risk
Mifepristone,Vamorolone,The metabolism of Valsartan can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Vandetanib,The serum concentration of Vamorolone can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Vardenafil,The metabolism of Vandetanib can be increased when combined with Mifepristone.,increase,no risk
Mifepristone,Velpatasvir,The metabolism of Vardenafil can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Vemurafenib,The serum concentration of Velpatasvir can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Venetoclax,The serum concentration of Vemurafenib can be decreased when it is combined with Mifepristone.,decrease,no risk
Mifepristone,Venlafaxine,The serum concentration of Venetoclax can be decreased when it is combined with Mifepristone.,decrease,no risk
Mifepristone,Verapamil,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Mifepristone.,increase,risk
Mifepristone,Vernakalant,The metabolism of Mifepristone can be decreased when combined with Verapamil.,decrease,no risk
Mifepristone,Vigabatrin,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Mifepristone.,increase,risk
Mifepristone,Vilanterol,The metabolism of Mifepristone can be increased when combined with Vigabatrin.,increase,no risk
Mifepristone,Vilazodone,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Mifepristone.,increase,risk
Mifepristone,Vildagliptin,The metabolism of Vilazodone can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Viloxazine,The risk or severity of hypoglycemia can be increased when Mifepristone is combined with Vildagliptin.,increase,risk
Mifepristone,Vinblastine,The metabolism of Mifepristone can be decreased when combined with Viloxazine.,decrease,no risk
Mifepristone,Vincristine,The serum concentration of Vinblastine can be decreased when it is combined with Mifepristone.,decrease,no risk
Mifepristone,Vindesine,The serum concentration of Vincristine can be decreased when it is combined with Mifepristone.,decrease,no risk
Mifepristone,Vinflunine,The metabolism of Vindesine can be increased when combined with Mifepristone.,increase,no risk
Mifepristone,Vinorelbine,The serum concentration of Vinflunine can be decreased when it is combined with Mifepristone.,decrease,no risk
Mifepristone,Vitamin E,The metabolism of Vinorelbine can be increased when combined with Mifepristone.,increase,no risk
Mifepristone,Voclosporin,The metabolism of Mifepristone can be increased when combined with Vitamin E.,increase,no risk
Mifepristone,Vonoprazan,The serum concentration of Voclosporin can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Vorapaxar,The metabolism of Vonoprazan can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Voriconazole,The risk or severity of adverse effects can be increased when Mifepristone is combined with Vorapaxar.,increase,risk
Mifepristone,Vorinostat,The metabolism of Mifepristone can be decreased when combined with Voriconazole.,decrease,no risk
Mifepristone,Vortioxetine,The therapeutic efficacy of Mifepristone can be decreased when used in combination with Vorinostat.,decrease,no risk
Mifepristone,Voxelotor,The serum concentration of Vortioxetine can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Voxilaprevir,The serum concentration of Voxelotor can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Warfarin,The serum concentration of Voxilaprevir can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Ximelagatran,The serum concentration of Warfarin can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Xylometazoline,The risk or severity of adverse effects can be increased when Mifepristone is combined with Ximelagatran.,increase,risk
Mifepristone,Yohimbine,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Mifepristone.,increase,risk
Mifepristone,Zafirlukast,The metabolism of Yohimbine can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Zaleplon,The metabolism of Zafirlukast can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Zanubrutinib,The metabolism of Mifepristone can be increased when combined with Zaleplon.,increase,no risk
Mifepristone,Zavegepant,The metabolism of Zanubrutinib can be increased when combined with Mifepristone.,increase,no risk
Mifepristone,Ziconotide,The serum concentration of Zavegepant can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Zidovudine,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Mifepristone.,increase,risk
Mifepristone,Zileuton,The serum concentration of Zidovudine can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Zimelidine,The metabolism of Zileuton can be decreased when combined with Mifepristone.,decrease,no risk
Mifepristone,Ziprasidone,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Mifepristone.,increase,risk
Mifepristone,Zolpidem,The risk or severity of QTc prolongation can be increased when Mifepristone is combined with Ziprasidone.,increase,risk
Mifepristone,Zonisamide,The metabolism of Zolpidem can be increased when combined with Mifepristone.,increase,no risk
Mifepristone,Zopiclone,The metabolism of Mifepristone can be increased when combined with Zonisamide.,increase,no risk
Mifepristone,Zuclopenthixol,The serum concentration of Zopiclone can be increased when it is combined with Mifepristone.,increase,no risk
Mifepristone,Zuranolone,The risk or severity of QTc prolongation can be increased when Mifepristone is combined with Zuclopenthixol.,increase,risk
Brompheniramine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Brompheniramine.,increase,risk
Brompheniramine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Brompheniramine.,increase,risk
Brompheniramine,Butaperazine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Butaperazine.,increase,risk
Brompheniramine,Butobarbital,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Butobarbital.,increase,risk
Brompheniramine,Butorphanol,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Butorphanol.,increase,risk
Brompheniramine,Butriptyline,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Butriptyline.,increase,risk
Brompheniramine,Butylscopolamine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Butylscopolamine.,increase,risk
Brompheniramine,Gabapentin,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Gabapentin.,increase,risk
Brompheniramine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Gabapentin enacarbil.,increase,risk
Brompheniramine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Gadobenic acid.,increase,risk
Brompheniramine,Galantamine,The therapeutic efficacy of Brompheniramine can be decreased when used in combination with Galantamine.,decrease,no risk
Brompheniramine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Brompheniramine.,increase,risk
Brompheniramine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Brompheniramine is combined with Ganaxolone.",increase,risk
Brompheniramine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Gatifloxacin.,increase,risk
Brompheniramine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Gemifloxacin.,increase,risk
Brompheniramine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Brompheniramine.,increase,risk
Brompheniramine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Gilteritinib.,increase,risk
Brompheniramine,Ginkgo biloba,The therapeutic efficacy of Brompheniramine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Brompheniramine,Glasdegib,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Glasdegib.,increase,risk
Brompheniramine,Glucagon,Brompheniramine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Brompheniramine,Glutethimide,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Glutethimide.,increase,risk
Brompheniramine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Brompheniramine.,decrease,no risk
Brompheniramine,Glycopyrronium,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Glycopyrronium.,increase,risk
Brompheniramine,Golimumab,The metabolism of Brompheniramine can be increased when combined with Golimumab.,increase,no risk
Brompheniramine,Goserelin,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Goserelin.,increase,risk
Brompheniramine,Granisetron,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Granisetron.,increase,risk
Brompheniramine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Grepafloxacin.,increase,risk
Brompheniramine,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Brompheniramine.,increase,risk
Brompheniramine,Guanfacine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Guanfacine.,increase,risk
Brompheniramine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Brompheniramine.,increase,risk
Brompheniramine,Halofantrine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Halofantrine.,increase,risk
Brompheniramine,Haloperidol,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Haloperidol.,increase,risk
Brompheniramine,Halothane,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Halothane.,increase,risk
Brompheniramine,Hexafluronium,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Hexafluronium.,increase,risk
Brompheniramine,Hexocyclium,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Hexocyclium.,increase,risk
Brompheniramine,Histrelin,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Histrelin.,increase,risk
Brompheniramine,Homatropine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Homatropine.,increase,risk
Brompheniramine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Brompheniramine.,increase,risk
Brompheniramine,Huperzine A,The therapeutic efficacy of Brompheniramine can be decreased when used in combination with Huperzine A.,decrease,no risk
Brompheniramine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Brompheniramine.,decrease,no risk
Brompheniramine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Brompheniramine.,decrease,no risk
Brompheniramine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Brompheniramine.,decrease,no risk
Brompheniramine,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Brompheniramine.,increase,no risk
Brompheniramine,Hydrocortisone,The metabolism of Brompheniramine can be increased when combined with Hydrocortisone.,increase,no risk
Brompheniramine,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Brompheniramine.,increase,no risk
Brompheniramine,Hydromorphone,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Hydromorphone.,increase,risk
Brompheniramine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Hydroxychloroquine.,increase,risk
Brompheniramine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Hydroxyzine.,increase,risk
Brompheniramine,Hyoscyamine,Brompheniramine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Brompheniramine,Ketamine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Ketamine.,increase,risk
Brompheniramine,Ketazolam,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Ketazolam.,increase,risk
Brompheniramine,Ketoconazole,The metabolism of Brompheniramine can be decreased when combined with Ketoconazole.,decrease,no risk
Brompheniramine,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Brompheniramine.,increase,no risk
Brompheniramine,Nalbuphine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Nalbuphine.,increase,risk
Brompheniramine,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Nalidixic acid.,increase,risk
Brompheniramine,Naloxegol,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Naloxegol.,increase,risk
Brompheniramine,Naltrexone,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Naltrexone.,increase,risk
Brompheniramine,Naphazoline,The risk or severity of Tachycardia can be increased when Brompheniramine is combined with Naphazoline.,increase,risk
Brompheniramine,Naratriptan,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Naratriptan.,increase,risk
Brompheniramine,Nefazodone,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Nefazodone.,increase,risk
Brompheniramine,Nelfinavir,The metabolism of Brompheniramine can be decreased when combined with Nelfinavir.,decrease,no risk
Brompheniramine,Neostigmine,The therapeutic efficacy of Brompheniramine can be decreased when used in combination with Neostigmine.,decrease,no risk
Brompheniramine,Nevirapine,The metabolism of Brompheniramine can be increased when combined with Nevirapine.,increase,no risk
Brompheniramine,Nialamide,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Nialamide.,increase,risk
Brompheniramine,Nicardipine,The risk or severity of adverse effects can be increased when Nicardipine is combined with Brompheniramine.,increase,risk
Brompheniramine,Nicotine,The metabolism of Brompheniramine can be decreased when combined with Nicotine.,decrease,no risk
Brompheniramine,Nifedipine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Nifedipine.,increase,risk
Brompheniramine,Nilotinib,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Nilotinib.,increase,risk
Brompheniramine,Nilvadipine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Nilvadipine.,increase,risk
Brompheniramine,Nimodipine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Nimodipine.,increase,risk
Brompheniramine,Nirogacestat,The metabolism of Brompheniramine can be increased when combined with Nirogacestat.,increase,no risk
Brompheniramine,Nitrazepam,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Nitrazepam.,increase,risk
Brompheniramine,Nitrendipine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Nitrendipine.,increase,risk
Brompheniramine,Nitrous oxide,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Nitrous oxide.,increase,risk
Brompheniramine,Nizatidine,The therapeutic efficacy of Brompheniramine can be decreased when used in combination with Nizatidine.,decrease,no risk
Brompheniramine,Nomifensine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Nomifensine.,increase,risk
Brompheniramine,Norepinephrine,The therapeutic efficacy of Norepinephrine can be increased when used in combination with Brompheniramine.,increase,no risk
Brompheniramine,Norfloxacin,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Norfloxacin.,increase,risk
Brompheniramine,Norgestimate,The metabolism of Norgestimate can be decreased when combined with Brompheniramine.,decrease,no risk
Brompheniramine,Normethadone,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Normethadone.,increase,risk
Brompheniramine,Nortriptyline,The risk or severity of CNS depression can be increased when Nortriptyline is combined with Brompheniramine.,increase,risk
Brompheniramine,Nylidrin,The risk or severity of Tachycardia can be increased when Brompheniramine is combined with Nylidrin.,increase,risk
Brompheniramine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Brompheniramine.,increase,risk
Brompheniramine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Ofloxacin.,increase,risk
Brompheniramine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Brompheniramine.,increase,risk
Brompheniramine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Brompheniramine is combined with Oliceridine.",increase,risk
Brompheniramine,Olodaterol,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Olodaterol.,increase,risk
Brompheniramine,Ondansetron,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Ondansetron.,increase,risk
Brompheniramine,Opium,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Opium.,increase,risk
Brompheniramine,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Brompheniramine.,increase,risk
Brompheniramine,Orphenadrine,Brompheniramine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Brompheniramine,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Brompheniramine.,decrease,no risk
Brompheniramine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Brompheniramine.,decrease,no risk
Brompheniramine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Brompheniramine.,increase,risk
Brompheniramine,Oxatomide,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Oxatomide.,increase,risk
Brompheniramine,Oxazepam,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Oxazepam.,increase,risk
Brompheniramine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Brompheniramine.,increase,risk
Brompheniramine,Oxitriptan,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Oxitriptan.,increase,risk
Brompheniramine,Oxprenolol,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Oxprenolol.,increase,risk
Brompheniramine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Oxybuprocaine.,increase,risk
Brompheniramine,Oxybutynin,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Oxybutynin.,increase,risk
Brompheniramine,Oxycodone,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Oxycodone.,increase,risk
Brompheniramine,Oxymetazoline,The risk or severity of Tachycardia can be increased when Brompheniramine is combined with Oxymetazoline.,increase,risk
Brompheniramine,Oxymorphone,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Oxymorphone.,increase,risk
Brompheniramine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Brompheniramine.,increase,risk
Brompheniramine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Brompheniramine.,decrease,no risk
Brompheniramine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Brompheniramine.,increase,risk
Brompheniramine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Brompheniramine.,increase,risk
Brompheniramine,Quazepam,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Quazepam.,increase,risk
Brompheniramine,Quetiapine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Quetiapine.,increase,risk
Brompheniramine,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Brompheniramine.,increase,no risk
Brompheniramine,Quinidine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Quinidine.,increase,risk
Brompheniramine,Quinine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Quinine.,increase,risk
Brompheniramine,Quinupramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Quinupramine.,increase,risk
Brompheniramine,Quizartinib,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Quizartinib.,increase,risk
Brompheniramine,Umeclidinium,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Umeclidinium.,increase,risk
Brompheniramine,Urethane,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Urethane.,increase,risk
Brompheniramine,Vadadustat,The serum concentration of Brompheniramine can be decreased when it is combined with Vadadustat.,decrease,no risk
Brompheniramine,Valproic acid,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Valproic acid.,increase,risk
Brompheniramine,Vandetanib,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Vandetanib.,increase,risk
Brompheniramine,Vardenafil,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Vardenafil.,increase,risk
Brompheniramine,Vecuronium,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Vecuronium.,increase,risk
Brompheniramine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Brompheniramine.,decrease,no risk
Brompheniramine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Brompheniramine.,increase,risk
Brompheniramine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Brompheniramine.,increase,risk
Brompheniramine,Vernakalant,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Vernakalant.,increase,risk
Brompheniramine,Vigabatrin,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Vigabatrin.,increase,risk
Brompheniramine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Brompheniramine.,increase,risk
Brompheniramine,Vilazodone,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Vilazodone.,increase,risk
Brompheniramine,Viloxazine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Viloxazine.,increase,risk
Brompheniramine,Voriconazole,The metabolism of Brompheniramine can be decreased when combined with Voriconazole.,decrease,no risk
Brompheniramine,Vorinostat,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Vorinostat.,increase,risk
Brompheniramine,Vortioxetine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Vortioxetine.,increase,risk
Brompheniramine,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Brompheniramine.,decrease,no risk
Brompheniramine,Xamoterol,The risk or severity of Tachycardia can be increased when Brompheniramine is combined with Xamoterol.,increase,risk
Brompheniramine,Xylometazoline,The risk or severity of Tachycardia can be increased when Brompheniramine is combined with Xylometazoline.,increase,risk
Brompheniramine,Yohimbine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Yohimbine.,increase,risk
Brompheniramine,Zaleplon,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Zaleplon.,increase,risk
Brompheniramine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Brompheniramine.,decrease,no risk
Brompheniramine,Ziconotide,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Ziconotide.,increase,risk
Brompheniramine,Zimelidine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Zimelidine.,increase,risk
Brompheniramine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Ziprasidone.,increase,risk
Brompheniramine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Brompheniramine.,increase,risk
Brompheniramine,Zolpidem,Brompheniramine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Brompheniramine,Zonisamide,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Zonisamide.,increase,risk
Brompheniramine,Zopiclone,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Zopiclone.,increase,risk
Brompheniramine,Zotepine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Zotepine.,increase,risk
Brompheniramine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Zuclopenthixol.,increase,risk
Brompheniramine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Brompheniramine.,increase,risk
Loperamide,Bretylium,Loperamide may increase the arrhythmogenic activities of Bretylium.,increase,no risk
Loperamide,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Loperamide.,decrease,no risk
Loperamide,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Loperamide.,increase,risk
Loperamide,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Loperamide.,increase,risk
Loperamide,Bumadizone,The risk or severity of hyperkalemia can be increased when Loperamide is combined with Bumadizone.,increase,risk
Loperamide,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Loperamide.,decrease,no risk
Loperamide,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Loperamide.,increase,risk
Loperamide,Butriptyline,The risk or severity of QTc prolongation can be increased when Loperamide is combined with Butriptyline.,increase,risk
Loperamide,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Loperamide.,increase,risk
Loperamide,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Loperamide.,increase,risk
Loperamide,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Loperamide.,increase,risk
Loperamide,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Loperamide.,increase,no risk
Loperamide,Gemfibrozil,The metabolism of Loperamide can be decreased when combined with Gemfibrozil.,decrease,no risk
Loperamide,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Loperamide is combined with Gemifloxacin.,increase,risk
Loperamide,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Loperamide.,increase,risk
Loperamide,Gilteritinib,The risk or severity of QTc prolongation can be increased when Loperamide is combined with Gilteritinib.,increase,risk
Loperamide,Glasdegib,The risk or severity of QTc prolongation can be increased when Loperamide is combined with Glasdegib.,increase,risk
Loperamide,Glecaprevir,The excretion of Loperamide can be decreased when combined with Glecaprevir.,decrease,no risk
Loperamide,Glofitamab,The serum concentration of Loperamide can be increased when it is combined with Glofitamab.,increase,no risk
Loperamide,Golimumab,The metabolism of Loperamide can be increased when combined with Golimumab.,increase,no risk
Loperamide,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Loperamide.,increase,risk
Loperamide,Granisetron,The risk or severity of QTc prolongation can be increased when Loperamide is combined with Granisetron.,increase,risk
Loperamide,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Loperamide.,increase,no risk
Loperamide,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Loperamide is combined with Grepafloxacin.,increase,risk
Loperamide,Guanfacine,Loperamide may increase the bradycardic activities of Guanfacine.,increase,no risk
Loperamide,Halofantrine,The risk or severity of QTc prolongation can be increased when Loperamide is combined with Halofantrine.,increase,risk
Loperamide,Haloperidol,The risk or severity of QTc prolongation can be increased when Loperamide is combined with Haloperidol.,increase,risk
Loperamide,Heparin,The risk or severity of hyperkalemia can be increased when Loperamide is combined with Heparin.,increase,risk
Loperamide,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Loperamide.,increase,risk
Loperamide,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Loperamide.,increase,risk
Loperamide,Hydrocortisone,The metabolism of Loperamide can be increased when combined with Hydrocortisone.,increase,no risk
Loperamide,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Loperamide.,decrease,no risk
Loperamide,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Loperamide is combined with Hydroxyzine.,increase,risk
Loperamide,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Loperamide.,increase,no risk
Loperamide,Ketamine,The metabolism of Ketamine can be decreased when combined with Loperamide.,decrease,no risk
Loperamide,Ketoconazole,The metabolism of Loperamide can be decreased when combined with Ketoconazole.,decrease,no risk
Loperamide,Ketoprofen,The risk or severity of hyperkalemia can be increased when Loperamide is combined with Ketoprofen.,increase,risk
Loperamide,Ketorolac,The metabolism of Loperamide can be decreased when combined with Ketorolac.,decrease,no risk
Loperamide,Nabumetone,The risk or severity of hyperkalemia can be increased when Nabumetone is combined with Loperamide.,increase,risk
Loperamide,Nadolol,Loperamide may increase the arrhythmogenic activities of Nadolol.,increase,no risk
Loperamide,Nadroparin,The risk or severity of hyperkalemia can be increased when Loperamide is combined with Nadroparin.,increase,risk
Loperamide,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Loperamide.,increase,risk
Loperamide,Naproxen,The metabolism of Loperamide can be decreased when combined with Naproxen.,decrease,no risk
Loperamide,Nebivolol,Loperamide may increase the arrhythmogenic activities of Nebivolol.,increase,no risk
Loperamide,Nefazodone,The metabolism of Loperamide can be decreased when combined with Nefazodone.,decrease,no risk
Loperamide,Nelfinavir,The metabolism of Loperamide can be decreased when combined with Nelfinavir.,decrease,no risk
Loperamide,Neratinib,The excretion of Loperamide can be decreased when combined with Neratinib.,decrease,no risk
Loperamide,Netupitant,The excretion of Loperamide can be decreased when combined with Netupitant.,decrease,no risk
Loperamide,Nicardipine,Nicardipine may increase the arrhythmogenic activities of Loperamide.,increase,no risk
Loperamide,Nicorandil,Loperamide may increase the arrhythmogenic activities of Nicorandil.,increase,no risk
Loperamide,Nifedipine,Loperamide may increase the arrhythmogenic activities of Nifedipine.,increase,no risk
Loperamide,Nilotinib,The metabolism of Loperamide can be decreased when combined with Nilotinib.,decrease,no risk
Loperamide,Nilutamide,The metabolism of Loperamide can be decreased when combined with Nilutamide.,decrease,no risk
Loperamide,Nilvadipine,Loperamide may increase the arrhythmogenic activities of Nilvadipine.,increase,no risk
Loperamide,Nimesulide,Loperamide may increase the arrhythmogenic activities of Nimesulide.,increase,no risk
Loperamide,Nimodipine,Nimodipine may increase the arrhythmogenic activities of Loperamide.,increase,no risk
Loperamide,Nintedanib,The serum concentration of Nintedanib can be increased when it is combined with Loperamide.,increase,no risk
Loperamide,Nirogacestat,The excretion of Loperamide can be decreased when combined with Nirogacestat.,decrease,no risk
Loperamide,Nisoldipine,Nisoldipine may increase the arrhythmogenic activities of Loperamide.,increase,no risk
Loperamide,Nitrendipine,Loperamide may increase the arrhythmogenic activities of Nitrendipine.,increase,no risk
Loperamide,Nitrofurantoin,The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Loperamide.,increase,risk
Loperamide,Norfloxacin,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Loperamide.,increase,risk
Loperamide,Norgestimate,The excretion of Loperamide can be decreased when combined with Norgestimate.,decrease,no risk
Loperamide,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Loperamide.,increase,no risk
Loperamide,Nylidrin,Loperamide may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Loperamide,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Loperamide.,increase,no risk
Loperamide,Ofloxacin,The risk or severity of QTc prolongation can be increased when Loperamide is combined with Ofloxacin.,increase,risk
Loperamide,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Loperamide.,increase,risk
Loperamide,Olmesartan,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Loperamide.,increase,risk
Loperamide,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Loperamide.,decrease,no risk
Loperamide,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Loperamide.,increase,no risk
Loperamide,Omaveloxolone,The serum concentration of Loperamide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Loperamide,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Loperamide.,decrease,no risk
Loperamide,Ondansetron,The risk or severity of QTc prolongation can be increased when Loperamide is combined with Ondansetron.,increase,risk
Loperamide,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Loperamide.,increase,risk
Loperamide,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Loperamide.,increase,no risk
Loperamide,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Loperamide.,increase,risk
Loperamide,Oxaprozin,The risk or severity of hyperkalemia can be increased when Loperamide is combined with Oxaprozin.,increase,risk
Loperamide,Oxatomide,The risk or severity of QTc prolongation can be increased when Loperamide is combined with Oxatomide.,increase,risk
Loperamide,Oxprenolol,Loperamide may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Loperamide,Oxybutynin,The metabolism of Loperamide can be decreased when combined with Oxybutynin.,decrease,no risk
Loperamide,Oxyphenbutazone,The risk or severity of hyperkalemia can be increased when Loperamide is combined with Oxyphenbutazone.,increase,risk
Loperamide,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Loperamide.,increase,risk
Loperamide,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Loperamide.,decrease,no risk
Loperamide,Quetiapine,The risk or severity of QTc prolongation can be increased when Loperamide is combined with Quetiapine.,increase,risk
Loperamide,Quinapril,The risk or severity of hyperkalemia can be increased when Loperamide is combined with Quinapril.,increase,risk
Loperamide,Quinidine,The excretion of Loperamide can be decreased when combined with Quinidine.,decrease,no risk
Loperamide,Quinine,The excretion of Loperamide can be decreased when combined with Quinine.,decrease,no risk
Loperamide,Quizartinib,The risk or severity of QTc prolongation can be increased when Loperamide is combined with Quizartinib.,increase,risk
Loperamide,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Loperamide.,increase,no risk
Loperamide,Umbralisib,The excretion of Loperamide can be decreased when combined with Umbralisib.,decrease,no risk
Loperamide,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Loperamide.,increase,no risk
Loperamide,Vadadustat,The serum concentration of Loperamide can be increased when it is combined with Vadadustat.,increase,no risk
Loperamide,Valdecoxib,The risk or severity of hyperkalemia can be increased when Valdecoxib is combined with Loperamide.,increase,risk
Loperamide,Valproic acid,The risk or severity of QTc prolongation can be increased when Loperamide is combined with Valproic acid.,increase,risk
Loperamide,Valsartan,The risk or severity of hyperkalemia can be increased when Valsartan is combined with Loperamide.,increase,risk
Loperamide,Vandetanib,The excretion of Loperamide can be decreased when combined with Vandetanib.,decrease,no risk
Loperamide,Vardenafil,The excretion of Loperamide can be decreased when combined with Vardenafil.,decrease,no risk
Loperamide,Velpatasvir,The excretion of Loperamide can be decreased when combined with Velpatasvir.,decrease,no risk
Loperamide,Vemurafenib,The serum concentration of Loperamide can be increased when it is combined with Vemurafenib.,increase,no risk
Loperamide,Venetoclax,The excretion of Loperamide can be decreased when combined with Venetoclax.,decrease,no risk
Loperamide,Verapamil,The excretion of Loperamide can be decreased when combined with Verapamil.,decrease,no risk
Loperamide,Vernakalant,Loperamide may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Loperamide,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Loperamide.,increase,risk
Loperamide,Viloxazine,The metabolism of Loperamide can be decreased when combined with Viloxazine.,decrease,no risk
Loperamide,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Loperamide.,increase,no risk
Loperamide,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Loperamide.,increase,no risk
Loperamide,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Loperamide.,increase,no risk
Loperamide,Voclosporin,The excretion of Loperamide can be decreased when combined with Voclosporin.,decrease,no risk
Loperamide,Vorapaxar,The excretion of Loperamide can be decreased when combined with Vorapaxar.,decrease,no risk
Loperamide,Voriconazole,The metabolism of Loperamide can be decreased when combined with Voriconazole.,decrease,no risk
Loperamide,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Loperamide.,increase,risk
Loperamide,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Loperamide.,decrease,no risk
Loperamide,Voxilaprevir,The excretion of Loperamide can be decreased when combined with Voxilaprevir.,decrease,no risk
Loperamide,Xylometazoline,Loperamide may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Loperamide,Ziconotide,Loperamide may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Loperamide,Zidovudine,The metabolism of Loperamide can be decreased when combined with Zidovudine.,decrease,no risk
Loperamide,Zimelidine,The metabolism of Loperamide can be decreased when combined with Zimelidine.,decrease,no risk
Loperamide,Ziprasidone,The risk or severity of QTc prolongation can be increased when Loperamide is combined with Ziprasidone.,increase,risk
Loperamide,Zofenopril,The risk or severity of hyperkalemia can be increased when Loperamide is combined with Zofenopril.,increase,risk
Loperamide,Zonisamide,The excretion of Loperamide can be decreased when combined with Zonisamide.,decrease,no risk
Loperamide,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Loperamide.,decrease,no risk
Loperamide,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Loperamide is combined with Zuclopenthixol.,increase,risk
Progabide,Gabapentin,The risk or severity of CNS depression can be increased when Progabide is combined with Gabapentin.,increase,risk
Progabide,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Progabide is combined with Gabapentin enacarbil.,increase,risk
Progabide,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Progabide.,increase,risk
Progabide,Gamolenic acid,The therapeutic efficacy of Progabide can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Progabide,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Progabide is combined with Ganaxolone.",increase,risk
Progabide,Ganciclovir,The therapeutic efficacy of Progabide can be decreased when used in combination with Ganciclovir.,decrease,no risk
Progabide,Gepirone,The risk or severity of CNS depression can be increased when Progabide is combined with Gepirone.,increase,risk
Progabide,Gestrinone,The metabolism of Gestrinone can be increased when combined with Progabide.,increase,no risk
Progabide,Glutethimide,The risk or severity of CNS depression can be increased when Progabide is combined with Glutethimide.,increase,risk
Progabide,Granisetron,The risk or severity of CNS depression can be increased when Progabide is combined with Granisetron.,increase,risk
Progabide,Guanfacine,The risk or severity of CNS depression can be increased when Progabide is combined with Guanfacine.,increase,risk
Progabide,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Progabide.,increase,risk
Progabide,Halofantrine,The therapeutic efficacy of Progabide can be decreased when used in combination with Halofantrine.,decrease,no risk
Progabide,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Progabide.,increase,risk
Progabide,Halothane,The risk or severity of CNS depression can be increased when Progabide is combined with Halothane.,increase,risk
Progabide,Hexafluronium,The risk or severity of CNS depression can be increased when Progabide is combined with Hexafluronium.,increase,risk
Progabide,Hydrocodone,Progabide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Progabide,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Progabide.,increase,risk
Progabide,Hydroxychloroquine,The therapeutic efficacy of Progabide can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Progabide,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Progabide.,increase,no risk
Progabide,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Progabide.,increase,no risk
Progabide,Ketamine,The risk or severity of CNS depression can be increased when Progabide is combined with Ketamine.,increase,risk
Progabide,Ketazolam,The risk or severity of CNS depression can be increased when Progabide is combined with Ketazolam.,increase,risk
Progabide,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Progabide.,increase,no risk
Progabide,Nalbuphine,The risk or severity of CNS depression can be increased when Progabide is combined with Nalbuphine.,increase,risk
Progabide,Nalidixic acid,The therapeutic efficacy of Progabide can be decreased when used in combination with Nalidixic acid.,decrease,no risk
Progabide,Naratriptan,The risk or severity of CNS depression can be increased when Progabide is combined with Naratriptan.,increase,risk
Progabide,Nefazodone,The risk or severity of adverse effects can be increased when Progabide is combined with Nefazodone.,increase,risk
Progabide,Nialamide,The risk or severity of CNS depression can be increased when Progabide is combined with Nialamide.,increase,risk
Progabide,Nitrazepam,The risk or severity of CNS depression can be increased when Progabide is combined with Nitrazepam.,increase,risk
Progabide,Nitrous oxide,The risk or severity of CNS depression can be increased when Progabide is combined with Nitrous oxide.,increase,risk
Progabide,Nomegestrol,The metabolism of Nomegestrol can be increased when combined with Progabide.,increase,no risk
Progabide,Nomegestrol acetate,The metabolism of Nomegestrol acetate can be increased when combined with Progabide.,increase,no risk
Progabide,Nomifensine,The risk or severity of CNS depression can be increased when Progabide is combined with Nomifensine.,increase,risk
Progabide,Nonoxynol-9,The metabolism of Nonoxynol-9 can be increased when combined with Progabide.,increase,no risk
Progabide,Norelgestromin,The metabolism of Norelgestromin can be increased when combined with Progabide.,increase,no risk
Progabide,Norethisterone,The metabolism of Norethisterone can be increased when combined with Progabide.,increase,no risk
Progabide,Norethynodrel,The metabolism of Norethynodrel can be increased when combined with Progabide.,increase,no risk
Progabide,Norgestimate,The metabolism of Norgestimate can be increased when combined with Progabide.,increase,no risk
Progabide,Norgestrel,The metabolism of Norgestrel can be increased when combined with Progabide.,increase,no risk
Progabide,Normethadone,The risk or severity of CNS depression can be increased when Progabide is combined with Normethadone.,increase,risk
Progabide,Nortriptyline,The risk or severity of CNS depression can be increased when Nortriptyline is combined with Progabide.,increase,risk
Progabide,Olanzapine,The therapeutic efficacy of Progabide can be decreased when used in combination with Olanzapine.,decrease,no risk
Progabide,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Progabide is combined with Oliceridine.",increase,risk
Progabide,Ondansetron,The risk or severity of CNS depression can be increased when Progabide is combined with Ondansetron.,increase,risk
Progabide,Opium,The risk or severity of CNS depression can be increased when Progabide is combined with Opium.,increase,risk
Progabide,Orlistat,Orlistat can cause a decrease in the absorption of Progabide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Progabide,Orphenadrine,Progabide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Progabide,Oxazepam,The risk or severity of CNS depression can be increased when Progabide is combined with Oxazepam.,increase,risk
Progabide,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Progabide.,increase,risk
Progabide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Progabide is combined with Oxetacaine.,increase,risk
Progabide,Oxitriptan,The risk or severity of CNS depression can be increased when Progabide is combined with Oxitriptan.,increase,risk
Progabide,Oxprenolol,The risk or severity of CNS depression can be increased when Progabide is combined with Oxprenolol.,increase,risk
Progabide,Oxtriphylline,Progabide may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Progabide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Progabide is combined with Oxybuprocaine.,increase,risk
Progabide,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Progabide.,increase,risk
Progabide,Oxymorphone,The risk or severity of CNS depression can be increased when Progabide is combined with Oxymorphone.,increase,risk
Progabide,Quazepam,The risk or severity of CNS depression can be increased when Progabide is combined with Quazepam.,increase,risk
Progabide,Quetiapine,The therapeutic efficacy of Progabide can be decreased when used in combination with Quetiapine.,decrease,no risk
Progabide,Quinidine,The therapeutic efficacy of Progabide can be decreased when used in combination with Quinidine.,decrease,no risk
Progabide,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Progabide.,increase,risk
Progabide,Quinupramine,The risk or severity of CNS depression can be increased when Progabide is combined with Quinupramine.,increase,risk
Progabide,Ulipristal,The metabolism of Ulipristal can be increased when combined with Progabide.,increase,no risk
Progabide,Urethane,The risk or severity of CNS depression can be increased when Progabide is combined with Urethane.,increase,risk
Progabide,Valganciclovir,The therapeutic efficacy of Progabide can be decreased when used in combination with Valganciclovir.,decrease,no risk
Progabide,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Progabide.,increase,risk
Progabide,Vecuronium,The risk or severity of CNS depression can be increased when Progabide is combined with Vecuronium.,increase,risk
Progabide,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Progabide.,increase,risk
Progabide,Vigabatrin,The risk or severity of CNS depression can be increased when Progabide is combined with Vigabatrin.,increase,risk
Progabide,Vilazodone,The risk or severity of CNS depression can be increased when Progabide is combined with Vilazodone.,increase,risk
Progabide,Viloxazine,The risk or severity of CNS depression can be increased when Progabide is combined with Viloxazine.,increase,risk
Progabide,Vortioxetine,The risk or severity of CNS depression can be increased when Progabide is combined with Vortioxetine.,increase,risk
Progabide,Warfarin,The risk or severity of adverse effects can be increased when Progabide is combined with Warfarin.,increase,risk
Progabide,Yohimbine,The risk or severity of CNS depression can be increased when Progabide is combined with Yohimbine.,increase,risk
Progabide,Zaleplon,The risk or severity of CNS depression can be increased when Progabide is combined with Zaleplon.,increase,risk
Progabide,Ziconotide,The risk or severity of CNS depression can be increased when Progabide is combined with Ziconotide.,increase,risk
Progabide,Zimelidine,The risk or severity of adverse effects can be increased when Progabide is combined with Zimelidine.,increase,risk
Progabide,Ziprasidone,The risk or severity of adverse effects can be increased when Progabide is combined with Ziprasidone.,increase,risk
Progabide,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Progabide.,increase,risk
Progabide,Zolpidem,Progabide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Progabide,Zonisamide,The risk or severity of CNS depression can be increased when Progabide is combined with Zonisamide.,increase,risk
Progabide,Zopiclone,The risk or severity of adverse effects can be increased when Progabide is combined with Zopiclone.,increase,risk
Progabide,Zotepine,The therapeutic efficacy of Progabide can be decreased when used in combination with Zotepine.,decrease,no risk
Progabide,Zuclopenthixol,The therapeutic efficacy of Progabide can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Progabide,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Progabide.,increase,risk
Clocortolone,Bendroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Clocortolone is combined with Bendroflumethiazide.,increase,risk
Clocortolone,Benzthiazide,The risk or severity of electrolyte imbalance can be increased when Clocortolone is combined with Benzthiazide.,increase,risk
Clocortolone,Bexagliflozin,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Bexagliflozin.,increase,risk
Clocortolone,Bromocriptine,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Bromocriptine.,increase,risk
Clocortolone,Gliclazide,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Gliclazide.,increase,risk
Clocortolone,Glimepiride,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Glimepiride.,increase,risk
Clocortolone,Glipizide,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Glipizide.,increase,risk
Clocortolone,Gliquidone,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Gliquidone.,increase,risk
Clocortolone,Glyburide,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Glyburide.,increase,risk
Clocortolone,Glymidine,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Glymidine.,increase,risk
Clocortolone,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Clocortolone is combined with Hydrochlorothiazide.,increase,risk
Clocortolone,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Clocortolone is combined with Hydroflumethiazide.,increase,risk
Clocortolone,Nateglinide,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Nateglinide.,increase,risk
Clocortolone,Quinine,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Quinine.,increase,risk
Clocortolone,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Clocortolone.,increase,risk
Clocortolone,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Clocortolone.,decrease,no risk
Clocortolone,Vildagliptin,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Vildagliptin.,increase,risk
Clocortolone,Voriconazole,The serum concentration of Clocortolone can be increased when it is combined with Voriconazole.,increase,no risk
Tolazamide,Bepotastine,Tolazamide may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Tolazamide,Bepridil,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Tolazamide.,increase,risk
Tolazamide,Betamethasone,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Tolazamide.,increase,risk
Tolazamide,Betamethasone phosphate,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Tolazamide.,increase,risk
Tolazamide,Betaxolol,The therapeutic efficacy of Tolazamide can be increased when used in combination with Betaxolol.,increase,no risk
Tolazamide,Bexagliflozin,Bexagliflozin may increase the hypoglycemic activities of Tolazamide.,increase,no risk
Tolazamide,Bexarotene,The metabolism of Tolazamide can be decreased when combined with Bexarotene.,decrease,no risk
Tolazamide,Bezafibrate,The risk or severity of hypoglycemia can be increased when Bezafibrate is combined with Tolazamide.,increase,risk
Tolazamide,Bicisate,Tolazamide may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Tolazamide,Bimekizumab,The metabolism of Tolazamide can be increased when combined with Bimekizumab.,increase,no risk
Tolazamide,Bismuth subgallate,Tolazamide may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Tolazamide,Bismuth subsalicylate,Bismuth subsalicylate may increase the hypoglycemic activities of Tolazamide.,increase,no risk
Tolazamide,Bisoprolol,The therapeutic efficacy of Tolazamide can be increased when used in combination with Bisoprolol.,increase,no risk
Tolazamide,Bisoxatin,Tolazamide may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Tolazamide,Bleomycin,Bleomycin may decrease the excretion rate of Tolazamide which could result in a higher serum level.,decrease,no risk
Tolazamide,Bortezomib,The metabolism of Tolazamide can be decreased when combined with Bortezomib.,decrease,no risk
Tolazamide,Bosentan,The therapeutic efficacy of Tolazamide can be increased when used in combination with Bosentan.,increase,no risk
Tolazamide,Brexpiprazole,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Tolazamide,Brivaracetam,Tolazamide may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Tolazamide,Bromazepam,Tolazamide may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Tolazamide,Bromocriptine,The risk or severity of hypoglycemia can be increased when Tolazamide is combined with Bromocriptine.,increase,risk
Tolazamide,Bromotheophylline,Bromotheophylline may increase the excretion rate of Tolazamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolazamide,Budesonide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Tolazamide.,increase,risk
Tolazamide,Bumadizone,The protein binding of Tolazamide can be decreased when combined with Bumadizone.,decrease,no risk
Tolazamide,Bumetanide,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Bumetanide.,decrease,no risk
Tolazamide,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Tolazamide.,decrease,no risk
Tolazamide,Bupropion,Tolazamide may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Tolazamide,Buserelin,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Buserelin.,decrease,no risk
Tolazamide,Buspirone,Buspirone may decrease the excretion rate of Tolazamide which could result in a higher serum level.,decrease,no risk
Tolazamide,Butabarbital,Butabarbital may decrease the excretion rate of Tolazamide which could result in a higher serum level.,decrease,no risk
Tolazamide,Butaperazine,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Butaperazine.,decrease,no risk
Tolazamide,Butriptyline,Butriptyline may decrease the hypoglycemic activities of Tolazamide.,decrease,no risk
Tolazamide,Gabapentin enacarbil,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Furosemide.,decrease,no risk
Tolazamide,Gadobenic acid,Tolazamide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Tolazamide,Gadodiamide,Gadobenic acid may decrease the excretion rate of Tolazamide which could result in a higher serum level.,decrease,no risk
Tolazamide,Gadofosveset trisodium,Gadodiamide may decrease the excretion rate of Tolazamide which could result in a higher serum level.,decrease,no risk
Tolazamide,Gadopentetic acid,Tolazamide may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Tolazamide,Gadoteric acid,Gadopentetic acid may decrease the excretion rate of Tolazamide which could result in a higher serum level.,decrease,no risk
Tolazamide,Gadoteridol,Tolazamide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Tolazamide,Ganciclovir,Gadoteridol may decrease the excretion rate of Tolazamide which could result in a higher serum level.,decrease,no risk
Tolazamide,Gatifloxacin,Tolazamide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Tolazamide,Gefapixant,The therapeutic efficacy of Tolazamide can be increased when used in combination with Gatifloxacin.,increase,no risk
Tolazamide,Gemcitabine,The therapeutic efficacy of Tolazamide can be increased when used in combination with Gefapixant.,increase,no risk
Tolazamide,Gemfibrozil,Gemcitabine may decrease the excretion rate of Tolazamide which could result in a higher serum level.,decrease,no risk
Tolazamide,Gemifloxacin,The metabolism of Tolazamide can be decreased when combined with Gemfibrozil.,decrease,no risk
Tolazamide,Gentamicin,The therapeutic efficacy of Tolazamide can be increased when used in combination with Gemifloxacin.,increase,no risk
Tolazamide,Gestrinone,Tolazamide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Tolazamide,Gimeracil,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Gestrinone.,decrease,no risk
Tolazamide,Ginkgo biloba,Tolazamide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Tolazamide,Givosiran,The metabolism of Tolazamide can be decreased when combined with Ginkgo biloba.,decrease,no risk
Tolazamide,Gliclazide,Givosiran may decrease the excretion rate of Tolazamide which could result in a higher serum level.,decrease,no risk
Tolazamide,Glimepiride,The risk or severity of hypoglycemia can be increased when Tolazamide is combined with Gliclazide.,increase,risk
Tolazamide,Glipizide,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Tolazamide.,increase,risk
Tolazamide,Gliquidone,The risk or severity of hypoglycemia can be increased when Tolazamide is combined with Glipizide.,increase,risk
Tolazamide,Glofitamab,The risk or severity of hypoglycemia can be increased when Tolazamide is combined with Gliquidone.,increase,risk
Tolazamide,Glyburide,The serum concentration of Tolazamide can be increased when it is combined with Glofitamab.,increase,no risk
Tolazamide,Glycerol phenylbutyrate,The risk or severity of hypoglycemia can be increased when Tolazamide is combined with Glyburide.,increase,risk
Tolazamide,Glycol salicylate,Tolazamide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Tolazamide,Glymidine,The protein binding of Tolazamide can be decreased when combined with Glycol salicylate.,decrease,no risk
Tolazamide,Golimumab,The risk or severity of hypoglycemia can be increased when Tolazamide is combined with Glymidine.,increase,risk
Tolazamide,Golodirsen,The metabolism of Tolazamide can be increased when combined with Golimumab.,increase,no risk
Tolazamide,Goserelin,Tolazamide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Tolazamide,Grepafloxacin,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Goserelin.,decrease,no risk
Tolazamide,Guanethidine,The therapeutic efficacy of Tolazamide can be increased when used in combination with Grepafloxacin.,increase,no risk
Tolazamide,Guanfacine,Tolazamide may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Tolazamide,Halcinonide,Tolazamide may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Tolazamide,Haloperidol,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Tolazamide.,increase,risk
Tolazamide,Halothane,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Haloperidol.,decrease,no risk
Tolazamide,Histrelin,The metabolism of Halothane can be decreased when combined with Tolazamide.,decrease,no risk
Tolazamide,Hydralazine,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Histrelin.,decrease,no risk
Tolazamide,Hydrochlorothiazide,Tolazamide may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Tolazamide,Hydrocortisone,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Tolazamide,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Tolazamide.,increase,risk
Tolazamide,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Tolazamide.,increase,risk
Tolazamide,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Tolazamide.,increase,risk
Tolazamide,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Tolazamide.,increase,risk
Tolazamide,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Tolazamide.,increase,risk
Tolazamide,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Tolazamide.,increase,risk
Tolazamide,Hydroflumethiazide,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Tolazamide.,increase,risk
Tolazamide,Hydromorphone,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Tolazamide,Hydroxocobalamin,Hydromorphone may decrease the excretion rate of Tolazamide which could result in a higher serum level.,decrease,no risk
Tolazamide,Hydroxychloroquine,Hydroxocobalamin may decrease the excretion rate of Tolazamide which could result in a higher serum level.,decrease,no risk
Tolazamide,Hydroxyethyl Starch,The therapeutic efficacy of Tolazamide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Tolazamide,Hydroxyprogesterone caproate,Tolazamide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Tolazamide,Kanamycin,Tolazamide may decrease the excretion rate of Ixazomib which could result in a higher serum level.,decrease,no risk
Tolazamide,Ketamine,Tolazamide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Tolazamide,Ketazolam,Tolazamide may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Tolazamide,Ketoprofen,Tolazamide may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Tolazamide,Ketorolac,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Tolazamide.,increase,risk
Tolazamide,Ketotifen,The protein binding of Tolazamide can be decreased when combined with Ketorolac.,decrease,no risk
Tolazamide,N-acetyltyrosine,Tolazamide may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Tolazamide,Nabilone,Tolazamide may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Tolazamide,Nabumetone,The metabolism of Tolazamide can be decreased when combined with Nabilone.,decrease,no risk
Tolazamide,Nadolol,The protein binding of Tolazamide can be decreased when combined with Nabumetone.,decrease,no risk
Tolazamide,Naldemedine,The therapeutic efficacy of Tolazamide can be increased when used in combination with Nadolol.,increase,no risk
Tolazamide,Nalidixic acid,Tolazamide may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Tolazamide,Nalmefene,The therapeutic efficacy of Tolazamide can be increased when used in combination with Nalidixic acid.,increase,no risk
Tolazamide,Naloxone,Tolazamide may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Tolazamide,Nandrolone decanoate,Tolazamide may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Tolazamide,Nandrolone phenpropionate,Nandrolone decanoate may increase the hypoglycemic activities of Tolazamide.,increase,no risk
Tolazamide,Naproxen,Nandrolone phenpropionate may increase the hypoglycemic activities of Tolazamide.,increase,no risk
Tolazamide,Nateglinide,The protein binding of Tolazamide can be decreased when combined with Naproxen.,decrease,no risk
Tolazamide,Nebivolol,The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Tolazamide.,increase,risk
Tolazamide,Nedaplatin,The therapeutic efficacy of Tolazamide can be increased when used in combination with Nebivolol.,increase,no risk
Tolazamide,Nedocromil,Tolazamide may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Tolazamide,Nefazodone,Nedocromil may decrease the excretion rate of Tolazamide which could result in a higher serum level.,decrease,no risk
Tolazamide,Nelfinavir,The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Tolazamide.,increase,risk
Tolazamide,Neomycin,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Nelfinavir.,decrease,no risk
Tolazamide,Netilmicin,Tolazamide may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Tolazamide,Netupitant,Tolazamide may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Tolazamide,Nevirapine,The metabolism of Netupitant can be decreased when combined with Tolazamide.,decrease,no risk
Tolazamide,Niacin,The metabolism of Tolazamide can be decreased when combined with Nevirapine.,decrease,no risk
Tolazamide,Nialamide,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Niacin.,decrease,no risk
Tolazamide,Nicardipine,Nialamide may increase the hypoglycemic activities of Tolazamide.,increase,no risk
Tolazamide,Niclosamide,The metabolism of Tolazamide can be decreased when combined with Nicardipine.,decrease,no risk
Tolazamide,Nicorandil,The metabolism of Niclosamide can be decreased when combined with Tolazamide.,decrease,no risk
Tolazamide,Nicotine,Tolazamide may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Tolazamide,Nifedipine,The risk or severity of adverse effects can be increased when Tolazamide is combined with Nicotine.,increase,risk
Tolazamide,Nilotinib,The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Tolazamide.,increase,risk
Tolazamide,Nilutamide,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Nilotinib.,decrease,no risk
Tolazamide,Nilvadipine,The metabolism of Tolazamide can be decreased when combined with Nilutamide.,decrease,no risk
Tolazamide,Nimesulide,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Tolazamide.,increase,risk
Tolazamide,Nimodipine,The protein binding of Tolazamide can be decreased when combined with Nimesulide.,decrease,no risk
Tolazamide,Nirogacestat,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Tolazamide.,increase,risk
Tolazamide,Nisoldipine,The metabolism of Nirogacestat can be decreased when combined with Tolazamide.,decrease,no risk
Tolazamide,Nitrendipine,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Tolazamide.,increase,risk
Tolazamide,Nitric Oxide,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Tolazamide.,increase,risk
Tolazamide,Nitrofurantoin,Nitric Oxide may decrease the excretion rate of Tolazamide which could result in a higher serum level.,decrease,no risk
Tolazamide,Nitroprusside,Nitrofurantoin may decrease the excretion rate of Tolazamide which could result in a higher serum level.,decrease,no risk
Tolazamide,Nomegestrol,Nitroprusside may decrease the excretion rate of Tolazamide which could result in a higher serum level.,decrease,no risk
Tolazamide,Nomegestrol acetate,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Nomegestrol.,decrease,no risk
Tolazamide,Nonoxynol-9,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Nomegestrol acetate.,decrease,no risk
Tolazamide,Norelgestromin,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Nonoxynol-9.,decrease,no risk
Tolazamide,Norethisterone,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Norelgestromin.,decrease,no risk
Tolazamide,Norethynodrel,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Norethisterone.,decrease,no risk
Tolazamide,Norfloxacin,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Norethynodrel.,decrease,no risk
Tolazamide,Norgestimate,The therapeutic efficacy of Tolazamide can be increased when used in combination with Norfloxacin.,increase,no risk
Tolazamide,Norgestrel,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Norgestimate.,decrease,no risk
Tolazamide,Nortriptyline,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Norgestrel.,decrease,no risk
Tolazamide,Noscapine,Nortriptyline may decrease the hypoglycemic activities of Tolazamide.,decrease,no risk
Tolazamide,Novobiocin,The metabolism of Tolazamide can be decreased when combined with Noscapine.,decrease,no risk
Tolazamide,Nylidrin,The therapeutic efficacy of Tolazamide can be increased when used in combination with Novobiocin.,increase,no risk
Tolazamide,Octinoxate,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Tolazamide.,increase,risk
Tolazamide,Octreotide,Tolazamide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Tolazamide,Ofloxacin,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Octreotide.,decrease,no risk
Tolazamide,Olanzapine,The therapeutic efficacy of Tolazamide can be increased when used in combination with Ofloxacin.,increase,no risk
Tolazamide,Olodaterol,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Olanzapine.,decrease,no risk
Tolazamide,Olsalazine,The metabolism of Olodaterol can be decreased when combined with Tolazamide.,decrease,no risk
Tolazamide,Ondansetron,Olsalazine may increase the hypoglycemic activities of Tolazamide.,increase,no risk
Tolazamide,Opium,The metabolism of Ondansetron can be decreased when combined with Tolazamide.,decrease,no risk
Tolazamide,Oritavancin,Tolazamide may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Tolazamide,Oseltamivir,The metabolism of Tolazamide can be decreased when combined with Oritavancin.,decrease,no risk
Tolazamide,Ospemifene,Oseltamivir may decrease the excretion rate of Tolazamide which could result in a higher serum level.,decrease,no risk
Tolazamide,Oxacillin,The metabolism of Ospemifene can be decreased when combined with Tolazamide.,decrease,no risk
Tolazamide,Oxandrolone,Oxacillin may decrease the excretion rate of Tolazamide which could result in a higher serum level.,decrease,no risk
Tolazamide,Oxaprozin,The metabolism of Tolazamide can be decreased when combined with Oxandrolone.,decrease,no risk
Tolazamide,Oxazepam,The protein binding of Tolazamide can be decreased when combined with Oxaprozin.,decrease,no risk
Tolazamide,Oxprenolol,Tolazamide may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Tolazamide,Oxybenzone,The therapeutic efficacy of Tolazamide can be increased when used in combination with Oxprenolol.,increase,no risk
Tolazamide,Oxymetholone,Tolazamide may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Tolazamide,Oxyphenbutazone,Oxymetholone may increase the hypoglycemic activities of Tolazamide.,increase,no risk
Tolazamide,Oxyquinoline,The protein binding of Tolazamide can be decreased when combined with Oxyphenbutazone.,decrease,no risk
Tolazamide,Quetiapine,Pyridoxine may decrease the excretion rate of Tolazamide which could result in a higher serum level.,decrease,no risk
Tolazamide,Quinestrol,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Quetiapine.,decrease,no risk
Tolazamide,Quinethazone,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Quinestrol.,decrease,no risk
Tolazamide,Quinidine,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Quinethazone.,decrease,no risk
Tolazamide,Quinine,Tolazamide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Tolazamide,Quinupramine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Tolazamide.,increase,risk
Dobutamine,Bromocriptine,Bromocriptine may increase the hypertensive and vasoconstricting activities of Dobutamine.,increase,no risk
Dobutamine,Bromotheophylline,The risk or severity of adverse effects can be increased when Dobutamine is combined with Bromotheophylline.,increase,risk
Dobutamine,Brompheniramine,The risk or severity of Tachycardia can be increased when Brompheniramine is combined with Dobutamine.,increase,risk
Dobutamine,Buclizine,The risk or severity of Tachycardia can be increased when Buclizine is combined with Dobutamine.,increase,risk
Dobutamine,Budesonide,The risk or severity of hypokalemia can be increased when Budesonide is combined with Dobutamine.,increase,risk
Dobutamine,Bumadizone,The risk or severity of hypertension can be increased when Dobutamine is combined with Bumadizone.,increase,risk
Dobutamine,Bumetanide,The risk or severity of hypokalemia can be increased when Dobutamine is combined with Bumetanide.,increase,risk
Dobutamine,Bupropion,Dobutamine may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Dobutamine,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Dobutamine.,increase,risk
Dobutamine,Butabarbital,Butabarbital may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Butriptyline,Butriptyline may increase the vasopressor activities of Dobutamine.,increase,no risk
Dobutamine,Butylscopolamine,The risk or severity of Tachycardia can be increased when Dobutamine is combined with Butylscopolamine.,increase,risk
Dobutamine,Gabapentin enacarbil,The risk or severity of hypokalemia can be increased when Dobutamine is combined with Furosemide.,increase,risk
Dobutamine,Gadobenic acid,Dobutamine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Dobutamine,Gadodiamide,Gadobenic acid may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Gadofosveset trisodium,Gadodiamide may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Gadopentetic acid,Dobutamine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Dobutamine,Gadoteric acid,Gadopentetic acid may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Gadoteridol,Dobutamine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Dobutamine,Gallamine triethiodide,Gadoteridol may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Ganciclovir,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Dobutamine.,increase,risk
Dobutamine,Gemcitabine,Dobutamine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Dobutamine,Gemfibrozil,Gemcitabine may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Gentamicin,Dobutamine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Dobutamine,Gimeracil,Dobutamine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Dobutamine,Givosiran,Dobutamine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Dobutamine,Glipizide,Givosiran may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Glyburide,Dobutamine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Dobutamine,Glycerol phenylbutyrate,The therapeutic efficacy of Glyburide can be decreased when used in combination with Dobutamine.,decrease,no risk
Dobutamine,Glycopyrronium,Dobutamine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Dobutamine,Golodirsen,The risk or severity of Tachycardia can be increased when Dobutamine is combined with Glycopyrronium.,increase,risk
Dobutamine,Goserelin,Dobutamine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Dobutamine,Guanabenz,Goserelin may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Guanadrel,Dobutamine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Dobutamine,Guanethidine,Dobutamine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Dobutamine,Guanfacine,Dobutamine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Dobutamine,Guanoxan,Dobutamine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Dobutamine,Haloperidol,Dobutamine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Dobutamine,Halothane,Haloperidol may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Hexocyclium,The risk or severity of hypertension can be increased when Dobutamine is combined with Halothane.,increase,risk
Dobutamine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Dobutamine is combined with Hexocyclium.,increase,risk
Dobutamine,Hyaluronidase,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Dobutamine.,increase,risk
Dobutamine,Hyaluronidase (human recombinant),The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Dobutamine.,increase,risk
Dobutamine,Hyaluronidase (ovine),The risk or severity of adverse effects can be increased when Hyaluronidase (human recombinant) is combined with Dobutamine.,increase,risk
Dobutamine,Hydralazine,The risk or severity of adverse effects can be increased when Hyaluronidase (ovine) is combined with Dobutamine.,increase,risk
Dobutamine,Hydrochlorothiazide,Dobutamine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Dobutamine,Hydrocortisone,The risk or severity of hypokalemia can be increased when Dobutamine is combined with Hydrochlorothiazide.,increase,risk
Dobutamine,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Dobutamine.,increase,risk
Dobutamine,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Dobutamine.,increase,risk
Dobutamine,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Dobutamine.,increase,risk
Dobutamine,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Dobutamine.,increase,risk
Dobutamine,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Dobutamine.,increase,risk
Dobutamine,Hydromorphone,The risk or severity of hypokalemia can be increased when Dobutamine is combined with Hydroflumethiazide.,increase,risk
Dobutamine,Hydroxocobalamin,Hydromorphone may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Hydroxyethyl Starch,Hydroxocobalamin may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Hyoscyamine,Dobutamine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Dobutamine,Kanamycin,Dobutamine may decrease the excretion rate of Ixazomib which could result in a higher serum level.,decrease,no risk
Dobutamine,Ketamine,Dobutamine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Dobutamine,Ketazolam,Dobutamine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Ketoprofen,Dobutamine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Dobutamine,Ketorolac,The risk or severity of hypertension can be increased when Dobutamine is combined with Ketoprofen.,increase,risk
Dobutamine,N-acetyltyrosine,Dobutamine may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Dobutamine,Nabilone,Dobutamine may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Dobutamine,Nabumetone,The risk or severity of Tachycardia can be increased when Nabilone is combined with Dobutamine.,increase,risk
Dobutamine,Nadolol,The risk or severity of hypertension can be increased when Nabumetone is combined with Dobutamine.,increase,risk
Dobutamine,Naldemedine,Nadolol may decrease the bronchodilatory activities of Dobutamine.,decrease,no risk
Dobutamine,Nalmefene,Dobutamine may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Dobutamine,Naloxone,Dobutamine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Dobutamine,Naphazoline,Dobutamine may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Dobutamine,Naproxen,The risk or severity of hypertension can be increased when Dobutamine is combined with Naphazoline.,increase,risk
Dobutamine,Naratriptan,The risk or severity of hypertension can be increased when Naproxen is combined with Dobutamine.,increase,risk
Dobutamine,Nateglinide,The risk or severity of hypertension can be increased when Dobutamine is combined with Naratriptan.,increase,risk
Dobutamine,Naxitamab,Nateglinide may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Nebivolol,The risk or severity of hypertension can be increased when Dobutamine is combined with Naxitamab.,increase,risk
Dobutamine,Nedaplatin,The therapeutic efficacy of Dobutamine can be decreased when used in combination with Nebivolol.,decrease,no risk
Dobutamine,Nedocromil,Dobutamine may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Dobutamine,Nefazodone,Nedocromil may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Neomycin,Nefazodone may increase the tachycardic activities of Dobutamine.,increase,no risk
Dobutamine,Netilmicin,Dobutamine may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Dobutamine,Nialamide,Dobutamine may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Dobutamine,Nicardipine,Nialamide may increase the hypertensive activities of Dobutamine.,increase,no risk
Dobutamine,Nicergoline,The therapeutic efficacy of Dobutamine can be decreased when used in combination with Nicardipine.,decrease,no risk
Dobutamine,Nicorandil,Nicergoline may increase the hypertensive and vasoconstricting activities of Dobutamine.,increase,no risk
Dobutamine,Nicotine,Dobutamine may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Dobutamine,Nifedipine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Dobutamine.,increase,risk
Dobutamine,Nilutamide,Dobutamine may decrease the excretion rate of Nifedipine which could result in a higher serum level.,decrease,no risk
Dobutamine,Nilvadipine,Nilutamide may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Nimesulide,Dobutamine may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Dobutamine,Nimodipine,The risk or severity of hypertension can be increased when Dobutamine is combined with Nimesulide.,increase,risk
Dobutamine,Nisoldipine,Dobutamine may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Dobutamine,Nitrendipine,Dobutamine may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Dobutamine,Nitric Oxide,Dobutamine may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Dobutamine,Nitrofurantoin,Nitric Oxide may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Nitroglycerin,Nitrofurantoin may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Nitroprusside,Dobutamine may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Dobutamine,Nitrous oxide,Dobutamine may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Dobutamine,Norepinephrine,The risk or severity of hypertension can be increased when Dobutamine is combined with Nitrous oxide.,increase,risk
Dobutamine,Nortriptyline,The therapeutic efficacy of Dobutamine can be increased when used in combination with Norepinephrine.,increase,no risk
Dobutamine,Nylidrin,Nortriptyline may increase the vasopressor activities of Dobutamine.,increase,no risk
Dobutamine,Octinoxate,The risk or severity of hypertension can be increased when Dobutamine is combined with Nylidrin.,increase,risk
Dobutamine,Olanzapine,Dobutamine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Dobutamine,Olmesartan,The therapeutic efficacy of Dobutamine can be decreased when used in combination with Olanzapine.,decrease,no risk
Dobutamine,Olodaterol,Dobutamine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Dobutamine,Olsalazine,The risk or severity of adverse effects can be increased when Dobutamine is combined with Olodaterol.,increase,risk
Dobutamine,Opicapone,Olsalazine may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Opium,The metabolism of Dobutamine can be decreased when combined with Opicapone.,decrease,no risk
Dobutamine,Orciprenaline,Dobutamine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Dobutamine,Orphenadrine,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Dobutamine.,increase,risk
Dobutamine,Oseltamivir,The risk or severity of Tachycardia can be increased when Dobutamine is combined with Orphenadrine.,increase,risk
Dobutamine,Oxacillin,Oseltamivir may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Oxaprozin,Oxacillin may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Oxazepam,The risk or severity of hypertension can be increased when Dobutamine is combined with Oxaprozin.,increase,risk
Dobutamine,Oxprenolol,Dobutamine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Dobutamine,Oxtriphylline,Oxprenolol may decrease the bronchodilatory activities of Dobutamine.,decrease,no risk
Dobutamine,Oxybenzone,The risk or severity of adverse effects can be increased when Dobutamine is combined with Oxtriphylline.,increase,risk
Dobutamine,Oxybutynin,Dobutamine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Dobutamine,Oxymetazoline,The risk or severity of Tachycardia can be increased when Dobutamine is combined with Oxybutynin.,increase,risk
Dobutamine,Oxyphenbutazone,Dobutamine may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Dobutamine,Oxyphencyclimine,The risk or severity of hypertension can be increased when Dobutamine is combined with Oxyphenbutazone.,increase,risk
Dobutamine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Dobutamine.,increase,risk
Dobutamine,Oxyquinoline,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Dobutamine.,increase,risk
Dobutamine,Quetiapine,Pyridoxine may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Quinapril,The therapeutic efficacy of Dobutamine can be decreased when used in combination with Quetiapine.,decrease,no risk
Dobutamine,Quinethazone,Dobutamine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Dobutamine,Quinidine,Quinethazone may increase the excretion rate of Dobutamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dobutamine,Quinupramine,Dobutamine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Dobutamine,Umeclidinium,The risk or severity of Tachycardia can be increased when Trospium is combined with Dobutamine.,increase,risk
Dobutamine,Vaborbactam,The risk or severity of Tachycardia can be increased when Dobutamine is combined with Umeclidinium.,increase,risk
Dobutamine,Valaciclovir,Dobutamine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Dobutamine,Valbenazine,Valaciclovir may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Valdecoxib,Dobutamine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Dobutamine,Valganciclovir,The risk or severity of hypertension can be increased when Valdecoxib is combined with Dobutamine.,increase,risk
Dobutamine,Valsartan,Dobutamine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Dobutamine,Vamorolone,Dobutamine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Dobutamine,Vancomycin,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Dobutamine.,increase,risk
Dobutamine,Varenicline,Dobutamine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Dobutamine,Vasopressin,Dobutamine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Dobutamine,Venlafaxine,Vasopressin may increase the hypertensive activities of Dobutamine.,increase,no risk
Dobutamine,Verapamil,Venlafaxine may increase the tachycardic activities of Dobutamine.,increase,no risk
Dobutamine,Vilanterol,Verapamil may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Vilazodone,The risk or severity of adverse effects can be increased when Dobutamine is combined with Vilanterol.,increase,risk
Dobutamine,Viloxazine,The risk or severity of hypertension can be increased when Dobutamine is combined with Vilazodone.,increase,risk
Dobutamine,Vortioxetine,Dobutamine may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Dobutamine,Warfarin,The risk or severity of hypertension can be increased when Dobutamine is combined with Vortioxetine.,increase,risk
Dobutamine,Xamoterol,Dobutamine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Dobutamine,Xylometazoline,The risk or severity of hypertension can be increased when Dobutamine is combined with Xamoterol.,increase,risk
Dobutamine,Yohimbine,The risk or severity of hypertension can be increased when Dobutamine is combined with Xylometazoline.,increase,risk
Dobutamine,Zaleplon,The risk or severity of hypertension can be increased when Dobutamine is combined with Yohimbine.,increase,risk
Dobutamine,Zanamivir,Dobutamine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Dobutamine,Ziprasidone,Zanamivir may decrease the excretion rate of Dobutamine which could result in a higher serum level.,decrease,no risk
Dobutamine,Zofenopril,The therapeutic efficacy of Dobutamine can be decreased when used in combination with Ziprasidone.,decrease,no risk
Dobutamine,Zolmitriptan,Dobutamine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Dobutamine,Zonisamide,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Dobutamine.,increase,risk
Dobutamine,Zuclopenthixol,Zonisamide may increase the excretion rate of Dobutamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Oxazepam,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Oxazepam.,increase,risk
Oxazepam,Budesonide,Oxazepam may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Oxazepam,Bumadizone,Bumadizone may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Bumetanide,Bumetanide may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Oxazepam,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Oxazepam.,increase,risk
Oxazepam,Buprenorphine,Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Oxazepam,Bupropion,The risk or severity of CNS depression can be increased when Oxazepam is combined with Bupropion.,increase,risk
Oxazepam,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Oxazepam.,increase,risk
Oxazepam,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Oxazepam.,increase,risk
Oxazepam,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Oxazepam.,increase,risk
Oxazepam,Butaperazine,The risk or severity of CNS depression can be increased when Oxazepam is combined with Butaperazine.,increase,risk
Oxazepam,Butobarbital,The risk or severity of CNS depression can be increased when Oxazepam is combined with Butobarbital.,increase,risk
Oxazepam,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Oxazepam.,increase,risk
Oxazepam,Butriptyline,The risk or severity of CNS depression can be increased when Oxazepam is combined with Butriptyline.,increase,risk
Oxazepam,Gabapentin,The risk or severity of CNS depression can be increased when Oxazepam is combined with Gabapentin.,increase,risk
Oxazepam,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Oxazepam is combined with Gabapentin enacarbil.,increase,risk
Oxazepam,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Gadodiamide,Gadodiamide may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Gadofosveset trisodium,Oxazepam may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Oxazepam,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Gadoteric acid,Oxazepam may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Oxazepam,Gadoteridol,Gadoteridol may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Oxazepam.,increase,risk
Oxazepam,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Oxazepam is combined with Ganaxolone.",increase,risk
Oxazepam,Ganciclovir,Oxazepam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Oxazepam,Gemcitabine,Gemcitabine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Gemfibrozil,Oxazepam may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Oxazepam,Gentamicin,Oxazepam may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Oxazepam,Gepirone,The risk or severity of CNS depression can be increased when Oxazepam is combined with Gepirone.,increase,risk
Oxazepam,Gimeracil,Oxazepam may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Oxazepam,Givosiran,Givosiran may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Glipizide,Oxazepam may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Oxazepam,Glutethimide,The risk or severity of CNS depression can be increased when Oxazepam is combined with Glutethimide.,increase,risk
Oxazepam,Glycerol phenylbutyrate,Oxazepam may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Oxazepam,Golodirsen,Oxazepam may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Oxazepam,Goserelin,Goserelin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Granisetron,The risk or severity of CNS depression can be increased when Oxazepam is combined with Granisetron.,increase,risk
Oxazepam,Guanethidine,Oxazepam may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Oxazepam,Guanfacine,The risk or severity of CNS depression can be increased when Oxazepam is combined with Guanfacine.,increase,risk
Oxazepam,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Oxazepam.,increase,risk
Oxazepam,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Oxazepam.,increase,risk
Oxazepam,Halothane,The risk or severity of CNS depression can be increased when Oxazepam is combined with Halothane.,increase,risk
Oxazepam,Hexafluronium,The risk or severity of CNS depression can be increased when Oxazepam is combined with Hexafluronium.,increase,risk
Oxazepam,Hydralazine,Oxazepam may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Oxazepam,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Oxazepam,Hydrocodone,Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Oxazepam,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Oxazepam,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Oxazepam.,increase,risk
Oxazepam,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Hydroxyethyl Starch,Oxazepam may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Oxazepam,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Oxazepam.,increase,no risk
Oxazepam,Kanamycin,Oxazepam may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Oxazepam,Ketamine,The risk or severity of CNS depression can be increased when Oxazepam is combined with Ketamine.,increase,risk
Oxazepam,Ketazolam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Ketazolam.,increase,risk
Oxazepam,Ketoconazole,The metabolism of Oxazepam can be decreased when combined with Ketoconazole.,decrease,no risk
Oxazepam,Ketoprofen,Ketoprofen may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Ketorolac,Ketorolac may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,N-acetyltyrosine,Oxazepam may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Oxazepam,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Oxazepam.,increase,no risk
Oxazepam,Nabumetone,Nabumetone may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Nadolol,Oxazepam may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Oxazepam,Nalbuphine,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Oxazepam.,increase,risk
Oxazepam,Naldemedine,Oxazepam may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Oxazepam,Nalmefene,Oxazepam may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Oxazepam,Naloxegol,The risk or severity of adverse effects can be increased when Naloxegol is combined with Oxazepam.,increase,risk
Oxazepam,Naloxone,Oxazepam may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Oxazepam,Naltrexone,The risk or severity of adverse effects can be increased when Naltrexone is combined with Oxazepam.,increase,risk
Oxazepam,Naphazoline,The risk or severity of CNS depression can be increased when Naphazoline is combined with Oxazepam.,increase,risk
Oxazepam,Naproxen,Naproxen may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Naratriptan,The risk or severity of CNS depression can be increased when Oxazepam is combined with Naratriptan.,increase,risk
Oxazepam,Nateglinide,Nateglinide may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Nedaplatin,Oxazepam may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Oxazepam,Nedocromil,Nedocromil may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Nefazodone,The risk or severity of adverse effects can be increased when Oxazepam is combined with Nefazodone.,increase,risk
Oxazepam,Neomycin,Oxazepam may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Oxazepam,Netilmicin,Oxazepam may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Oxazepam,Nialamide,The risk or severity of CNS depression can be increased when Oxazepam is combined with Nialamide.,increase,risk
Oxazepam,Nicorandil,Oxazepam may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Oxazepam,Nifedipine,Oxazepam may decrease the excretion rate of Nifedipine which could result in a higher serum level.,decrease,no risk
Oxazepam,Nilutamide,Nilutamide may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Nimesulide,Nimesulide may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Nisoldipine,Nisoldipine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Nitrazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Nitrazepam.,increase,risk
Oxazepam,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Nitroprusside,Nitroprusside may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Nitrous oxide,The risk or severity of CNS depression can be increased when Oxazepam is combined with Nitrous oxide.,increase,risk
Oxazepam,Nomifensine,The risk or severity of CNS depression can be increased when Oxazepam is combined with Nomifensine.,increase,risk
Oxazepam,Normethadone,The risk or severity of adverse effects can be increased when Normethadone is combined with Oxazepam.,increase,risk
Oxazepam,Nortriptyline,The risk or severity of CNS depression can be increased when Nortriptyline is combined with Oxazepam.,increase,risk
Oxazepam,Octinoxate,Oxazepam may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Oxazepam,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Oxazepam.,increase,risk
Oxazepam,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Oxazepam is combined with Oliceridine.",increase,risk
Oxazepam,Olsalazine,Olsalazine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Ondansetron,The risk or severity of CNS depression can be increased when Oxazepam is combined with Ondansetron.,increase,risk
Oxazepam,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Oxazepam.,increase,risk
Oxazepam,Orphenadrine,Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Oxazepam,Oseltamivir,Oseltamivir may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Oxacillin,Oxacillin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Oxaprozin,Oxaprozin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Oxazepam.,increase,risk
Oxazepam,Oxitriptan,The risk or severity of CNS depression can be increased when Oxazepam is combined with Oxitriptan.,increase,risk
Oxazepam,Oxprenolol,The risk or severity of CNS depression can be increased when Oxazepam is combined with Oxprenolol.,increase,risk
Oxazepam,Oxtriphylline,The therapeutic efficacy of Oxazepam can be decreased when used in combination with Oxtriphylline.,decrease,no risk
Oxazepam,Oxybenzone,Oxazepam may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Oxazepam,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxazepam is combined with Oxybuprocaine.,increase,risk
Oxazepam,Oxycodone,The risk or severity of adverse effects can be increased when Oxycodone is combined with Oxazepam.,increase,risk
Oxazepam,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Oxazepam.,increase,risk
Oxazepam,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Oxyquinoline,Oxazepam may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Oxazepam,Quazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Quazepam.,increase,risk
Oxazepam,Quetiapine,The risk or severity of CNS depression can be increased when Oxazepam is combined with Quetiapine.,increase,risk
Oxazepam,Quinethazone,Quinethazone may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Oxazepam,Quinidine,Oxazepam may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Oxazepam,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Oxazepam.,increase,risk
Oxazepam,Quinupramine,The risk or severity of CNS depression can be increased when Oxazepam is combined with Quinupramine.,increase,risk
Oxazepam,Urethane,The risk or severity of CNS depression can be increased when Oxazepam is combined with Urethane.,increase,risk
Oxazepam,Vaborbactam,Oxazepam may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Oxazepam,Valaciclovir,Valaciclovir may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Valbenazine,Oxazepam may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Oxazepam,Valdecoxib,Valdecoxib may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Valganciclovir,Oxazepam may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Oxazepam,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Oxazepam.,increase,risk
Oxazepam,Vancomycin,Oxazepam may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Oxazepam,Varenicline,Oxazepam may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Oxazepam,Vecuronium,The risk or severity of CNS depression can be increased when Oxazepam is combined with Vecuronium.,increase,risk
Oxazepam,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Oxazepam.,increase,risk
Oxazepam,Verapamil,Verapamil may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Vigabatrin,The risk or severity of CNS depression can be increased when Oxazepam is combined with Vigabatrin.,increase,risk
Oxazepam,Vilanterol,Oxazepam may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Oxazepam,Vilazodone,The risk or severity of CNS depression can be increased when Oxazepam is combined with Vilazodone.,increase,risk
Oxazepam,Viloxazine,The risk or severity of CNS depression can be increased when Oxazepam is combined with Viloxazine.,increase,risk
Oxazepam,Voriconazole,The serum concentration of Oxazepam can be increased when it is combined with Voriconazole.,increase,no risk
Oxazepam,Vortioxetine,The risk or severity of CNS depression can be increased when Oxazepam is combined with Vortioxetine.,increase,risk
Oxazepam,Warfarin,Oxazepam may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Oxazepam,Yohimbine,The therapeutic efficacy of Oxazepam can be increased when used in combination with Yohimbine.,increase,no risk
Oxazepam,Zaleplon,The risk or severity of CNS depression can be increased when Oxazepam is combined with Zaleplon.,increase,risk
Oxazepam,Zanamivir,Zanamivir may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxazepam,Ziconotide,The risk or severity of CNS depression can be increased when Oxazepam is combined with Ziconotide.,increase,risk
Oxazepam,Zimelidine,The risk or severity of adverse effects can be increased when Oxazepam is combined with Zimelidine.,increase,risk
Oxazepam,Ziprasidone,The risk or severity of adverse effects can be increased when Oxazepam is combined with Ziprasidone.,increase,risk
Oxazepam,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Oxazepam.,increase,risk
Oxazepam,Zolpidem,Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Oxazepam,Zonisamide,The risk or severity of CNS depression can be increased when Oxazepam is combined with Zonisamide.,increase,risk
Oxazepam,Zopiclone,The risk or severity of adverse effects can be increased when Oxazepam is combined with Zopiclone.,increase,risk
Oxazepam,Zotepine,The risk or severity of CNS depression can be increased when Oxazepam is combined with Zotepine.,increase,risk
Oxazepam,Zuclopenthixol,The risk or severity of CNS depression can be increased when Oxazepam is combined with Zuclopenthixol.,increase,risk
Oxazepam,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Oxazepam.,increase,risk
Donepezil,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Donepezil.,increase,risk
Donepezil,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Donepezil.,increase,risk
Donepezil,Bretylium,Donepezil may increase the bradycardic activities of Bretylium.,increase,no risk
Donepezil,Brexanolone,The risk or severity of CNS depression can be increased when Donepezil is combined with Brexanolone.,increase,risk
Donepezil,Brexpiprazole,The risk or severity of CNS depression can be increased when Donepezil is combined with Brexpiprazole.,increase,risk
Donepezil,Brigatinib,Brigatinib may decrease the excretion rate of Donepezil which could result in a higher serum level.,decrease,no risk
Donepezil,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Donepezil.,increase,no risk
Donepezil,Brivaracetam,The risk or severity of CNS depression can be increased when Donepezil is combined with Brivaracetam.,increase,risk
Donepezil,Bromazepam,The risk or severity of CNS depression can be increased when Donepezil is combined with Bromazepam.,increase,risk
Donepezil,Bromocriptine,The risk or severity of CNS depression can be increased when Donepezil is combined with Bromocriptine.,increase,risk
Donepezil,Bromperidol,The risk or severity of CNS depression can be increased when Donepezil is combined with Bromperidol.,increase,risk
Donepezil,Brompheniramine,The therapeutic efficacy of Brompheniramine can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Buclizine,The therapeutic efficacy of Buclizine can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Budesonide,The therapeutic efficacy of Donepezil can be decreased when used in combination with Budesonide.,decrease,no risk
Donepezil,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Donepezil.,increase,risk
Donepezil,Buprenorphine,Donepezil may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Donepezil,Bupropion,The metabolism of Donepezil can be decreased when combined with Bupropion.,decrease,no risk
Donepezil,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Donepezil.,increase,risk
Donepezil,Butabarbital,The therapeutic efficacy of Butabarbital can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Butalbital,The therapeutic efficacy of Butalbital can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Butaperazine,The risk or severity of CNS depression can be increased when Donepezil is combined with Butaperazine.,increase,risk
Donepezil,Butobarbital,The therapeutic efficacy of Butobarbital can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Donepezil.,increase,risk
Donepezil,Butriptyline,The risk or severity of CNS depression can be increased when Donepezil is combined with Butriptyline.,increase,risk
Donepezil,Butylscopolamine,The therapeutic efficacy of Butylscopolamine can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Gabapentin,The metabolism of Donepezil can be decreased when combined with Fusidic acid.,decrease,no risk
Donepezil,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Donepezil is combined with Gabapentin.,increase,risk
Donepezil,Galantamine,The risk or severity of CNS depression can be increased when Donepezil is combined with Gabapentin enacarbil.,increase,risk
Donepezil,Gallamine triethiodide,Galantamine may increase the bradycardic activities of Donepezil.,increase,no risk
Donepezil,Ganaxolone,The risk or severity of CNS depression can be increased when Donepezil is combined with gamma-Hydroxybutyric acid.,increase,risk
Donepezil,Gefitinib,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Donepezil is combined with Ganaxolone.",increase,risk
Donepezil,Gemfibrozil,Gefitinib may decrease the excretion rate of Donepezil which could result in a higher serum level.,decrease,no risk
Donepezil,Gepirone,The metabolism of Donepezil can be decreased when combined with Gemfibrozil.,decrease,no risk
Donepezil,Gilteritinib,The risk or severity of CNS depression can be increased when Donepezil is combined with Gepirone.,increase,risk
Donepezil,Givosiran,Gilteritinib may decrease the excretion rate of Donepezil which could result in a higher serum level.,decrease,no risk
Donepezil,Glasdegib,The serum concentration of Donepezil can be increased when it is combined with Givosiran.,increase,no risk
Donepezil,Glecaprevir,Glasdegib may decrease the excretion rate of Donepezil which could result in a higher serum level.,decrease,no risk
Donepezil,Gliclazide,Glecaprevir may decrease the excretion rate of Donepezil which could result in a higher serum level.,decrease,no risk
Donepezil,Glimepiride,The metabolism of Gliclazide can be decreased when combined with Donepezil.,decrease,no risk
Donepezil,Glipizide,The metabolism of Donepezil can be decreased when combined with Glimepiride.,decrease,no risk
Donepezil,Gliquidone,The metabolism of Glipizide can be decreased when combined with Donepezil.,decrease,no risk
Donepezil,Glofitamab,The metabolism of Gliquidone can be decreased when combined with Donepezil.,decrease,no risk
Donepezil,Glutethimide,The serum concentration of Donepezil can be increased when it is combined with Glofitamab.,increase,no risk
Donepezil,Glyburide,The risk or severity of CNS depression can be increased when Donepezil is combined with Glutethimide.,increase,risk
Donepezil,Glycerol phenylbutyrate,The metabolism of Donepezil can be decreased when combined with Glyburide.,decrease,no risk
Donepezil,Glycopyrronium,The metabolism of Donepezil can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Donepezil,Golimumab,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Granisetron,The metabolism of Donepezil can be increased when combined with Golimumab.,increase,no risk
Donepezil,Grazoprevir,The risk or severity of CNS depression can be increased when Donepezil is combined with Granisetron.,increase,risk
Donepezil,Guanfacine,Grazoprevir may decrease the excretion rate of Donepezil which could result in a higher serum level.,decrease,no risk
Donepezil,Halazepam,The risk or severity of CNS depression can be increased when Donepezil is combined with Guanfacine.,increase,risk
Donepezil,Halofantrine,The risk or severity of CNS depression can be increased when Halazepam is combined with Donepezil.,increase,risk
Donepezil,Haloperidol,The metabolism of Donepezil can be decreased when combined with Halofantrine.,decrease,no risk
Donepezil,Halothane,The risk or severity of CNS depression can be increased when Haloperidol is combined with Donepezil.,increase,risk
Donepezil,Hexafluronium,The risk or severity of CNS depression can be increased when Donepezil is combined with Halothane.,increase,risk
Donepezil,Hexocyclium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Homatropine,The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Homatropine methylbromide,The therapeutic efficacy of Homatropine can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Hydrocodone,The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Hydrocortisone,Donepezil may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Donepezil,Hydrocortisone acetate,The therapeutic efficacy of Donepezil can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Donepezil,Hydrocortisone butyrate,The therapeutic efficacy of Donepezil can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Donepezil,Hydrocortisone cypionate,The therapeutic efficacy of Donepezil can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Donepezil,Hydrocortisone succinate,The therapeutic efficacy of Donepezil can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Donepezil,Hydromorphone,The therapeutic efficacy of Donepezil can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Donepezil,Hydroxychloroquine,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Donepezil.,increase,risk
Donepezil,Hydroxyzine,The metabolism of Donepezil can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Donepezil,Hyoscyamine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Donepezil.,increase,no risk
Donepezil,Ketamine,The metabolism of Donepezil can be increased when combined with Ivosidenib.,increase,no risk
Donepezil,Ketazolam,The risk or severity of CNS depression can be increased when Donepezil is combined with Ketamine.,increase,risk
Donepezil,Ketoconazole,The risk or severity of CNS depression can be increased when Donepezil is combined with Ketazolam.,increase,risk
Donepezil,Ketorolac,The metabolism of Donepezil can be decreased when combined with Ketoconazole.,decrease,no risk
Donepezil,Nabilone,Donepezil may increase the neuromuscular blocking activities of Moxisylyte.,increase,no risk
Donepezil,Nabumetone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Donepezil.,increase,no risk
Donepezil,Nadolol,The metabolism of Donepezil can be decreased when combined with Nabumetone.,decrease,no risk
Donepezil,Nalbuphine,Donepezil may increase the bradycardic activities of Nadolol.,increase,no risk
Donepezil,Naloxegol,The risk or severity of CNS depression can be increased when Donepezil is combined with Nalbuphine.,increase,risk
Donepezil,Naltrexone,The risk or severity of respiratory depression can be increased when Naloxegol is combined with Donepezil.,increase,risk
Donepezil,Naproxen,The risk or severity of respiratory depression can be increased when Naltrexone is combined with Donepezil.,increase,risk
Donepezil,Naratriptan,The metabolism of Donepezil can be decreased when combined with Naproxen.,decrease,no risk
Donepezil,Nateglinide,The risk or severity of CNS depression can be increased when Donepezil is combined with Naratriptan.,increase,risk
Donepezil,Nebivolol,The metabolism of Donepezil can be decreased when combined with Nateglinide.,decrease,no risk
Donepezil,Nefazodone,Donepezil may increase the bradycardic activities of Nebivolol.,increase,no risk
Donepezil,Nelfinavir,The metabolism of Donepezil can be decreased when combined with Nefazodone.,decrease,no risk
Donepezil,Netupitant,The metabolism of Donepezil can be decreased when combined with Nelfinavir.,decrease,no risk
Donepezil,Nevirapine,The metabolism of Donepezil can be decreased when combined with Netupitant.,decrease,no risk
Donepezil,Niacin,The metabolism of Donepezil can be decreased when combined with Nevirapine.,decrease,no risk
Donepezil,Nialamide,The metabolism of Donepezil can be decreased when combined with Niacin.,decrease,no risk
Donepezil,Nicardipine,The risk or severity of CNS depression can be increased when Donepezil is combined with Nialamide.,increase,risk
Donepezil,Nicergoline,The therapeutic efficacy of Nicardipine can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Niclosamide,The metabolism of Donepezil can be decreased when combined with Nicergoline.,decrease,no risk
Donepezil,Nicotine,The metabolism of Niclosamide can be decreased when combined with Donepezil.,decrease,no risk
Donepezil,Nifedipine,The risk or severity of adverse effects can be increased when Donepezil is combined with Nicotine.,increase,risk
Donepezil,Nilotinib,Donepezil may increase the bradycardic activities of Nifedipine.,increase,no risk
Donepezil,Nilutamide,The metabolism of Donepezil can be decreased when combined with Nilotinib.,decrease,no risk
Donepezil,Nilvadipine,The metabolism of Donepezil can be decreased when combined with Nilutamide.,decrease,no risk
Donepezil,Nimesulide,The metabolism of Donepezil can be decreased when combined with Nilvadipine.,decrease,no risk
Donepezil,Nimodipine,Donepezil may increase the bradycardic activities of Nimesulide.,increase,no risk
Donepezil,Nirogacestat,Nimodipine may increase the bradycardic activities of Donepezil.,increase,no risk
Donepezil,Nisoldipine,The metabolism of Nirogacestat can be decreased when combined with Donepezil.,decrease,no risk
Donepezil,Nitrazepam,Nisoldipine may increase the bradycardic activities of Donepezil.,increase,no risk
Donepezil,Nitrendipine,The risk or severity of CNS depression can be increased when Donepezil is combined with Nitrazepam.,increase,risk
Donepezil,Nitrous oxide,Donepezil may increase the bradycardic activities of Nitrendipine.,increase,no risk
Donepezil,Nomifensine,The risk or severity of CNS depression can be increased when Donepezil is combined with Nitrous oxide.,increase,risk
Donepezil,Norgestimate,The risk or severity of CNS depression can be increased when Donepezil is combined with Nomifensine.,increase,risk
Donepezil,Normethadone,The metabolism of Norgestimate can be decreased when combined with Donepezil.,decrease,no risk
Donepezil,Nortriptyline,The risk or severity of CNS depression can be increased when Donepezil is combined with Normethadone.,increase,risk
Donepezil,Noscapine,The therapeutic efficacy of Nortriptyline can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Novobiocin,The metabolism of Donepezil can be decreased when combined with Noscapine.,decrease,no risk
Donepezil,Nylidrin,Novobiocin may decrease the excretion rate of Donepezil which could result in a higher serum level.,decrease,no risk
Donepezil,Octreotide,Donepezil may increase the bradycardic activities of Nylidrin.,increase,no risk
Donepezil,Olanzapine,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Donepezil.,increase,no risk
Donepezil,Oliceridine,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Olodaterol,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Donepezil is combined with Oliceridine.",increase,risk
Donepezil,Omaveloxolone,The metabolism of Olodaterol can be decreased when combined with Donepezil.,decrease,no risk
Donepezil,Ondansetron,The serum concentration of Donepezil can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Donepezil,Opium,The risk or severity of CNS depression can be increased when Donepezil is combined with Ondansetron.,increase,risk
Donepezil,Oritavancin,The risk or severity of CNS depression can be increased when Donepezil is combined with Opium.,increase,risk
Donepezil,Orphenadrine,The metabolism of Donepezil can be decreased when combined with Oritavancin.,decrease,no risk
Donepezil,Osilodrostat,The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Osimertinib,The metabolism of Donepezil can be decreased when combined with Osilodrostat.,decrease,no risk
Donepezil,Ospemifene,Osimertinib may decrease the excretion rate of Donepezil which could result in a higher serum level.,decrease,no risk
Donepezil,Oteseconazole,The metabolism of Donepezil can be decreased when combined with Ospemifene.,decrease,no risk
Donepezil,Oxamniquine,The serum concentration of Donepezil can be increased when it is combined with Oteseconazole.,increase,no risk
Donepezil,Oxandrolone,The metabolism of Donepezil can be decreased when combined with Oxamniquine.,decrease,no risk
Donepezil,Oxazepam,The metabolism of Donepezil can be decreased when combined with Oxandrolone.,decrease,no risk
Donepezil,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxazepam is combined with Donepezil.,increase,risk
Donepezil,Oxitriptan,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Donepezil.,increase,risk
Donepezil,Oxprenolol,The risk or severity of CNS depression can be increased when Donepezil is combined with Oxitriptan.,increase,risk
Donepezil,Oxybuprocaine,Donepezil may increase the bradycardic activities of Oxprenolol.,increase,no risk
Donepezil,Oxybutynin,Donepezil may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Donepezil,Oxycodone,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Oxymorphone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Donepezil.,increase,risk
Donepezil,Oxyphencyclimine,The risk or severity of CNS depression can be increased when Donepezil is combined with Oxymorphone.,increase,risk
Donepezil,Oxyphenonium,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Quazepam,The risk or severity of CNS depression can be increased when Donepezil is combined with Pyrantel.,increase,risk
Donepezil,Quetiapine,The risk or severity of CNS depression can be increased when Donepezil is combined with Quazepam.,increase,risk
Donepezil,Quinidine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Quinine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Quinupramine,The metabolism of Donepezil can be decreased when combined with Quinine.,decrease,no risk
Donepezil,Umeclidinium,The metabolism of Tucatinib can be decreased when combined with Donepezil.,decrease,no risk
Donepezil,Urethane,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Vadadustat,The risk or severity of CNS depression can be increased when Donepezil is combined with Urethane.,increase,risk
Donepezil,Valbenazine,The serum concentration of Donepezil can be increased when it is combined with Vadadustat.,increase,no risk
Donepezil,Valdecoxib,The metabolism of Valbenazine can be decreased when combined with Donepezil.,decrease,no risk
Donepezil,Valproic acid,The metabolism of Donepezil can be decreased when combined with Valdecoxib.,decrease,no risk
Donepezil,Valsartan,The risk or severity of CNS depression can be increased when Valproic acid is combined with Donepezil.,increase,risk
Donepezil,Vamorolone,The metabolism of Donepezil can be decreased when combined with Valsartan.,decrease,no risk
Donepezil,Vandetanib,The therapeutic efficacy of Donepezil can be decreased when used in combination with Vamorolone.,decrease,no risk
Donepezil,Vardenafil,Vandetanib may decrease the excretion rate of Donepezil which could result in a higher serum level.,decrease,no risk
Donepezil,Varenicline,The metabolism of Vardenafil can be decreased when combined with Donepezil.,decrease,no risk
Donepezil,Vecuronium,The risk or severity of adverse effects can be increased when Donepezil is combined with Varenicline.,increase,risk
Donepezil,Velpatasvir,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Vemurafenib,Velpatasvir may decrease the excretion rate of Donepezil which could result in a higher serum level.,decrease,no risk
Donepezil,Venetoclax,Vemurafenib may decrease the excretion rate of Donepezil which could result in a higher serum level.,decrease,no risk
Donepezil,Venlafaxine,The metabolism of Donepezil can be decreased when combined with Venetoclax.,decrease,no risk
Donepezil,Verapamil,The metabolism of Donepezil can be decreased when combined with Venlafaxine.,decrease,no risk
Donepezil,Vernakalant,The metabolism of Donepezil can be decreased when combined with Verapamil.,decrease,no risk
Donepezil,Vigabatrin,The metabolism of Vernakalant can be decreased when combined with Donepezil.,decrease,no risk
Donepezil,Vilazodone,The risk or severity of CNS depression can be increased when Donepezil is combined with Vigabatrin.,increase,risk
Donepezil,Viloxazine,The metabolism of Donepezil can be decreased when combined with Vilazodone.,decrease,no risk
Donepezil,Vinblastine,The metabolism of Donepezil can be decreased when combined with Viloxazine.,decrease,no risk
Donepezil,Vinorelbine,The metabolism of Donepezil can be decreased when combined with Vinblastine.,decrease,no risk
Donepezil,Vismodegib,The metabolism of Donepezil can be decreased when combined with Vinorelbine.,decrease,no risk
Donepezil,Voriconazole,Vismodegib may decrease the excretion rate of Donepezil which could result in a higher serum level.,decrease,no risk
Donepezil,Vortioxetine,The metabolism of Donepezil can be decreased when combined with Voriconazole.,decrease,no risk
Donepezil,Voxelotor,The risk or severity of CNS depression can be increased when Donepezil is combined with Vortioxetine.,increase,risk
Donepezil,Voxilaprevir,The metabolism of Voxelotor can be decreased when combined with Donepezil.,decrease,no risk
Donepezil,Warfarin,Voxilaprevir may decrease the excretion rate of Donepezil which could result in a higher serum level.,decrease,no risk
Donepezil,Ximelagatran,The metabolism of Donepezil can be increased when combined with Warfarin.,increase,no risk
Donepezil,Yohimbine,The metabolism of Ximelagatran can be decreased when combined with Donepezil.,decrease,no risk
Donepezil,Zafirlukast,The risk or severity of CNS depression can be increased when Donepezil is combined with Yohimbine.,increase,risk
Donepezil,Zaleplon,The metabolism of Donepezil can be decreased when combined with Zafirlukast.,decrease,no risk
Donepezil,Ziconotide,The risk or severity of CNS depression can be increased when Donepezil is combined with Zaleplon.,increase,risk
Donepezil,Zidovudine,The risk or severity of CNS depression can be increased when Donepezil is combined with Ziconotide.,increase,risk
Donepezil,Zileuton,The metabolism of Donepezil can be decreased when combined with Zidovudine.,decrease,no risk
Donepezil,Zimelidine,The metabolism of Donepezil can be decreased when combined with Zileuton.,decrease,no risk
Donepezil,Ziprasidone,The risk or severity of adverse effects can be increased when Donepezil is combined with Zimelidine.,increase,risk
Donepezil,Zolmitriptan,The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Donepezil.,decrease,no risk
Donepezil,Zolpidem,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Donepezil.,increase,risk
Donepezil,Zonisamide,Donepezil may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Donepezil,Zopiclone,The risk or severity of CNS depression can be increased when Donepezil is combined with Zonisamide.,increase,risk
Donepezil,Zotepine,The risk or severity of adverse effects can be increased when Donepezil is combined with Zopiclone.,increase,risk
Donepezil,Zuclopenthixol,The risk or severity of CNS depression can be increased when Donepezil is combined with Zotepine.,increase,risk
Donepezil,Zuranolone,The risk or severity of CNS depression can be increased when Donepezil is combined with Zuclopenthixol.,increase,risk
Nalbuphine,Gabapentin,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Gabapentin.,increase,risk
Nalbuphine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Gabapentin enacarbil.,increase,risk
Nalbuphine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Nalbuphine.,increase,risk
Nalbuphine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Nalbuphine is combined with Ganaxolone.",increase,risk
Nalbuphine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Nalbuphine.,increase,risk
Nalbuphine,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Nalbuphine.,decrease,no risk
Nalbuphine,Glutethimide,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Glutethimide.,increase,risk
Nalbuphine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Nalbuphine.,decrease,no risk
Nalbuphine,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Nalbuphine.,increase,risk
Nalbuphine,Granisetron,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Granisetron.,increase,risk
Nalbuphine,Guanfacine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Guanfacine.,increase,risk
Nalbuphine,Halazepam,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Halazepam.,increase,risk
Nalbuphine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Nalbuphine.,increase,risk
Nalbuphine,Halothane,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Halothane.,increase,risk
Nalbuphine,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Nalbuphine.,increase,risk
Nalbuphine,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Nalbuphine.,increase,risk
Nalbuphine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Nalbuphine.,increase,risk
Nalbuphine,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Nalbuphine.,decrease,no risk
Nalbuphine,Hydrocodone,The therapeutic efficacy of Hydrocodone can be decreased when used in combination with Nalbuphine.,decrease,no risk
Nalbuphine,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Nalbuphine.,decrease,no risk
Nalbuphine,Hydromorphone,The therapeutic efficacy of Hydromorphone can be decreased when used in combination with Nalbuphine.,decrease,no risk
Nalbuphine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Nalbuphine.,increase,no risk
Nalbuphine,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Nalbuphine.,increase,risk
Nalbuphine,Ketamine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Ketamine.,increase,risk
Nalbuphine,Ketazolam,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ketazolam.,increase,risk
Nalbuphine,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Nalbuphine.,increase,no risk
Nalbuphine,Naldemedine,The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Naldemedine.,decrease,no risk
Nalbuphine,Nalmefene,The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Nalmefene.,decrease,no risk
Nalbuphine,Naloxegol,Nalbuphine may increase the opioid antagonism activities of Naloxegol.,increase,no risk
Nalbuphine,Naloxone,The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Naloxone.,decrease,no risk
Nalbuphine,Naltrexone,The therapeutic efficacy of Naltrexone can be decreased when used in combination with Nalbuphine.,decrease,no risk
Nalbuphine,Naphazoline,Naphazoline may increase the central nervous system depressant (CNS depressant) activities of Nalbuphine.,increase,no risk
Nalbuphine,Naratriptan,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Naratriptan.,increase,risk
Nalbuphine,Nefazodone,The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Nefazodone.,increase,risk
Nalbuphine,Nialamide,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Nialamide.,increase,risk
Nalbuphine,Nicardipine,The risk or severity of adverse effects can be increased when Nicardipine is combined with Nalbuphine.,increase,risk
Nalbuphine,Nitrazepam,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Nitrazepam.,increase,risk
Nalbuphine,Nitrous oxide,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Nitrous oxide.,increase,risk
Nalbuphine,Nomifensine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Nomifensine.,increase,risk
Nalbuphine,Normethadone,The therapeutic efficacy of Normethadone can be decreased when used in combination with Nalbuphine.,decrease,no risk
Nalbuphine,Nortriptyline,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Nalbuphine.,increase,risk
Nalbuphine,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Nalbuphine.,increase,risk
Nalbuphine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Nalbuphine is combined with Oliceridine.",increase,risk
Nalbuphine,Ondansetron,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Ondansetron.,increase,risk
Nalbuphine,Opium,The therapeutic efficacy of Opium can be decreased when used in combination with Nalbuphine.,decrease,no risk
Nalbuphine,Orphenadrine,Nalbuphine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Nalbuphine,Oxazepam,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Oxazepam.,increase,risk
Nalbuphine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Nalbuphine.,increase,risk
Nalbuphine,Oxitriptan,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Oxitriptan.,increase,risk
Nalbuphine,Oxprenolol,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Oxprenolol.,increase,risk
Nalbuphine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Oxybuprocaine.,increase,risk
Nalbuphine,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Nalbuphine.,increase,risk
Nalbuphine,Oxycodone,The therapeutic efficacy of Oxycodone can be decreased when used in combination with Nalbuphine.,decrease,no risk
Nalbuphine,Oxymorphone,The therapeutic efficacy of Oxymorphone can be decreased when used in combination with Nalbuphine.,decrease,no risk
Nalbuphine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Nalbuphine.,increase,risk
Nalbuphine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Nalbuphine.,decrease,no risk
Nalbuphine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Nalbuphine.,increase,risk
Nalbuphine,Quazepam,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Quazepam.,increase,risk
Nalbuphine,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Nalbuphine.,increase,risk
Nalbuphine,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Nalbuphine.,decrease,no risk
Nalbuphine,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Nalbuphine.,increase,risk
Nalbuphine,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Nalbuphine.,increase,risk
Nalbuphine,Quinupramine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Quinupramine.,increase,risk
Nalbuphine,Umeclidinium,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Nalbuphine.,increase,risk
Nalbuphine,Urethane,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Urethane.,increase,risk
Nalbuphine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Valproate bismuth.,increase,risk
Nalbuphine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Nalbuphine.,increase,risk
Nalbuphine,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Nalbuphine.,increase,risk
Nalbuphine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Venlafaxine.,increase,risk
Nalbuphine,Vigabatrin,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Vigabatrin.,increase,risk
Nalbuphine,Vilazodone,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Vilazodone.,increase,risk
Nalbuphine,Viloxazine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Viloxazine.,increase,risk
Nalbuphine,Vortioxetine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Vortioxetine.,increase,risk
Nalbuphine,Yohimbine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Yohimbine.,increase,risk
Nalbuphine,Zaleplon,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Zaleplon.,increase,risk
Nalbuphine,Ziconotide,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Ziconotide.,increase,risk
Nalbuphine,Zimelidine,The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Zimelidine.,increase,risk
Nalbuphine,Ziprasidone,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ziprasidone.,increase,risk
Nalbuphine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Nalbuphine.,increase,risk
Nalbuphine,Zolpidem,Nalbuphine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Nalbuphine,Zonisamide,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Zonisamide.,increase,risk
Nalbuphine,Zopiclone,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Zopiclone.,increase,risk
Nalbuphine,Zotepine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Zotepine.,increase,risk
Nalbuphine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Zuclopenthixol.,increase,risk
Nalbuphine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Nalbuphine.,increase,risk
Clofazimine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Gadobenic acid.,increase,risk
Clofazimine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Clofazimine.,increase,risk
Clofazimine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Gatifloxacin.,increase,risk
Clofazimine,Gefitinib,Clofazimine may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Clofazimine,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Gemifloxacin.,increase,risk
Clofazimine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Glasdegib,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Glasdegib.,increase,risk
Clofazimine,Glecaprevir,Clofazimine may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Clofazimine,Glyburide,Clofazimine may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Clofazimine,Goserelin,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Goserelin.,increase,risk
Clofazimine,Granisetron,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Granisetron.,increase,risk
Clofazimine,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Grepafloxacin.,increase,risk
Clofazimine,Halofantrine,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Halofantrine.,increase,risk
Clofazimine,Haloperidol,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Haloperidol.,increase,risk
Clofazimine,Histrelin,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Histrelin.,increase,risk
Clofazimine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Hydrochlorothiazide.,increase,risk
Clofazimine,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Hydroxychloroquine.,increase,risk
Clofazimine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Hydroxyzine.,increase,risk
Clofazimine,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Clofazimine.,increase,risk
Clofazimine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Ketoconazole.,increase,risk
Clofazimine,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Nalidixic acid.,increase,risk
Clofazimine,Naloxegol,The serum concentration of Naloxegol can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Nelfinavir,The metabolism of Nelfinavir can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Neratinib,The serum concentration of Neratinib can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Netupitant,The metabolism of Netupitant can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Nicardipine,The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Clofazimine.,increase,risk
Clofazimine,Nifedipine,The metabolism of Nifedipine can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Nilotinib,The serum concentration of Nilotinib can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Nilvadipine,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Nilvadipine.,increase,risk
Clofazimine,Nimodipine,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Nimodipine.,increase,risk
Clofazimine,Nintedanib,The serum concentration of Nintedanib can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Nisoldipine,The metabolism of Nisoldipine can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Nitrendipine,The metabolism of Nitrendipine can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Nitrofurantoin,Clofazimine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,decrease,no risk
Clofazimine,Norethisterone,The metabolism of Norethisterone can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Norfloxacin,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Norfloxacin.,increase,risk
Clofazimine,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Clofazimine.,increase,risk
Clofazimine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Ofloxacin.,increase,risk
Clofazimine,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Clofazimine.,increase,risk
Clofazimine,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Olodaterol,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Olodaterol.,increase,risk
Clofazimine,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Ombitasvir,Clofazimine may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Clofazimine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Orphenadrine,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Orphenadrine.,increase,risk
Clofazimine,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Clofazimine.,increase,risk
Clofazimine,Oxatomide,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Oxatomide.,increase,risk
Clofazimine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Clofazimine is combined with Oxetacaine.,increase,risk
Clofazimine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Clofazimine is combined with Oxybuprocaine.,increase,risk
Clofazimine,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Clofazimine.,increase,risk
Clofazimine,Ozanimod,Clofazimine may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Clofazimine,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Quinine,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Quinine.,increase,risk
Clofazimine,Quizartinib,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Quizartinib.,increase,risk
Clofazimine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Udenafil,The metabolism of Udenafil can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Valproic acid,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Valproic acid.,increase,risk
Clofazimine,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Velpatasvir,Clofazimine may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Clofazimine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Clofazimine.,increase,risk
Clofazimine,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Vernakalant,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Vernakalant.,increase,risk
Clofazimine,Verteporfin,Clofazimine may increase the photosensitizing activities of Verteporfin.,increase,no risk
Clofazimine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Clofazimine.,decrease,no risk
Clofazimine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Clofazimine.,increase,risk
Clofazimine,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Vincristine,The excretion of Vincristine can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Clofazimine.,increase,risk
Clofazimine,Vorinostat,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Vorinostat.,increase,risk
Clofazimine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Voxilaprevir,Clofazimine may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Clofazimine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Clofazimine.,increase,no risk
Clofazimine,Zidovudine,Clofazimine may decrease the excretion rate of Zidovudine which could result in a higher serum level.,decrease,no risk
Clofazimine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Ziprasidone.,increase,risk
Clofazimine,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Clofazimine.,decrease,no risk
Clofazimine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Zuclopenthixol.,increase,risk
Flurandrenolide,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Flurandrenolide.,increase,risk
Flurandrenolide,Vadadustat,The serum concentration of Flurandrenolide can be increased when it is combined with Vadadustat.,increase,no risk
Flurandrenolide,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Flurandrenolide.,decrease,no risk
Flurandrenolide,Vildagliptin,The risk or severity of hyperglycemia can be increased when Flurandrenolide is combined with Vildagliptin.,increase,risk
Flurandrenolide,Viloxazine,The metabolism of Flurandrenolide can be decreased when combined with Viloxazine.,decrease,no risk
Flurandrenolide,Voriconazole,The serum concentration of Flurandrenolide can be increased when it is combined with Voriconazole.,increase,no risk
Cysteamine,Bismuth subnitrate,The bioavailability of Cysteamine can be decreased when combined with Bismuth subnitrate.,decrease,no risk
Cysteamine,Hydrotalcite,The bioavailability of Cysteamine can be decreased when combined with Hydrotalcite.,decrease,no risk
Cysteamine,Nizatidine,The bioavailability of Cysteamine can be decreased when combined with Nizatidine.,decrease,no risk
Cysteamine,Olanzapine,Olanzapine can cause an increase in the absorption of Cysteamine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Cysteamine,Omeprazole,The bioavailability of Cysteamine can be decreased when combined with Omeprazole.,decrease,no risk
Cysteamine,Vonoprazan,The bioavailability of Cysteamine can be decreased when combined with Vonoprazan.,decrease,no risk
Methylphenobarbital,Biperiden,The risk or severity of adverse effects can be increased when Biperiden is combined with Methylphenobarbital.,increase,risk
Methylphenobarbital,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Methylphenobarbital.,decrease,no risk
Methylphenobarbital,Bisoprolol,Methylphenobarbital may increase the hypotensive activities of Bisoprolol.,increase,no risk
Methylphenobarbital,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Methylphenobarbital.,decrease,no risk
Methylphenobarbital,Boceprevir,The serum concentration of Boceprevir can be decreased when it is combined with Methylphenobarbital.,decrease,no risk
Methylphenobarbital,Borage oil,The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Borage oil.,decrease,no risk
Methylphenobarbital,Bortezomib,The metabolism of Bortezomib can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Bosutinib,The metabolism of Bosutinib can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Botulinum toxin type A.,increase,risk
Methylphenobarbital,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Botulinum toxin type B.,increase,risk
Methylphenobarbital,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Bretylium,Methylphenobarbital may increase the hypotensive activities of Bretylium.,increase,no risk
Methylphenobarbital,Brexanolone,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Brexanolone.,increase,risk
Methylphenobarbital,Brexpiprazole,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Brexpiprazole.,increase,risk
Methylphenobarbital,Brigatinib,The metabolism of Brigatinib can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Methylphenobarbital.,increase,no risk
Methylphenobarbital,Brivaracetam,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Brivaracetam.,increase,risk
Methylphenobarbital,Bromazepam,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Bromazepam.,increase,risk
Methylphenobarbital,Bromocriptine,Methylphenobarbital may increase the hypotensive activities of Bromocriptine.,increase,no risk
Methylphenobarbital,Bromotheophylline,The serum concentration of Bromotheophylline can be decreased when it is combined with Methylphenobarbital.,decrease,no risk
Methylphenobarbital,Bromperidol,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Bromperidol.,increase,risk
Methylphenobarbital,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Methylphenobarbital.,increase,risk
Methylphenobarbital,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Methylphenobarbital.,increase,risk
Methylphenobarbital,Bumetanide,Methylphenobarbital may increase the hypotensive activities of Bumetanide.,increase,no risk
Methylphenobarbital,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Methylphenobarbital is combined with Bupivacaine.,increase,risk
Methylphenobarbital,Buprenorphine,Methylphenobarbital may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Methylphenobarbital,Bupropion,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Bupropion.,increase,risk
Methylphenobarbital,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Methylphenobarbital.,increase,risk
Methylphenobarbital,Busulfan,The metabolism of Busulfan can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Butabarbital,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Butabarbital.,increase,risk
Methylphenobarbital,Butacaine,The risk or severity of methemoglobinemia can be increased when Methylphenobarbital is combined with Butacaine.,increase,risk
Methylphenobarbital,Butalbital,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Butalbital.,increase,risk
Methylphenobarbital,Butamben,The risk or severity of methemoglobinemia can be increased when Methylphenobarbital is combined with Butamben.,increase,risk
Methylphenobarbital,Butaperazine,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Butaperazine.,increase,risk
Methylphenobarbital,Butobarbital,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Butobarbital.,increase,risk
Methylphenobarbital,Butorphanol,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Butorphanol.,increase,risk
Methylphenobarbital,Butriptyline,The metabolism of Butriptyline can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Butylscopolamine,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Butylscopolamine.,increase,risk
Methylphenobarbital,Gabapentin,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Gabapentin.,increase,risk
Methylphenobarbital,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Gabapentin enacarbil.,increase,risk
Methylphenobarbital,Galantamine,The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Galantamine.,decrease,no risk
Methylphenobarbital,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Methylphenobarbital.,increase,risk
Methylphenobarbital,Gamolenic acid,The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Methylphenobarbital,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Methylphenobarbital is combined with Ganaxolone.",increase,risk
Methylphenobarbital,Ganciclovir,The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Ganciclovir.,decrease,no risk
Methylphenobarbital,Gemfibrozil,The metabolism of Methylphenobarbital can be decreased when combined with Gemfibrozil.,decrease,no risk
Methylphenobarbital,Gepirone,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Gepirone.,increase,risk
Methylphenobarbital,Gestrinone,The metabolism of Gestrinone can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Ginkgo biloba,The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Methylphenobarbital,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Methylphenobarbital.,decrease,no risk
Methylphenobarbital,Glofitamab,The serum concentration of Methylphenobarbital can be increased when it is combined with Glofitamab.,increase,no risk
Methylphenobarbital,Glutethimide,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Glutethimide.,increase,risk
Methylphenobarbital,Glyburide,The metabolism of Glyburide can be decreased when combined with Methylphenobarbital.,decrease,no risk
Methylphenobarbital,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Methylphenobarbital.,decrease,no risk
Methylphenobarbital,Glycopyrronium,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Glycopyrronium.,increase,risk
Methylphenobarbital,Golimumab,The metabolism of Methylphenobarbital can be increased when combined with Golimumab.,increase,no risk
Methylphenobarbital,Granisetron,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Granisetron.,increase,risk
Methylphenobarbital,Griseofulvin,The serum concentration of Griseofulvin can be decreased when it is combined with Methylphenobarbital.,decrease,no risk
Methylphenobarbital,Guanfacine,Methylphenobarbital may increase the hypotensive activities of Guanfacine.,increase,no risk
Methylphenobarbital,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Methylphenobarbital.,increase,risk
Methylphenobarbital,Halofantrine,The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Halofantrine.,decrease,no risk
Methylphenobarbital,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Methylphenobarbital.,increase,risk
Methylphenobarbital,Halothane,Methylphenobarbital may increase the hypotensive activities of Halothane.,increase,no risk
Methylphenobarbital,Hexafluronium,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Hexafluronium.,increase,risk
Methylphenobarbital,Hexocyclium,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Hexocyclium.,increase,risk
Methylphenobarbital,Homatropine,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Homatropine.,increase,risk
Methylphenobarbital,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Methylphenobarbital.,increase,risk
Methylphenobarbital,Huperzine A,The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Huperzine A.,decrease,no risk
Methylphenobarbital,Hydralazine,Methylphenobarbital may increase the hypotensive activities of Hydralazine.,increase,no risk
Methylphenobarbital,Hydrochlorothiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Methylphenobarbital is combined with Hydrochlorothiazide.,increase,risk
Methylphenobarbital,Hydrocodone,Methylphenobarbital may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Methylphenobarbital,Hydrocortisone,The metabolism of Methylphenobarbital can be increased when combined with Hydrocortisone.,increase,no risk
Methylphenobarbital,Hydroflumethiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Methylphenobarbital is combined with Hydroflumethiazide.,increase,risk
Methylphenobarbital,Hydromorphone,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Hydromorphone.,increase,risk
Methylphenobarbital,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Methylphenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Methylphenobarbital,Hydroxychloroquine,The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Methylphenobarbital,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Methylphenobarbital.,increase,no risk
Methylphenobarbital,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Methylphenobarbital.,increase,risk
Methylphenobarbital,Kaolin,Kaolin can cause a decrease in the absorption of Methylphenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Methylphenobarbital,Ketamine,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Ketamine.,increase,risk
Methylphenobarbital,Ketazolam,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Ketazolam.,increase,risk
Methylphenobarbital,Ketoconazole,The metabolism of Methylphenobarbital can be decreased when combined with Ketoconazole.,decrease,no risk
Methylphenobarbital,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Methylphenobarbital.,increase,no risk
Methylphenobarbital,Nadolol,Methylphenobarbital may increase the hypotensive activities of Nadolol.,increase,no risk
Methylphenobarbital,Nalbuphine,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Nalbuphine.,increase,risk
Methylphenobarbital,Nalidixic acid,The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Nalidixic acid.,decrease,no risk
Methylphenobarbital,Naloxegol,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Naloxegol.,increase,risk
Methylphenobarbital,Naltrexone,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Naltrexone.,increase,risk
Methylphenobarbital,Naphazoline,The risk or severity of CNS depression can be increased when Naphazoline is combined with Methylphenobarbital.,increase,risk
Methylphenobarbital,Naratriptan,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Naratriptan.,increase,risk
Methylphenobarbital,Nebivolol,Methylphenobarbital may increase the hypotensive activities of Nebivolol.,increase,no risk
Methylphenobarbital,Nefazodone,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Nefazodone.,increase,risk
Methylphenobarbital,Nelfinavir,The metabolism of Methylphenobarbital can be decreased when combined with Nelfinavir.,decrease,no risk
Methylphenobarbital,Neostigmine,The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Neostigmine.,decrease,no risk
Methylphenobarbital,Neratinib,The metabolism of Neratinib can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Nesiritide,Methylphenobarbital may increase the hypotensive activities of Nesiritide.,increase,no risk
Methylphenobarbital,Netupitant,The metabolism of Netupitant can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Nevirapine,The metabolism of Methylphenobarbital can be increased when combined with Nevirapine.,increase,no risk
Methylphenobarbital,Nialamide,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Nialamide.,increase,risk
Methylphenobarbital,Nicardipine,Methylphenobarbital may increase the hypotensive activities of Nicardipine.,increase,no risk
Methylphenobarbital,Nicotine,The metabolism of Methylphenobarbital can be decreased when combined with Nicotine.,decrease,no risk
Methylphenobarbital,Nifedipine,Methylphenobarbital may increase the hypotensive activities of Nifedipine.,increase,no risk
Methylphenobarbital,Nilotinib,The metabolism of Nilotinib can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Nilutamide,The metabolism of Methylphenobarbital can be decreased when combined with Nilutamide.,decrease,no risk
Methylphenobarbital,Nilvadipine,Methylphenobarbital may increase the hypotensive activities of Nilvadipine.,increase,no risk
Methylphenobarbital,Nimesulide,The metabolism of Nimesulide can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Nimodipine,Methylphenobarbital may increase the hypotensive activities of Nimodipine.,increase,no risk
Methylphenobarbital,Nintedanib,The metabolism of Nintedanib can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Methylphenobarbital.,decrease,no risk
Methylphenobarbital,Nisoldipine,Methylphenobarbital may increase the hypotensive activities of Nisoldipine.,increase,no risk
Methylphenobarbital,Nitrazepam,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Nitrazepam.,increase,risk
Methylphenobarbital,Nitrendipine,Methylphenobarbital may increase the hypotensive activities of Nitrendipine.,increase,no risk
Methylphenobarbital,Nitric Oxide,Methylphenobarbital may increase the hypotensive activities of Nitric Oxide.,increase,no risk
Methylphenobarbital,Nitroglycerin,Methylphenobarbital may increase the hypotensive activities of Nitroglycerin.,increase,no risk
Methylphenobarbital,Nitroprusside,Methylphenobarbital may increase the hypotensive activities of Nitroprusside.,increase,no risk
Methylphenobarbital,Nitrous acid,Methylphenobarbital may increase the hypotensive activities of Nitrous acid.,increase,no risk
Methylphenobarbital,Nitrous oxide,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Nitrous oxide.,increase,risk
Methylphenobarbital,Nizatidine,The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Nizatidine.,decrease,no risk
Methylphenobarbital,Nomegestrol,The metabolism of Nomegestrol can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Nomegestrol acetate,The metabolism of Nomegestrol acetate can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Nomifensine,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Nomifensine.,increase,risk
Methylphenobarbital,Nonoxynol-9,The metabolism of Nonoxynol-9 can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Norelgestromin,The metabolism of Norelgestromin can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Norethisterone,The metabolism of Norethisterone can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Norethynodrel,The metabolism of Norethynodrel can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Norgestimate,The metabolism of Norgestimate can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Norgestrel,The metabolism of Norgestrel can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Normethadone,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Normethadone.,increase,risk
Methylphenobarbital,Nortriptyline,The metabolism of Nortriptyline can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Nylidrin,The metabolism of Nylidrin can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Obinutuzumab,Methylphenobarbital may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Methylphenobarbital,Olanzapine,Methylphenobarbital may increase the hypotensive activities of Olanzapine.,increase,no risk
Methylphenobarbital,Olaparib,The metabolism of Olaparib can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Methylphenobarbital is combined with Oliceridine.",increase,risk
Methylphenobarbital,Olmesartan,Methylphenobarbital may increase the hypotensive activities of Olmesartan.,increase,no risk
Methylphenobarbital,Omeprazole,The metabolism of Methylphenobarbital can be decreased when combined with Omeprazole.,decrease,no risk
Methylphenobarbital,Ondansetron,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Ondansetron.,increase,risk
Methylphenobarbital,Opicapone,Methylphenobarbital may increase the hypotensive activities of Opicapone.,increase,no risk
Methylphenobarbital,Opium,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Opium.,increase,risk
Methylphenobarbital,Oritavancin,The metabolism of Methylphenobarbital can be decreased when combined with Oritavancin.,decrease,no risk
Methylphenobarbital,Orlistat,Orlistat can cause a decrease in the absorption of Methylphenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Methylphenobarbital,Orphenadrine,Methylphenobarbital may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Methylphenobarbital,Osilodrostat,The metabolism of Methylphenobarbital can be decreased when combined with Osilodrostat.,decrease,no risk
Methylphenobarbital,Osimertinib,The metabolism of Osimertinib can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Methylphenobarbital.,decrease,no risk
Methylphenobarbital,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Methylphenobarbital.,increase,risk
Methylphenobarbital,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Methylphenobarbital.,increase,risk
Methylphenobarbital,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Methylphenobarbital is combined with Oxetacaine.,increase,risk
Methylphenobarbital,Oxitriptan,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Oxitriptan.,increase,risk
Methylphenobarbital,Oxprenolol,Methylphenobarbital may increase the hypotensive activities of Oxprenolol.,increase,no risk
Methylphenobarbital,Oxtriphylline,The serum concentration of Oxtriphylline can be decreased when it is combined with Methylphenobarbital.,decrease,no risk
Methylphenobarbital,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Methylphenobarbital is combined with Oxybuprocaine.,increase,risk
Methylphenobarbital,Oxybutynin,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Oxybutynin.,increase,risk
Methylphenobarbital,Oxycodone,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Oxycodone.,increase,risk
Methylphenobarbital,Oxymorphone,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Oxymorphone.,increase,risk
Methylphenobarbital,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Methylphenobarbital.,increase,risk
Methylphenobarbital,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Methylphenobarbital.,decrease,no risk
Methylphenobarbital,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Methylphenobarbital.,increase,risk
Methylphenobarbital,Quazepam,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Quazepam.,increase,risk
Methylphenobarbital,Quetiapine,Methylphenobarbital may increase the hypotensive activities of Quetiapine.,increase,no risk
Methylphenobarbital,Quinapril,Methylphenobarbital may increase the hypotensive activities of Quinapril.,increase,no risk
Methylphenobarbital,Quinethazone,The risk or severity of hypotension and orthostatic hypotension can be increased when Methylphenobarbital is combined with Quinethazone.,increase,risk
Methylphenobarbital,Quinidine,The serum concentration of Methylphenobarbital can be increased when it is combined with Quinidine.,increase,no risk
Methylphenobarbital,Quinine,The serum concentration of Methylphenobarbital can be increased when it is combined with Quinine.,increase,no risk
Methylphenobarbital,Quinupramine,The metabolism of Quinupramine can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Methylphenobarbital.,decrease,no risk
Methylphenobarbital,Umeclidinium,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Umeclidinium.,increase,risk
Methylphenobarbital,Urethane,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Urethane.,increase,risk
Methylphenobarbital,Vadadustat,The serum concentration of Methylphenobarbital can be decreased when it is combined with Vadadustat.,decrease,no risk
Methylphenobarbital,Valganciclovir,The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Valganciclovir.,decrease,no risk
Methylphenobarbital,Valproic acid,"The serum concentration of Phenobarbital, an active metabolite of Methylphenobarbital, can be increased when used in combination with Valproic acid.",increase,no risk
Methylphenobarbital,Valsartan,Methylphenobarbital may increase the hypotensive activities of Valsartan.,increase,no risk
Methylphenobarbital,Vandetanib,The metabolism of Vandetanib can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Vecuronium,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Vecuronium.,increase,risk
Methylphenobarbital,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Methylphenobarbital.,decrease,no risk
Methylphenobarbital,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Venetoclax,The metabolism of Venetoclax can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Methylphenobarbital.,increase,risk
Methylphenobarbital,Verapamil,Methylphenobarbital may increase the hypotensive activities of Verapamil.,increase,no risk
Methylphenobarbital,Vericiguat,Methylphenobarbital may increase the hypotensive activities of Vericiguat.,increase,no risk
Methylphenobarbital,Vigabatrin,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Vigabatrin.,increase,risk
Methylphenobarbital,Vilazodone,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Vilazodone.,increase,risk
Methylphenobarbital,Viloxazine,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Viloxazine.,increase,risk
Methylphenobarbital,Vinblastine,The metabolism of Vinblastine can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Vincristine,The metabolism of Vincristine can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Vindesine,The metabolism of Vindesine can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Vinflunine,The metabolism of Vinflunine can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Vonoprazan,The metabolism of Methylphenobarbital can be decreased when combined with Vonoprazan.,decrease,no risk
Methylphenobarbital,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Voriconazole,The serum concentration of Voriconazole can be decreased when it is combined with Methylphenobarbital.,decrease,no risk
Methylphenobarbital,Vortioxetine,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Vortioxetine.,increase,risk
Methylphenobarbital,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Methylphenobarbital.,decrease,no risk
Methylphenobarbital,Warfarin,The metabolism of Warfarin can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Xylometazoline,The metabolism of Xylometazoline can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Yohimbine,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Yohimbine.,increase,risk
Methylphenobarbital,Zafirlukast,The metabolism of Methylphenobarbital can be decreased when combined with Zafirlukast.,decrease,no risk
Methylphenobarbital,Zaleplon,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Zaleplon.,increase,risk
Methylphenobarbital,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Ziconotide,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Ziconotide.,increase,risk
Methylphenobarbital,Zimelidine,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Zimelidine.,increase,risk
Methylphenobarbital,Zinc,Zinc can cause a decrease in the absorption of Methylphenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Methylphenobarbital,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Methylphenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Methylphenobarbital,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Methylphenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Methylphenobarbital,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Methylphenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Methylphenobarbital,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Methylphenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Methylphenobarbital,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Methylphenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Methylphenobarbital,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Methylphenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Methylphenobarbital,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Methylphenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Methylphenobarbital,Ziprasidone,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Ziprasidone.,increase,risk
Methylphenobarbital,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Methylphenobarbital.,increase,risk
Methylphenobarbital,Zolpidem,Methylphenobarbital may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Methylphenobarbital,Zonisamide,The metabolism of Zonisamide can be increased when combined with Methylphenobarbital.,increase,no risk
Methylphenobarbital,Zopiclone,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Zopiclone.,increase,risk
Methylphenobarbital,Zotepine,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Zotepine.,increase,risk
Methylphenobarbital,Zuclopenthixol,The risk or severity of CNS depression can be increased when Methylphenobarbital is combined with Zuclopenthixol.,increase,risk
Methylphenobarbital,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Methylphenobarbital.,increase,risk
Perphenazine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Perphenazine.,increase,risk
Perphenazine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Perphenazine.,increase,risk
Perphenazine,Butaperazine,The risk or severity of CNS depression can be increased when Perphenazine is combined with Butaperazine.,increase,risk
Perphenazine,Butobarbital,The risk or severity of CNS depression can be increased when Perphenazine is combined with Butobarbital.,increase,risk
Perphenazine,Butorphanol,The risk or severity of hypotension and CNS depression can be increased when Perphenazine is combined with Butorphanol.,increase,risk
Perphenazine,Butriptyline,The serum concentration of Butriptyline can be increased when it is combined with Perphenazine.,increase,no risk
Perphenazine,Gabapentin,The risk or severity of CNS depression can be increased when Perphenazine is combined with Gabapentin.,increase,risk
Perphenazine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Perphenazine is combined with Gabapentin enacarbil.,increase,risk
Perphenazine,Galantamine,The metabolism of Galantamine can be decreased when combined with Perphenazine.,decrease,no risk
Perphenazine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Perphenazine.,increase,risk
Perphenazine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Perphenazine is combined with Ganaxolone.",increase,risk
Perphenazine,Gatifloxacin,The metabolism of Perphenazine can be decreased when combined with Gatifloxacin.,decrease,no risk
Perphenazine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Perphenazine.,decrease,no risk
Perphenazine,Gemfibrozil,The metabolism of Perphenazine can be decreased when combined with Gemfibrozil.,decrease,no risk
Perphenazine,Gemifloxacin,The metabolism of Perphenazine can be decreased when combined with Gemifloxacin.,decrease,no risk
Perphenazine,Gepirone,The risk or severity of CNS depression can be increased when Perphenazine is combined with Gepirone.,increase,risk
Perphenazine,Givosiran,The serum concentration of Perphenazine can be increased when it is combined with Givosiran.,increase,no risk
Perphenazine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Perphenazine.,decrease,no risk
Perphenazine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Perphenazine.,decrease,no risk
Perphenazine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Perphenazine.,decrease,no risk
Perphenazine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Perphenazine.,decrease,no risk
Perphenazine,Glofitamab,The serum concentration of Perphenazine can be increased when it is combined with Glofitamab.,increase,no risk
Perphenazine,Glutethimide,The risk or severity of CNS depression can be increased when Perphenazine is combined with Glutethimide.,increase,risk
Perphenazine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Perphenazine.,decrease,no risk
Perphenazine,Glycerol phenylbutyrate,The metabolism of Perphenazine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Perphenazine,Golimumab,The metabolism of Perphenazine can be increased when combined with Golimumab.,increase,no risk
Perphenazine,Granisetron,The risk or severity of CNS depression can be increased when Perphenazine is combined with Granisetron.,increase,risk
Perphenazine,Grepafloxacin,The metabolism of Perphenazine can be decreased when combined with Grepafloxacin.,decrease,no risk
Perphenazine,Guanabenz,The metabolism of Perphenazine can be decreased when combined with Guanabenz.,decrease,no risk
Perphenazine,Guanfacine,The risk or severity of CNS depression can be increased when Perphenazine is combined with Guanfacine.,increase,risk
Perphenazine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Perphenazine.,increase,risk
Perphenazine,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Perphenazine.,increase,risk
Perphenazine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Perphenazine.,increase,risk
Perphenazine,Halothane,The risk or severity of CNS depression can be increased when Perphenazine is combined with Halothane.,increase,risk
Perphenazine,Hexafluronium,The risk or severity of CNS depression can be increased when Perphenazine is combined with Hexafluronium.,increase,risk
Perphenazine,Hydrocodone,Perphenazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Perphenazine,Hydromorphone,The risk or severity of hypotension and CNS depression can be increased when Perphenazine is combined with Hydromorphone.,increase,risk
Perphenazine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Perphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Perphenazine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Perphenazine.,increase,risk
Perphenazine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Perphenazine.,increase,no risk
Perphenazine,Hyoscyamine,Perphenazine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Perphenazine,Ketamine,The risk or severity of CNS depression can be increased when Perphenazine is combined with Ketamine.,increase,risk
Perphenazine,Ketazolam,The risk or severity of CNS depression can be increased when Perphenazine is combined with Ketazolam.,increase,risk
Perphenazine,Ketoconazole,The metabolism of Perphenazine can be decreased when combined with Ketoconazole.,decrease,no risk
Perphenazine,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Perphenazine.,increase,no risk
Perphenazine,Nabumetone,The metabolism of Perphenazine can be decreased when combined with Nabumetone.,decrease,no risk
Perphenazine,Nadolol,The serum concentration of Nadolol can be increased when it is combined with Perphenazine.,increase,no risk
Perphenazine,Nafcillin,The metabolism of Perphenazine can be increased when combined with Nafcillin.,increase,no risk
Perphenazine,Nalbuphine,The risk or severity of hypotension and CNS depression can be increased when Perphenazine is combined with Nalbuphine.,increase,risk
Perphenazine,Nalidixic acid,The metabolism of Perphenazine can be decreased when combined with Nalidixic acid.,decrease,no risk
Perphenazine,Naloxegol,The risk or severity of hypotension and CNS depression can be increased when Perphenazine is combined with Naloxegol.,increase,risk
Perphenazine,Naltrexone,The risk or severity of hypotension and CNS depression can be increased when Perphenazine is combined with Naltrexone.,increase,risk
Perphenazine,Naproxen,The metabolism of Perphenazine can be decreased when combined with Naproxen.,decrease,no risk
Perphenazine,Naratriptan,The risk or severity of adverse effects can be increased when Naratriptan is combined with Perphenazine.,increase,risk
Perphenazine,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Perphenazine.,decrease,no risk
Perphenazine,Naxitamab,Perphenazine may increase the neurotoxic activities of Naxitamab.,increase,no risk
Perphenazine,Nebivolol,The serum concentration of Nebivolol can be increased when it is combined with Perphenazine.,increase,no risk
Perphenazine,Nefazodone,The risk or severity of adverse effects can be increased when Perphenazine is combined with Nefazodone.,increase,risk
Perphenazine,Neomycin,Perphenazine may increase the neurotoxic activities of Neomycin.,increase,no risk
Perphenazine,Netupitant,The metabolism of Netupitant can be decreased when combined with Perphenazine.,decrease,no risk
Perphenazine,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Perphenazine.,decrease,no risk
Perphenazine,Niacin,The metabolism of Perphenazine can be decreased when combined with Niacin.,decrease,no risk
Perphenazine,Nialamide,The risk or severity of extrapyramidal symptoms can be increased when Nialamide is combined with Perphenazine.,increase,risk
Perphenazine,Nicardipine,The metabolism of Perphenazine can be decreased when combined with Nicardipine.,decrease,no risk
Perphenazine,Nicergoline,The metabolism of Nicergoline can be decreased when combined with Perphenazine.,decrease,no risk
Perphenazine,Niclosamide,The metabolism of Perphenazine can be decreased when combined with Niclosamide.,decrease,no risk
Perphenazine,Nifedipine,The metabolism of Nifedipine can be decreased when combined with Perphenazine.,decrease,no risk
Perphenazine,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Perphenazine.,decrease,no risk
Perphenazine,Nitrazepam,The risk or severity of CNS depression can be increased when Perphenazine is combined with Nitrazepam.,increase,risk
Perphenazine,Nitrous oxide,The risk or severity of CNS depression can be increased when Perphenazine is combined with Nitrous oxide.,increase,risk
Perphenazine,Nomifensine,The risk or severity of CNS depression can be increased when Perphenazine is combined with Nomifensine.,increase,risk
Perphenazine,Norfloxacin,The metabolism of Perphenazine can be decreased when combined with Norfloxacin.,decrease,no risk
Perphenazine,Normethadone,The risk or severity of hypotension and CNS depression can be increased when Perphenazine is combined with Normethadone.,increase,risk
Perphenazine,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Perphenazine.,increase,no risk
Perphenazine,Obeticholic acid,The metabolism of Perphenazine can be decreased when combined with Obeticholic acid.,decrease,no risk
Perphenazine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Perphenazine.,increase,risk
Perphenazine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Perphenazine is combined with Oliceridine.",increase,risk
Perphenazine,Ondansetron,The risk or severity of CNS depression can be increased when Perphenazine is combined with Ondansetron.,increase,risk
Perphenazine,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Perphenazine.,decrease,no risk
Perphenazine,Opium,The risk or severity of hypotension and CNS depression can be increased when Perphenazine is combined with Opium.,increase,risk
Perphenazine,Oritavancin,The metabolism of Perphenazine can be decreased when combined with Oritavancin.,decrease,no risk
Perphenazine,Orphenadrine,Perphenazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Perphenazine,Osilodrostat,The metabolism of Perphenazine can be decreased when combined with Osilodrostat.,decrease,no risk
Perphenazine,Osimertinib,The serum concentration of Perphenazine can be decreased when it is combined with Osimertinib.,decrease,no risk
Perphenazine,Ospemifene,The metabolism of Perphenazine can be decreased when combined with Ospemifene.,decrease,no risk
Perphenazine,Oxamniquine,The metabolism of Perphenazine can be decreased when combined with Oxamniquine.,decrease,no risk
Perphenazine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Perphenazine.,increase,risk
Perphenazine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Perphenazine.,increase,risk
Perphenazine,Oxitriptan,The risk or severity of CNS depression can be increased when Perphenazine is combined with Oxitriptan.,increase,risk
Perphenazine,Oxprenolol,The serum concentration of Oxprenolol can be increased when it is combined with Perphenazine.,increase,no risk
Perphenazine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Perphenazine.,decrease,no risk
Perphenazine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Perphenazine is combined with Oxybuprocaine.,increase,risk
Perphenazine,Oxybutynin,The metabolism of Perphenazine can be decreased when combined with Oxybutynin.,decrease,no risk
Perphenazine,Oxycodone,The risk or severity of hypotension and CNS depression can be increased when Perphenazine is combined with Oxycodone.,increase,risk
Perphenazine,Oxymorphone,The risk or severity of hypotension and CNS depression can be increased when Perphenazine is combined with Oxymorphone.,increase,risk
Perphenazine,Quazepam,The risk or severity of CNS depression can be increased when Perphenazine is combined with Quazepam.,increase,risk
Perphenazine,Quetiapine,The risk or severity of CNS depression can be increased when Perphenazine is combined with Quetiapine.,increase,risk
Perphenazine,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Perphenazine.,decrease,no risk
Perphenazine,Quinidine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Perphenazine.,increase,risk
Perphenazine,Quinine,The metabolism of Perphenazine can be decreased when combined with Quinine.,decrease,no risk
Perphenazine,Quinupramine,The serum concentration of Quinupramine can be increased when it is combined with Perphenazine.,increase,no risk
Perphenazine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Perphenazine.,decrease,no risk
Perphenazine,Urethane,The risk or severity of CNS depression can be increased when Perphenazine is combined with Urethane.,increase,risk
Perphenazine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Perphenazine.,decrease,no risk
Perphenazine,Valproate bismuth,Perphenazine may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Perphenazine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Perphenazine.,increase,risk
Perphenazine,Vecuronium,The risk or severity of CNS depression can be increased when Perphenazine is combined with Vecuronium.,increase,risk
Perphenazine,Vemurafenib,The serum concentration of Perphenazine can be increased when it is combined with Vemurafenib.,increase,no risk
Perphenazine,Venlafaxine,The metabolism of Perphenazine can be decreased when combined with Venlafaxine.,decrease,no risk
Perphenazine,Verapamil,The metabolism of Perphenazine can be decreased when combined with Verapamil.,decrease,no risk
Perphenazine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Perphenazine.,decrease,no risk
Perphenazine,Vigabatrin,The risk or severity of CNS depression can be increased when Perphenazine is combined with Vigabatrin.,increase,risk
Perphenazine,Vilazodone,The metabolism of Perphenazine can be decreased when combined with Vilazodone.,decrease,no risk
Perphenazine,Viloxazine,The metabolism of Perphenazine can be decreased when combined with Viloxazine.,decrease,no risk
Perphenazine,Vinblastine,The metabolism of Perphenazine can be decreased when combined with Vinblastine.,decrease,no risk
Perphenazine,Vincristine,Vincristine may increase the neurotoxic activities of Perphenazine.,increase,no risk
Perphenazine,Vinorelbine,The metabolism of Perphenazine can be decreased when combined with Vinorelbine.,decrease,no risk
Perphenazine,Viomycin,Perphenazine may increase the neurotoxic activities of Viomycin.,increase,no risk
Perphenazine,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Perphenazine.,increase,risk
Perphenazine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Perphenazine.,decrease,no risk
Perphenazine,Warfarin,The metabolism of Perphenazine can be decreased when combined with Warfarin.,decrease,no risk
Perphenazine,Yohimbine,The risk or severity of CNS depression can be increased when Perphenazine is combined with Yohimbine.,increase,risk
Perphenazine,Zaleplon,The risk or severity of CNS depression can be increased when Perphenazine is combined with Zaleplon.,increase,risk
Perphenazine,Ziconotide,The risk or severity of CNS depression can be increased when Perphenazine is combined with Ziconotide.,increase,risk
Perphenazine,Zileuton,The metabolism of Perphenazine can be decreased when combined with Zileuton.,decrease,no risk
Perphenazine,Zimelidine,The risk or severity of adverse effects can be increased when Perphenazine is combined with Zimelidine.,increase,risk
Perphenazine,Ziprasidone,The risk or severity of adverse effects can be increased when Perphenazine is combined with Ziprasidone.,increase,risk
Perphenazine,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Perphenazine.,increase,risk
Perphenazine,Zolpidem,Perphenazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Perphenazine,Zonisamide,The risk or severity of CNS depression can be increased when Perphenazine is combined with Zonisamide.,increase,risk
Perphenazine,Zopiclone,The risk or severity of adverse effects can be increased when Perphenazine is combined with Zopiclone.,increase,risk
Perphenazine,Zotepine,The risk or severity of CNS depression can be increased when Perphenazine is combined with Zotepine.,increase,risk
Perphenazine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Perphenazine is combined with Zuclopenthixol.,increase,risk
Perphenazine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Perphenazine.,increase,risk
Dacarbazine,Bendamustine,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Bendamustine.,increase,risk
Dacarbazine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dacarbazine,Benorilate,Benorilate may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Benserazide,Dacarbazine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Dacarbazine,Benzatropine,Benzatropine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Benznidazole,Dacarbazine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Dacarbazine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Benzocaine.,increase,risk
Dacarbazine,Benzthiazide,Benzthiazide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dacarbazine,Benzydamine,Benzydamine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Benzyl alcohol.,increase,risk
Dacarbazine,Bepotastine,Dacarbazine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Dacarbazine.,increase,risk
Dacarbazine,Betaxolol,The metabolism of Dacarbazine can be decreased when combined with Betaxolol.,decrease,no risk
Dacarbazine,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Dacarbazine.,increase,risk
Dacarbazine,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Dacarbazine.,increase,risk
Dacarbazine,Bicisate,Dacarbazine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Dacarbazine,Bimekizumab,The metabolism of Dacarbazine can be increased when combined with Bimekizumab.,increase,no risk
Dacarbazine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Dacarbazine.,decrease,no risk
Dacarbazine,Bismuth subgallate,Dacarbazine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Dacarbazine,Bisoprolol,Bisoprolol may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Bisoxatin,Dacarbazine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Dacarbazine,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Dacarbazine.,increase,risk
Dacarbazine,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Dacarbazine.,increase,risk
Dacarbazine,Blinatumomab,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Blinatumomab.,increase,risk
Dacarbazine,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Dacarbazine.",decrease,no risk
Dacarbazine,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Dacarbazine.,increase,risk
Dacarbazine,Bosutinib,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Bosutinib.,increase,risk
Dacarbazine,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Brentuximab vedotin.,increase,risk
Dacarbazine,Brivaracetam,Dacarbazine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Dacarbazine,Brodalumab,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Brodalumab.,increase,risk
Dacarbazine,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Dacarbazine.,decrease,no risk
Dacarbazine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dacarbazine,Budesonide,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Budesonide.,increase,risk
Dacarbazine,Bumadizone,Bumadizone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Bumetanide,Bumetanide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dacarbazine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Bupivacaine.,increase,risk
Dacarbazine,Bupropion,Dacarbazine may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Dacarbazine,Buspirone,Buspirone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Busulfan,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Busulfan.,increase,risk
Dacarbazine,Butabarbital,Butabarbital may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Butacaine,The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Butacaine.,increase,risk
Dacarbazine,Butamben,The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Butamben.,increase,risk
Dacarbazine,Gabapentin enacarbil,Dacarbazine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Dacarbazine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Gadodiamide,Gadodiamide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Gadofosveset trisodium,Dacarbazine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Dacarbazine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Gadoteric acid,Dacarbazine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Dacarbazine,Gadoteridol,Gadoteridol may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Ganciclovir,Dacarbazine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Dacarbazine,Gatifloxacin,The metabolism of Dacarbazine can be decreased when combined with Gatifloxacin.,decrease,no risk
Dacarbazine,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Dacarbazine.,increase,risk
Dacarbazine,Gemfibrozil,The metabolism of Dacarbazine can be decreased when combined with Gemfibrozil.,decrease,no risk
Dacarbazine,Gemifloxacin,The metabolism of Dacarbazine can be decreased when combined with Gemifloxacin.,decrease,no risk
Dacarbazine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dacarbazine.,increase,risk
Dacarbazine,Gentamicin,Dacarbazine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Dacarbazine,Gimeracil,Dacarbazine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Dacarbazine,Givosiran,The serum concentration of Dacarbazine can be increased when it is combined with Givosiran.,increase,no risk
Dacarbazine,Glatiramer,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Glatiramer.,increase,risk
Dacarbazine,Glipizide,Dacarbazine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Dacarbazine,Glofitamab,The serum concentration of Dacarbazine can be increased when it is combined with Glofitamab.,increase,no risk
Dacarbazine,Glycerol phenylbutyrate,Dacarbazine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Dacarbazine,Golimumab,The metabolism of Dacarbazine can be increased when combined with Golimumab.,increase,no risk
Dacarbazine,Golodirsen,Dacarbazine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Dacarbazine,Goserelin,Goserelin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Grepafloxacin,The metabolism of Dacarbazine can be decreased when combined with Grepafloxacin.,decrease,no risk
Dacarbazine,Guanabenz,The metabolism of Dacarbazine can be decreased when combined with Guanabenz.,decrease,no risk
Dacarbazine,Guanethidine,Dacarbazine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Guanfacine,Dacarbazine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Guselkumab,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Guselkumab.,increase,risk
Dacarbazine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Dacarbazine.,decrease,no risk
Dacarbazine,Haloperidol,The metabolism of Dacarbazine can be decreased when combined with Haloperidol.,decrease,no risk
Dacarbazine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Dacarbazine.,increase,risk
Dacarbazine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Dacarbazine.,decrease,no risk
Dacarbazine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Dacarbazine.,decrease,no risk
Dacarbazine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Dacarbazine.,increase,risk
Dacarbazine,Hydralazine,Dacarbazine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dacarbazine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Hydrocortisone acetate.,increase,risk
Dacarbazine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Hydrocortisone butyrate.,increase,risk
Dacarbazine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Hydrocortisone succinate.,increase,risk
Dacarbazine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dacarbazine,Hydromorphone,Hydromorphone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Hydroxychloroquine.,increase,risk
Dacarbazine,Hydroxyethyl Starch,Dacarbazine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Dacarbazine,Hydroxyurea,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Hydroxyurea.,increase,risk
Dacarbazine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Dacarbazine.,decrease,no risk
Dacarbazine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Dacarbazine.,decrease,no risk
Dacarbazine,Kanamycin,Dacarbazine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Dacarbazine,Ketamine,Dacarbazine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Ketazolam,Dacarbazine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Dacarbazine,Ketoconazole,The metabolism of Dacarbazine can be decreased when combined with Ketoconazole.,decrease,no risk
Dacarbazine,Ketoprofen,Ketoprofen may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Ketorolac,Ketorolac may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,N-acetyltyrosine,Dacarbazine may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Nabumetone,The metabolism of Dacarbazine can be decreased when combined with Nabumetone.,decrease,no risk
Dacarbazine,Nadolol,Dacarbazine may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Dacarbazine,Nadroparin,The risk or severity of bleeding can be increased when Nadroparin is combined with Dacarbazine.,increase,risk
Dacarbazine,Nafcillin,The metabolism of Dacarbazine can be increased when combined with Nafcillin.,increase,no risk
Dacarbazine,Naldemedine,Dacarbazine may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Nalidixic acid,The metabolism of Dacarbazine can be decreased when combined with Nalidixic acid.,decrease,no risk
Dacarbazine,Nalmefene,Dacarbazine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Dacarbazine,Naloxone,Dacarbazine may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Dacarbazine,Naproxen,The metabolism of Dacarbazine can be decreased when combined with Naproxen.,decrease,no risk
Dacarbazine,Natalizumab,The risk or severity of immunosuppression can be increased when Dacarbazine is combined with Natalizumab.,increase,risk
Dacarbazine,Nateglinide,Nateglinide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Nedaplatin,Dacarbazine may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Dacarbazine,Nedocromil,Nedocromil may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Nefazodone,Dacarbazine may decrease the excretion rate of Nefazodone which could result in a higher serum level.,decrease,no risk
Dacarbazine,Nelarabine,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Nelarabine.,increase,risk
Dacarbazine,Neomycin,Dacarbazine may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Dacarbazine,Netilmicin,Dacarbazine may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Dacarbazine,Nevirapine,The metabolism of Dacarbazine can be decreased when combined with Nevirapine.,decrease,no risk
Dacarbazine,Niclosamide,The metabolism of Dacarbazine can be decreased when combined with Niclosamide.,decrease,no risk
Dacarbazine,Nicorandil,Dacarbazine may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Dacarbazine,Nifedipine,The metabolism of Nifedipine can be decreased when combined with Dacarbazine.,decrease,no risk
Dacarbazine,Nilotinib,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Nilotinib.,increase,risk
Dacarbazine,Nilutamide,Nilutamide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Nimesulide,The risk or severity of bleeding can be increased when Nimesulide is combined with Dacarbazine.,increase,risk
Dacarbazine,Nisoldipine,Nisoldipine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Nitroprusside,Nitroprusside may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Norfloxacin,The metabolism of Dacarbazine can be decreased when combined with Norfloxacin.,decrease,no risk
Dacarbazine,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Dacarbazine.,decrease,no risk
Dacarbazine,Obeticholic acid,The risk or severity of adverse effects can be increased when Obeticholic acid is combined with Dacarbazine.,increase,risk
Dacarbazine,Obinutuzumab,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Obinutuzumab.,increase,risk
Dacarbazine,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Dacarbazine.,increase,no risk
Dacarbazine,Octinoxate,Dacarbazine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Dacarbazine,Ofatumumab,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Ofatumumab.,increase,risk
Dacarbazine,Olanzapine,The metabolism of Dacarbazine can be decreased when combined with Olanzapine.,decrease,no risk
Dacarbazine,Olaparib,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Olaparib.,increase,risk
Dacarbazine,Olsalazine,Olsalazine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Dacarbazine.,decrease,no risk
Dacarbazine,Opium,Dacarbazine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Dacarbazine,Orphenadrine,The metabolism of Dacarbazine can be decreased when combined with Orphenadrine.,decrease,no risk
Dacarbazine,Oseltamivir,Oseltamivir may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Osilodrostat,The serum concentration of Dacarbazine can be increased when it is combined with Osilodrostat.,increase,no risk
Dacarbazine,Osimertinib,The serum concentration of Dacarbazine can be decreased when it is combined with Osimertinib.,decrease,no risk
Dacarbazine,Oxacillin,Oxacillin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Dacarbazine.,increase,risk
Dacarbazine,Oxaprozin,Oxaprozin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Oxazepam,Oxazepam may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Oxetacaine.,increase,risk
Dacarbazine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Dacarbazine.,decrease,no risk
Dacarbazine,Oxybenzone,Dacarbazine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Dacarbazine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Oxybuprocaine.,increase,risk
Dacarbazine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Oxyquinoline,Dacarbazine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Dacarbazine,Ozanimod,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Ozanimod.,increase,risk
Dacarbazine,Quetiapine,Dacarbazine may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Quinethazone,Quinethazone may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dacarbazine,Quinidine,The metabolism of Dacarbazine can be decreased when combined with Quinidine.,decrease,no risk
Dacarbazine,Quinine,The metabolism of Dacarbazine can be decreased when combined with Quinine.,decrease,no risk
Dacarbazine,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Dacarbazine.,increase,risk
Dacarbazine,Upadacitinib,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Upadacitinib.,increase,risk
Dacarbazine,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Dacarbazine.,increase,risk
Dacarbazine,Vaborbactam,Dacarbazine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Dacarbazine,Valaciclovir,Valaciclovir may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Valbenazine,Dacarbazine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Valdecoxib,Valdecoxib may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Valganciclovir,Dacarbazine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Dacarbazine,Valproic acid,The metabolism of Dacarbazine can be decreased when combined with Valproic acid.,decrease,no risk
Dacarbazine,Vancomycin,Dacarbazine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Dacarbazine,Varenicline,Dacarbazine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Dacarbazine,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Dacarbazine.,increase,risk
Dacarbazine,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Dacarbazine.,decrease,no risk
Dacarbazine,Vedolizumab,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Vedolizumab.,increase,risk
Dacarbazine,Vemurafenib,The serum concentration of Dacarbazine can be increased when it is combined with Vemurafenib.,increase,no risk
Dacarbazine,Venlafaxine,Venlafaxine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Verapamil,The metabolism of Dacarbazine can be decreased when combined with Verapamil.,decrease,no risk
Dacarbazine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Dacarbazine.,decrease,no risk
Dacarbazine,Vilanterol,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Vilanterol.,increase,risk
Dacarbazine,Viloxazine,The metabolism of Dacarbazine can be decreased when combined with Viloxazine.,decrease,no risk
Dacarbazine,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Dacarbazine.,increase,risk
Dacarbazine,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Dacarbazine.,increase,risk
Dacarbazine,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Dacarbazine.,increase,risk
Dacarbazine,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Dacarbazine.,increase,risk
Dacarbazine,Voclosporin,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Voclosporin.,increase,risk
Dacarbazine,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Dacarbazine.,increase,risk
Dacarbazine,Vorinostat,The risk or severity of adverse effects can be increased when Dacarbazine is combined with Vorinostat.,increase,risk
Dacarbazine,Vortioxetine,Dacarbazine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Dacarbazine.,decrease,no risk
Dacarbazine,Warfarin,The metabolism of Dacarbazine can be decreased when combined with Warfarin.,decrease,no risk
Dacarbazine,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Dacarbazine.,increase,risk
Dacarbazine,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Dacarbazine.,increase,risk
Dacarbazine,Zaleplon,Dacarbazine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Dacarbazine,Zanamivir,Zanamivir may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,decrease,no risk
Dacarbazine,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Dacarbazine.,increase,risk
Dacarbazine,Zileuton,The metabolism of Dacarbazine can be decreased when combined with Zileuton.,decrease,no risk
Dacarbazine,Zolmitriptan,The metabolism of Dacarbazine can be decreased when combined with Zolmitriptan.,decrease,no risk
Dacarbazine,Zolpidem,The metabolism of Dacarbazine can be decreased when combined with Zolpidem.,decrease,no risk
Dacarbazine,Zonisamide,Zonisamide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dacarbazine,Zotepine,The metabolism of Zotepine can be decreased when combined with Dacarbazine.,decrease,no risk
Pseudoephedrine,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Pseudoephedrine.,increase,risk
Pseudoephedrine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Pseudoephedrine.,increase,risk
Pseudoephedrine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Glutamic acid,The serum concentration of Pseudoephedrine can be decreased when it is combined with Glutamic acid.,decrease,no risk
Pseudoephedrine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Pseudoephedrine is combined with Glycopyrronium.,increase,risk
Pseudoephedrine,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Granisetron,The risk or severity of serotonin syndrome can be increased when Pseudoephedrine is combined with Granisetron.,increase,risk
Pseudoephedrine,Guanabenz,Pseudoephedrine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Pseudoephedrine,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Guanethidine,The serum concentration of Pseudoephedrine can be decreased when it is combined with Guanethidine.,decrease,no risk
Pseudoephedrine,Guanfacine,Pseudoephedrine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Pseudoephedrine,Guanoxan,Pseudoephedrine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Pseudoephedrine,Haloperidol,The therapeutic efficacy of Pseudoephedrine can be decreased when used in combination with Haloperidol.,decrease,no risk
Pseudoephedrine,Halothane,The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Halothane.,increase,risk
Pseudoephedrine,Hexocyclium,The risk or severity of Tachycardia can be increased when Pseudoephedrine is combined with Hexocyclium.,increase,risk
Pseudoephedrine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Pseudoephedrine.,increase,risk
Pseudoephedrine,Hydralazine,Pseudoephedrine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Pseudoephedrine,Hydrochlorothiazide,Pseudoephedrine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Pseudoephedrine,Hydroflumethiazide,Pseudoephedrine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Pseudoephedrine,Hydromorphone,Pseudoephedrine may increase the analgesic activities of Hydromorphone.,increase,no risk
Pseudoephedrine,Hydrotalcite,The serum concentration of Pseudoephedrine can be increased when it is combined with Hydrotalcite.,increase,no risk
Pseudoephedrine,Hydroxyzine,Pseudoephedrine may decrease the sedative activities of Hydroxyzine.,decrease,no risk
Pseudoephedrine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Pseudoephedrine.,increase,risk
Pseudoephedrine,Ketamine,The risk or severity of Tachycardia can be increased when Pseudoephedrine is combined with Ketamine.,increase,risk
Pseudoephedrine,Ketoprofen,The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Ketoprofen.,increase,risk
Pseudoephedrine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Pseudoephedrine.,increase,risk
Pseudoephedrine,Ketotifen,Pseudoephedrine may decrease the sedative activities of Ketotifen.,decrease,no risk
Pseudoephedrine,Nabilone,The risk or severity of Tachycardia can be increased when Nabilone is combined with Pseudoephedrine.,increase,risk
Pseudoephedrine,Nabumetone,The risk or severity of hypertension can be increased when Nabumetone is combined with Pseudoephedrine.,increase,risk
Pseudoephedrine,Nadolol,The therapeutic efficacy of Nadolol can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Nalbuphine,Pseudoephedrine may increase the analgesic activities of Nalbuphine.,increase,no risk
Pseudoephedrine,Naloxegol,Pseudoephedrine may increase the analgesic activities of Naloxegol.,increase,no risk
Pseudoephedrine,Naltrexone,Pseudoephedrine may increase the analgesic activities of Naltrexone.,increase,no risk
Pseudoephedrine,Naphazoline,The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Naphazoline.,increase,risk
Pseudoephedrine,Naratriptan,The metabolism of Naratriptan can be decreased when combined with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Nateglinide,The therapeutic efficacy of Nateglinide can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Naxitamab,The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Naxitamab.,increase,risk
Pseudoephedrine,Nebivolol,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Nefazodone,The therapeutic efficacy of Nefazodone can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Niacinamide ascorbate,The serum concentration of Pseudoephedrine can be decreased when it is combined with Niacinamide ascorbate.,decrease,no risk
Pseudoephedrine,Nialamide,Nialamide may increase the hypertensive activities of Pseudoephedrine.,increase,no risk
Pseudoephedrine,Nicardipine,The therapeutic efficacy of Nicardipine can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Nicergoline,The therapeutic efficacy of Nicergoline can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Nicorandil,Pseudoephedrine may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Pseudoephedrine,Nicotine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Pseudoephedrine.,increase,risk
Pseudoephedrine,Nilvadipine,Pseudoephedrine may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Pseudoephedrine,Nimesulide,The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Nimesulide.,increase,risk
Pseudoephedrine,Nimodipine,Pseudoephedrine may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Pseudoephedrine,Nisoldipine,Pseudoephedrine may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Pseudoephedrine,Nitrendipine,Pseudoephedrine may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Pseudoephedrine,Nitroglycerin,Pseudoephedrine may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Pseudoephedrine,Nitroprusside,Pseudoephedrine may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Pseudoephedrine,Nitrous oxide,The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Nitrous oxide.,increase,risk
Pseudoephedrine,Nizatidine,Pseudoephedrine may decrease the sedative activities of Nizatidine.,decrease,no risk
Pseudoephedrine,Norepinephrine,The therapeutic efficacy of Pseudoephedrine can be increased when used in combination with Norepinephrine.,increase,no risk
Pseudoephedrine,Normethadone,Pseudoephedrine may increase the analgesic activities of Normethadone.,increase,no risk
Pseudoephedrine,Nortriptyline,Pseudoephedrine may decrease the sedative activities of Nortriptyline.,decrease,no risk
Pseudoephedrine,Nylidrin,The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Nylidrin.,increase,risk
Pseudoephedrine,Olanzapine,Pseudoephedrine may decrease the sedative activities of Olanzapine.,decrease,no risk
Pseudoephedrine,Oliceridine,The risk or severity of serotonin syndrome can be increased when Pseudoephedrine is combined with Oliceridine.,increase,risk
Pseudoephedrine,Olmesartan,Pseudoephedrine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Pseudoephedrine,Olodaterol,The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Olodaterol.,increase,risk
Pseudoephedrine,Ondansetron,The risk or severity of serotonin syndrome can be increased when Pseudoephedrine is combined with Ondansetron.,increase,risk
Pseudoephedrine,Opium,Pseudoephedrine may increase the analgesic activities of Opium.,increase,no risk
Pseudoephedrine,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Pseudoephedrine.,increase,risk
Pseudoephedrine,Orphenadrine,Pseudoephedrine may decrease the sedative activities of Orphenadrine.,decrease,no risk
Pseudoephedrine,Oxaprozin,The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Oxaprozin.,increase,risk
Pseudoephedrine,Oxatomide,Pseudoephedrine may decrease the sedative activities of Oxatomide.,decrease,no risk
Pseudoephedrine,Oxprenolol,The therapeutic efficacy of Oxprenolol can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Oxtriphylline,The risk or severity of adverse effects can be increased when Pseudoephedrine is combined with Oxtriphylline.,increase,risk
Pseudoephedrine,Oxybutynin,The risk or severity of Tachycardia can be increased when Pseudoephedrine is combined with Oxybutynin.,increase,risk
Pseudoephedrine,Oxycodone,Pseudoephedrine may increase the analgesic activities of Oxycodone.,increase,no risk
Pseudoephedrine,Oxymetazoline,The absorption of Pseudoephedrine can be decreased when combined with Oxymetazoline.,decrease,no risk
Pseudoephedrine,Oxymorphone,Pseudoephedrine may increase the analgesic activities of Oxymorphone.,increase,no risk
Pseudoephedrine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Oxyphenbutazone.,increase,risk
Pseudoephedrine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Pseudoephedrine.,increase,risk
Pseudoephedrine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Pseudoephedrine.,increase,risk
Pseudoephedrine,Oxytocin,The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Oxytocin.,increase,risk
Pseudoephedrine,Quetiapine,Pseudoephedrine may decrease the sedative activities of Quetiapine.,decrease,no risk
Pseudoephedrine,Quinapril,Pseudoephedrine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Pseudoephedrine,Quinidine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Quinupramine,The therapeutic efficacy of Quinupramine can be increased when used in combination with Pseudoephedrine.,increase,no risk
Pseudoephedrine,Umeclidinium,The risk or severity of Tachycardia can be increased when Pseudoephedrine is combined with Umeclidinium.,increase,risk
Pseudoephedrine,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Pseudoephedrine.,increase,risk
Pseudoephedrine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Pseudoephedrine is combined with Valproate bismuth.,increase,risk
Pseudoephedrine,Valproic acid,The risk or severity of serotonin syndrome can be increased when Valproic acid is combined with Pseudoephedrine.,increase,risk
Pseudoephedrine,Valsartan,Pseudoephedrine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Pseudoephedrine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Pseudoephedrine is combined with Venlafaxine.,increase,risk
Pseudoephedrine,Verapamil,The therapeutic efficacy of Verapamil can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Vilanterol,The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Vilanterol.,increase,risk
Pseudoephedrine,Vilazodone,The risk or severity of serotonin syndrome can be increased when Pseudoephedrine is combined with Vilazodone.,increase,risk
Pseudoephedrine,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Vortioxetine,The risk or severity of serotonin syndrome can be increased when Pseudoephedrine is combined with Vortioxetine.,increase,risk
Pseudoephedrine,Xamoterol,The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Xamoterol.,increase,risk
Pseudoephedrine,Xylometazoline,The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Xylometazoline.,increase,risk
Pseudoephedrine,Yohimbine,The therapeutic efficacy of Yohimbine can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Zimelidine,The risk or severity of serotonin syndrome can be increased when Pseudoephedrine is combined with Zimelidine.,increase,risk
Pseudoephedrine,Zinc ascorbate,The serum concentration of Pseudoephedrine can be decreased when it is combined with Zinc ascorbate.,decrease,no risk
Pseudoephedrine,Ziprasidone,Pseudoephedrine may decrease the sedative activities of Ziprasidone.,decrease,no risk
Pseudoephedrine,Zofenopril,Pseudoephedrine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Pseudoephedrine,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Zonisamide,Zonisamide may decrease the excretion rate of Pseudoephedrine which could result in a higher serum level.,decrease,no risk
Pseudoephedrine,Zotepine,Zotepine may decrease the stimulatory activities of Pseudoephedrine.,decrease,no risk
Pseudoephedrine,Zuclopenthixol,Pseudoephedrine may decrease the sedative activities of Zuclopenthixol.,decrease,no risk
Temozolomide,Bepotastine,Temozolomide may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Temozolomide,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Temozolomide.,increase,risk
Temozolomide,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Temozolomide.,increase,risk
Temozolomide,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Temozolomide.,increase,risk
Temozolomide,Bicisate,Temozolomide may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Temozolomide,Bimekizumab,The risk or severity of adverse effects can be increased when Temozolomide is combined with Bimekizumab.,increase,risk
Temozolomide,Bismuth subgallate,Temozolomide may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Temozolomide,Bisoprolol,Bisoprolol may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Bisoxatin,Temozolomide may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Temozolomide,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Temozolomide.,increase,risk
Temozolomide,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Temozolomide.,increase,risk
Temozolomide,Blinatumomab,The risk or severity of adverse effects can be increased when Temozolomide is combined with Blinatumomab.,increase,risk
Temozolomide,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Temozolomide.",decrease,no risk
Temozolomide,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Temozolomide.,increase,risk
Temozolomide,Bosutinib,The risk or severity of adverse effects can be increased when Temozolomide is combined with Bosutinib.,increase,risk
Temozolomide,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Temozolomide is combined with Brentuximab vedotin.,increase,risk
Temozolomide,Brivaracetam,Temozolomide may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Temozolomide,Brodalumab,The risk or severity of adverse effects can be increased when Temozolomide is combined with Brodalumab.,increase,risk
Temozolomide,Bromazepam,Temozolomide may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Temozolomide,Bromotheophylline,Bromotheophylline may increase the excretion rate of Temozolomide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Temozolomide,Budesonide,The risk or severity of adverse effects can be increased when Temozolomide is combined with Budesonide.,increase,risk
Temozolomide,Bumadizone,Bumadizone may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Bumetanide,Bumetanide may increase the excretion rate of Temozolomide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Temozolomide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Temozolomide is combined with Bupivacaine.,increase,risk
Temozolomide,Bupropion,Temozolomide may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Temozolomide,Buspirone,Buspirone may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Busulfan,The risk or severity of adverse effects can be increased when Temozolomide is combined with Busulfan.,increase,risk
Temozolomide,Butabarbital,Butabarbital may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Butacaine,The risk or severity of methemoglobinemia can be increased when Temozolomide is combined with Butacaine.,increase,risk
Temozolomide,Butamben,The risk or severity of methemoglobinemia can be increased when Temozolomide is combined with Butamben.,increase,risk
Temozolomide,Gabapentin enacarbil,Temozolomide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Temozolomide,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Gadodiamide,Gadodiamide may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Gadofosveset trisodium,Temozolomide may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Temozolomide,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Gadoteric acid,Temozolomide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Temozolomide,Gadoteridol,Gadoteridol may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Ganciclovir,Temozolomide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Temozolomide,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Temozolomide.,increase,risk
Temozolomide,Gemfibrozil,Temozolomide may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Temozolomide,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Temozolomide.,increase,risk
Temozolomide,Gentamicin,Temozolomide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Temozolomide,Gimeracil,Temozolomide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Temozolomide,Givosiran,Givosiran may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Glatiramer,The risk or severity of adverse effects can be increased when Temozolomide is combined with Glatiramer.,increase,risk
Temozolomide,Glipizide,Temozolomide may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Temozolomide,Glycerol phenylbutyrate,Temozolomide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Temozolomide,Golimumab,The risk or severity of adverse effects can be increased when Temozolomide is combined with Golimumab.,increase,risk
Temozolomide,Golodirsen,Temozolomide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Temozolomide,Goserelin,Goserelin may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Guanethidine,Temozolomide may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Temozolomide,Guanfacine,Temozolomide may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Temozolomide,Guselkumab,The risk or severity of adverse effects can be increased when Temozolomide is combined with Guselkumab.,increase,risk
Temozolomide,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Temozolomide.,decrease,no risk
Temozolomide,Haloperidol,Haloperidol may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Temozolomide.,increase,risk
Temozolomide,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Temozolomide.,decrease,no risk
Temozolomide,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Temozolomide.,decrease,no risk
Temozolomide,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Temozolomide.,increase,risk
Temozolomide,Hydralazine,Temozolomide may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Temozolomide,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Temozolomide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Temozolomide,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Temozolomide is combined with Hydrocortisone acetate.,increase,risk
Temozolomide,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Temozolomide is combined with Hydrocortisone butyrate.,increase,risk
Temozolomide,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Temozolomide is combined with Hydrocortisone succinate.,increase,risk
Temozolomide,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Temozolomide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Temozolomide,Hydromorphone,Hydromorphone may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Temozolomide is combined with Hydroxychloroquine.,increase,risk
Temozolomide,Hydroxyethyl Starch,Temozolomide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Temozolomide,Hydroxyurea,The risk or severity of adverse effects can be increased when Temozolomide is combined with Hydroxyurea.,increase,risk
Temozolomide,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Temozolomide.,decrease,no risk
Temozolomide,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Temozolomide.,decrease,no risk
Temozolomide,Kanamycin,Temozolomide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Temozolomide,Ketamine,Temozolomide may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Temozolomide,Ketazolam,Temozolomide may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Temozolomide,Ketoprofen,Ketoprofen may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Ketorolac,Ketorolac may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,N-acetyltyrosine,Temozolomide may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Temozolomide,Nabumetone,Nabumetone may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Nadolol,Temozolomide may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Temozolomide,Nadroparin,The risk or severity of bleeding can be increased when Nadroparin is combined with Temozolomide.,increase,risk
Temozolomide,Naldemedine,Temozolomide may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Temozolomide,Nalmefene,Temozolomide may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Temozolomide,Naloxone,Temozolomide may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Temozolomide,Naproxen,Naproxen may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Natalizumab,The risk or severity of immunosuppression can be increased when Temozolomide is combined with Natalizumab.,increase,risk
Temozolomide,Nateglinide,Nateglinide may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Nedaplatin,Temozolomide may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Temozolomide,Nedocromil,Nedocromil may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Nefazodone,Temozolomide may decrease the excretion rate of Nefazodone which could result in a higher serum level.,decrease,no risk
Temozolomide,Nelarabine,The risk or severity of adverse effects can be increased when Temozolomide is combined with Nelarabine.,increase,risk
Temozolomide,Neomycin,Temozolomide may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Temozolomide,Netilmicin,Temozolomide may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Temozolomide,Nicorandil,Temozolomide may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Temozolomide,Nifedipine,Temozolomide may decrease the excretion rate of Nifedipine which could result in a higher serum level.,decrease,no risk
Temozolomide,Nilotinib,The risk or severity of adverse effects can be increased when Temozolomide is combined with Nilotinib.,increase,risk
Temozolomide,Nilutamide,Nilutamide may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Nimesulide,The risk or severity of bleeding can be increased when Nimesulide is combined with Temozolomide.,increase,risk
Temozolomide,Nisoldipine,Nisoldipine may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Nitroprusside,Nitroprusside may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Temozolomide.,decrease,no risk
Temozolomide,Obinutuzumab,The risk or severity of adverse effects can be increased when Temozolomide is combined with Obinutuzumab.,increase,risk
Temozolomide,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Temozolomide.,increase,no risk
Temozolomide,Octinoxate,Temozolomide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Temozolomide,Ofatumumab,The risk or severity of adverse effects can be increased when Temozolomide is combined with Ofatumumab.,increase,risk
Temozolomide,Olaparib,The risk or severity of adverse effects can be increased when Temozolomide is combined with Olaparib.,increase,risk
Temozolomide,Olsalazine,Olsalazine may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Opium,Temozolomide may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Temozolomide,Oseltamivir,Oseltamivir may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Oxacillin,Oxacillin may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Temozolomide.,increase,risk
Temozolomide,Oxaprozin,Oxaprozin may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Oxazepam,Oxazepam may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Temozolomide is combined with Oxetacaine.,increase,risk
Temozolomide,Oxybenzone,Temozolomide may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Temozolomide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Temozolomide is combined with Oxybuprocaine.,increase,risk
Temozolomide,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Temozolomide which could result in a higher serum level.,decrease,no risk
Temozolomide,Oxyquinoline,Temozolomide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Temozolomide,Ozanimod,The risk or severity of adverse effects can be increased when Temozolomide is combined with Ozanimod.,increase,risk
Levorphanol,Gabapentin,The risk or severity of CNS depression can be increased when Levorphanol is combined with Gabapentin.,increase,risk
Levorphanol,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Levorphanol is combined with Gabapentin enacarbil.,increase,risk
Levorphanol,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Levorphanol.,increase,risk
Levorphanol,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Levorphanol is combined with Ganaxolone.",increase,risk
Levorphanol,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Levorphanol.,increase,risk
Levorphanol,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Levorphanol.,decrease,no risk
Levorphanol,Glutethimide,The risk or severity of CNS depression can be increased when Levorphanol is combined with Glutethimide.,increase,risk
Levorphanol,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Levorphanol.,decrease,no risk
Levorphanol,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Levorphanol.,increase,risk
Levorphanol,Granisetron,The risk or severity of CNS depression can be increased when Levorphanol is combined with Granisetron.,increase,risk
Levorphanol,Guanfacine,The risk or severity of CNS depression can be increased when Levorphanol is combined with Guanfacine.,increase,risk
Levorphanol,Halazepam,The risk or severity of adverse effects can be increased when Levorphanol is combined with Halazepam.,increase,risk
Levorphanol,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Levorphanol.,increase,risk
Levorphanol,Halothane,The risk or severity of CNS depression can be increased when Levorphanol is combined with Halothane.,increase,risk
Levorphanol,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Levorphanol.,increase,risk
Levorphanol,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Levorphanol.,increase,risk
Levorphanol,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Levorphanol.,increase,risk
Levorphanol,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Levorphanol.,decrease,no risk
Levorphanol,Hydrocodone,Levorphanol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Levorphanol,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Levorphanol.,decrease,no risk
Levorphanol,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Levorphanol.,increase,risk
Levorphanol,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Levorphanol.,increase,no risk
Levorphanol,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Levorphanol.,increase,risk
Levorphanol,Ketamine,The risk or severity of CNS depression can be increased when Levorphanol is combined with Ketamine.,increase,risk
Levorphanol,Ketazolam,The risk or severity of adverse effects can be increased when Levorphanol is combined with Ketazolam.,increase,risk
Levorphanol,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Levorphanol.,increase,no risk
Levorphanol,Nalbuphine,The therapeutic efficacy of Levorphanol can be decreased when used in combination with Nalbuphine.,decrease,no risk
Levorphanol,Naldemedine,The therapeutic efficacy of Levorphanol can be decreased when used in combination with Naldemedine.,decrease,no risk
Levorphanol,Nalmefene,The therapeutic efficacy of Levorphanol can be decreased when used in combination with Nalmefene.,decrease,no risk
Levorphanol,Naloxegol,The risk or severity of adverse effects can be increased when Levorphanol is combined with Naloxegol.,increase,risk
Levorphanol,Naloxone,The therapeutic efficacy of Levorphanol can be decreased when used in combination with Naloxone.,decrease,no risk
Levorphanol,Naltrexone,The risk or severity of adverse effects can be increased when Naltrexone is combined with Levorphanol.,increase,risk
Levorphanol,Naphazoline,Naphazoline may increase the central nervous system depressant (CNS depressant) activities of Levorphanol.,increase,no risk
Levorphanol,Naratriptan,The risk or severity of CNS depression can be increased when Levorphanol is combined with Naratriptan.,increase,risk
Levorphanol,Nefazodone,The risk or severity of serotonin syndrome can be increased when Levorphanol is combined with Nefazodone.,increase,risk
Levorphanol,Nialamide,The risk or severity of adverse effects can be increased when Levorphanol is combined with Nialamide.,increase,risk
Levorphanol,Nicardipine,The risk or severity of adverse effects can be increased when Nicardipine is combined with Levorphanol.,increase,risk
Levorphanol,Nitrazepam,The risk or severity of adverse effects can be increased when Levorphanol is combined with Nitrazepam.,increase,risk
Levorphanol,Nitrous oxide,The risk or severity of CNS depression can be increased when Levorphanol is combined with Nitrous oxide.,increase,risk
Levorphanol,Nomifensine,The risk or severity of CNS depression can be increased when Levorphanol is combined with Nomifensine.,increase,risk
Levorphanol,Normethadone,The risk or severity of adverse effects can be increased when Levorphanol is combined with Normethadone.,increase,risk
Levorphanol,Nortriptyline,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Levorphanol.,increase,risk
Levorphanol,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Levorphanol.,increase,risk
Levorphanol,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Levorphanol is combined with Oliceridine.",increase,risk
Levorphanol,Ondansetron,The risk or severity of CNS depression can be increased when Levorphanol is combined with Ondansetron.,increase,risk
Levorphanol,Opium,The risk or severity of adverse effects can be increased when Levorphanol is combined with Opium.,increase,risk
Levorphanol,Orphenadrine,Levorphanol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Levorphanol,Oxazepam,The risk or severity of adverse effects can be increased when Levorphanol is combined with Oxazepam.,increase,risk
Levorphanol,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Levorphanol.,increase,risk
Levorphanol,Oxitriptan,The risk or severity of CNS depression can be increased when Levorphanol is combined with Oxitriptan.,increase,risk
Levorphanol,Oxprenolol,The risk or severity of CNS depression can be increased when Levorphanol is combined with Oxprenolol.,increase,risk
Levorphanol,Oxybuprocaine,The risk or severity of CNS depression can be increased when Levorphanol is combined with Oxybuprocaine.,increase,risk
Levorphanol,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Levorphanol.,increase,risk
Levorphanol,Oxycodone,The risk or severity of adverse effects can be increased when Oxycodone is combined with Levorphanol.,increase,risk
Levorphanol,Oxymorphone,The risk or severity of adverse effects can be increased when Levorphanol is combined with Oxymorphone.,increase,risk
Levorphanol,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Levorphanol.,increase,risk
Levorphanol,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Levorphanol.,decrease,no risk
Levorphanol,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Levorphanol.,increase,risk
Levorphanol,Quazepam,The risk or severity of adverse effects can be increased when Levorphanol is combined with Quazepam.,increase,risk
Levorphanol,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Levorphanol.,increase,risk
Levorphanol,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Levorphanol.,decrease,no risk
Levorphanol,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Levorphanol.,increase,risk
Levorphanol,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Levorphanol.,increase,risk
Levorphanol,Quinupramine,The risk or severity of CNS depression can be increased when Levorphanol is combined with Quinupramine.,increase,risk
Levorphanol,Umeclidinium,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Levorphanol.,increase,risk
Levorphanol,Urethane,The risk or severity of CNS depression can be increased when Levorphanol is combined with Urethane.,increase,risk
Levorphanol,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Levorphanol is combined with Valproate bismuth.,increase,risk
Levorphanol,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Levorphanol.,increase,risk
Levorphanol,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Levorphanol.,increase,risk
Levorphanol,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Levorphanol is combined with Venlafaxine.,increase,risk
Levorphanol,Vigabatrin,The risk or severity of CNS depression can be increased when Levorphanol is combined with Vigabatrin.,increase,risk
Levorphanol,Vilazodone,The risk or severity of CNS depression can be increased when Levorphanol is combined with Vilazodone.,increase,risk
Levorphanol,Viloxazine,The risk or severity of CNS depression can be increased when Levorphanol is combined with Viloxazine.,increase,risk
Levorphanol,Vortioxetine,The risk or severity of CNS depression can be increased when Levorphanol is combined with Vortioxetine.,increase,risk
Levorphanol,Yohimbine,The risk or severity of CNS depression can be increased when Levorphanol is combined with Yohimbine.,increase,risk
Levorphanol,Zaleplon,The risk or severity of CNS depression can be increased when Levorphanol is combined with Zaleplon.,increase,risk
Levorphanol,Ziconotide,The risk or severity of CNS depression can be increased when Levorphanol is combined with Ziconotide.,increase,risk
Levorphanol,Zimelidine,The risk or severity of serotonin syndrome can be increased when Levorphanol is combined with Zimelidine.,increase,risk
Levorphanol,Ziprasidone,The risk or severity of adverse effects can be increased when Levorphanol is combined with Ziprasidone.,increase,risk
Levorphanol,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Levorphanol.,increase,risk
Levorphanol,Zolpidem,Levorphanol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Levorphanol,Zonisamide,The risk or severity of CNS depression can be increased when Levorphanol is combined with Zonisamide.,increase,risk
Levorphanol,Zopiclone,The risk or severity of adverse effects can be increased when Levorphanol is combined with Zopiclone.,increase,risk
Levorphanol,Zotepine,The risk or severity of CNS depression can be increased when Levorphanol is combined with Zotepine.,increase,risk
Levorphanol,Zuclopenthixol,The risk or severity of CNS depression can be increased when Levorphanol is combined with Zuclopenthixol.,increase,risk
Levorphanol,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Levorphanol.,increase,risk
Aminolevulinic acid,Benzocaine,The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Benzocaine.,increase,risk
Aminolevulinic acid,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Benzyl alcohol.,increase,risk
Aminolevulinic acid,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Bupivacaine.,increase,risk
Aminolevulinic acid,Butacaine,The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Butacaine.,increase,risk
Aminolevulinic acid,Butamben,The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Butamben.,increase,risk
Aminolevulinic acid,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Oxetacaine.,increase,risk
Aminolevulinic acid,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Oxybuprocaine.,increase,risk
Aminolevulinic acid,Verteporfin,Aminolevulinic acid may increase the photosensitizing activities of Verteporfin.,increase,no risk
Chlorphenesin,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Chlorphenesin.,increase,no risk
Chlorphenesin,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Chlorphenesin is combined with Ganaxolone.",increase,risk
Chlorphenesin,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Chlorphenesin.,increase,risk
Chlorphenesin,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Chlorphenesin is combined with Oliceridine.",increase,risk
Chlorphenesin,Ziprasidone,The risk or severity of adverse effects can be increased when Chlorphenesin is combined with Ziprasidone.,increase,risk
Chlorphenesin,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Chlorphenesin.,increase,risk
Terbinafine,Galantamine,The metabolism of Galantamine can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Terbinafine is combined with Ganciclovir.",increase,risk
Terbinafine,Gatifloxacin,The metabolism of Terbinafine can be decreased when combined with Gatifloxacin.,decrease,no risk
Terbinafine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Gemfibrozil,The metabolism of Terbinafine can be decreased when combined with Gemfibrozil.,decrease,no risk
Terbinafine,Gemifloxacin,The metabolism of Terbinafine can be decreased when combined with Gemifloxacin.,decrease,no risk
Terbinafine,Gestrinone,The metabolism of Gestrinone can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Ginkgo biloba,The metabolism of Terbinafine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Terbinafine,Givosiran,The serum concentration of Terbinafine can be increased when it is combined with Givosiran.,increase,no risk
Terbinafine,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Glimepiride,The metabolism of Terbinafine can be decreased when combined with Glimepiride.,decrease,no risk
Terbinafine,Glipizide,The metabolism of Glipizide can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Glofitamab,The serum concentration of Terbinafine can be increased when it is combined with Glofitamab.,increase,no risk
Terbinafine,Glyburide,The metabolism of Terbinafine can be decreased when combined with Glyburide.,decrease,no risk
Terbinafine,Golimumab,The metabolism of Terbinafine can be increased when combined with Golimumab.,increase,no risk
Terbinafine,Grepafloxacin,The metabolism of Terbinafine can be decreased when combined with Grepafloxacin.,decrease,no risk
Terbinafine,Guanabenz,The metabolism of Terbinafine can be decreased when combined with Guanabenz.,decrease,no risk
Terbinafine,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Terbinafine.,increase,no risk
Terbinafine,Halothane,The metabolism of Halothane can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Hydrocortisone,The metabolism of Terbinafine can be increased when combined with Hydrocortisone.,increase,no risk
Terbinafine,Hydromorphone,The metabolism of Terbinafine can be decreased when combined with Hydromorphone.,decrease,no risk
Terbinafine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Ketamine,The metabolism of Ketamine can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Ketoconazole,The metabolism of Terbinafine can be decreased when combined with Ketoconazole.,decrease,no risk
Terbinafine,Ketoprofen,The metabolism of Terbinafine can be decreased when combined with Ketoprofen.,decrease,no risk
Terbinafine,Ketorolac,The metabolism of Terbinafine can be decreased when combined with Ketorolac.,decrease,no risk
Terbinafine,Nabilone,The metabolism of Terbinafine can be decreased when combined with Nabilone.,decrease,no risk
Terbinafine,Nabumetone,The metabolism of Terbinafine can be decreased when combined with Nabumetone.,decrease,no risk
Terbinafine,Nadolol,The metabolism of Nadolol can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Nafarelin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Terbinafine.",increase,risk
Terbinafine,Nafcillin,The metabolism of Terbinafine can be increased when combined with Nafcillin.,increase,no risk
Terbinafine,Nalidixic acid,The metabolism of Terbinafine can be decreased when combined with Nalidixic acid.,decrease,no risk
Terbinafine,Naltrexone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Terbinafine.",increase,risk
Terbinafine,Naproxen,The metabolism of Terbinafine can be decreased when combined with Naproxen.,decrease,no risk
Terbinafine,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Nebivolol,The metabolism of Nebivolol can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Nefazodone,The metabolism of Terbinafine can be decreased when combined with Nefazodone.,decrease,no risk
Terbinafine,Nelfinavir,The metabolism of Terbinafine can be decreased when combined with Nelfinavir.,decrease,no risk
Terbinafine,Neratinib,The metabolism of Neratinib can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Netupitant,The metabolism of Netupitant can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Niacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Terbinafine.",increase,risk
Terbinafine,Nicardipine,The metabolism of Terbinafine can be decreased when combined with Nicardipine.,decrease,no risk
Terbinafine,Nicergoline,The metabolism of Nicergoline can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Niclosamide,The metabolism of Terbinafine can be decreased when combined with Niclosamide.,decrease,no risk
Terbinafine,Nifedipine,The metabolism of Nifedipine can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Nilotinib,The metabolism of Terbinafine can be decreased when combined with Nilotinib.,decrease,no risk
Terbinafine,Nilutamide,The metabolism of Terbinafine can be decreased when combined with Nilutamide.,decrease,no risk
Terbinafine,Nilvadipine,The metabolism of Terbinafine can be decreased when combined with Nilvadipine.,decrease,no risk
Terbinafine,Nintedanib,The metabolism of Nintedanib can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Nizatidine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Terbinafine.",increase,risk
Terbinafine,Nomegestrol,The metabolism of Nomegestrol can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Nomegestrol acetate,The metabolism of Nomegestrol acetate can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Norelgestromin,The metabolism of Norelgestromin can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Norethisterone,The metabolism of Norethisterone can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Norethynodrel,The metabolism of Norethynodrel can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Norfloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Terbinafine is combined with Norfloxacin.",increase,risk
Terbinafine,Norgestimate,The metabolism of Norgestimate can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Norgestrel,The metabolism of Norgestrel can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Noscapine,The metabolism of Terbinafine can be decreased when combined with Noscapine.,decrease,no risk
Terbinafine,Obeticholic acid,The metabolism of Terbinafine can be decreased when combined with Obeticholic acid.,decrease,no risk
Terbinafine,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Terbinafine is combined with Ofloxacin.",increase,risk
Terbinafine,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Olaparib,The metabolism of Olaparib can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Terbinafine.,increase,no risk
Terbinafine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Omaveloxolone,The serum concentration of Terbinafine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Terbinafine,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Opium,The metabolism of Opium can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Oritavancin,The metabolism of Terbinafine can be decreased when combined with Oritavancin.,decrease,no risk
Terbinafine,Orphenadrine,The metabolism of Terbinafine can be decreased when combined with Orphenadrine.,decrease,no risk
Terbinafine,Osilodrostat,The metabolism of Terbinafine can be decreased when combined with Osilodrostat.,decrease,no risk
Terbinafine,Osimertinib,The serum concentration of Terbinafine can be decreased when it is combined with Osimertinib.,decrease,no risk
Terbinafine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Oxandrolone,The metabolism of Terbinafine can be decreased when combined with Oxandrolone.,decrease,no risk
Terbinafine,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Oxybutynin,The metabolism of Terbinafine can be decreased when combined with Oxybutynin.,decrease,no risk
Terbinafine,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Quinidine,The metabolism of Quinidine can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Quinine,The metabolism of Quinine can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Terbinafine is combined with Ubidecarenone.",increase,risk
Terbinafine,Ulipristal,The metabolism of Ulipristal can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Vadadustat,The serum concentration of Terbinafine can be increased when it is combined with Vadadustat.,increase,no risk
Terbinafine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Valdecoxib,The metabolism of Terbinafine can be decreased when combined with Valdecoxib.,decrease,no risk
Terbinafine,Valproic acid,The metabolism of Terbinafine can be decreased when combined with Valproic acid.,decrease,no risk
Terbinafine,Valsartan,The metabolism of Terbinafine can be decreased when combined with Valsartan.,decrease,no risk
Terbinafine,Vandetanib,The metabolism of Vandetanib can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Vemurafenib,The serum concentration of Terbinafine can be increased when it is combined with Vemurafenib.,increase,no risk
Terbinafine,Venetoclax,The metabolism of Venetoclax can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Verapamil,The metabolism of Terbinafine can be decreased when combined with Verapamil.,decrease,no risk
Terbinafine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Viloxazine,The metabolism of Terbinafine can be decreased when combined with Viloxazine.,decrease,no risk
Terbinafine,Vinblastine,The metabolism of Vinblastine can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Vincristine,The metabolism of Vincristine can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Vindesine,The metabolism of Vindesine can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Vinflunine,The metabolism of Vinflunine can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Voriconazole,The metabolism of Terbinafine can be decreased when combined with Voriconazole.,decrease,no risk
Terbinafine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Warfarin,The metabolism of Warfarin can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Zafirlukast,The metabolism of Terbinafine can be decreased when combined with Zafirlukast.,decrease,no risk
Terbinafine,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Zidovudine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Terbinafine.",increase,risk
Terbinafine,Zileuton,The metabolism of Terbinafine can be decreased when combined with Zileuton.,decrease,no risk
Terbinafine,Zimelidine,The metabolism of Terbinafine can be decreased when combined with Zimelidine.,decrease,no risk
Terbinafine,Ziprasidone,The metabolism of Terbinafine can be decreased when combined with Ziprasidone.,decrease,no risk
Terbinafine,Zolmitriptan,The metabolism of Terbinafine can be decreased when combined with Zolmitriptan.,decrease,no risk
Terbinafine,Zolpidem,The metabolism of Zolpidem can be increased when combined with Terbinafine.,increase,no risk
Terbinafine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Zotepine,The metabolism of Zotepine can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Terbinafine.,decrease,no risk
Terbinafine,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Terbinafine.,decrease,no risk
Penicillamine,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Penicillamine is combined with Ganciclovir.",increase,risk
Penicillamine,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Penicillamine.,increase,risk
Penicillamine,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Penicillamine is combined with Gemfibrozil.",increase,risk
Penicillamine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Penicillamine.,increase,risk
Penicillamine,Glatiramer,The risk or severity of adverse effects can be increased when Penicillamine is combined with Glatiramer.,increase,risk
Penicillamine,Glecaprevir,The excretion of Penicillamine can be decreased when combined with Glecaprevir.,decrease,no risk
Penicillamine,Golimumab,The risk or severity of adverse effects can be increased when Penicillamine is combined with Golimumab.,increase,risk
Penicillamine,Guselkumab,The risk or severity of adverse effects can be increased when Penicillamine is combined with Guselkumab.,increase,risk
Penicillamine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Penicillamine.,decrease,no risk
Penicillamine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Penicillamine.,increase,risk
Penicillamine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Penicillamine.,decrease,no risk
Penicillamine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Penicillamine.,decrease,no risk
Penicillamine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Penicillamine.,increase,risk
Penicillamine,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Penicillamine.,increase,risk
Penicillamine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Penicillamine is combined with Hydrocortisone acetate.,increase,risk
Penicillamine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Penicillamine is combined with Hydrocortisone butyrate.,increase,risk
Penicillamine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Penicillamine is combined with Hydrocortisone succinate.,increase,risk
Penicillamine,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Penicillamine.,increase,risk
Penicillamine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Penicillamine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Penicillamine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Penicillamine is combined with Hydroxychloroquine.,increase,risk
Penicillamine,Hydroxyurea,The risk or severity of adverse effects can be increased when Penicillamine is combined with Hydroxyurea.,increase,risk
Penicillamine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Penicillamine.,decrease,no risk
Penicillamine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Penicillamine.,decrease,no risk
Penicillamine,Ketoconazole,The excretion of Penicillamine can be decreased when combined with Ketoconazole.,decrease,no risk
Penicillamine,Nadroparin,The risk or severity of bleeding can be increased when Nadroparin is combined with Penicillamine.,increase,risk
Penicillamine,Nafarelin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Penicillamine.",increase,risk
Penicillamine,Naltrexone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Penicillamine.",increase,risk
Penicillamine,Natalizumab,The risk or severity of immunosuppression can be increased when Penicillamine is combined with Natalizumab.,increase,risk
Penicillamine,Nelarabine,The risk or severity of adverse effects can be increased when Penicillamine is combined with Nelarabine.,increase,risk
Penicillamine,Nelfinavir,The excretion of Penicillamine can be decreased when combined with Nelfinavir.,decrease,no risk
Penicillamine,Niacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Penicillamine.",increase,risk
Penicillamine,Nicardipine,The excretion of Penicillamine can be decreased when combined with Nicardipine.,decrease,no risk
Penicillamine,Nilotinib,The risk or severity of adverse effects can be increased when Penicillamine is combined with Nilotinib.,increase,risk
Penicillamine,Nimesulide,The risk or severity of bleeding can be increased when Nimesulide is combined with Penicillamine.,increase,risk
Penicillamine,Nizatidine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Penicillamine.",increase,risk
Penicillamine,Norfloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Penicillamine is combined with Norfloxacin.",increase,risk
Penicillamine,Novobiocin,The excretion of Penicillamine can be decreased when combined with Novobiocin.,decrease,no risk
Penicillamine,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Penicillamine.,decrease,no risk
Penicillamine,Nystatin,The excretion of Penicillamine can be decreased when combined with Nystatin.,decrease,no risk
Penicillamine,Obinutuzumab,The risk or severity of adverse effects can be increased when Penicillamine is combined with Obinutuzumab.,increase,risk
Penicillamine,Ocrelizumab,The risk or severity of adverse effects can be increased when Penicillamine is combined with Ocrelizumab.,increase,risk
Penicillamine,Ofatumumab,The risk or severity of adverse effects can be increased when Penicillamine is combined with Ofatumumab.,increase,risk
Penicillamine,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Penicillamine is combined with Ofloxacin.",increase,risk
Penicillamine,Olaparib,The risk or severity of adverse effects can be increased when Penicillamine is combined with Olaparib.,increase,risk
Penicillamine,Ouabain,The excretion of Penicillamine can be decreased when combined with Ouabain.,decrease,no risk
Penicillamine,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Penicillamine.,increase,risk
Penicillamine,Ozanimod,The risk or severity of adverse effects can be increased when Penicillamine is combined with Ozanimod.,increase,risk
Penicillamine,Quinidine,The excretion of Penicillamine can be decreased when combined with Quinidine.,decrease,no risk
Penicillamine,Quinine,The excretion of Penicillamine can be decreased when combined with Quinine.,decrease,no risk
Penicillamine,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Penicillamine is combined with Ubidecarenone.",increase,risk
Penicillamine,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Penicillamine.,increase,risk
Penicillamine,Upadacitinib,The risk or severity of adverse effects can be increased when Penicillamine is combined with Upadacitinib.,increase,risk
Penicillamine,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Penicillamine.,increase,risk
Penicillamine,Valsartan,The excretion of Penicillamine can be decreased when combined with Valsartan.,decrease,no risk
Penicillamine,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Penicillamine.,increase,risk
Penicillamine,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Penicillamine.,decrease,no risk
Penicillamine,Vedolizumab,The risk or severity of adverse effects can be increased when Penicillamine is combined with Vedolizumab.,increase,risk
Penicillamine,Velpatasvir,The excretion of Penicillamine can be decreased when combined with Velpatasvir.,decrease,no risk
Penicillamine,Venetoclax,The excretion of Penicillamine can be decreased when combined with Venetoclax.,decrease,no risk
Penicillamine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Penicillamine.,decrease,no risk
Penicillamine,Vilanterol,The risk or severity of adverse effects can be increased when Penicillamine is combined with Vilanterol.,increase,risk
Penicillamine,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Penicillamine.,increase,risk
Penicillamine,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Penicillamine.,increase,risk
Penicillamine,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Penicillamine.,increase,risk
Penicillamine,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Penicillamine.,increase,risk
Penicillamine,Voclosporin,The risk or severity of adverse effects can be increased when Penicillamine is combined with Voclosporin.,increase,risk
Penicillamine,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Penicillamine.,increase,risk
Penicillamine,Vorinostat,The risk or severity of adverse effects can be increased when Penicillamine is combined with Vorinostat.,increase,risk
Penicillamine,Voxilaprevir,The excretion of Penicillamine can be decreased when combined with Voxilaprevir.,decrease,no risk
Penicillamine,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Penicillamine.,increase,risk
Penicillamine,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Penicillamine.,increase,risk
Penicillamine,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Penicillamine.,increase,risk
Penicillamine,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Penicillamine.,increase,risk
Prednisolone,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Prednisolone.",decrease,no risk
Prednisolone,Bortezomib,The metabolism of Bortezomib can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Bosutinib,The metabolism of Bosutinib can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Botulinum toxin type A,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Prednisolone.,increase,risk
Prednisolone,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Brigatinib,The metabolism of Brigatinib can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Brodalumab,The risk or severity of adverse effects can be increased when Prednisolone is combined with Brodalumab.,increase,risk
Prednisolone,Bromocriptine,The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Bromocriptine.,increase,risk
Prednisolone,Budesonide,The risk or severity of adverse effects can be increased when Prednisolone is combined with Budesonide.,increase,risk
Prednisolone,Bumadizone,The risk or severity of gastrointestinal irritation can be increased when Prednisolone is combined with Bumadizone.,increase,risk
Prednisolone,Bumetanide,The risk or severity of hypokalemia can be increased when Prednisolone is combined with Bumetanide.,increase,risk
Prednisolone,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Prednisolone is combined with Bupivacaine.,increase,risk
Prednisolone,Busulfan,The metabolism of Busulfan can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Butacaine,The risk or severity of methemoglobinemia can be increased when Prednisolone is combined with Butacaine.,increase,risk
Prednisolone,Butamben,The risk or severity of methemoglobinemia can be increased when Prednisolone is combined with Butamben.,increase,risk
Prednisolone,Galantamine,The therapeutic efficacy of Galantamine can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Gatifloxacin,The risk or severity of tendinopathy can be increased when Prednisolone is combined with Gatifloxacin.,increase,risk
Prednisolone,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Prednisolone.,increase,risk
Prednisolone,Gemifloxacin,The risk or severity of tendinopathy can be increased when Prednisolone is combined with Gemifloxacin.,increase,risk
Prednisolone,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Prednisolone.,increase,risk
Prednisolone,Gestrinone,The serum concentration of Prednisolone can be increased when it is combined with Gestrinone.,increase,no risk
Prednisolone,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Ginkgo biloba,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Glatiramer,The risk or severity of adverse effects can be increased when Prednisolone is combined with Glatiramer.,increase,risk
Prednisolone,Gliclazide,The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Gliclazide.,increase,risk
Prednisolone,Glimepiride,The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Glimepiride.,increase,risk
Prednisolone,Glipizide,The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Glipizide.,increase,risk
Prednisolone,Gliquidone,The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Gliquidone.,increase,risk
Prednisolone,Glofitamab,The serum concentration of Prednisolone can be increased when it is combined with Glofitamab.,increase,no risk
Prednisolone,Glyburide,The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Glyburide.,increase,risk
Prednisolone,Glycerol phenylbutyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Glycol salicylate,The risk or severity of gastrointestinal irritation can be increased when Prednisolone is combined with Glycol salicylate.,increase,risk
Prednisolone,Glymidine,The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Glymidine.,increase,risk
Prednisolone,Golimumab,The risk or severity of adverse effects can be increased when Prednisolone is combined with Golimumab.,increase,risk
Prednisolone,Grepafloxacin,The risk or severity of tendinopathy can be increased when Prednisolone is combined with Grepafloxacin.,increase,risk
Prednisolone,Guselkumab,The risk or severity of adverse effects can be increased when Prednisolone is combined with Guselkumab.,increase,risk
Prednisolone,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Prednisolone.,increase,no risk
Prednisolone,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Huperzine A,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Prednisolone is combined with Hydrochlorothiazide.,increase,risk
Prednisolone,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Prednisolone is combined with Hydrocortisone acetate.,increase,risk
Prednisolone,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Prednisolone is combined with Hydrocortisone butyrate.,increase,risk
Prednisolone,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Prednisolone is combined with Hydrocortisone succinate.,increase,risk
Prednisolone,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Prednisolone is combined with Hydroflumethiazide.,increase,risk
Prednisolone,Hydrotalcite,The bioavailability of Prednisolone can be decreased when combined with Hydrotalcite.,decrease,no risk
Prednisolone,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Prednisolone is combined with Hydroxychloroquine.,increase,risk
Prednisolone,Hydroxyprogesterone caproate,The serum concentration of Prednisolone can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Prednisolone,Hydroxyurea,The risk or severity of adverse effects can be increased when Prednisolone is combined with Hydroxyurea.,increase,risk
Prednisolone,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Ketamine,The therapeutic efficacy of Ketamine can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Ketoconazole,The metabolism of Prednisolone can be decreased when combined with Ketoconazole.,decrease,no risk
Prednisolone,Ketoprofen,The risk or severity of gastrointestinal irritation can be increased when Prednisolone is combined with Ketoprofen.,increase,risk
Prednisolone,Ketorolac,The risk or severity of gastrointestinal irritation can be increased when Prednisolone is combined with Ketorolac.,increase,risk
Prednisolone,Nabumetone,The risk or severity of gastrointestinal irritation can be increased when Prednisolone is combined with Nabumetone.,increase,risk
Prednisolone,Nalidixic acid,The risk or severity of tendinopathy can be increased when Prednisolone is combined with Nalidixic acid.,increase,risk
Prednisolone,Nandrolone decanoate,The risk or severity of edema formation can be increased when Nandrolone decanoate is combined with Prednisolone.,increase,risk
Prednisolone,Nandrolone phenpropionate,The risk or severity of edema formation can be increased when Nandrolone phenpropionate is combined with Prednisolone.,increase,risk
Prednisolone,Naproxen,The risk or severity of gastrointestinal irritation can be increased when Prednisolone is combined with Naproxen.,increase,risk
Prednisolone,Natalizumab,The risk or severity of immunosuppression can be increased when Prednisolone is combined with Natalizumab.,increase,risk
Prednisolone,Nateglinide,The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Nateglinide.,increase,risk
Prednisolone,Nefazodone,The metabolism of Prednisolone can be decreased when combined with Nefazodone.,decrease,no risk
Prednisolone,Nelarabine,The risk or severity of adverse effects can be increased when Prednisolone is combined with Nelarabine.,increase,risk
Prednisolone,Nelfinavir,The metabolism of Prednisolone can be decreased when combined with Nelfinavir.,decrease,no risk
Prednisolone,Neostigmine,The therapeutic efficacy of Neostigmine can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Neratinib,The metabolism of Neratinib can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Netupitant,The metabolism of Prednisolone can be decreased when combined with Netupitant.,decrease,no risk
Prednisolone,Nicardipine,The metabolism of Prednisolone can be decreased when combined with Nicardipine.,decrease,no risk
Prednisolone,Nicorandil,The risk or severity of ulceration can be increased when Prednisolone is combined with Nicorandil.,increase,risk
Prednisolone,Nilotinib,The metabolism of Prednisolone can be decreased when combined with Nilotinib.,decrease,no risk
Prednisolone,Nilvadipine,The metabolism of Prednisolone can be decreased when combined with Nilvadipine.,decrease,no risk
Prednisolone,Nimesulide,The risk or severity of gastrointestinal irritation can be increased when Prednisolone is combined with Nimesulide.,increase,risk
Prednisolone,Nintedanib,The metabolism of Nintedanib can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Nizatidine,The therapeutic efficacy of Nizatidine can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Nomegestrol,The serum concentration of Prednisolone can be increased when it is combined with Nomegestrol.,increase,no risk
Prednisolone,Nomegestrol acetate,The serum concentration of Prednisolone can be increased when it is combined with Nomegestrol acetate.,increase,no risk
Prednisolone,Norelgestromin,The serum concentration of Prednisolone can be increased when it is combined with Norelgestromin.,increase,no risk
Prednisolone,Norepinephrine,The risk or severity of hypokalemia can be increased when Prednisolone is combined with Norepinephrine.,increase,risk
Prednisolone,Norethisterone,The serum concentration of Prednisolone can be increased when it is combined with Norethisterone.,increase,no risk
Prednisolone,Norethynodrel,The serum concentration of Prednisolone can be increased when it is combined with Norethynodrel.,increase,no risk
Prednisolone,Norfloxacin,The risk or severity of tendinopathy can be increased when Prednisolone is combined with Norfloxacin.,increase,risk
Prednisolone,Norgestimate,The serum concentration of Prednisolone can be increased when it is combined with Norgestimate.,increase,no risk
Prednisolone,Norgestrel,The serum concentration of Prednisolone can be increased when it is combined with Norgestrel.,increase,no risk
Prednisolone,Nortriptyline,The metabolism of Nortriptyline can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Obinutuzumab,The risk or severity of adverse effects can be increased when Prednisolone is combined with Obinutuzumab.,increase,risk
Prednisolone,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Prednisolone.,increase,no risk
Prednisolone,Ofatumumab,The risk or severity of adverse effects can be increased when Prednisolone is combined with Ofatumumab.,increase,risk
Prednisolone,Ofloxacin,The risk or severity of tendinopathy can be increased when Prednisolone is combined with Ofloxacin.,increase,risk
Prednisolone,Olaparib,The metabolism of Olaparib can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Prednisolone.,decrease,no risk
Prednisolone,Olodaterol,The risk or severity of hypokalemia can be increased when Prednisolone is combined with Olodaterol.,increase,risk
Prednisolone,Olsalazine,The serum concentration of Olsalazine can be decreased when it is combined with Prednisolone.,decrease,no risk
Prednisolone,Omaveloxolone,The serum concentration of Prednisolone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Prednisolone,Orciprenaline,The risk or severity of hypokalemia can be increased when Prednisolone is combined with Orciprenaline.,increase,risk
Prednisolone,Osimertinib,The metabolism of Osimertinib can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Prednisolone.,increase,risk
Prednisolone,Oxandrolone,The risk or severity of fluid retention can be increased when Prednisolone is combined with Oxandrolone.,increase,risk
Prednisolone,Oxaprozin,The risk or severity of gastrointestinal irritation can be increased when Prednisolone is combined with Oxaprozin.,increase,risk
Prednisolone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Prednisolone is combined with Oxetacaine.,increase,risk
Prednisolone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Prednisolone is combined with Oxybuprocaine.,increase,risk
Prednisolone,Oxymetholone,The risk or severity of fluid retention can be increased when Prednisolone is combined with Oxymetholone.,increase,risk
Prednisolone,Oxyphenbutazone,The risk or severity of gastrointestinal irritation can be increased when Prednisolone is combined with Oxyphenbutazone.,increase,risk
Prednisolone,Ozanimod,The risk or severity of adverse effects can be increased when Prednisolone is combined with Ozanimod.,increase,risk
Prednisolone,Quinestrol,The serum concentration of Prednisolone can be increased when it is combined with Quinestrol.,increase,no risk
Prednisolone,Quinethazone,Prednisolone may increase the hypokalemic activities of Quinethazone.,increase,no risk
Prednisolone,Quinidine,The metabolism of Quinidine can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Quinine,The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Quinine.,increase,risk
Prednisolone,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Prednisolone.,increase,risk
Prednisolone,Ulipristal,The serum concentration of Prednisolone can be increased when it is combined with Ulipristal.,increase,no risk
Prednisolone,Upadacitinib,The risk or severity of adverse effects can be increased when Prednisolone is combined with Upadacitinib.,increase,risk
Prednisolone,Vadadustat,The serum concentration of Prednisolone can be increased when it is combined with Vadadustat.,increase,no risk
Prednisolone,Valdecoxib,The risk or severity of gastrointestinal irritation can be increased when Prednisolone is combined with Valdecoxib.,increase,risk
Prednisolone,Vandetanib,The metabolism of Vandetanib can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Vecuronium,The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Prednisolone.,increase,risk
Prednisolone,Vedolizumab,The risk or severity of adverse effects can be increased when Prednisolone is combined with Vedolizumab.,increase,risk
Prednisolone,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Venetoclax,The metabolism of Venetoclax can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Verapamil,The metabolism of Prednisolone can be decreased when combined with Verapamil.,decrease,no risk
Prednisolone,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Vilanterol,The risk or severity of adverse effects can be increased when Prednisolone is combined with Vilanterol.,increase,risk
Prednisolone,Vildagliptin,The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Vildagliptin.,increase,risk
Prednisolone,Viloxazine,The metabolism of Prednisolone can be decreased when combined with Viloxazine.,decrease,no risk
Prednisolone,Vinblastine,The metabolism of Vinblastine can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Vincristine,The metabolism of Vincristine can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Vindesine,The metabolism of Vindesine can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Vinflunine,The metabolism of Vinflunine can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Vitamin D,The therapeutic efficacy of Vitamin D can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Voclosporin,The risk or severity of adverse effects can be increased when Prednisolone is combined with Voclosporin.,increase,risk
Prednisolone,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Voriconazole,The metabolism of Prednisolone can be decreased when combined with Voriconazole.,decrease,no risk
Prednisolone,Vorinostat,The risk or severity of adverse effects can be increased when Prednisolone is combined with Vorinostat.,increase,risk
Prednisolone,Warfarin,Prednisolone may increase the anticoagulant activities of Warfarin.,increase,no risk
Prednisolone,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Prednisolone.,decrease,no risk
Prednisolone,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Prednisolone.,increase,risk
Prednisolone,Zimelidine,The metabolism of Prednisolone can be decreased when combined with Zimelidine.,decrease,no risk
Prednisolone,Ziprasidone,The metabolism of Prednisolone can be decreased when combined with Ziprasidone.,decrease,no risk
Prednisolone,Zolpidem,The metabolism of Zolpidem can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Prednisolone.,increase,no risk
Prednisolone,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Prednisolone.,decrease,no risk
Diflunisal,Betamethasone,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Diflunisal.,increase,risk
Diflunisal,Betamethasone phosphate,The risk or severity of gastrointestinal irritation can be increased when Betamethasone phosphate is combined with Diflunisal.,increase,risk
Diflunisal,Betaxolol,Diflunisal may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Diflunisal,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Diflunisal.,increase,risk
Diflunisal,Betulinic Acid,The risk or severity of adverse effects can be increased when Diflunisal is combined with Betulinic Acid.,increase,risk
Diflunisal,Bexagliflozin,Diflunisal may increase the hypoglycemic activities of Bexagliflozin.,increase,no risk
Diflunisal,Bicisate,Diflunisal may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Diflunisal,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Bismuth subgallate,Diflunisal may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Diflunisal,Bismuth subsalicylate,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Bisoprolol,Diflunisal may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Diflunisal,Bisoxatin,Diflunisal may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Diflunisal,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Bivalirudin.,increase,risk
Diflunisal,Bleomycin,Diflunisal may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Diflunisal,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Brexpiprazole,The risk or severity of hypertension can be increased when Diflunisal is combined with Brexpiprazole.,increase,risk
Diflunisal,Brinzolamide,The risk or severity of electrolyte abnormality can be increased when Brinzolamide is combined with Diflunisal.,increase,risk
Diflunisal,Brivaracetam,Diflunisal may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Diflunisal,Bromazepam,Diflunisal may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Diflunisal,Bromfenac,The therapeutic efficacy of Diflunisal can be decreased when used in combination with Bromfenac.,decrease,no risk
Diflunisal,Bromocriptine,Diflunisal may increase the hypoglycemic activities of Bromocriptine.,increase,no risk
Diflunisal,Bromotheophylline,Bromotheophylline may increase the excretion rate of Diflunisal which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Diflunisal,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Diflunisal.,increase,risk
Diflunisal,Bufexamac,The therapeutic efficacy of Diflunisal can be decreased when used in combination with Bufexamac.,decrease,no risk
Diflunisal,Bumadizone,The risk or severity of adverse effects can be increased when Diflunisal is combined with Bumadizone.,increase,risk
Diflunisal,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Diflunisal.,decrease,no risk
Diflunisal,Bupropion,Diflunisal may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Diflunisal,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Diflunisal.,increase,risk
Diflunisal,Butabarbital,Diflunisal may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Diflunisal,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Diflunisal.,increase,risk
Diflunisal,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when Furosemide is combined with Diflunisal.,increase,risk
Diflunisal,Gadobenic acid,Diflunisal may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Diflunisal,Gadodiamide,Diflunisal may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Diflunisal,Gadofosveset trisodium,Diflunisal may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Diflunisal,Gadopentetic acid,Diflunisal may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Diflunisal,Gadoteric acid,Diflunisal may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Diflunisal,Gadoteridol,Diflunisal may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Diflunisal,Ganciclovir,Diflunisal may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Diflunisal,Gatifloxacin,Diflunisal may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Diflunisal,Gemcitabine,Diflunisal may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Diflunisal,Gemfibrozil,Diflunisal may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Diflunisal,Gemifloxacin,The metabolism of Gemfibrozil can be decreased when combined with Diflunisal.,decrease,no risk
Diflunisal,Gentamicin,Diflunisal may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Diflunisal,Gimeracil,Diflunisal may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Diflunisal,Ginkgo biloba,Diflunisal may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Diflunisal,Givosiran,The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Diflunisal.,increase,risk
Diflunisal,Glasdegib,The risk or severity of nephrotoxicity can be increased when Diflunisal is combined with Givosiran.,increase,risk
Diflunisal,Gliclazide,The metabolism of Glasdegib can be decreased when combined with Diflunisal.,decrease,no risk
Diflunisal,Glimepiride,Diflunisal may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Diflunisal,Glipizide,Diflunisal may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Diflunisal,Gliquidone,Diflunisal may increase the hypoglycemic activities of Glipizide.,increase,no risk
Diflunisal,Glyburide,Diflunisal may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Diflunisal,Glycerol phenylbutyrate,Diflunisal may increase the hypoglycemic activities of Glyburide.,increase,no risk
Diflunisal,Glycol salicylate,Diflunisal may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Diflunisal,Glymidine,The risk or severity of adverse effects can be increased when Diflunisal is combined with Glycol salicylate.,increase,risk
Diflunisal,Golodirsen,Diflunisal may increase the hypoglycemic activities of Glymidine.,increase,no risk
Diflunisal,Goserelin,Diflunisal may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Diflunisal,Grepafloxacin,Diflunisal may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Diflunisal,Guanabenz,Diflunisal may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Diflunisal,Guanadrel,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Guanethidine,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Guanfacine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Guanoxan,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Haloperidol,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Halothane,The therapeutic efficacy of Haloperidol can be increased when used in combination with Diflunisal.,increase,no risk
Diflunisal,Heparin,The risk or severity of hypertension can be increased when Diflunisal is combined with Halothane.,increase,risk
Diflunisal,Hydralazine,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Heparin.,increase,risk
Diflunisal,Hydrochlorothiazide,Diflunisal may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Diflunisal,Hydrocortisone,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Diflunisal.,increase,risk
Diflunisal,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Diflunisal.,increase,risk
Diflunisal,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Diflunisal.,increase,risk
Diflunisal,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Diflunisal.,increase,risk
Diflunisal,Hydroflumethiazide,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Diflunisal.,increase,risk
Diflunisal,Hydromorphone,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Hydroxocobalamin,Diflunisal may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Diflunisal,Hydroxyethyl Starch,Diflunisal may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Diflunisal,Kanamycin,Diflunisal may decrease the excretion rate of Ixazomib which could result in a higher serum level.,decrease,no risk
Diflunisal,Ketamine,Diflunisal may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Diflunisal,Ketazolam,Diflunisal may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Diflunisal,Ketoconazole,Diflunisal may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Diflunisal,Ketoprofen,The risk or severity of hyperkalemia can be increased when Diflunisal is combined with Ketoconazole.,increase,risk
Diflunisal,Ketorolac,The risk or severity of bleeding and gastrointestinal bleeding can be increased when Diflunisal is combined with Ketoprofen.,increase,risk
Diflunisal,N-acetyltyrosine,The metabolism of Mycophenolic acid can be decreased when combined with Diflunisal.,decrease,no risk
Diflunisal,Nabumetone,Diflunisal may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Diflunisal,Nadolol,The therapeutic efficacy of Diflunisal can be decreased when used in combination with Nabumetone.,decrease,no risk
Diflunisal,Nadroparin,Diflunisal may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Diflunisal,Naldemedine,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Nadroparin.,increase,risk
Diflunisal,Nalidixic acid,Diflunisal may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Diflunisal,Nalmefene,Diflunisal may increase the neuroexcitatory activities of Nalidixic acid.,increase,no risk
Diflunisal,Naloxone,Diflunisal may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Diflunisal,Naphazoline,Diflunisal may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Diflunisal,Naproxen,The risk or severity of hypertension can be increased when Diflunisal is combined with Naphazoline.,increase,risk
Diflunisal,Naratriptan,The therapeutic efficacy of Diflunisal can be decreased when used in combination with Naproxen.,decrease,no risk
Diflunisal,Nateglinide,The risk or severity of hypertension can be increased when Diflunisal is combined with Naratriptan.,increase,risk
Diflunisal,Naxitamab,Diflunisal may increase the hypoglycemic activities of Nateglinide.,increase,no risk
Diflunisal,Nebivolol,The risk or severity of hypertension can be increased when Diflunisal is combined with Naxitamab.,increase,risk
Diflunisal,Nedaplatin,Diflunisal may decrease the antihypertensive activities of Nebivolol.,decrease,no risk
Diflunisal,Nedocromil,Diflunisal may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Diflunisal,Nefazodone,Diflunisal may decrease the excretion rate of Nedocromil which could result in a higher serum level.,decrease,no risk
Diflunisal,Neomycin,The risk or severity of gastrointestinal bleeding can be increased when Nefazodone is combined with Diflunisal.,increase,risk
Diflunisal,Nepafenac,The risk or severity of nephrotoxicity can be increased when Diflunisal is combined with Neomycin.,increase,risk
Diflunisal,Netilmicin,The therapeutic efficacy of Diflunisal can be decreased when used in combination with Nepafenac.,decrease,no risk
Diflunisal,Nialamide,Diflunisal may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Diflunisal,Nicardipine,The risk or severity of hypertension can be increased when Diflunisal is combined with Nialamide.,increase,risk
Diflunisal,Nicergoline,The therapeutic efficacy of Nicardipine can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Nicorandil,The risk or severity of hypertension can be increased when Nicergoline is combined with Diflunisal.,increase,risk
Diflunisal,Nifedipine,The therapeutic efficacy of Nicorandil can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Nilutamide,The risk or severity of hyperkalemia can be increased when Diflunisal is combined with Nifedipine.,increase,risk
Diflunisal,Nilvadipine,Diflunisal may decrease the excretion rate of Nilutamide which could result in a higher serum level.,decrease,no risk
Diflunisal,Nimesulide,The therapeutic efficacy of Nilvadipine can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Nimodipine,The risk or severity of adverse effects can be increased when Diflunisal is combined with Nimesulide.,increase,risk
Diflunisal,Nisoldipine,The therapeutic efficacy of Nimodipine can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Nitrendipine,The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Nitric Oxide,The therapeutic efficacy of Nitrendipine can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Nitrofurantoin,Diflunisal may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Diflunisal,Nitroglycerin,The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Diflunisal.,increase,risk
Diflunisal,Nitroprusside,The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Nitrous oxide,The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Norepinephrine,The risk or severity of hypertension can be increased when Diflunisal is combined with Nitrous oxide.,increase,risk
Diflunisal,Norfloxacin,The risk or severity of hypertension can be increased when Norepinephrine is combined with Diflunisal.,increase,risk
Diflunisal,Nortriptyline,Diflunisal may increase the neuroexcitatory activities of Norfloxacin.,increase,no risk
Diflunisal,Nylidrin,The risk or severity of gastrointestinal bleeding can be increased when Nortriptyline is combined with Diflunisal.,increase,risk
Diflunisal,Octinoxate,The risk or severity of hypertension can be increased when Diflunisal is combined with Nylidrin.,increase,risk
Diflunisal,Ofloxacin,Diflunisal may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Diflunisal,Olmesartan,Diflunisal may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Diflunisal,Olodaterol,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Diflunisal.",increase,risk
Diflunisal,Olsalazine,The risk or severity of hypertension can be increased when Diflunisal is combined with Olodaterol.,increase,risk
Diflunisal,Omacetaxine mepesuccinate,The risk or severity of nephrotoxicity can be increased when Diflunisal is combined with Olsalazine.,increase,risk
Diflunisal,Opium,The risk or severity of bleeding can be increased when Diflunisal is combined with Omacetaxine mepesuccinate.,increase,risk
Diflunisal,Orciprenaline,Diflunisal may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Diflunisal,Oseltamivir,The risk or severity of hypertension can be increased when Orciprenaline is combined with Diflunisal.,increase,risk
Diflunisal,Ouabain,Diflunisal may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Diflunisal,Oxacillin,The serum concentration of Ouabain can be decreased when it is combined with Diflunisal.,decrease,no risk
Diflunisal,Oxaliplatin,Diflunisal may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Diflunisal,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Diflunisal.,increase,risk
Diflunisal,Oxazepam,The therapeutic efficacy of Diflunisal can be decreased when used in combination with Oxaprozin.,decrease,no risk
Diflunisal,Oxprenolol,The metabolism of Oxazepam can be decreased when combined with Diflunisal.,decrease,no risk
Diflunisal,Oxybenzone,Diflunisal may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Diflunisal,Oxymetazoline,Diflunisal may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Diflunisal,Oxyphenbutazone,The risk or severity of hypertension can be increased when Diflunisal is combined with Oxymetazoline.,increase,risk
Diflunisal,Oxyquinoline,The risk or severity of adverse effects can be increased when Diflunisal is combined with Oxyphenbutazone.,increase,risk
Diflunisal,Quetiapine,Diflunisal may decrease the excretion rate of Pyridoxine which could result in a higher serum level.,decrease,no risk
Diflunisal,Quinapril,The risk or severity of hypertension can be increased when Diflunisal is combined with Quetiapine.,increase,risk
Diflunisal,Quinethazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Diflunisal is combined with Quinapril.",increase,risk
Diflunisal,Quinidine,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Quinine,Diflunisal may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Diflunisal,Quinupramine,Diflunisal may increase the hypoglycemic activities of Quinine.,increase,no risk
Diflunisal,Unoprostone,Diflunisal may increase the neuroexcitatory activities of Trovafloxacin.,increase,no risk
Diflunisal,Urokinase,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Diflunisal.,decrease,no risk
Diflunisal,Vaborbactam,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Urokinase.,increase,risk
Diflunisal,Vadadustat,Diflunisal may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Diflunisal,Valaciclovir,The serum concentration of Vadadustat can be increased when it is combined with Diflunisal.,increase,no risk
Diflunisal,Valbenazine,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Diflunisal.,increase,risk
Diflunisal,Valdecoxib,Diflunisal may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Diflunisal,Valganciclovir,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Diflunisal.,increase,risk
Diflunisal,Valproic acid,Diflunisal may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Diflunisal,Valsartan,The serum concentration of Valproic acid can be increased when it is combined with Diflunisal.,increase,no risk
Diflunisal,Vamorolone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Diflunisal.",increase,risk
Diflunisal,Vancomycin,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Diflunisal.,increase,risk
Diflunisal,Varenicline,Diflunisal may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Diflunisal,Varicella zoster vaccine (live/attenuated),Diflunisal may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Diflunisal,Venlafaxine,The risk or severity of adverse effects can be increased when Diflunisal is combined with Varicella zoster vaccine (live/attenuated).,increase,risk
Diflunisal,Verapamil,Venlafaxine may increase the antiplatelet activities of Diflunisal.,increase,no risk
Diflunisal,Vericiguat,The risk or severity of bleeding can be increased when Verapamil is combined with Diflunisal.,increase,risk
Diflunisal,Vilanterol,The metabolism of Vericiguat can be decreased when combined with Diflunisal.,decrease,no risk
Diflunisal,Vilazodone,The risk or severity of hypertension can be increased when Diflunisal is combined with Vilanterol.,increase,risk
Diflunisal,Vildagliptin,The risk or severity of hypertension can be increased when Diflunisal is combined with Vilazodone.,increase,risk
Diflunisal,Viloxazine,Diflunisal may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Diflunisal,Vorapaxar,Diflunisal may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Diflunisal,Voriconazole,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Vorapaxar.,increase,risk
Diflunisal,Vortioxetine,The serum concentration of Diflunisal can be increased when it is combined with Voriconazole.,increase,no risk
Diflunisal,Warfarin,The risk or severity of hypertension can be increased when Diflunisal is combined with Vortioxetine.,increase,risk
Diflunisal,Xamoterol,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Warfarin.,increase,risk
Diflunisal,Ximelagatran,The risk or severity of hypertension can be increased when Diflunisal is combined with Xamoterol.,increase,risk
Diflunisal,Xylometazoline,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Ximelagatran.,increase,risk
Diflunisal,Yohimbine,The risk or severity of hypertension can be increased when Diflunisal is combined with Xylometazoline.,increase,risk
Diflunisal,Zalcitabine,The risk or severity of hypertension can be increased when Diflunisal is combined with Yohimbine.,increase,risk
Diflunisal,Zaleplon,The excretion of Zalcitabine can be decreased when combined with Diflunisal.,decrease,no risk
Diflunisal,Zanamivir,Diflunisal may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Diflunisal,Zidovudine,Diflunisal may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Diflunisal,Zileuton,The risk or severity of bleeding can be increased when Zidovudine is combined with Diflunisal.,increase,risk
Diflunisal,Zimelidine,The metabolism of Zileuton can be decreased when combined with Diflunisal.,decrease,no risk
Diflunisal,Ziprasidone,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Diflunisal.,increase,risk
Diflunisal,Zofenopril,The risk or severity of hypertension can be increased when Ziprasidone is combined with Diflunisal.,increase,risk
Diflunisal,Zoledronic acid,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Diflunisal is combined with Zofenopril.",increase,risk
Diflunisal,Zolmitriptan,The risk or severity of gastrointestinal bleeding can be increased when Diflunisal is combined with Zoledronic acid.,increase,risk
Diflunisal,Zonisamide,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Diflunisal.,increase,risk
Diflunisal,Zuclopenthixol,The risk or severity of adverse effects can be increased when Diflunisal is combined with Zonisamide.,increase,risk
Vardenafil,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Boceprevir,The metabolism of Vardenafil can be decreased when combined with Boceprevir.,decrease,no risk
Vardenafil,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Bosentan,The metabolism of Vardenafil can be increased when combined with Bosentan.,increase,no risk
Vardenafil,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Brentuximab vedotin,The metabolism of Vardenafil can be decreased when combined with Brentuximab vedotin.,decrease,no risk
Vardenafil,Bretylium,Vardenafil may increase the antihypertensive activities of Bretylium.,increase,no risk
Vardenafil,Brexpiprazole,The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Brexpiprazole.,increase,risk
Vardenafil,Brimonidine,The risk or severity of hypotension can be increased when Vardenafil is combined with Brimonidine.,increase,risk
Vardenafil,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Bromocriptine,The metabolism of Vardenafil can be decreased when combined with Bromocriptine.,decrease,no risk
Vardenafil,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Vardenafil.,increase,risk
Vardenafil,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Vardenafil.,increase,risk
Vardenafil,Budesonide,The metabolism of Vardenafil can be increased when combined with Budesonide.,increase,no risk
Vardenafil,Bumetanide,The risk or severity of hypotension can be increased when Vardenafil is combined with Bumetanide.,increase,risk
Vardenafil,Bupivacaine,The risk or severity of hypotension can be increased when Vardenafil is combined with Bupivacaine.,increase,risk
Vardenafil,Buprenorphine,The metabolism of Vardenafil can be decreased when combined with Buprenorphine.,decrease,no risk
Vardenafil,Bupropion,The metabolism of Bupropion can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Buserelin,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Buserelin.,increase,risk
Vardenafil,Buspirone,The metabolism of Vardenafil can be decreased when combined with Buspirone.,decrease,no risk
Vardenafil,Butriptyline,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Butriptyline.,increase,risk
Vardenafil,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Gadobenic acid.,increase,risk
Vardenafil,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Vardenafil.,increase,risk
Vardenafil,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Gatifloxacin.,increase,risk
Vardenafil,Gefitinib,The metabolism of Vardenafil can be decreased when combined with Gefitinib.,decrease,no risk
Vardenafil,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Gemfibrozil,The metabolism of Vardenafil can be decreased when combined with Gemfibrozil.,decrease,no risk
Vardenafil,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Gemifloxacin.,increase,risk
Vardenafil,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Vardenafil.,increase,risk
Vardenafil,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Ginkgo biloba,The metabolism of Vardenafil can be decreased when combined with Ginkgo biloba.,decrease,no risk
Vardenafil,Glasdegib,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Glasdegib.,increase,risk
Vardenafil,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Glimepiride,The metabolism of Vardenafil can be decreased when combined with Glimepiride.,decrease,no risk
Vardenafil,Glipizide,The metabolism of Glipizide can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Glofitamab,The serum concentration of Vardenafil can be increased when it is combined with Glofitamab.,increase,no risk
Vardenafil,Glyburide,The metabolism of Vardenafil can be decreased when combined with Glyburide.,decrease,no risk
Vardenafil,Golimumab,The metabolism of Vardenafil can be increased when combined with Golimumab.,increase,no risk
Vardenafil,Goserelin,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Goserelin.,increase,risk
Vardenafil,Granisetron,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Granisetron.,increase,risk
Vardenafil,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Grepafloxacin.,increase,risk
Vardenafil,Guanabenz,Vardenafil may increase the antihypertensive activities of Guanabenz.,increase,no risk
Vardenafil,Guanadrel,Vardenafil may increase the antihypertensive activities of Guanadrel.,increase,no risk
Vardenafil,Guanethidine,Vardenafil may increase the antihypertensive activities of Guanethidine.,increase,no risk
Vardenafil,Guanfacine,Vardenafil may increase the antihypertensive activities of Guanfacine.,increase,no risk
Vardenafil,Guanoxan,Vardenafil may increase the antihypertensive activities of Guanoxan.,increase,no risk
Vardenafil,Halofantrine,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Halofantrine.,increase,risk
Vardenafil,Haloperidol,The metabolism of Vardenafil can be decreased when combined with Haloperidol.,decrease,no risk
Vardenafil,Halothane,The metabolism of Halothane can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Histrelin,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Histrelin.,increase,risk
Vardenafil,Hydralazine,The metabolism of Vardenafil can be decreased when combined with Hydralazine.,decrease,no risk
Vardenafil,Hydrochlorothiazide,Vardenafil may increase the antihypertensive activities of Hydrochlorothiazide.,increase,no risk
Vardenafil,Hydrocortisone,The metabolism of Vardenafil can be decreased when combined with Hydrocortisone.,decrease,no risk
Vardenafil,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Hydroflumethiazide,Vardenafil may increase the antihypertensive activities of Hydroflumethiazide.,increase,no risk
Vardenafil,Hydromorphone,The metabolism of Vardenafil can be decreased when combined with Hydromorphone.,decrease,no risk
Vardenafil,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Hydroxychloroquine.,increase,risk
Vardenafil,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Hydroxyzine.,increase,risk
Vardenafil,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Vardenafil.,increase,risk
Vardenafil,Ketamine,The metabolism of Ketamine can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Ketazolam,The metabolism of Vardenafil can be decreased when combined with Ketazolam.,decrease,no risk
Vardenafil,Ketoconazole,The serum concentration of Vardenafil can be increased when it is combined with Ketoconazole.,increase,no risk
Vardenafil,Ketorolac,The metabolism of Vardenafil can be decreased when combined with Ketorolac.,decrease,no risk
Vardenafil,Nabilone,The metabolism of Vardenafil can be decreased when combined with Nabilone.,decrease,no risk
Vardenafil,Nabumetone,The metabolism of Vardenafil can be decreased when combined with Nabumetone.,decrease,no risk
Vardenafil,Nadolol,Vardenafil may increase the antihypertensive activities of Nadolol.,increase,no risk
Vardenafil,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Nalidixic acid.,increase,risk
Vardenafil,Naloxegol,The serum concentration of Naloxegol can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Naproxen,The metabolism of Vardenafil can be decreased when combined with Naproxen.,decrease,no risk
Vardenafil,Nateglinide,The metabolism of Vardenafil can be decreased when combined with Nateglinide.,decrease,no risk
Vardenafil,Nebivolol,Vardenafil may increase the antihypertensive activities of Nebivolol.,increase,no risk
Vardenafil,Nefazodone,The metabolism of Vardenafil can be decreased when combined with Nefazodone.,decrease,no risk
Vardenafil,Nelfinavir,The metabolism of Vardenafil can be decreased when combined with Nelfinavir.,decrease,no risk
Vardenafil,Neratinib,The serum concentration of Vardenafil can be increased when it is combined with Neratinib.,increase,no risk
Vardenafil,Nesiritide,The risk or severity of hypotension can be increased when Vardenafil is combined with Nesiritide.,increase,risk
Vardenafil,Netupitant,The metabolism of Vardenafil can be decreased when combined with Netupitant.,decrease,no risk
Vardenafil,Nevirapine,The metabolism of Vardenafil can be decreased when combined with Nevirapine.,decrease,no risk
Vardenafil,Nicardipine,The metabolism of Vardenafil can be decreased when combined with Nicardipine.,decrease,no risk
Vardenafil,Nicergoline,The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Nicergoline.,increase,risk
Vardenafil,Niclosamide,The metabolism of Niclosamide can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Nicorandil,Vardenafil may increase the hypotensive activities of Nicorandil.,increase,no risk
Vardenafil,Nifedipine,The risk or severity of hypotension can be increased when Vardenafil is combined with Nifedipine.,increase,risk
Vardenafil,Nilotinib,The metabolism of Vardenafil can be decreased when combined with Nilotinib.,decrease,no risk
Vardenafil,Nilutamide,The metabolism of Vardenafil can be decreased when combined with Nilutamide.,decrease,no risk
Vardenafil,Nilvadipine,The metabolism of Vardenafil can be decreased when combined with Nilvadipine.,decrease,no risk
Vardenafil,Nimodipine,Vardenafil may increase the antihypertensive activities of Nimodipine.,increase,no risk
Vardenafil,Nintedanib,The serum concentration of Nintedanib can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Nisoldipine,Vardenafil may increase the antihypertensive activities of Nisoldipine.,increase,no risk
Vardenafil,Nitrendipine,Vardenafil may increase the antihypertensive activities of Nitrendipine.,increase,no risk
Vardenafil,Nitric Oxide,The metabolism of Vardenafil can be decreased when combined with Nitric Oxide.,decrease,no risk
Vardenafil,Nitroglycerin,The risk or severity of hypotension can be increased when Vardenafil is combined with Nitroglycerin.,increase,risk
Vardenafil,Nitroprusside,Vardenafil may increase the antihypertensive activities of Nitroprusside.,increase,no risk
Vardenafil,Nitrous acid,The risk or severity of hypotension can be increased when Vardenafil is combined with Nitrous acid.,increase,risk
Vardenafil,Norethisterone,The metabolism of Vardenafil can be decreased when combined with Norethisterone.,decrease,no risk
Vardenafil,Norfloxacin,The metabolism of Vardenafil can be decreased when combined with Norfloxacin.,decrease,no risk
Vardenafil,Norgestimate,The serum concentration of Vardenafil can be increased when it is combined with Norgestimate.,increase,no risk
Vardenafil,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Noscapine,The metabolism of Vardenafil can be decreased when combined with Noscapine.,decrease,no risk
Vardenafil,Obinutuzumab,The risk or severity of hypotension can be increased when Vardenafil is combined with Obinutuzumab.,increase,risk
Vardenafil,Octreotide,The metabolism of Vardenafil can be decreased when combined with Octreotide.,decrease,no risk
Vardenafil,Ofloxacin,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Ofloxacin.,increase,risk
Vardenafil,Olanzapine,The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Olanzapine.,increase,risk
Vardenafil,Olaparib,The metabolism of Vardenafil can be decreased when combined with Olaparib.,decrease,no risk
Vardenafil,Olmesartan,Vardenafil may increase the antihypertensive activities of Olmesartan.,increase,no risk
Vardenafil,Olodaterol,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Olodaterol.,increase,risk
Vardenafil,Olutasidenib,The therapeutic efficacy of Vardenafil can be decreased when used in combination with Olutasidenib.,decrease,no risk
Vardenafil,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Omaveloxolone,The serum concentration of Vardenafil can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Vardenafil,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Ondansetron,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Ondansetron.,increase,risk
Vardenafil,Opicapone,The risk or severity of hypotension can be increased when Vardenafil is combined with Opicapone.,increase,risk
Vardenafil,Oritavancin,The metabolism of Vardenafil can be decreased when combined with Oritavancin.,decrease,no risk
Vardenafil,Orphenadrine,The metabolism of Vardenafil can be decreased when combined with Orphenadrine.,decrease,no risk
Vardenafil,Osilodrostat,The metabolism of Vardenafil can be decreased when combined with Osilodrostat.,decrease,no risk
Vardenafil,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Vardenafil.,increase,risk
Vardenafil,Oxandrolone,The metabolism of Vardenafil can be decreased when combined with Oxandrolone.,decrease,no risk
Vardenafil,Oxatomide,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Oxatomide.,increase,risk
Vardenafil,Oxcarbazepine,The metabolism of Vardenafil can be increased when combined with Oxcarbazepine.,increase,no risk
Vardenafil,Oxetacaine,The metabolism of Vardenafil can be decreased when combined with Oxetacaine.,decrease,no risk
Vardenafil,Oxprenolol,Vardenafil may increase the antihypertensive activities of Oxprenolol.,increase,no risk
Vardenafil,Oxybutynin,The metabolism of Vardenafil can be decreased when combined with Oxybutynin.,decrease,no risk
Vardenafil,Oxycodone,The metabolism of Vardenafil can be decreased when combined with Oxycodone.,decrease,no risk
Vardenafil,Oxymetholone,The metabolism of Vardenafil can be decreased when combined with Oxymetholone.,decrease,no risk
Vardenafil,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Vardenafil.,increase,risk
Vardenafil,Quetiapine,The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Quetiapine.,increase,risk
Vardenafil,Quinapril,Vardenafil may increase the antihypertensive activities of Quinapril.,increase,no risk
Vardenafil,Quinidine,The metabolism of Vardenafil can be decreased when combined with Quinidine.,decrease,no risk
Vardenafil,Quinine,The metabolism of Vardenafil can be decreased when combined with Quinine.,decrease,no risk
Vardenafil,Quinupristin,The metabolism of Vardenafil can be decreased when combined with Quinupristin.,decrease,no risk
Vardenafil,Quizartinib,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Quizartinib.,increase,risk
Vardenafil,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Udenafil,The risk or severity of adverse effects can be increased when Vardenafil is combined with Udenafil.,increase,risk
Vardenafil,Umbralisib,The serum concentration of Vardenafil can be increased when it is combined with Umbralisib.,increase,no risk
Vardenafil,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Vadadustat,The serum concentration of Vardenafil can be increased when it is combined with Vadadustat.,increase,no risk
Vardenafil,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Valdecoxib,The metabolism of Vardenafil can be decreased when combined with Valdecoxib.,decrease,no risk
Vardenafil,Valproic acid,The metabolism of Vardenafil can be decreased when combined with Valproic acid.,decrease,no risk
Vardenafil,Valsartan,The metabolism of Vardenafil can be decreased when combined with Valsartan.,decrease,no risk
Vardenafil,Vandetanib,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Vandetanib.,increase,risk
Vardenafil,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Vemurafenib,The serum concentration of Vardenafil can be increased when it is combined with Vemurafenib.,increase,no risk
Vardenafil,Venetoclax,The metabolism of Vardenafil can be decreased when combined with Venetoclax.,decrease,no risk
Vardenafil,Verapamil,The metabolism of Vardenafil can be decreased when combined with Verapamil.,decrease,no risk
Vardenafil,Vericiguat,The risk or severity of hypotension can be increased when Vardenafil is combined with Vericiguat.,increase,risk
Vardenafil,Vernakalant,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Vernakalant.,increase,risk
Vardenafil,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Vardenafil.,increase,risk
Vardenafil,Viloxazine,The metabolism of Vardenafil can be decreased when combined with Viloxazine.,decrease,no risk
Vardenafil,Vinblastine,The metabolism of Vardenafil can be decreased when combined with Vinblastine.,decrease,no risk
Vardenafil,Vincristine,The excretion of Vincristine can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Vorapaxar,The serum concentration of Vardenafil can be increased when it is combined with Vorapaxar.,increase,no risk
Vardenafil,Voriconazole,The metabolism of Vardenafil can be decreased when combined with Voriconazole.,decrease,no risk
Vardenafil,Vorinostat,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Vorinostat.,increase,risk
Vardenafil,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Vardenafil.,increase,no risk
Vardenafil,Warfarin,The metabolism of Vardenafil can be increased when combined with Warfarin.,increase,no risk
Vardenafil,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Zafirlukast,The metabolism of Vardenafil can be decreased when combined with Zafirlukast.,decrease,no risk
Vardenafil,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Zidovudine,The metabolism of Vardenafil can be decreased when combined with Zidovudine.,decrease,no risk
Vardenafil,Zileuton,The metabolism of Vardenafil can be decreased when combined with Zileuton.,decrease,no risk
Vardenafil,Zimelidine,The metabolism of Vardenafil can be decreased when combined with Zimelidine.,decrease,no risk
Vardenafil,Ziprasidone,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Ziprasidone.,increase,risk
Vardenafil,Zofenopril,Vardenafil may increase the antihypertensive activities of Zofenopril.,increase,no risk
Vardenafil,Zolpidem,The metabolism of Vardenafil can be decreased when combined with Zolpidem.,decrease,no risk
Vardenafil,Zonisamide,The serum concentration of Vardenafil can be increased when it is combined with Zonisamide.,increase,no risk
Vardenafil,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Vardenafil.,decrease,no risk
Vardenafil,Zuclopenthixol,The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Zuclopenthixol.,increase,risk
Ranitidine,Betamethasone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Ranitidine.",increase,risk
Ranitidine,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Bezafibrate,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ranitidine is combined with Bezafibrate.",increase,risk
Ranitidine,Bicisate,Ranitidine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Ranitidine,Bifonazole,Ranitidine can cause a decrease in the absorption of Bifonazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ranitidine,Bimekizumab,The metabolism of Ranitidine can be increased when combined with Bimekizumab.,increase,no risk
Ranitidine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Ranitidine.,decrease,no risk
Ranitidine,Bismuth subgallate,Ranitidine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Ranitidine,Bisoprolol,Bisoprolol may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Bisoxatin,Ranitidine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Ranitidine,Bleomycin,Bleomycin may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Bosutinib,Ranitidine can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ranitidine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Brivaracetam,Ranitidine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Ranitidine,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Ranitidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ranitidine,Budesonide,Ranitidine can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ranitidine,Bumadizone,Bumadizone may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Bumetanide,The excretion of Ranitidine can be decreased when combined with Bumetanide.,decrease,no risk
Ranitidine,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Bupropion,The excretion of Ranitidine can be decreased when combined with Bupropion.,decrease,no risk
Ranitidine,Buspirone,The metabolism of Buspirone can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Butabarbital,Butabarbital may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Gabapentin enacarbil,Ranitidine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ranitidine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Gadodiamide,Gadodiamide may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Gadofosveset trisodium,Ranitidine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ranitidine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Gadoteric acid,Ranitidine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ranitidine,Gadoteridol,Gadoteridol may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Galantamine,The metabolism of Galantamine can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Ganciclovir,The excretion of Ranitidine can be decreased when combined with Ganciclovir.,decrease,no risk
Ranitidine,Gatifloxacin,The metabolism of Ranitidine can be decreased when combined with Gatifloxacin.,decrease,no risk
Ranitidine,Gefitinib,Ranitidine can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ranitidine,Gemcitabine,Gemcitabine may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Gemfibrozil,The excretion of Ranitidine can be decreased when combined with Gemfibrozil.,decrease,no risk
Ranitidine,Gemifloxacin,The metabolism of Ranitidine can be decreased when combined with Gemifloxacin.,decrease,no risk
Ranitidine,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Ranitidine.,increase,no risk
Ranitidine,Gilteritinib,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Ranitidine.,increase,risk
Ranitidine,Gimeracil,Ranitidine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ranitidine,Givosiran,The serum concentration of Ranitidine can be increased when it is combined with Givosiran.,increase,no risk
Ranitidine,Gliclazide,The serum concentration of Gliclazide can be increased when it is combined with Ranitidine.,increase,no risk
Ranitidine,Glimepiride,The serum concentration of Glimepiride can be increased when it is combined with Ranitidine.,increase,no risk
Ranitidine,Glipizide,The serum concentration of Glipizide can be increased when it is combined with Ranitidine.,increase,no risk
Ranitidine,Gliquidone,The serum concentration of Gliquidone can be increased when it is combined with Ranitidine.,increase,no risk
Ranitidine,Glofitamab,The serum concentration of Ranitidine can be increased when it is combined with Glofitamab.,increase,no risk
Ranitidine,Glyburide,The serum concentration of Glyburide can be increased when it is combined with Ranitidine.,increase,no risk
Ranitidine,Glycerol phenylbutyrate,Ranitidine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ranitidine,Golimumab,The metabolism of Ranitidine can be increased when combined with Golimumab.,increase,no risk
Ranitidine,Golodirsen,Ranitidine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ranitidine,Goserelin,Goserelin may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Grepafloxacin,The serum concentration of Ranitidine can be increased when it is combined with Grepafloxacin.,increase,no risk
Ranitidine,Guanabenz,The metabolism of Ranitidine can be decreased when combined with Guanabenz.,decrease,no risk
Ranitidine,Guanethidine,Ranitidine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Guanfacine,The risk or severity of adverse effects can be increased when Ranitidine is combined with Guanfacine.,increase,risk
Ranitidine,Guanidine,The excretion of Ranitidine can be decreased when combined with Guanidine.,decrease,no risk
Ranitidine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Ranitidine.,increase,no risk
Ranitidine,Histamine,The serum concentration of Histamine can be increased when it is combined with Ranitidine.,increase,no risk
Ranitidine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Ranitidine.,decrease,no risk
Ranitidine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Ranitidine.,decrease,no risk
Ranitidine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Ranitidine.,decrease,no risk
Ranitidine,Hydralazine,Ranitidine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Ranitidine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Ranitidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ranitidine,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ranitidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ranitidine,Hydromorphone,Hydromorphone may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Hydroxyethyl Starch,Ranitidine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ranitidine,Hyoscyamine,Ranitidine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Ranitidine,Kanamycin,Ranitidine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ranitidine,Ketamine,Ranitidine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ranitidine,Ketazolam,Ranitidine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Ranitidine,Ketoconazole,Ranitidine can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ranitidine,Ketoprofen,The excretion of Ranitidine can be decreased when combined with Ketoprofen.,decrease,no risk
Ranitidine,Ketorolac,Ketorolac may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,N-acetyltyrosine,Ranitidine may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Ranitidine,Nabumetone,The metabolism of Ranitidine can be decreased when combined with Nabumetone.,decrease,no risk
Ranitidine,Nadolol,The metabolism of Nadolol can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Nafarelin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Ranitidine.",increase,risk
Ranitidine,Nafcillin,The metabolism of Ranitidine can be increased when combined with Nafcillin.,increase,no risk
Ranitidine,Naldemedine,Ranitidine may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Ranitidine,Nalidixic acid,The metabolism of Ranitidine can be decreased when combined with Nalidixic acid.,decrease,no risk
Ranitidine,Nalmefene,Ranitidine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Ranitidine,Naloxone,Ranitidine may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Ranitidine,Naltrexone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Ranitidine.",increase,risk
Ranitidine,Naproxen,The metabolism of Ranitidine can be decreased when combined with Naproxen.,decrease,no risk
Ranitidine,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Nebivolol,The metabolism of Nebivolol can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Nedaplatin,Ranitidine may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Ranitidine,Nedocromil,Nedocromil may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Nefazodone,The metabolism of Nefazodone can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Nelfinavir,Ranitidine can cause a decrease in the absorption of Nelfinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ranitidine,Neomycin,Ranitidine may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Ranitidine,Netilmicin,Ranitidine may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Ranitidine,Netupitant,The metabolism of Netupitant can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Niacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Ranitidine.",increase,risk
Ranitidine,Nicergoline,The metabolism of Nicergoline can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Niclosamide,The metabolism of Ranitidine can be decreased when combined with Niclosamide.,decrease,no risk
Ranitidine,Nicorandil,Ranitidine may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Ranitidine,Nicotine,The serum concentration of Ranitidine can be increased when it is combined with Nicotine.,increase,no risk
Ranitidine,Nifedipine,The metabolism of Nifedipine can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Nilotinib,Ranitidine can cause a decrease in the absorption of Nilotinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ranitidine,Nilutamide,Nilutamide may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Nimesulide,Nimesulide may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Nirogacestat,The serum concentration of Nirogacestat can be decreased when it is combined with Ranitidine.,decrease,no risk
Ranitidine,Nisoldipine,Nisoldipine may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Nitroprusside,Nitroprusside may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Nizatidine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Ranitidine.",increase,risk
Ranitidine,Norepinephrine,The serum concentration of Ranitidine can be increased when it is combined with Norepinephrine.,increase,no risk
Ranitidine,Norfloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ranitidine is combined with Norfloxacin.",increase,risk
Ranitidine,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Ranitidine.,increase,no risk
Ranitidine,Novobiocin,The excretion of Ranitidine can be decreased when combined with Novobiocin.,decrease,no risk
Ranitidine,Obeticholic acid,The metabolism of Ranitidine can be decreased when combined with Obeticholic acid.,decrease,no risk
Ranitidine,Octinoxate,Ranitidine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ranitidine,Octreotide,Ranitidine can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ranitidine,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ranitidine is combined with Ofloxacin.",increase,risk
Ranitidine,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Olsalazine,Olsalazine may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Opium,The metabolism of Opium can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Orphenadrine,The metabolism of Ranitidine can be decreased when combined with Orphenadrine.,decrease,no risk
Ranitidine,Oseltamivir,Oseltamivir may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Osilodrostat,The metabolism of Ranitidine can be decreased when combined with Osilodrostat.,decrease,no risk
Ranitidine,Osimertinib,The serum concentration of Ranitidine can be decreased when it is combined with Osimertinib.,decrease,no risk
Ranitidine,Oteseconazole,Ranitidine can cause a decrease in the absorption of Oteseconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ranitidine,Ouabain,The excretion of Ranitidine can be decreased when combined with Ouabain.,decrease,no risk
Ranitidine,Oxacillin,Oxacillin may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Ranitidine.,increase,no risk
Ranitidine,Oxaprozin,Oxaprozin may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Oxazepam,Oxazepam may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Oxprenolol,The serum concentration of Ranitidine can be increased when it is combined with Oxprenolol.,increase,no risk
Ranitidine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Oxybenzone,Ranitidine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Ranitidine,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Oxyquinoline,Ranitidine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ranitidine,Oxytetracycline,The excretion of Ranitidine can be decreased when combined with Oxytetracycline.,decrease,no risk
Ranitidine,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Quinethazone,Quinethazone may increase the excretion rate of Ranitidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ranitidine,Quinidine,The metabolism of Ranitidine can be decreased when combined with Quinidine.,decrease,no risk
Ranitidine,Quinine,The serum concentration of Ranitidine can be increased when it is combined with Quinine.,increase,no risk
Ranitidine,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ranitidine is combined with Ubidecarenone.",increase,risk
Ranitidine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Vaborbactam,Ranitidine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ranitidine,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Ranitidine.,increase,no risk
Ranitidine,Valaciclovir,Valaciclovir may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Valdecoxib,Valdecoxib may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Valganciclovir,Ranitidine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Ranitidine,Valproic acid,The excretion of Ranitidine can be decreased when combined with Valproic acid.,decrease,no risk
Ranitidine,Vancomycin,Ranitidine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ranitidine,Vandetanib,The serum concentration of Ranitidine can be increased when it is combined with Vandetanib.,increase,no risk
Ranitidine,Varenicline,The excretion of Varenicline can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Vemurafenib,The serum concentration of Ranitidine can be increased when it is combined with Vemurafenib.,increase,no risk
Ranitidine,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Verapamil,The metabolism of Ranitidine can be decreased when combined with Verapamil.,decrease,no risk
Ranitidine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Vilanterol,Ranitidine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Ranitidine,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Viloxazine,The metabolism of Ranitidine can be decreased when combined with Viloxazine.,decrease,no risk
Ranitidine,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Ranitidine.",increase,risk
Ranitidine,Voriconazole,Ranitidine can cause a decrease in the absorption of Voriconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ranitidine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Ranitidine.,increase,no risk
Ranitidine,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Zaleplon,Ranitidine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Ranitidine,Zanamivir,Zanamivir may decrease the excretion rate of Ranitidine which could result in a higher serum level.,decrease,no risk
Ranitidine,Zidovudine,The excretion of Ranitidine can be decreased when combined with Zidovudine.,decrease,no risk
Ranitidine,Zileuton,The metabolism of Ranitidine can be decreased when combined with Zileuton.,decrease,no risk
Ranitidine,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Zonisamide,Zonisamide may increase the excretion rate of Ranitidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ranitidine,Zotepine,The metabolism of Zotepine can be decreased when combined with Ranitidine.,decrease,no risk
Ranitidine,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Ranitidine.,decrease,no risk
Tacrolimus,Bacillus calmette-guerin substrain connaught live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Tacrolimus.,increase,risk
Tacrolimus,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Tacrolimus.,decrease,no risk
Tacrolimus,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Tacrolimus.,increase,risk
Tacrolimus,Bacitracin,The risk or severity of nephrotoxicity can be increased when Bacitracin is combined with Tacrolimus.,increase,risk
Tacrolimus,Baclofen,Tacrolimus may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Tacrolimus,Balsalazide,The risk or severity of renal failure can be increased when Balsalazide is combined with Tacrolimus.,increase,risk
Tacrolimus,Baricitinib,Tacrolimus may increase the immunosuppressive activities of Baricitinib.,increase,no risk
Tacrolimus,Basiliximab,Tacrolimus may increase the immunosuppressive activities of Basiliximab.,increase,no risk
Tacrolimus,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Tacrolimus.,increase,risk
Tacrolimus,Beclomethasone dipropionate,Tacrolimus may increase the immunosuppressive activities of Beclomethasone dipropionate.,increase,no risk
Tacrolimus,Bedaquiline,The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Bedaquiline.,increase,risk
Tacrolimus,Belantamab mafodotin,The serum concentration of Belantamab mafodotin can be increased when it is combined with Tacrolimus.,increase,no risk
Tacrolimus,Belatacept,Tacrolimus may increase the immunosuppressive activities of Belatacept.,increase,no risk
Tacrolimus,Belimumab,Tacrolimus may increase the immunosuppressive activities of Belimumab.,increase,no risk
Tacrolimus,Belinostat,Tacrolimus may increase the immunosuppressive activities of Belinostat.,increase,no risk
Tacrolimus,Belumosudil,Tacrolimus may increase the immunosuppressive activities of Belumosudil.,increase,no risk
Tacrolimus,Belzutifan,The serum concentration of Tacrolimus can be decreased when it is combined with Belzutifan.,decrease,no risk
Tacrolimus,Bemiparin,The risk or severity of hyperkalemia can be increased when Tacrolimus is combined with Bemiparin.,increase,risk
Tacrolimus,Benazepril,The risk or severity of hyperkalemia can be increased when Benazepril is combined with Tacrolimus.,increase,risk
Tacrolimus,Bendamustine,Tacrolimus may increase the immunosuppressive activities of Bendamustine.,increase,no risk
Tacrolimus,Bendroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Tacrolimus.,increase,risk
Tacrolimus,Benorilate,The risk or severity of renal failure can be increased when Benorilate is combined with Tacrolimus.,increase,risk
Tacrolimus,Benoxaprofen,The risk or severity of renal failure can be increased when Benoxaprofen is combined with Tacrolimus.,increase,risk
Tacrolimus,Benserazide,Tacrolimus may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Tacrolimus,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Tacrolimus.,increase,risk
Tacrolimus,Benznidazole,Tacrolimus may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Tacrolimus,Benzthiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Tacrolimus.,increase,risk
Tacrolimus,Benzydamine,The risk or severity of renal failure can be increased when Benzydamine is combined with Tacrolimus.,increase,risk
Tacrolimus,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Tacrolimus.,decrease,no risk
Tacrolimus,Bepotastine,Tacrolimus may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Tacrolimus,Bepridil,Bepridil may increase the immunosuppressive activities of Tacrolimus.,increase,no risk
Tacrolimus,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Tacrolimus.,increase,no risk
Tacrolimus,Betamethasone,Tacrolimus may increase the immunosuppressive activities of Betamethasone.,increase,no risk
Tacrolimus,Betamethasone phosphate,The metabolism of Tacrolimus can be increased when combined with Betamethasone phosphate.,increase,no risk
Tacrolimus,Betaxolol,The risk or severity of hyperkalemia can be increased when Betaxolol is combined with Tacrolimus.,increase,risk
Tacrolimus,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Tacrolimus.,increase,no risk
Tacrolimus,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Tacrolimus.,decrease,no risk
Tacrolimus,Bexarotene,Tacrolimus may increase the immunosuppressive activities of Bexarotene.,increase,no risk
Tacrolimus,Bezafibrate,Tacrolimus may increase the nephrotoxic activities of Bezafibrate.,increase,no risk
Tacrolimus,Bicalutamide,The serum concentration of Tacrolimus can be increased when it is combined with Bicalutamide.,increase,no risk
Tacrolimus,Bicisate,Tacrolimus may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Tacrolimus,Bifonazole,The serum concentration of Tacrolimus can be increased when it is combined with Bifonazole.,increase,no risk
Tacrolimus,Bilastine,The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Bilastine.,increase,risk
Tacrolimus,Bimekizumab,Tacrolimus may increase the immunosuppressive activities of Bimekizumab.,increase,no risk
Tacrolimus,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Tacrolimus.,increase,no risk
Tacrolimus,Bioallethrin,Bioallethrin may increase the immunosuppressive activities of Tacrolimus.,increase,no risk
Tacrolimus,Bismuth subgallate,Tacrolimus may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Tacrolimus,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Tacrolimus.,increase,no risk
Tacrolimus,Bisoxatin,Tacrolimus may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Tacrolimus,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tacrolimus.,increase,risk
Tacrolimus,Bleomycin,Tacrolimus may increase the immunosuppressive activities of Bleomycin.,increase,no risk
Tacrolimus,Blinatumomab,Tacrolimus may increase the immunosuppressive activities of Blinatumomab.,increase,no risk
Tacrolimus,Boceprevir,The serum concentration of Tacrolimus can be increased when it is combined with Boceprevir.,increase,no risk
Tacrolimus,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Tacrolimus.",decrease,no risk
Tacrolimus,Bortezomib,Tacrolimus may increase the immunosuppressive activities of Bortezomib.,increase,no risk
Tacrolimus,Bosentan,The metabolism of Tacrolimus can be increased when combined with Bosentan.,increase,no risk
Tacrolimus,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Tacrolimus.,increase,no risk
Tacrolimus,Brentuximab vedotin,The serum concentration of Tacrolimus can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Tacrolimus,Bretylium,The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Bretylium.,increase,risk
Tacrolimus,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Tacrolimus.,decrease,no risk
Tacrolimus,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Tacrolimus.,increase,no risk
Tacrolimus,Brivaracetam,Tacrolimus may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Tacrolimus,Brodalumab,Tacrolimus may increase the immunosuppressive activities of Brodalumab.,increase,no risk
Tacrolimus,Bromazepam,Tacrolimus may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Tacrolimus,Bromocriptine,The serum concentration of Tacrolimus can be increased when it is combined with Bromocriptine.,increase,no risk
Tacrolimus,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Tacrolimus.,increase,risk
Tacrolimus,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Tacrolimus.,increase,risk
Tacrolimus,Budesonide,Tacrolimus may increase the immunosuppressive activities of Budesonide.,increase,no risk
Tacrolimus,Bumadizone,The risk or severity of renal failure can be increased when Bumadizone is combined with Tacrolimus.,increase,risk
Tacrolimus,Bumetanide,The risk or severity of nephrotoxicity can be increased when Tacrolimus is combined with Bumetanide.,increase,risk
Tacrolimus,Buprenorphine,The serum concentration of Tacrolimus can be increased when it is combined with Buprenorphine.,increase,no risk
Tacrolimus,Bupropion,Tacrolimus may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Tacrolimus,Buserelin,The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Buserelin.,increase,risk
Tacrolimus,Buspirone,The metabolism of Tacrolimus can be decreased when combined with Buspirone.,decrease,no risk
Tacrolimus,Busulfan,Tacrolimus may increase the immunosuppressive activities of Busulfan.,increase,no risk
Tacrolimus,Butabarbital,Tacrolimus may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Tacrolimus,Butalbital,The metabolism of Tacrolimus can be increased when combined with Butalbital.,increase,no risk
Tacrolimus,Butriptyline,The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Butriptyline.,increase,risk
Benzphetamine,Bosentan,Benzphetamine may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Benzphetamine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Benzphetamine.,increase,risk
Benzphetamine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Benzphetamine.,increase,risk
Benzphetamine,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Benzphetamine.,decrease,no risk
Benzphetamine,Brexanolone,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Brexanolone.,increase,risk
Benzphetamine,Brexpiprazole,The therapeutic efficacy of Brexpiprazole can be decreased when used in combination with Benzphetamine.,decrease,no risk
Benzphetamine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Benzphetamine.,increase,no risk
Benzphetamine,Brivaracetam,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Brivaracetam.,increase,risk
Benzphetamine,Bromazepam,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Bromazepam.,increase,risk
Benzphetamine,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Benzphetamine.,decrease,no risk
Benzphetamine,Bromotheophylline,The risk or severity of adverse effects can be increased when Benzphetamine is combined with Bromotheophylline.,increase,risk
Benzphetamine,Bromperidol,Bromperidol may decrease the stimulatory activities of Benzphetamine.,decrease,no risk
Benzphetamine,Brompheniramine,Benzphetamine may decrease the sedative activities of Brompheniramine.,decrease,no risk
Benzphetamine,Buclizine,Benzphetamine may decrease the sedative activities of Buclizine.,decrease,no risk
Benzphetamine,Bumadizone,The risk or severity of hypertension can be increased when Benzphetamine is combined with Bumadizone.,increase,risk
Benzphetamine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Benzphetamine.,increase,risk
Benzphetamine,Buprenorphine,Benzphetamine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Benzphetamine,Bupropion,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Bupropion.,increase,risk
Benzphetamine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Benzphetamine.,increase,risk
Benzphetamine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Benzphetamine.,increase,risk
Benzphetamine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Benzphetamine.,increase,risk
Benzphetamine,Butaperazine,Butaperazine may decrease the stimulatory activities of Benzphetamine.,decrease,no risk
Benzphetamine,Butobarbital,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Butobarbital.,increase,risk
Benzphetamine,Butorphanol,Benzphetamine may increase the analgesic activities of Butorphanol.,increase,no risk
Benzphetamine,Butriptyline,Benzphetamine may decrease the sedative activities of Butriptyline.,decrease,no risk
Benzphetamine,Butylscopolamine,The risk or severity of Tachycardia can be increased when Benzphetamine is combined with Butylscopolamine.,increase,risk
Benzphetamine,Gabapentin,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Gabapentin.,increase,risk
Benzphetamine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Gabapentin enacarbil.,increase,risk
Benzphetamine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Benzphetamine.,increase,risk
Benzphetamine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Benzphetamine is combined with Ganaxolone.",increase,risk
Benzphetamine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Benzphetamine.,increase,risk
Benzphetamine,Glofitamab,The serum concentration of Benzphetamine can be increased when it is combined with Glofitamab.,increase,no risk
Benzphetamine,Glutamic acid,The serum concentration of Benzphetamine can be decreased when it is combined with Glutamic acid.,decrease,no risk
Benzphetamine,Glutethimide,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Glutethimide.,increase,risk
Benzphetamine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Benzphetamine.,decrease,no risk
Benzphetamine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Benzphetamine is combined with Glycopyrronium.,increase,risk
Benzphetamine,Golimumab,The metabolism of Benzphetamine can be increased when combined with Golimumab.,increase,no risk
Benzphetamine,Granisetron,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Granisetron.,increase,risk
Benzphetamine,Guanabenz,Benzphetamine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Benzphetamine,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Benzphetamine.,decrease,no risk
Benzphetamine,Guanethidine,The serum concentration of Benzphetamine can be decreased when it is combined with Guanethidine.,decrease,no risk
Benzphetamine,Guanfacine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Guanfacine.,increase,risk
Benzphetamine,Guanoxan,Benzphetamine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Benzphetamine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Benzphetamine.,increase,risk
Benzphetamine,Haloperidol,The therapeutic efficacy of Benzphetamine can be decreased when used in combination with Haloperidol.,decrease,no risk
Benzphetamine,Halothane,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Halothane.,increase,risk
Benzphetamine,Hexafluronium,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Hexafluronium.,increase,risk
Benzphetamine,Hexocyclium,The risk or severity of Tachycardia can be increased when Benzphetamine is combined with Hexocyclium.,increase,risk
Benzphetamine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Benzphetamine.,increase,risk
Benzphetamine,Hydralazine,Benzphetamine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Benzphetamine,Hydrochlorothiazide,Benzphetamine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Benzphetamine,Hydrocodone,Benzphetamine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Benzphetamine,Hydrocortisone,The metabolism of Benzphetamine can be increased when combined with Hydrocortisone.,increase,no risk
Benzphetamine,Hydroflumethiazide,Benzphetamine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Benzphetamine,Hydromorphone,Benzphetamine may increase the analgesic activities of Hydromorphone.,increase,no risk
Benzphetamine,Hydrotalcite,The serum concentration of Benzphetamine can be increased when it is combined with Hydrotalcite.,increase,no risk
Benzphetamine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Benzphetamine.,increase,no risk
Benzphetamine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Benzphetamine.,increase,risk
Benzphetamine,Ketamine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Ketamine.,increase,risk
Benzphetamine,Ketazolam,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Ketazolam.,increase,risk
Benzphetamine,Ketoconazole,The metabolism of Benzphetamine can be decreased when combined with Ketoconazole.,decrease,no risk
Benzphetamine,Ketoprofen,The risk or severity of hypertension can be increased when Benzphetamine is combined with Ketoprofen.,increase,risk
Benzphetamine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Benzphetamine.,increase,risk
Benzphetamine,Ketotifen,Benzphetamine may decrease the sedative activities of Ketotifen.,decrease,no risk
Benzphetamine,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Benzphetamine.,increase,no risk
Benzphetamine,Nabumetone,The risk or severity of hypertension can be increased when Nabumetone is combined with Benzphetamine.,increase,risk
Benzphetamine,Nadolol,The therapeutic efficacy of Nadolol can be decreased when used in combination with Benzphetamine.,decrease,no risk
Benzphetamine,Nalbuphine,Benzphetamine may increase the analgesic activities of Nalbuphine.,increase,no risk
Benzphetamine,Naloxegol,Benzphetamine may increase the analgesic activities of Naloxegol.,increase,no risk
Benzphetamine,Naltrexone,Benzphetamine may increase the analgesic activities of Naltrexone.,increase,no risk
Benzphetamine,Naphazoline,The risk or severity of hypertension can be increased when Benzphetamine is combined with Naphazoline.,increase,risk
Benzphetamine,Naproxen,The risk or severity of hypertension can be increased when Naproxen is combined with Benzphetamine.,increase,risk
Benzphetamine,Naratriptan,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Naratriptan.,increase,risk
Benzphetamine,Naxitamab,The risk or severity of hypertension can be increased when Benzphetamine is combined with Naxitamab.,increase,risk
Benzphetamine,Nebivolol,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Benzphetamine.,decrease,no risk
Benzphetamine,Nefazodone,The metabolism of Benzphetamine can be decreased when combined with Nefazodone.,decrease,no risk
Benzphetamine,Nelfinavir,The metabolism of Benzphetamine can be decreased when combined with Nelfinavir.,decrease,no risk
Benzphetamine,Netupitant,The metabolism of Benzphetamine can be decreased when combined with Netupitant.,decrease,no risk
Benzphetamine,Nevirapine,The metabolism of Benzphetamine can be increased when combined with Nevirapine.,increase,no risk
Benzphetamine,Niacinamide ascorbate,The serum concentration of Benzphetamine can be decreased when it is combined with Niacinamide ascorbate.,decrease,no risk
Benzphetamine,Nialamide,Nialamide may increase the hypertensive activities of Benzphetamine.,increase,no risk
Benzphetamine,Nicardipine,The therapeutic efficacy of Nicardipine can be decreased when used in combination with Benzphetamine.,decrease,no risk
Benzphetamine,Nicergoline,The therapeutic efficacy of Nicergoline can be decreased when used in combination with Benzphetamine.,decrease,no risk
Benzphetamine,Nicorandil,Benzphetamine may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Benzphetamine,Nicotine,The metabolism of Benzphetamine can be decreased when combined with Nicotine.,decrease,no risk
Benzphetamine,Nilotinib,The metabolism of Benzphetamine can be decreased when combined with Nilotinib.,decrease,no risk
Benzphetamine,Nilvadipine,The metabolism of Benzphetamine can be decreased when combined with Nilvadipine.,decrease,no risk
Benzphetamine,Nimesulide,The risk or severity of hypertension can be increased when Benzphetamine is combined with Nimesulide.,increase,risk
Benzphetamine,Nimodipine,Benzphetamine may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Benzphetamine,Nirogacestat,The metabolism of Benzphetamine can be increased when combined with Nirogacestat.,increase,no risk
Benzphetamine,Nisoldipine,Benzphetamine may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Benzphetamine,Nitrazepam,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Nitrazepam.,increase,risk
Benzphetamine,Nitrendipine,Benzphetamine may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Benzphetamine,Nitroglycerin,Benzphetamine may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Benzphetamine,Nitroprusside,Benzphetamine may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Benzphetamine,Nitrous oxide,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Nitrous oxide.,increase,risk
Benzphetamine,Nizatidine,Benzphetamine may decrease the sedative activities of Nizatidine.,decrease,no risk
Benzphetamine,Nomifensine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Nomifensine.,increase,risk
Benzphetamine,Norepinephrine,The therapeutic efficacy of Benzphetamine can be increased when used in combination with Norepinephrine.,increase,no risk
Benzphetamine,Norgestimate,The metabolism of Norgestimate can be decreased when combined with Benzphetamine.,decrease,no risk
Benzphetamine,Normethadone,Benzphetamine may increase the analgesic activities of Normethadone.,increase,no risk
Benzphetamine,Nortriptyline,Benzphetamine may decrease the sedative activities of Nortriptyline.,decrease,no risk
Benzphetamine,Nylidrin,The risk or severity of hypertension can be increased when Benzphetamine is combined with Nylidrin.,increase,risk
Benzphetamine,Olanzapine,Benzphetamine may decrease the sedative activities of Olanzapine.,decrease,no risk
Benzphetamine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Benzphetamine is combined with Oliceridine.",increase,risk
Benzphetamine,Olmesartan,Benzphetamine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Benzphetamine,Olodaterol,The risk or severity of hypertension can be increased when Benzphetamine is combined with Olodaterol.,increase,risk
Benzphetamine,Omaveloxolone,The serum concentration of Benzphetamine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Benzphetamine,Ondansetron,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Ondansetron.,increase,risk
Benzphetamine,Opium,Benzphetamine may increase the analgesic activities of Opium.,increase,no risk
Benzphetamine,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Benzphetamine.,increase,risk
Benzphetamine,Orphenadrine,Benzphetamine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Benzphetamine,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Benzphetamine.,decrease,no risk
Benzphetamine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Benzphetamine.,decrease,no risk
Benzphetamine,Oxaprozin,The risk or severity of hypertension can be increased when Benzphetamine is combined with Oxaprozin.,increase,risk
Benzphetamine,Oxatomide,Benzphetamine may decrease the sedative activities of Oxatomide.,decrease,no risk
Benzphetamine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Benzphetamine.,increase,risk
Benzphetamine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Benzphetamine.,increase,risk
Benzphetamine,Oxitriptan,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Oxitriptan.,increase,risk
Benzphetamine,Oxprenolol,The therapeutic efficacy of Oxprenolol can be decreased when used in combination with Benzphetamine.,decrease,no risk
Benzphetamine,Oxtriphylline,The risk or severity of adverse effects can be increased when Benzphetamine is combined with Oxtriphylline.,increase,risk
Benzphetamine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Oxybuprocaine.,increase,risk
Benzphetamine,Oxybutynin,The risk or severity of Tachycardia can be increased when Benzphetamine is combined with Oxybutynin.,increase,risk
Benzphetamine,Oxycodone,Benzphetamine may increase the analgesic activities of Oxycodone.,increase,no risk
Benzphetamine,Oxymetazoline,Benzphetamine may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Benzphetamine,Oxymorphone,Benzphetamine may increase the analgesic activities of Oxymorphone.,increase,no risk
Benzphetamine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Benzphetamine is combined with Oxyphenbutazone.,increase,risk
Benzphetamine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Benzphetamine.,increase,risk
Benzphetamine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Benzphetamine.,increase,risk
Benzphetamine,Quazepam,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Quazepam.,increase,risk
Benzphetamine,Quetiapine,Benzphetamine may decrease the sedative activities of Quetiapine.,decrease,no risk
Benzphetamine,Quinapril,Benzphetamine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Benzphetamine,Quinidine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Benzphetamine.,decrease,no risk
Benzphetamine,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Benzphetamine.,increase,risk
Benzphetamine,Quinupramine,The therapeutic efficacy of Quinupramine can be increased when used in combination with Benzphetamine.,increase,no risk
Benzphetamine,Umeclidinium,The risk or severity of Tachycardia can be increased when Benzphetamine is combined with Umeclidinium.,increase,risk
Benzphetamine,Urethane,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Urethane.,increase,risk
Benzphetamine,Vadadustat,The serum concentration of Benzphetamine can be decreased when it is combined with Vadadustat.,decrease,no risk
Benzphetamine,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Benzphetamine.,increase,risk
Benzphetamine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Benzphetamine is combined with Valproate bismuth.,increase,risk
Benzphetamine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Benzphetamine.,increase,risk
Benzphetamine,Valsartan,Benzphetamine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Benzphetamine,Vecuronium,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Vecuronium.,increase,risk
Benzphetamine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Benzphetamine.,decrease,no risk
Benzphetamine,Venetoclax,The metabolism of Benzphetamine can be decreased when combined with Venetoclax.,decrease,no risk
Benzphetamine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Benzphetamine is combined with Venlafaxine.,increase,risk
Benzphetamine,Verapamil,The therapeutic efficacy of Verapamil can be decreased when used in combination with Benzphetamine.,decrease,no risk
Benzphetamine,Vigabatrin,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Vigabatrin.,increase,risk
Benzphetamine,Vilanterol,The risk or severity of hypertension can be increased when Benzphetamine is combined with Vilanterol.,increase,risk
Benzphetamine,Vilazodone,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Vilazodone.,increase,risk
Benzphetamine,Viloxazine,The metabolism of Benzphetamine can be decreased when combined with Viloxazine.,decrease,no risk
Benzphetamine,Voriconazole,The metabolism of Benzphetamine can be decreased when combined with Voriconazole.,decrease,no risk
Benzphetamine,Vortioxetine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Vortioxetine.,increase,risk
Benzphetamine,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Benzphetamine.,decrease,no risk
Benzphetamine,Warfarin,The risk or severity of adverse effects can be increased when Benzphetamine is combined with Warfarin.,increase,risk
Benzphetamine,Xamoterol,The risk or severity of hypertension can be increased when Benzphetamine is combined with Xamoterol.,increase,risk
Benzphetamine,Xylometazoline,The risk or severity of hypertension can be increased when Benzphetamine is combined with Xylometazoline.,increase,risk
Benzphetamine,Yohimbine,The therapeutic efficacy of Yohimbine can be decreased when used in combination with Benzphetamine.,decrease,no risk
Benzphetamine,Zaleplon,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Zaleplon.,increase,risk
Benzphetamine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Benzphetamine.,decrease,no risk
Benzphetamine,Ziconotide,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Ziconotide.,increase,risk
Benzphetamine,Zimelidine,The risk or severity of adverse effects can be increased when Benzphetamine is combined with Zimelidine.,increase,risk
Benzphetamine,Zinc ascorbate,The serum concentration of Benzphetamine can be decreased when it is combined with Zinc ascorbate.,decrease,no risk
Benzphetamine,Ziprasidone,The risk or severity of adverse effects can be increased when Benzphetamine is combined with Ziprasidone.,increase,risk
Benzphetamine,Zofenopril,Benzphetamine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Benzphetamine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Benzphetamine.,increase,risk
Benzphetamine,Zolpidem,Benzphetamine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Benzphetamine,Zonisamide,Zonisamide may decrease the excretion rate of Benzphetamine which could result in a higher serum level.,decrease,no risk
Benzphetamine,Zopiclone,The risk or severity of adverse effects can be increased when Benzphetamine is combined with Zopiclone.,increase,risk
Benzphetamine,Zotepine,Zotepine may decrease the stimulatory activities of Benzphetamine.,decrease,no risk
Benzphetamine,Zuclopenthixol,Benzphetamine may decrease the sedative activities of Zuclopenthixol.,decrease,no risk
Benzphetamine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Benzphetamine.,increase,risk
Alprenolol,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Alprenolol.,increase,no risk
Alprenolol,Bethanechol,The risk or severity of adverse effects can be increased when Alprenolol is combined with Bethanechol.,increase,risk
Alprenolol,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Alprenolol.,decrease,no risk
Alprenolol,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Alprenolol.,increase,no risk
Alprenolol,Bimatoprost,Alprenolol may increase the hypotensive activities of Bimatoprost.,increase,no risk
Alprenolol,Bimekizumab,The metabolism of Alprenolol can be increased when combined with Bimekizumab.,increase,no risk
Alprenolol,Bioallethrin,Alprenolol may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Alprenolol,Biperiden,The metabolism of Alprenolol can be decreased when combined with Biperiden.,decrease,no risk
Alprenolol,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Alprenolol.,increase,risk
Alprenolol,Bortezomib,The metabolism of Alprenolol can be decreased when combined with Bortezomib.,decrease,no risk
Alprenolol,Bosentan,Bosentan may increase the hypotensive activities of Alprenolol.,increase,no risk
Alprenolol,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Alprenolol.,increase,risk
Alprenolol,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Alprenolol.,increase,risk
Alprenolol,Bouteloua gracilis pollen,The risk of a hypersensitivity reaction to Bouteloua gracilis pollen is increased when it is combined with Alprenolol.,increase,risk
Alprenolol,Bretylium,Alprenolol may increase the arrhythmogenic activities of Bretylium.,increase,no risk
Alprenolol,Brexanolone,The risk or severity of CNS depression can be increased when Alprenolol is combined with Brexanolone.,increase,risk
Alprenolol,Brexpiprazole,Alprenolol may increase the orthostatic hypotensive activities of Brexpiprazole.,increase,no risk
Alprenolol,Brimonidine,Brimonidine may increase the antihypertensive activities of Alprenolol.,increase,no risk
Alprenolol,Brivaracetam,The risk or severity of CNS depression can be increased when Alprenolol is combined with Brivaracetam.,increase,risk
Alprenolol,Bromazepam,The risk or severity of CNS depression can be increased when Alprenolol is combined with Bromazepam.,increase,risk
Alprenolol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Alprenolol.,increase,no risk
Alprenolol,Bromotheophylline,The risk or severity of adverse effects can be increased when Alprenolol is combined with Bromotheophylline.,increase,risk
Alprenolol,Bromperidol,The risk or severity of CNS depression can be increased when Alprenolol is combined with Bromperidol.,increase,risk
Alprenolol,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Alprenolol.,increase,risk
Alprenolol,Bromus secalinus pollen,The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Alprenolol.,increase,risk
Alprenolol,Bumadizone,Bumadizone may decrease the antihypertensive activities of Alprenolol.,decrease,no risk
Alprenolol,Bumetanide,Bumetanide may increase the hypotensive activities of Alprenolol.,increase,no risk
Alprenolol,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Alprenolol.,increase,no risk
Alprenolol,Buprenorphine,Alprenolol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Alprenolol,Bupropion,The metabolism of Alprenolol can be decreased when combined with Bupropion.,decrease,no risk
Alprenolol,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Alprenolol.,increase,risk
Alprenolol,Butabarbital,The serum concentration of Alprenolol can be decreased when it is combined with Butabarbital.,decrease,no risk
Alprenolol,Butalbital,The serum concentration of Alprenolol can be decreased when it is combined with Butalbital.,decrease,no risk
Alprenolol,Butaperazine,The serum concentration of Alprenolol can be increased when it is combined with Butaperazine.,increase,no risk
Alprenolol,Butobarbital,The risk or severity of CNS depression can be increased when Alprenolol is combined with Butobarbital.,increase,risk
Alprenolol,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Alprenolol.,increase,risk
Alprenolol,Butriptyline,The risk or severity of CNS depression can be increased when Alprenolol is combined with Butriptyline.,increase,risk
Ritodrine,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Ritodrine.,increase,risk
Ritodrine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Ritodrine.,decrease,no risk
Ritodrine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Ritodrine is combined with Glycopyrronium.,increase,risk
Ritodrine,Guanabenz,Ritodrine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Ritodrine,Guanadrel,Ritodrine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Ritodrine,Guanethidine,Ritodrine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Ritodrine,Guanfacine,Ritodrine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Ritodrine,Guanoxan,Ritodrine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Ritodrine,Halothane,The risk or severity of hypertension can be increased when Ritodrine is combined with Halothane.,increase,risk
Ritodrine,Hexocyclium,The risk or severity of Tachycardia can be increased when Ritodrine is combined with Hexocyclium.,increase,risk
Ritodrine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Ritodrine.,increase,risk
Ritodrine,Hydralazine,Ritodrine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Ritodrine,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Ritodrine is combined with Hydrochlorothiazide.,increase,risk
Ritodrine,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Ritodrine.,increase,risk
Ritodrine,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Ritodrine.,increase,risk
Ritodrine,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Ritodrine.,increase,risk
Ritodrine,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Ritodrine.,increase,risk
Ritodrine,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Ritodrine.,increase,risk
Ritodrine,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Ritodrine is combined with Hydroflumethiazide.,increase,risk
Ritodrine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Ritodrine.,increase,risk
Ritodrine,Ketamine,The risk or severity of Tachycardia can be increased when Ritodrine is combined with Ketamine.,increase,risk
Ritodrine,Ketoprofen,The risk or severity of hypertension can be increased when Ritodrine is combined with Ketoprofen.,increase,risk
Ritodrine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Ritodrine.,increase,risk
Ritodrine,Nabilone,The risk or severity of Tachycardia can be increased when Nabilone is combined with Ritodrine.,increase,risk
Ritodrine,Nabumetone,The risk or severity of hypertension can be increased when Nabumetone is combined with Ritodrine.,increase,risk
Ritodrine,Nadolol,Nadolol may decrease the bronchodilatory activities of Ritodrine.,decrease,no risk
Ritodrine,Naphazoline,The risk or severity of hypertension can be increased when Ritodrine is combined with Naphazoline.,increase,risk
Ritodrine,Naproxen,The risk or severity of hypertension can be increased when Naproxen is combined with Ritodrine.,increase,risk
Ritodrine,Naratriptan,The risk or severity of hypertension can be increased when Ritodrine is combined with Naratriptan.,increase,risk
Ritodrine,Naxitamab,The risk or severity of hypertension can be increased when Ritodrine is combined with Naxitamab.,increase,risk
Ritodrine,Nebivolol,The therapeutic efficacy of Ritodrine can be decreased when used in combination with Nebivolol.,decrease,no risk
Ritodrine,Nefazodone,Nefazodone may increase the tachycardic activities of Ritodrine.,increase,no risk
Ritodrine,Nialamide,The risk or severity of hypertension can be increased when Ritodrine is combined with Nialamide.,increase,risk
Ritodrine,Nicardipine,The therapeutic efficacy of Ritodrine can be decreased when used in combination with Nicardipine.,decrease,no risk
Ritodrine,Nicergoline,Nicergoline may increase the hypertensive and vasoconstricting activities of Ritodrine.,increase,no risk
Ritodrine,Nicorandil,Ritodrine may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Ritodrine,Nicotine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Ritodrine.,increase,risk
Ritodrine,Nilvadipine,Ritodrine may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Ritodrine,Nimesulide,The risk or severity of hypertension can be increased when Ritodrine is combined with Nimesulide.,increase,risk
Ritodrine,Nimodipine,Ritodrine may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Ritodrine,Nisoldipine,Ritodrine may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Ritodrine,Nitrendipine,Ritodrine may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Ritodrine,Nitroglycerin,Ritodrine may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Ritodrine,Nitroprusside,Ritodrine may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Ritodrine,Nitrous oxide,The risk or severity of hypertension can be increased when Ritodrine is combined with Nitrous oxide.,increase,risk
Ritodrine,Norepinephrine,The therapeutic efficacy of Ritodrine can be increased when used in combination with Norepinephrine.,increase,no risk
Ritodrine,Nortriptyline,The therapeutic efficacy of Ritodrine can be decreased when used in combination with Nortriptyline.,decrease,no risk
Ritodrine,Nylidrin,The risk or severity of hypertension can be increased when Ritodrine is combined with Nylidrin.,increase,risk
Ritodrine,Olanzapine,The therapeutic efficacy of Ritodrine can be decreased when used in combination with Olanzapine.,decrease,no risk
Ritodrine,Olmesartan,Ritodrine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Ritodrine,Olodaterol,The risk or severity of adverse effects can be increased when Ritodrine is combined with Olodaterol.,increase,risk
Ritodrine,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Ritodrine.,increase,risk
Ritodrine,Orphenadrine,The risk or severity of Tachycardia can be increased when Ritodrine is combined with Orphenadrine.,increase,risk
Ritodrine,Oxaprozin,The risk or severity of hypertension can be increased when Ritodrine is combined with Oxaprozin.,increase,risk
Ritodrine,Oxprenolol,Oxprenolol may decrease the bronchodilatory activities of Ritodrine.,decrease,no risk
Ritodrine,Oxtriphylline,The risk or severity of adverse effects can be increased when Ritodrine is combined with Oxtriphylline.,increase,risk
Ritodrine,Oxybutynin,The risk or severity of Tachycardia can be increased when Ritodrine is combined with Oxybutynin.,increase,risk
Ritodrine,Oxymetazoline,The risk or severity of hypertension can be increased when Ritodrine is combined with Oxymetazoline.,increase,risk
Ritodrine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Ritodrine is combined with Oxyphenbutazone.,increase,risk
Ritodrine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Ritodrine.,increase,risk
Ritodrine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Ritodrine.,increase,risk
Ritodrine,Quetiapine,The therapeutic efficacy of Ritodrine can be decreased when used in combination with Quetiapine.,decrease,no risk
Ritodrine,Quinapril,Ritodrine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Ritodrine,Quinethazone,Ritodrine may increase the hypokalemic activities of Quinethazone.,increase,no risk
Ritodrine,Quinidine,The therapeutic efficacy of Ritodrine can be decreased when used in combination with Quinidine.,decrease,no risk
Ritodrine,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Ritodrine.,increase,risk
Ritodrine,Umeclidinium,The risk or severity of Tachycardia can be increased when Ritodrine is combined with Umeclidinium.,increase,risk
Ritodrine,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Ritodrine.,increase,risk
Ritodrine,Valsartan,Ritodrine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Ritodrine,Vamorolone,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Ritodrine.,increase,risk
Ritodrine,Venlafaxine,Venlafaxine may increase the tachycardic activities of Ritodrine.,increase,no risk
Ritodrine,Verapamil,The therapeutic efficacy of Ritodrine can be decreased when used in combination with Verapamil.,decrease,no risk
Ritodrine,Vilanterol,The risk or severity of adverse effects can be increased when Ritodrine is combined with Vilanterol.,increase,risk
Ritodrine,Vilazodone,The risk or severity of hypertension can be increased when Ritodrine is combined with Vilazodone.,increase,risk
Ritodrine,Vortioxetine,The risk or severity of hypertension can be increased when Ritodrine is combined with Vortioxetine.,increase,risk
Ritodrine,Xamoterol,The risk or severity of hypertension can be increased when Ritodrine is combined with Xamoterol.,increase,risk
Ritodrine,Xylometazoline,The risk or severity of hypertension can be increased when Ritodrine is combined with Xylometazoline.,increase,risk
Ritodrine,Yohimbine,The risk or severity of hypertension can be increased when Ritodrine is combined with Yohimbine.,increase,risk
Ritodrine,Ziprasidone,The therapeutic efficacy of Ritodrine can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ritodrine,Zofenopril,Ritodrine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Ritodrine,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Ritodrine.,increase,risk
Ritodrine,Zuclopenthixol,The therapeutic efficacy of Ritodrine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Benzonatate,Betaine,Betaine may increase the neuromuscular blocking activities of Benzonatate.,increase,no risk
Benzonatate,Galantamine,Galantamine may increase the neuromuscular blocking activities of Benzonatate.,increase,no risk
Benzonatate,Gallamine triethiodide,Gallamine triethiodide may increase the neuromuscular blocking activities of Benzonatate.,increase,no risk
Benzonatate,Ginkgo biloba,Ginkgo biloba may increase the neuromuscular blocking activities of Benzonatate.,increase,no risk
Benzonatate,Hexafluronium,Hexafluronium may increase the neuromuscular blocking activities of Benzonatate.,increase,no risk
Benzonatate,Huperzine A,Huperzine A may increase the neuromuscular blocking activities of Benzonatate.,increase,no risk
Benzonatate,Ketamine,Ketamine may increase the neuromuscular blocking activities of Benzonatate.,increase,no risk
Benzonatate,Neostigmine,Neostigmine may increase the neuromuscular blocking activities of Benzonatate.,increase,no risk
Benzonatate,Nizatidine,Nizatidine may increase the neuromuscular blocking activities of Benzonatate.,increase,no risk
Benzonatate,Oxybuprocaine,The serum concentration of Oxybuprocaine can be increased when it is combined with Benzonatate.,increase,no risk
Dorzolamide,Nadolol,Dorzolamide may increase the hypotensive activities of Nadolol.,increase,no risk
Dorzolamide,Nebivolol,Dorzolamide may increase the hypotensive activities of Nebivolol.,increase,no risk
Dorzolamide,Nicardipine,Nicardipine may increase the hypotensive activities of Dorzolamide.,increase,no risk
Dorzolamide,Nicorandil,Dorzolamide may increase the hypotensive activities of Nicorandil.,increase,no risk
Dorzolamide,Nilvadipine,Dorzolamide may increase the hypotensive activities of Nilvadipine.,increase,no risk
Dorzolamide,Nimodipine,Nimodipine may increase the hypotensive activities of Dorzolamide.,increase,no risk
Dorzolamide,Nisoldipine,Nisoldipine may increase the hypotensive activities of Dorzolamide.,increase,no risk
Dorzolamide,Nitrendipine,Dorzolamide may increase the hypotensive activities of Nitrendipine.,increase,no risk
Dorzolamide,Nitroglycerin,Nitroglycerin may increase the hypotensive activities of Dorzolamide.,increase,no risk
Dorzolamide,Nitroprusside,Nitroprusside may increase the hypotensive activities of Dorzolamide.,increase,no risk
Dorzolamide,Oliceridine,The therapeutic efficacy of Dorzolamide can be decreased when used in combination with Oliceridine.,decrease,no risk
Dorzolamide,Olmesartan,Olmesartan may increase the hypotensive activities of Dorzolamide.,increase,no risk
Dorzolamide,Olsalazine,The risk or severity of metabolic acidosis can be increased when Dorzolamide is combined with Olsalazine.,increase,risk
Dorzolamide,Oxprenolol,Dorzolamide may increase the hypotensive activities of Oxprenolol.,increase,no risk
Dorzolamide,Quetiapine,Quetiapine may increase the hypotensive activities of Dorzolamide.,increase,no risk
Dorzolamide,Quinapril,Dorzolamide may increase the hypotensive activities of Quinapril.,increase,no risk
Dorzolamide,Quinine,Quinine may increase the hypotensive activities of Dorzolamide.,increase,no risk
Dorzolamide,Unoprostone,Dorzolamide may increase the hypotensive activities of Unoprostone.,increase,no risk
Dorzolamide,Valsartan,Valsartan may increase the hypotensive activities of Dorzolamide.,increase,no risk
Dorzolamide,Ziconotide,The risk or severity of CNS depression can be increased when Dorzolamide is combined with Ziconotide.,increase,risk
Dorzolamide,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Dorzolamide.,increase,no risk
Dorzolamide,Zofenopril,Dorzolamide may increase the hypotensive activities of Zofenopril.,increase,no risk
Dorzolamide,Zonisamide,The risk or severity of adverse effects can be increased when Zonisamide is combined with Dorzolamide.,increase,risk
Suprofen,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Suprofen.,increase,risk
Suprofen,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Suprofen.,decrease,no risk
Suprofen,Voriconazole,The serum concentration of Suprofen can be increased when it is combined with Voriconazole.,increase,no risk
Terbutaline,Benzylpenicilloyl polylysine,Terbutaline may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Terbutaline,Bepotastine,Terbutaline may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Terbutaline,Bepridil,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Bepridil.,increase,risk
Terbutaline,Berotralstat,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Berotralstat.,increase,risk
Terbutaline,Betahistine,The therapeutic efficacy of Terbutaline can be decreased when used in combination with Betahistine.,decrease,no risk
Terbutaline,Betamethasone,The therapeutic efficacy of Terbutaline can be decreased when used in combination with Betamethasone.,decrease,no risk
Terbutaline,Betamethasone phosphate,The therapeutic efficacy of Terbutaline can be decreased when used in combination with Betamethasone phosphate.,decrease,no risk
Terbutaline,Betaxolol,The therapeutic efficacy of Terbutaline can be decreased when used in combination with Betaxolol.,decrease,no risk
Terbutaline,Bethanechol,The risk or severity of adverse effects can be increased when Terbutaline is combined with Bethanechol.,increase,risk
Terbutaline,Bethanidine,Terbutaline may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Terbutaline,Bicisate,Terbutaline may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Terbutaline,Bilastine,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Bilastine.,increase,risk
Terbutaline,Biperiden,The therapeutic efficacy of Biperiden can be decreased when used in combination with Terbutaline.,decrease,no risk
Terbutaline,Bismuth subgallate,Terbutaline may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Terbutaline,Bisoprolol,The therapeutic efficacy of Terbutaline can be decreased when used in combination with Bisoprolol.,decrease,no risk
Terbutaline,Bisoxatin,Terbutaline may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Terbutaline,Bleomycin,Bleomycin may decrease the excretion rate of Terbutaline which could result in a higher serum level.,decrease,no risk
Terbutaline,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Terbutaline.,increase,risk
Terbutaline,Bosentan,Terbutaline may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Terbutaline,Bretylium,Terbutaline may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Terbutaline,Brexpiprazole,The therapeutic efficacy of Terbutaline can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Terbutaline,Brivaracetam,Terbutaline may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Terbutaline,Bromazepam,Terbutaline may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Terbutaline,Bromocriptine,Bromocriptine may increase the hypertensive and vasoconstricting activities of Terbutaline.,increase,no risk
Terbutaline,Bromotheophylline,The risk or severity of adverse effects can be increased when Terbutaline is combined with Bromotheophylline.,increase,risk
Terbutaline,Brompheniramine,The therapeutic efficacy of Brompheniramine can be decreased when used in combination with Terbutaline.,decrease,no risk
Terbutaline,Buclizine,The therapeutic efficacy of Buclizine can be decreased when used in combination with Terbutaline.,decrease,no risk
Terbutaline,Budesonide,The therapeutic efficacy of Terbutaline can be decreased when used in combination with Budesonide.,decrease,no risk
Terbutaline,Bumadizone,The risk or severity of hypertension can be increased when Terbutaline is combined with Bumadizone.,increase,risk
Terbutaline,Bumetanide,The risk or severity of hypokalemia can be increased when Terbutaline is combined with Bumetanide.,increase,risk
Terbutaline,Bupropion,Terbutaline may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Terbutaline,Buserelin,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Buserelin.,increase,risk
Terbutaline,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Terbutaline.,increase,risk
Terbutaline,Butabarbital,The therapeutic efficacy of Butabarbital can be decreased when used in combination with Terbutaline.,decrease,no risk
Terbutaline,Butalbital,The therapeutic efficacy of Butalbital can be decreased when used in combination with Terbutaline.,decrease,no risk
Terbutaline,Butobarbital,The therapeutic efficacy of Butobarbital can be decreased when used in combination with Terbutaline.,decrease,no risk
Terbutaline,Butriptyline,The risk or severity of hypertension can be increased when Butriptyline is combined with Terbutaline.,increase,risk
Terbutaline,Butylscopolamine,The therapeutic efficacy of Butylscopolamine can be decreased when used in combination with Terbutaline.,decrease,no risk
Terbutaline,Gabapentin enacarbil,Terbutaline may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Terbutaline,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Gadobenic acid.,increase,risk
Terbutaline,Gadodiamide,Gadodiamide may decrease the excretion rate of Terbutaline which could result in a higher serum level.,decrease,no risk
Terbutaline,Gadofosveset trisodium,Terbutaline may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Terbutaline,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Terbutaline which could result in a higher serum level.,decrease,no risk
Terbutaline,Gadoteric acid,Terbutaline may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Terbutaline,Gadoteridol,Gadoteridol may decrease the excretion rate of Terbutaline which could result in a higher serum level.,decrease,no risk
Terbutaline,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Terbutaline.,increase,risk
Terbutaline,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Terbutaline.,decrease,no risk
Terbutaline,Ganciclovir,Terbutaline may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Terbutaline,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Gatifloxacin.,increase,risk
Terbutaline,Gemcitabine,Gemcitabine may decrease the excretion rate of Terbutaline which could result in a higher serum level.,decrease,no risk
Terbutaline,Gemfibrozil,Terbutaline may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Terbutaline,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Gemifloxacin.,increase,risk
Terbutaline,Gentamicin,Terbutaline may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Terbutaline,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Terbutaline.,increase,risk
Terbutaline,Gilteritinib,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Gilteritinib.,increase,risk
Terbutaline,Gimeracil,Terbutaline may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Terbutaline,Givosiran,Givosiran may decrease the excretion rate of Terbutaline which could result in a higher serum level.,decrease,no risk
Terbutaline,Glasdegib,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Glasdegib.,increase,risk
Terbutaline,Glipizide,Terbutaline may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Terbutaline,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Terbutaline.,decrease,no risk
Terbutaline,Glycerol phenylbutyrate,Terbutaline may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Terbutaline,Glycopyrronium,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Terbutaline.,decrease,no risk
Terbutaline,Golodirsen,Terbutaline may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Terbutaline,Goserelin,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Goserelin.,increase,risk
Terbutaline,Granisetron,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Granisetron.,increase,risk
Terbutaline,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Grepafloxacin.,increase,risk
Terbutaline,Guanabenz,Terbutaline may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Terbutaline,Guanadrel,Terbutaline may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Terbutaline,Guanethidine,Terbutaline may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Terbutaline,Guanfacine,Terbutaline may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Terbutaline,Guanoxan,Terbutaline may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Terbutaline,Halofantrine,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Halofantrine.,increase,risk
Terbutaline,Haloperidol,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Haloperidol.,increase,risk
Terbutaline,Halothane,The risk or severity of hypertension can be increased when Terbutaline is combined with Halothane.,increase,risk
Terbutaline,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Terbutaline.,decrease,no risk
Terbutaline,Hexocyclium,The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Terbutaline.,decrease,no risk
Terbutaline,Histrelin,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Histrelin.,increase,risk
Terbutaline,Homatropine methylbromide,The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Terbutaline.,decrease,no risk
Terbutaline,Hydralazine,Terbutaline may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Terbutaline,N-acetyltyrosine,Terbutaline may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Terbutaline,Nabilone,The risk or severity of Tachycardia can be increased when Nabilone is combined with Terbutaline.,increase,risk
Terbutaline,Nabumetone,The risk or severity of hypertension can be increased when Nabumetone is combined with Terbutaline.,increase,risk
Terbutaline,Nadolol,Nadolol may decrease the bronchodilatory activities of Terbutaline.,decrease,no risk
Terbutaline,Naldemedine,Terbutaline may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Terbutaline,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Nalidixic acid.,increase,risk
Terbutaline,Nalmefene,Terbutaline may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Terbutaline,Naloxone,Terbutaline may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Terbutaline,Naphazoline,The risk or severity of hypertension can be increased when Terbutaline is combined with Naphazoline.,increase,risk
Terbutaline,Naproxen,The risk or severity of hypertension can be increased when Naproxen is combined with Terbutaline.,increase,risk
Terbutaline,Naratriptan,The risk or severity of hypertension can be increased when Terbutaline is combined with Naratriptan.,increase,risk
Terbutaline,Nateglinide,Nateglinide may decrease the excretion rate of Terbutaline which could result in a higher serum level.,decrease,no risk
Terbutaline,Naxitamab,The risk or severity of hypertension can be increased when Terbutaline is combined with Naxitamab.,increase,risk
Terbutaline,Nebivolol,The therapeutic efficacy of Terbutaline can be decreased when used in combination with Nebivolol.,decrease,no risk
Terbutaline,Nedaplatin,Terbutaline may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Terbutaline,Nedocromil,Nedocromil may decrease the excretion rate of Terbutaline which could result in a higher serum level.,decrease,no risk
Terbutaline,Nefazodone,Nefazodone may increase the tachycardic activities of Terbutaline.,increase,no risk
Terbutaline,Nelfinavir,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Terbutaline.,increase,risk
Terbutaline,Neomycin,Terbutaline may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Terbutaline,Netilmicin,Terbutaline may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Terbutaline,Nialamide,The risk or severity of hypertension can be increased when Terbutaline is combined with Nialamide.,increase,risk
Terbutaline,Nicardipine,The therapeutic efficacy of Terbutaline can be decreased when used in combination with Nicardipine.,decrease,no risk
Terbutaline,Nicergoline,Nicergoline may increase the hypertensive and vasoconstricting activities of Terbutaline.,increase,no risk
Terbutaline,Nicorandil,Terbutaline may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Terbutaline,Nicotine,The risk or severity of adverse effects can be increased when Terbutaline is combined with Nicotine.,increase,risk
Terbutaline,Nifedipine,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Nifedipine.,increase,risk
Terbutaline,Nilotinib,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Nilotinib.,increase,risk
Terbutaline,Nilutamide,Nilutamide may decrease the excretion rate of Terbutaline which could result in a higher serum level.,decrease,no risk
Terbutaline,Nilvadipine,Terbutaline may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Terbutaline,Nimesulide,The risk or severity of hypertension can be increased when Terbutaline is combined with Nimesulide.,increase,risk
Terbutaline,Nimodipine,Terbutaline may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Terbutaline,Nisoldipine,Terbutaline may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Terbutaline,Nitrendipine,Terbutaline may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Terbutaline,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Terbutaline which could result in a higher serum level.,decrease,no risk
Terbutaline,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Terbutaline which could result in a higher serum level.,decrease,no risk
Terbutaline,Nitroglycerin,Terbutaline may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Terbutaline,Nitroprusside,Terbutaline may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Terbutaline,Nitrous oxide,The risk or severity of hypertension can be increased when Terbutaline is combined with Nitrous oxide.,increase,risk
Terbutaline,Norepinephrine,The therapeutic efficacy of Terbutaline can be increased when used in combination with Norepinephrine.,increase,no risk
Terbutaline,Norfloxacin,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Norfloxacin.,increase,risk
Terbutaline,Nortriptyline,The therapeutic efficacy of Terbutaline can be decreased when used in combination with Nortriptyline.,decrease,no risk
Terbutaline,Nylidrin,The risk or severity of hypertension can be increased when Terbutaline is combined with Nylidrin.,increase,risk
Terbutaline,Octinoxate,Terbutaline may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Terbutaline,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Terbutaline.,increase,risk
Terbutaline,Ofloxacin,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Ofloxacin.,increase,risk
Terbutaline,Olanzapine,The therapeutic efficacy of Terbutaline can be decreased when used in combination with Olanzapine.,decrease,no risk
Terbutaline,Olmesartan,Terbutaline may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Terbutaline,Olodaterol,The risk or severity of adverse effects can be increased when Terbutaline is combined with Olodaterol.,increase,risk
Terbutaline,Olsalazine,Olsalazine may decrease the excretion rate of Terbutaline which could result in a higher serum level.,decrease,no risk
Terbutaline,Ondansetron,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Ondansetron.,increase,risk
Terbutaline,Opium,Terbutaline may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Terbutaline,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Terbutaline.,increase,risk
Terbutaline,Orphenadrine,The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Terbutaline.,decrease,no risk
Terbutaline,Oseltamivir,Oseltamivir may decrease the excretion rate of Terbutaline which could result in a higher serum level.,decrease,no risk
Terbutaline,Oxacillin,Oxacillin may decrease the excretion rate of Terbutaline which could result in a higher serum level.,decrease,no risk
Terbutaline,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Terbutaline.,increase,risk
Terbutaline,Oxaprozin,The risk or severity of hypertension can be increased when Terbutaline is combined with Oxaprozin.,increase,risk
Terbutaline,Oxatomide,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Oxatomide.,increase,risk
Terbutaline,Oxazepam,Oxazepam may decrease the excretion rate of Terbutaline which could result in a higher serum level.,decrease,no risk
Terbutaline,Oxprenolol,Oxprenolol may decrease the bronchodilatory activities of Terbutaline.,decrease,no risk
Terbutaline,Oxtriphylline,The risk or severity of adverse effects can be increased when Terbutaline is combined with Oxtriphylline.,increase,risk
Terbutaline,Oxybenzone,Terbutaline may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Terbutaline,Oxybuprocaine,Terbutaline may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Terbutaline,Oxybutynin,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Terbutaline.,decrease,no risk
Terbutaline,Oxymetazoline,The risk or severity of hypertension can be increased when Terbutaline is combined with Oxymetazoline.,increase,risk
Terbutaline,Oxyphenbutazone,The risk or severity of hypertension can be increased when Terbutaline is combined with Oxyphenbutazone.,increase,risk
Terbutaline,Oxyphencyclimine,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Terbutaline.,decrease,no risk
Terbutaline,Oxyphenonium,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Terbutaline.,decrease,no risk
Terbutaline,Oxyquinoline,Terbutaline may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Terbutaline,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Terbutaline.,increase,risk
Terbutaline,Quetiapine,The therapeutic efficacy of Terbutaline can be decreased when used in combination with Quetiapine.,decrease,no risk
Terbutaline,Quinapril,Terbutaline may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Terbutaline,Quinethazone,Quinethazone may increase the excretion rate of Terbutaline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Terbutaline,Quinidine,Terbutaline may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Terbutaline,Quinine,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Quinine.,increase,risk
Terbutaline,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Terbutaline.,increase,risk
Terbutaline,Quizartinib,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Quizartinib.,increase,risk
Terbutaline,Umeclidinium,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Terbutaline.,decrease,no risk
Terbutaline,Vaborbactam,Terbutaline may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Terbutaline,Valaciclovir,Valaciclovir may decrease the excretion rate of Terbutaline which could result in a higher serum level.,decrease,no risk
Terbutaline,Valbenazine,Terbutaline may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Terbutaline,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Terbutaline.,increase,risk
Terbutaline,Valganciclovir,Terbutaline may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Terbutaline,Valproic acid,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Valproic acid.,increase,risk
Terbutaline,Valsartan,Terbutaline may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Terbutaline,Vamorolone,The therapeutic efficacy of Terbutaline can be decreased when used in combination with Vamorolone.,decrease,no risk
Terbutaline,Vancomycin,Terbutaline may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Terbutaline,Vandetanib,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Vandetanib.,increase,risk
Terbutaline,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Terbutaline.,increase,risk
Terbutaline,Varenicline,The risk or severity of adverse effects can be increased when Terbutaline is combined with Varenicline.,increase,risk
Terbutaline,Vecuronium,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Terbutaline.,decrease,no risk
Terbutaline,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Terbutaline.,increase,risk
Terbutaline,Venlafaxine,Venlafaxine may increase the tachycardic activities of Terbutaline.,increase,no risk
Terbutaline,Verapamil,Verapamil may decrease the excretion rate of Terbutaline which could result in a higher serum level.,decrease,no risk
Terbutaline,Vernakalant,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Vernakalant.,increase,risk
Terbutaline,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Terbutaline.,increase,risk
Terbutaline,Vilazodone,The risk or severity of hypertension can be increased when Terbutaline is combined with Vilazodone.,increase,risk
Terbutaline,Viloxazine,Terbutaline may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Terbutaline,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Terbutaline.,increase,risk
Terbutaline,Vorinostat,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Vorinostat.,increase,risk
Terbutaline,Vortioxetine,The risk or severity of hypertension can be increased when Terbutaline is combined with Vortioxetine.,increase,risk
Terbutaline,Warfarin,Terbutaline may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Terbutaline,Xamoterol,The risk or severity of hypertension can be increased when Terbutaline is combined with Xamoterol.,increase,risk
Terbutaline,Xylometazoline,The risk or severity of hypertension can be increased when Terbutaline is combined with Xylometazoline.,increase,risk
Terbutaline,Yohimbine,The risk or severity of hypertension can be increased when Terbutaline is combined with Yohimbine.,increase,risk
Terbutaline,Zaleplon,Terbutaline may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Terbutaline,Zanamivir,Zanamivir may decrease the excretion rate of Terbutaline which could result in a higher serum level.,decrease,no risk
Terbutaline,Ziprasidone,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Ziprasidone.,increase,risk
Terbutaline,Zofenopril,Terbutaline may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Terbutaline,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Terbutaline.,increase,risk
Terbutaline,Zonisamide,Zonisamide may increase the excretion rate of Terbutaline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Terbutaline,Zuclopenthixol,The therapeutic efficacy of Terbutaline can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Conivaptan,Bedaquiline,The metabolism of Bedaquiline can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Belantamab mafodotin,The serum concentration of Belantamab mafodotin can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Belinostat,The serum concentration of Belinostat can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Belumosudil,The metabolism of Belumosudil can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Belzutifan,The serum concentration of Conivaptan can be decreased when it is combined with Belzutifan.,decrease,no risk
Conivaptan,Benazepril,The risk or severity of adverse effects can be increased when Benazepril is combined with Conivaptan.,increase,risk
Conivaptan,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Bendroflumethiazide,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Conivaptan.,increase,risk
Conivaptan,Benserazide,Conivaptan may increase the excretion rate of Benserazide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Benzatropine,Conivaptan may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Benzhydrocodone,The therapeutic efficacy of Conivaptan can be decreased when used in combination with Benzhydrocodone.,decrease,no risk
Conivaptan,Benznidazole,Conivaptan may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Benzphetamine,The metabolism of Benzphetamine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Benzydamine,Conivaptan may increase the excretion rate of Benzydamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Bepotastine,Conivaptan may increase the excretion rate of Bepotastine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Bepridil,The metabolism of Bepridil can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Betamethasone,The metabolism of Betamethasone can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Betaxolol,The risk or severity of adverse effects can be increased when Betaxolol is combined with Conivaptan.,increase,risk
Conivaptan,Bethanidine,Conivaptan may increase the hypotensive activities of Bethanidine.,increase,no risk
Conivaptan,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Bicisate,Conivaptan may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Bifonazole,The metabolism of Conivaptan can be decreased when combined with Bifonazole.,decrease,no risk
Conivaptan,Bimekizumab,The metabolism of Conivaptan can be increased when combined with Bimekizumab.,increase,no risk
Conivaptan,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Bisacodyl,The risk or severity of dehydration can be increased when Conivaptan is combined with Bisacodyl.,increase,risk
Conivaptan,Bismuth subgallate,Conivaptan may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Bisoprolol,The metabolism of Bisoprolol can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Bisoxatin,The risk or severity of dehydration can be increased when Conivaptan is combined with Bisoxatin.,increase,risk
Conivaptan,Bleomycin,Conivaptan may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Boceprevir,The metabolism of Conivaptan can be decreased when combined with Boceprevir.,decrease,no risk
Conivaptan,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Bosentan,The metabolism of Bosentan can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Bretylium,The risk or severity of adverse effects can be increased when Conivaptan is combined with Bretylium.,increase,risk
Conivaptan,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Bromazepam,Conivaptan may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Budesonide,The metabolism of Budesonide can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Bumetanide,Conivaptan may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Bupropion,Conivaptan may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Buspirone,The metabolism of Buspirone can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Busulfan,The metabolism of Busulfan can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Butabarbital,Butabarbital may increase the hypotensive activities of Conivaptan.,increase,no risk
Conivaptan,Butalbital,The metabolism of Conivaptan can be increased when combined with Butalbital.,increase,no risk
Conivaptan,Butorphanol,The therapeutic efficacy of Conivaptan can be decreased when used in combination with Butorphanol.,decrease,no risk
Conivaptan,Gabapentin enacarbil,Conivaptan may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Gadobenic acid,Conivaptan may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Gadodiamide,Conivaptan may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Gadofosveset trisodium,Conivaptan may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Gadopentetic acid,Conivaptan may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Gadoteric acid,Conivaptan may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Gadoteridol,Conivaptan may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Galantamine,The metabolism of Galantamine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Ganciclovir,Conivaptan may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Gimeracil,Conivaptan may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Ginkgo biloba,The metabolism of Conivaptan can be decreased when combined with Ginkgo biloba.,decrease,no risk
Conivaptan,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Glecaprevir,The metabolism of Conivaptan can be decreased when combined with Glecaprevir.,decrease,no risk
Conivaptan,Glipizide,Conivaptan may increase the excretion rate of Glipizide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Glofitamab,The serum concentration of Conivaptan can be increased when it is combined with Glofitamab.,increase,no risk
Conivaptan,Gluconic Acid,The risk or severity of dehydration can be increased when Conivaptan is combined with Gluconic Acid.,increase,risk
Conivaptan,Glyburide,The metabolism of Glyburide can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Glycerin,The risk or severity of dehydration can be increased when Conivaptan is combined with Glycerin.,increase,risk
Conivaptan,Glycerol phenylbutyrate,The metabolism of Conivaptan can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Conivaptan,Golimumab,The metabolism of Conivaptan can be increased when combined with Golimumab.,increase,no risk
Conivaptan,Golodirsen,Conivaptan may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Goserelin,Conivaptan may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Granisetron,The metabolism of Granisetron can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Grapefruit,The serum concentration of Conivaptan can be increased when it is combined with Grapefruit.,increase,no risk
Conivaptan,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Griseofulvin,The metabolism of Conivaptan can be increased when combined with Griseofulvin.,increase,no risk
Conivaptan,Guanabenz,Conivaptan may increase the hypotensive activities of Guanabenz.,increase,no risk
Conivaptan,Guanadrel,Conivaptan may increase the hypotensive activities of Guanadrel.,increase,no risk
Conivaptan,Guanethidine,Conivaptan may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Guanoxan,Conivaptan may increase the hypotensive activities of Guanoxan.,increase,no risk
Conivaptan,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Halothane,The risk or severity of adverse effects can be increased when Conivaptan is combined with Halothane.,increase,risk
Conivaptan,Hydralazine,The serum concentration of Conivaptan can be increased when it is combined with Hydralazine.,increase,no risk
Conivaptan,Hydrochlorothiazide,The risk or severity of adverse effects can be increased when Conivaptan is combined with Hydrochlorothiazide.,increase,risk
Conivaptan,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Hydrocortamate,The metabolism of Conivaptan can be increased when combined with Hydrocortamate.,increase,no risk
Conivaptan,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Hydroflumethiazide,The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Conivaptan.,increase,risk
Conivaptan,Hydromorphone,Conivaptan may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Hydroxocobalamin,Conivaptan may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Hydroxyethyl Starch,Conivaptan may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Ketamine,The metabolism of Ketamine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Ketoconazole,The metabolism of Conivaptan can be decreased when combined with Ketoconazole.,decrease,no risk
Conivaptan,Ketoprofen,Conivaptan may increase the excretion rate of Ketoprofen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,N-acetyltyrosine,Conivaptan may increase the excretion rate of N-acetyltyrosine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Nabilone,The metabolism of Nabilone can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Nadolol,Conivaptan may increase the excretion rate of Nadolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Nafcillin,The metabolism of Conivaptan can be increased when combined with Nafcillin.,increase,no risk
Conivaptan,Nalbuphine,The therapeutic efficacy of Conivaptan can be decreased when used in combination with Nalbuphine.,decrease,no risk
Conivaptan,Naldemedine,Conivaptan may increase the excretion rate of Naldemedine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Nalmefene,Conivaptan may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Naloxegol,The serum concentration of Naloxegol can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Naloxone,Conivaptan may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Naltrexone,The therapeutic efficacy of Conivaptan can be decreased when used in combination with Naltrexone.,decrease,no risk
Conivaptan,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Nebivolol,The metabolism of Nebivolol can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Nedaplatin,Conivaptan may increase the excretion rate of Nedaplatin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Nedocromil,Conivaptan may increase the excretion rate of Nedocromil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Nefazodone,The metabolism of Conivaptan can be decreased when combined with Nefazodone.,decrease,no risk
Conivaptan,Nelfinavir,The metabolism of Conivaptan can be decreased when combined with Nelfinavir.,decrease,no risk
Conivaptan,Neratinib,The serum concentration of Neratinib can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Nesiritide,The risk or severity of adverse effects can be increased when Conivaptan is combined with Nesiritide.,increase,risk
Conivaptan,Netupitant,The metabolism of Netupitant can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Niacin,The serum concentration of Conivaptan can be increased when it is combined with Niacin.,increase,no risk
Conivaptan,Nialamide,Nialamide may increase the orthostatic hypotensive activities of Conivaptan.,increase,no risk
Conivaptan,Nicardipine,The metabolism of Nicardipine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Nicergoline,The serum concentration of Nicergoline can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Nicorandil,Nicorandil may increase the hypotensive activities of Conivaptan.,increase,no risk
Conivaptan,Nifedipine,The metabolism of Nifedipine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Nilotinib,The metabolism of Nilotinib can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Nilutamide,Conivaptan may increase the excretion rate of Nilutamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Nilvadipine,The metabolism of Nilvadipine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Nimesulide,The metabolism of Nimesulide can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Nimodipine,The metabolism of Nimodipine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Nintedanib,The metabolism of Nintedanib can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Nirmatrelvir,The metabolism of Nirmatrelvir can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Nisoldipine,The metabolism of Nisoldipine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Nitrazepam,The metabolism of Nitrazepam can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Nitrendipine,The metabolism of Nitrendipine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Nitric Oxide,Conivaptan may increase the excretion rate of Nitric Oxide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Nitrofurantoin,Conivaptan may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Nitroglycerin,The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Conivaptan.,increase,risk
Conivaptan,Nitroprusside,Conivaptan may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Nitrous acid,The risk or severity of adverse effects can be increased when Conivaptan is combined with Nitrous acid.,increase,risk
Conivaptan,Nomegestrol,The metabolism of Nomegestrol can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Nomegestrol acetate,The metabolism of Nomegestrol acetate can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Norelgestromin,The metabolism of Norelgestromin can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Norepinephrine,The risk or severity of Cardiac Arrhythmia can be increased when Norepinephrine is combined with Conivaptan.,increase,risk
Conivaptan,Norethisterone,The metabolism of Norethisterone can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Norethynodrel,The metabolism of Norethynodrel can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Norgestimate,The metabolism of Norgestimate can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Norgestrel,The metabolism of Norgestrel can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Normethadone,The therapeutic efficacy of Conivaptan can be decreased when used in combination with Normethadone.,decrease,no risk
Conivaptan,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Noscapine,The serum concentration of Conivaptan can be increased when it is combined with Noscapine.,increase,no risk
Conivaptan,Nylidrin,The metabolism of Nylidrin can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Obinutuzumab,The risk or severity of adverse effects can be increased when Conivaptan is combined with Obinutuzumab.,increase,risk
Conivaptan,Octinoxate,Conivaptan may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Octreotide,The serum concentration of Conivaptan can be increased when it is combined with Octreotide.,increase,no risk
Conivaptan,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Conivaptan.,increase,risk
Conivaptan,Olaparib,The metabolism of Olaparib can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Conivaptan.,increase,risk
Conivaptan,Olutasidenib,The therapeutic efficacy of Conivaptan can be decreased when used in combination with Olutasidenib.,decrease,no risk
Conivaptan,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Opicapone,The risk or severity of adverse effects can be increased when Conivaptan is combined with Opicapone.,increase,risk
Conivaptan,Opium,The metabolism of Opium can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Oritavancin,The metabolism of Conivaptan can be increased when combined with Oritavancin.,increase,no risk
Conivaptan,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Oseltamivir,Conivaptan may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Oxacillin,Conivaptan may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Oxaprozin,Conivaptan may increase the excretion rate of Oxaprozin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Oxazepam,Conivaptan may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Oxcarbazepine,The metabolism of Conivaptan can be increased when combined with Oxcarbazepine.,increase,no risk
Conivaptan,Oxprenolol,The risk or severity of adverse effects can be increased when Conivaptan is combined with Oxprenolol.,increase,risk
Conivaptan,Oxybenzone,Conivaptan may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Oxyphenisatin acetate,The risk or severity of dehydration can be increased when Conivaptan is combined with Oxyphenisatin acetate.,increase,risk
Conivaptan,Oxyquinoline,Conivaptan may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Quazepam,The metabolism of Quazepam can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Quinapril,The risk or severity of adverse effects can be increased when Conivaptan is combined with Quinapril.,increase,risk
Conivaptan,Quinidine,The metabolism of Quinidine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Quinine,The metabolism of Quinine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Quinupristin,The metabolism of Conivaptan can be decreased when combined with Quinupristin.,decrease,no risk
Conivaptan,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Udenafil,The metabolism of Udenafil can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Vaborbactam,Conivaptan may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Vadadustat,The serum concentration of Conivaptan can be increased when it is combined with Vadadustat.,increase,no risk
Conivaptan,Valaciclovir,Conivaptan may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Valganciclovir,Conivaptan may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Valproic acid,The serum concentration of Conivaptan can be increased when it is combined with Valproic acid.,increase,no risk
Conivaptan,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Conivaptan.,increase,risk
Conivaptan,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Vancomycin,Conivaptan may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Varenicline,Conivaptan may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Verapamil,The metabolism of Verapamil can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Vericiguat,The risk or severity of adverse effects can be increased when Conivaptan is combined with Vericiguat.,increase,risk
Conivaptan,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Conivaptan.,increase,no risk
Conivaptan,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Viloxazine,The metabolism of Conivaptan can be decreased when combined with Viloxazine.,decrease,no risk
Conivaptan,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Vincristine,The excretion of Vincristine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Vindesine,The metabolism of Vindesine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Voriconazole,The metabolism of Conivaptan can be decreased when combined with Voriconazole.,decrease,no risk
Conivaptan,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Voxelotor,The serum concentration of Conivaptan can be increased when it is combined with Voxelotor.,increase,no risk
Conivaptan,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Warfarin,The metabolism of Warfarin can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Zafirlukast,The serum concentration of Conivaptan can be increased when it is combined with Zafirlukast.,increase,no risk
Conivaptan,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Zanamivir,Conivaptan may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conivaptan,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Ziconotide,The risk or severity of CNS depression can be increased when Conivaptan is combined with Ziconotide.,increase,risk
Conivaptan,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Zileuton,The metabolism of Zileuton can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Zimelidine,The metabolism of Conivaptan can be decreased when combined with Zimelidine.,decrease,no risk
Conivaptan,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Zofenopril,Conivaptan may increase the hypotensive activities of Zofenopril.,increase,no risk
Conivaptan,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Zotepine,The metabolism of Zotepine can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Conivaptan.,decrease,no risk
Conivaptan,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Conivaptan.,increase,no risk
Loteprednol,Bendroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Loteprednol is combined with Bendroflumethiazide.,increase,risk
Loteprednol,Benzthiazide,The risk or severity of electrolyte imbalance can be increased when Loteprednol is combined with Benzthiazide.,increase,risk
Loteprednol,Bexagliflozin,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Bexagliflozin.,increase,risk
Loteprednol,Bromocriptine,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Bromocriptine.,increase,risk
Loteprednol,Gliclazide,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Gliclazide.,increase,risk
Loteprednol,Glimepiride,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Glimepiride.,increase,risk
Loteprednol,Glipizide,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Glipizide.,increase,risk
Loteprednol,Gliquidone,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Gliquidone.,increase,risk
Loteprednol,Glyburide,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Glyburide.,increase,risk
Loteprednol,Glymidine,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Glymidine.,increase,risk
Loteprednol,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Loteprednol is combined with Hydrochlorothiazide.,increase,risk
Loteprednol,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Loteprednol is combined with Hydroflumethiazide.,increase,risk
Loteprednol,Nateglinide,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Nateglinide.,increase,risk
Loteprednol,Quinine,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Quinine.,increase,risk
Loteprednol,Vildagliptin,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Vildagliptin.,increase,risk
Loteprednol,Voriconazole,The serum concentration of Loteprednol can be increased when it is combined with Voriconazole.,increase,no risk
Flupentixol,Bosutinib,The risk or severity of myelosuppression can be increased when Flupentixol is combined with Bosutinib.,increase,risk
Flupentixol,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Flupentixol.,increase,risk
Flupentixol,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Flupentixol.,increase,risk
Flupentixol,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Flupentixol.,increase,risk
Flupentixol,Brexanolone,The risk or severity of CNS depression can be increased when Flupentixol is combined with Brexanolone.,increase,risk
Flupentixol,Brexpiprazole,"Flupentixol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Brexpiprazole.",increase,no risk
Flupentixol,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Flupentixol.,increase,no risk
Flupentixol,Brivaracetam,The risk or severity of CNS depression can be increased when Flupentixol is combined with Brivaracetam.,increase,risk
Flupentixol,Bromazepam,Flupentixol may increase the sedative activities of Bromazepam.,increase,no risk
Flupentixol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Flupentixol.,decrease,no risk
Flupentixol,Bromperidol,The risk or severity of CNS depression can be increased when Flupentixol is combined with Bromperidol.,increase,risk
Flupentixol,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Flupentixol.,increase,risk
Flupentixol,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Flupentixol.,increase,risk
Flupentixol,Bumadizone,The risk or severity of hypertension can be increased when Flupentixol is combined with Bumadizone.,increase,risk
Flupentixol,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Flupentixol.,increase,risk
Flupentixol,Buprenorphine,Flupentixol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Flupentixol,Bupropion,The risk or severity of CNS depression can be increased when Flupentixol is combined with Bupropion.,increase,risk
Flupentixol,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Flupentixol.,increase,risk
Flupentixol,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Flupentixol.,increase,risk
Flupentixol,Busulfan,The risk or severity of myelosuppression can be increased when Flupentixol is combined with Busulfan.,increase,risk
Flupentixol,Butabarbital,Flupentixol may increase the sedative activities of Butabarbital.,increase,no risk
Flupentixol,Butalbital,Flupentixol may increase the sedative activities of Butalbital.,increase,no risk
Flupentixol,Butaperazine,The risk or severity of CNS depression can be increased when Flupentixol is combined with Butaperazine.,increase,risk
Flupentixol,Butobarbital,Flupentixol may increase the sedative activities of Butobarbital.,increase,no risk
Flupentixol,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Flupentixol.,increase,risk
Flupentixol,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Flupentixol.,increase,risk
Flupentixol,Butylscopolamine,The risk or severity of Tachycardia can be increased when Flupentixol is combined with Butylscopolamine.,increase,risk
Flupentixol,Gabapentin,The risk or severity of CNS depression can be increased when Flupentixol is combined with Gabapentin.,increase,risk
Flupentixol,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Flupentixol is combined with Gabapentin enacarbil.,increase,risk
Flupentixol,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Flupentixol.,increase,risk
Flupentixol,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Flupentixol.,increase,risk
Flupentixol,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Flupentixol.,increase,risk
Flupentixol,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Flupentixol is combined with Ganaxolone.",increase,risk
Flupentixol,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Flupentixol.,increase,risk
Flupentixol,Gemcitabine,The risk or severity of myelosuppression can be increased when Flupentixol is combined with Gemcitabine.,increase,risk
Flupentixol,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Flupentixol.,increase,risk
Flupentixol,Gemtuzumab ozogamicin,The risk or severity of myelosuppression can be increased when Flupentixol is combined with Gemtuzumab ozogamicin.,increase,risk
Flupentixol,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Flupentixol.,increase,risk
Flupentixol,Gilteritinib,The therapeutic efficacy of Flupentixol can be decreased when used in combination with Gilteritinib.,decrease,no risk
Flupentixol,Glasdegib,The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Flupentixol.,increase,risk
Flupentixol,Glucagon,Flupentixol may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Flupentixol,Glutethimide,Flupentixol may increase the sedative activities of Glutethimide.,increase,no risk
Flupentixol,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Flupentixol.,decrease,no risk
Flupentixol,Glycopyrronium,The risk or severity of adverse effects can be increased when Flupentixol is combined with Glycopyrronium.,increase,risk
Flupentixol,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Flupentixol.,increase,risk
Flupentixol,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Flupentixol.,increase,risk
Flupentixol,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Flupentixol.,increase,risk
Flupentixol,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Flupentixol.,decrease,no risk
Flupentixol,Guanadrel,Flupentixol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Flupentixol,Guanethidine,Flupentixol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Flupentixol,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Flupentixol.,decrease,no risk
Flupentixol,Guanoxan,Flupentixol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Flupentixol,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Flupentixol.,increase,risk
Flupentixol,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Flupentixol.,increase,risk
Flupentixol,Haloperidol,The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Flupentixol.,increase,risk
Flupentixol,Halothane,The risk or severity of CNS depression can be increased when Flupentixol is combined with Halothane.,increase,risk
Flupentixol,Hexafluronium,The risk or severity of CNS depression can be increased when Flupentixol is combined with Hexafluronium.,increase,risk
Flupentixol,Hexocyclium,The risk or severity of Tachycardia can be increased when Flupentixol is combined with Hexocyclium.,increase,risk
Flupentixol,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Flupentixol.,increase,risk
Flupentixol,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Flupentixol.,increase,risk
Flupentixol,Hydralazine,Flupentixol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Flupentixol,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Flupentixol.,increase,risk
Flupentixol,Hydrocodone,Flupentixol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Flupentixol,Hydroflumethiazide,Flupentixol may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Flupentixol,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Flupentixol.,increase,risk
Flupentixol,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Flupentixol.,increase,risk
Flupentixol,Hydroxyurea,The risk or severity of myelosuppression can be increased when Flupentixol is combined with Hydroxyurea.,increase,risk
Flupentixol,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Flupentixol is combined with Hydroxyzine.,increase,risk
Flupentixol,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Flupentixol.,increase,risk
Flupentixol,Ketamine,The risk or severity of CNS depression can be increased when Flupentixol is combined with Ketamine.,increase,risk
Flupentixol,Ketazolam,The risk or severity of CNS depression can be increased when Flupentixol is combined with Ketazolam.,increase,risk
Flupentixol,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Flupentixol.,increase,risk
Flupentixol,Ketoprofen,The risk or severity of hypertension can be increased when Flupentixol is combined with Ketoprofen.,increase,risk
Flupentixol,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Flupentixol.,increase,risk
Eprosartan,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Eprosartan is combined with Ganciclovir.",increase,risk
Eprosartan,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Eprosartan is combined with Gemfibrozil.",increase,risk
Eprosartan,Glycol salicylate,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Eprosartan is combined with Glycol salicylate.",increase,risk
Eprosartan,Guanabenz,Guanabenz may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Guanadrel,Guanadrel may increase the hypotensive activities of Eprosartan.,increase,no risk
Eprosartan,Guanethidine,Eprosartan may increase the hypotensive activities of Guanethidine.,increase,no risk
Eprosartan,Guanfacine,Guanfacine may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Guanoxan,Eprosartan may increase the hypotensive activities of Guanoxan.,increase,no risk
Eprosartan,Halothane,Halothane may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Eprosartan.,increase,risk
Eprosartan,Hydralazine,Eprosartan may increase the hypotensive activities of Hydralazine.,increase,no risk
Eprosartan,Hydroflumethiazide,The therapeutic efficacy of Eprosartan can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Eprosartan,Ketoconazole,The risk or severity of hyperkalemia can be increased when Eprosartan is combined with Ketoconazole.,increase,risk
Eprosartan,Ketoprofen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Eprosartan is combined with Ketoprofen.",increase,risk
Eprosartan,Ketorolac,The therapeutic efficacy of Eprosartan can be decreased when used in combination with Ketorolac.,decrease,no risk
Eprosartan,Nabilone,The risk or severity of adverse effects can be increased when Nabilone is combined with Eprosartan.,increase,risk
Eprosartan,Nabumetone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Eprosartan is combined with Nabumetone.",increase,risk
Eprosartan,Nadolol,Eprosartan may increase the hypotensive activities of Nadolol.,increase,no risk
Eprosartan,Nadroparin,The risk or severity of hyperkalemia can be increased when Nadroparin is combined with Eprosartan.,increase,risk
Eprosartan,Nafarelin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Eprosartan.",increase,risk
Eprosartan,Naltrexone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Eprosartan.",increase,risk
Eprosartan,Naphazoline,Naphazoline may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Naproxen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Eprosartan is combined with Naproxen.",increase,risk
Eprosartan,Naratriptan,Naratriptan may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Naxitamab,Naxitamab may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Nebivolol,Eprosartan may increase the hypotensive activities of Nebivolol.,increase,no risk
Eprosartan,Nefazodone,Nefazodone may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Nesiritide,The risk or severity of adverse effects can be increased when Eprosartan is combined with Nesiritide.,increase,risk
Eprosartan,Niacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Eprosartan.",increase,risk
Eprosartan,Nialamide,Nialamide may increase the hypotensive activities of Eprosartan.,increase,no risk
Eprosartan,Nicardipine,Nicardipine may increase the hypotensive activities of Eprosartan.,increase,no risk
Eprosartan,Nicergoline,Nicergoline may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Nicorandil,The risk or severity of hyperkalemia can be increased when Nicorandil is combined with Eprosartan.,increase,risk
Eprosartan,Nifedipine,The risk or severity of adverse effects can be increased when Eprosartan is combined with Nifedipine.,increase,risk
Eprosartan,Nilvadipine,Eprosartan may increase the hypotensive activities of Nilvadipine.,increase,no risk
Eprosartan,Nimesulide,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Eprosartan is combined with Nimesulide.",increase,risk
Eprosartan,Nimodipine,Nimodipine may increase the hypotensive activities of Eprosartan.,increase,no risk
Eprosartan,Nisoldipine,Nisoldipine may increase the hypotensive activities of Eprosartan.,increase,no risk
Eprosartan,Nitrendipine,Eprosartan may increase the hypotensive activities of Nitrendipine.,increase,no risk
Eprosartan,Nitric Oxide,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Eprosartan.,increase,risk
Eprosartan,Nitrofurantoin,The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Eprosartan.,increase,risk
Eprosartan,Nitroglycerin,Nitroglycerin may increase the hypotensive activities of Eprosartan.,increase,no risk
Eprosartan,Nitroprusside,Nitroprusside may increase the hypotensive activities of Eprosartan.,increase,no risk
Eprosartan,Nitrous acid,The risk or severity of adverse effects can be increased when Eprosartan is combined with Nitrous acid.,increase,risk
Eprosartan,Nitrous oxide,Nitrous oxide may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Nizatidine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Eprosartan.",increase,risk
Eprosartan,Norepinephrine,Norepinephrine may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Norfloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Eprosartan is combined with Norfloxacin.",increase,risk
Eprosartan,Nortriptyline,Nortriptyline may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Nylidrin,Nylidrin may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Obinutuzumab,Eprosartan may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Eprosartan,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Eprosartan is combined with Ofloxacin.",increase,risk
Eprosartan,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Eprosartan.,increase,risk
Eprosartan,Olmesartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Olmesartan is combined with Eprosartan.",increase,risk
Eprosartan,Olodaterol,Olodaterol may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Opicapone,The risk or severity of adverse effects can be increased when Eprosartan is combined with Opicapone.,increase,risk
Eprosartan,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Oxaprozin,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Eprosartan is combined with Oxaprozin.",increase,risk
Eprosartan,Oxprenolol,Eprosartan may increase the hypotensive activities of Oxprenolol.,increase,no risk
Eprosartan,Oxymetazoline,The therapeutic efficacy of Eprosartan can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Eprosartan,Oxyphenbutazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Eprosartan is combined with Oxyphenbutazone.",increase,risk
Eprosartan,Quetiapine,Quetiapine may increase the hypotensive activities of Eprosartan.,increase,no risk
Eprosartan,Quinapril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Quinapril is combined with Eprosartan.",increase,risk
Eprosartan,Quinidine,Quinidine may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Quinine,Quinine may increase the hypotensive activities of Eprosartan.,increase,no risk
Eprosartan,Quinupramine,Quinupramine may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Eprosartan is combined with Ubidecarenone.",increase,risk
Eprosartan,Udenafil,Udenafil may increase the antihypertensive activities of Eprosartan.,increase,no risk
Eprosartan,Unoprostone,Eprosartan may increase the hypotensive activities of Unoprostone.,increase,no risk
Eprosartan,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Eprosartan.,increase,risk
Eprosartan,Valdecoxib,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Eprosartan is combined with Valdecoxib.",increase,risk
Eprosartan,Valsartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Valsartan is combined with Eprosartan.",increase,risk
Eprosartan,Vardenafil,Vardenafil may increase the antihypertensive activities of Eprosartan.,increase,no risk
Eprosartan,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Eprosartan.,increase,risk
Eprosartan,Vericiguat,The risk or severity of adverse effects can be increased when Eprosartan is combined with Vericiguat.,increase,risk
Eprosartan,Vilanterol,Vilanterol may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Vilazodone,Vilazodone may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Vildagliptin,The risk or severity of angioedema can be increased when Eprosartan is combined with Vildagliptin.,increase,risk
Eprosartan,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Eprosartan.",increase,risk
Eprosartan,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Xamoterol,Xamoterol may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Yohimbine,Yohimbine may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Zidovudine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Eprosartan.",increase,risk
Eprosartan,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Eprosartan.,increase,no risk
Eprosartan,Zofenopril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Zofenopril is combined with Eprosartan.",increase,risk
Eprosartan,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Eprosartan,Zonisamide,The risk or severity of hyperkalemia can be increased when Eprosartan is combined with Zonisamide.,increase,risk
Eprosartan,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Eprosartan.,decrease,no risk
Sirolimus,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Sirolimus.,decrease,no risk
Sirolimus,Bepridil,Bepridil may increase the immunosuppressive activities of Sirolimus.,increase,no risk
Sirolimus,Berotralstat,The serum concentration of Sirolimus can be increased when it is combined with Berotralstat.,increase,no risk
Sirolimus,Betamethasone,The serum concentration of Betamethasone can be increased when it is combined with Sirolimus.,increase,no risk
Sirolimus,Betamethasone phosphate,The metabolism of Sirolimus can be increased when combined with Betamethasone phosphate.,increase,no risk
Sirolimus,Betrixaban,The serum concentration of Sirolimus can be increased when it is combined with Betrixaban.,increase,no risk
Sirolimus,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Sirolimus.,decrease,no risk
Sirolimus,Bexarotene,The metabolism of Sirolimus can be increased when combined with Bexarotene.,increase,no risk
Sirolimus,Bicalutamide,The metabolism of Sirolimus can be decreased when combined with Bicalutamide.,decrease,no risk
Sirolimus,Bifonazole,The metabolism of Sirolimus can be decreased when combined with Bifonazole.,decrease,no risk
Sirolimus,Bimekizumab,The metabolism of Sirolimus can be increased when combined with Bimekizumab.,increase,no risk
Sirolimus,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Sirolimus.,increase,no risk
Sirolimus,Bioallethrin,Bioallethrin may increase the immunosuppressive activities of Sirolimus.,increase,no risk
Sirolimus,Bisoprolol,The serum concentration of Sirolimus can be increased when it is combined with Bisoprolol.,increase,no risk
Sirolimus,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Sirolimus.,increase,risk
Sirolimus,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Sirolimus.,increase,risk
Sirolimus,Blinatumomab,The risk or severity of adverse effects can be increased when Sirolimus is combined with Blinatumomab.,increase,risk
Sirolimus,Boceprevir,The metabolism of Sirolimus can be decreased when combined with Boceprevir.,decrease,no risk
Sirolimus,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Sirolimus.",decrease,no risk
Sirolimus,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Sirolimus.,increase,risk
Sirolimus,Bosentan,The metabolism of Sirolimus can be increased when combined with Bosentan.,increase,no risk
Sirolimus,Bosutinib,The metabolism of Sirolimus can be decreased when combined with Bosutinib.,decrease,no risk
Sirolimus,Brentuximab vedotin,The serum concentration of Sirolimus can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Sirolimus,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Sirolimus.,increase,no risk
Sirolimus,Brodalumab,The risk or severity of adverse effects can be increased when Sirolimus is combined with Brodalumab.,increase,risk
Sirolimus,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Sirolimus.,increase,no risk
Sirolimus,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Sirolimus.,decrease,no risk
Sirolimus,Budesonide,The serum concentration of Budesonide can be increased when it is combined with Sirolimus.,increase,no risk
Sirolimus,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Sirolimus is combined with Bupivacaine.,increase,risk
Sirolimus,Buprenorphine,The metabolism of Sirolimus can be decreased when combined with Buprenorphine.,decrease,no risk
Sirolimus,Buspirone,The metabolism of Buspirone can be decreased when combined with Sirolimus.,decrease,no risk
Sirolimus,Busulfan,The risk or severity of adverse effects can be increased when Sirolimus is combined with Busulfan.,increase,risk
Sirolimus,Butacaine,The risk or severity of methemoglobinemia can be increased when Sirolimus is combined with Butacaine.,increase,risk
Sirolimus,Butalbital,The metabolism of Sirolimus can be increased when combined with Butalbital.,increase,no risk
Sirolimus,Butamben,The risk or severity of methemoglobinemia can be increased when Sirolimus is combined with Butamben.,increase,risk
Sirolimus,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Sirolimus.,decrease,no risk
Sirolimus,Gefitinib,The metabolism of Sirolimus can be decreased when combined with Gefitinib.,decrease,no risk
Sirolimus,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Sirolimus.,increase,risk
Sirolimus,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Sirolimus.,increase,risk
Sirolimus,Gilteritinib,The metabolism of Sirolimus can be decreased when combined with Gilteritinib.,decrease,no risk
Sirolimus,Ginkgo biloba,The metabolism of Sirolimus can be decreased when combined with Ginkgo biloba.,decrease,no risk
Sirolimus,Glasdegib,The serum concentration of Sirolimus can be increased when it is combined with Glasdegib.,increase,no risk
Sirolimus,Glatiramer,The risk or severity of adverse effects can be increased when Sirolimus is combined with Glatiramer.,increase,risk
Sirolimus,Glecaprevir,The serum concentration of Sirolimus can be increased when it is combined with Glecaprevir.,increase,no risk
Sirolimus,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Sirolimus.,decrease,no risk
Sirolimus,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Sirolimus.,decrease,no risk
Sirolimus,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Sirolimus.,decrease,no risk
Sirolimus,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Sirolimus.,decrease,no risk
Sirolimus,Glofitamab,The serum concentration of Sirolimus can be increased when it is combined with Glofitamab.,increase,no risk
Sirolimus,Glyburide,The metabolism of Sirolimus can be decreased when combined with Glyburide.,decrease,no risk
Sirolimus,Glycerol phenylbutyrate,The metabolism of Sirolimus can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Sirolimus,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Sirolimus.,decrease,no risk
Sirolimus,Golimumab,The metabolism of Sirolimus can be increased when combined with Golimumab.,increase,no risk
Sirolimus,Grapefruit,The serum concentration of Sirolimus can be increased when it is combined with Grapefruit.,increase,no risk
Sirolimus,Grazoprevir,The serum concentration of Sirolimus can be increased when it is combined with Grazoprevir.,increase,no risk
Sirolimus,Griseofulvin,The metabolism of Sirolimus can be increased when combined with Griseofulvin.,increase,no risk
Sirolimus,Guselkumab,The risk or severity of adverse effects can be increased when Sirolimus is combined with Guselkumab.,increase,risk
Sirolimus,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Sirolimus.,decrease,no risk
Sirolimus,Halofantrine,The metabolism of Sirolimus can be decreased when combined with Halofantrine.,decrease,no risk
Sirolimus,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Sirolimus.,increase,no risk
Sirolimus,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Sirolimus.,increase,risk
Sirolimus,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Sirolimus.,decrease,no risk
Sirolimus,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Sirolimus.,decrease,no risk
Sirolimus,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Sirolimus.,increase,risk
Sirolimus,Hydralazine,The serum concentration of Sirolimus can be increased when it is combined with Hydralazine.,increase,no risk
Sirolimus,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Sirolimus.,increase,risk
Sirolimus,Hydrocortamate,The metabolism of Sirolimus can be increased when combined with Hydrocortamate.,increase,no risk
Sirolimus,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Sirolimus.,increase,no risk
Sirolimus,Hydrocortisone acetate,The metabolism of Sirolimus can be increased when combined with Hydrocortisone acetate.,increase,no risk
Sirolimus,Hydrocortisone butyrate,The metabolism of Sirolimus can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Sirolimus,Hydrocortisone cypionate,The metabolism of Sirolimus can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Sirolimus,Hydrocortisone phosphate,The metabolism of Sirolimus can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Sirolimus,Hydrocortisone succinate,The metabolism of Sirolimus can be increased when combined with Hydrocortisone succinate.,increase,no risk
Sirolimus,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Sirolimus.,increase,risk
Sirolimus,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Sirolimus is combined with Hydroxychloroquine.,increase,risk
Sirolimus,Hydroxyprogesterone caproate,The metabolism of Sirolimus can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Sirolimus,Hydroxyurea,The risk or severity of adverse effects can be increased when Sirolimus is combined with Hydroxyurea.,increase,risk
Sirolimus,Hydroxyzine,The metabolism of Sirolimus can be decreased when combined with Hydroxyzine.,decrease,no risk
Sirolimus,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Sirolimus.,decrease,no risk
Sirolimus,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Sirolimus.,decrease,no risk
Sirolimus,Ketazolam,The serum concentration of Sirolimus can be increased when it is combined with Ketazolam.,increase,no risk
Sirolimus,Ketoconazole,The serum concentration of the active metabolites of Sirolimus can be increased when Sirolimus is used in combination with Ketoconazole.,increase,no risk
Sirolimus,Nadroparin,The risk or severity of bleeding can be increased when Nadroparin is combined with Sirolimus.,increase,risk
Sirolimus,Nafcillin,The metabolism of Sirolimus can be increased when combined with Nafcillin.,increase,no risk
Sirolimus,Natalizumab,The risk or severity of immunosuppression can be increased when Sirolimus is combined with Natalizumab.,increase,risk
Sirolimus,Nateglinide,The metabolism of Sirolimus can be decreased when combined with Nateglinide.,decrease,no risk
Sirolimus,Nefazodone,The metabolism of Sirolimus can be decreased when combined with Nefazodone.,decrease,no risk
Sirolimus,Nelarabine,The risk or severity of adverse effects can be increased when Sirolimus is combined with Nelarabine.,increase,risk
Sirolimus,Nelfinavir,The metabolism of Sirolimus can be decreased when combined with Nelfinavir.,decrease,no risk
Sirolimus,Neratinib,The serum concentration of Sirolimus can be increased when it is combined with Neratinib.,increase,no risk
Sirolimus,Netupitant,The serum concentration of Sirolimus can be increased when it is combined with Netupitant.,increase,no risk
Sirolimus,Nevirapine,The metabolism of Sirolimus can be decreased when combined with Nevirapine.,decrease,no risk
Sirolimus,Niacin,The serum concentration of Sirolimus can be increased when it is combined with Niacin.,increase,no risk
Sirolimus,Nicardipine,Nicardipine may increase the immunosuppressive activities of Sirolimus.,increase,no risk
Sirolimus,Nicergoline,The serum concentration of Nicergoline can be increased when it is combined with Sirolimus.,increase,no risk
Sirolimus,Nifedipine,Nifedipine may increase the immunosuppressive activities of Sirolimus.,increase,no risk
Sirolimus,Nilotinib,The metabolism of Sirolimus can be decreased when combined with Nilotinib.,decrease,no risk
Sirolimus,Nilvadipine,Nilvadipine may increase the immunosuppressive activities of Sirolimus.,increase,no risk
Sirolimus,Nimesulide,Nimesulide may increase the immunosuppressive activities of Sirolimus.,increase,no risk
Sirolimus,Nimodipine,Nimodipine may increase the immunosuppressive activities of Sirolimus.,increase,no risk
Sirolimus,Nintedanib,The metabolism of Sirolimus can be decreased when combined with Nintedanib.,decrease,no risk
Sirolimus,Nirogacestat,The serum concentration of Sirolimus can be increased when it is combined with Nirogacestat.,increase,no risk
Sirolimus,Nisoldipine,Nisoldipine may increase the immunosuppressive activities of Sirolimus.,increase,no risk
Sirolimus,Nitrendipine,Nitrendipine may increase the immunosuppressive activities of Sirolimus.,increase,no risk
Sirolimus,Norethisterone,The metabolism of Sirolimus can be decreased when combined with Norethisterone.,decrease,no risk
Sirolimus,Norgestimate,The serum concentration of Sirolimus can be increased when it is combined with Norgestimate.,increase,no risk
Sirolimus,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Sirolimus.,increase,no risk
Sirolimus,Noscapine,The serum concentration of Sirolimus can be increased when it is combined with Noscapine.,increase,no risk
Sirolimus,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Sirolimus.,decrease,no risk
Sirolimus,Nylidrin,Nylidrin may increase the immunosuppressive activities of Sirolimus.,increase,no risk
Sirolimus,Obinutuzumab,The risk or severity of adverse effects can be increased when Sirolimus is combined with Obinutuzumab.,increase,risk
Sirolimus,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Sirolimus.,increase,no risk
Sirolimus,Octreotide,The serum concentration of Sirolimus can be increased when it is combined with Octreotide.,increase,no risk
Sirolimus,Ofatumumab,The risk or severity of adverse effects can be increased when Sirolimus is combined with Ofatumumab.,increase,risk
Sirolimus,Olaparib,The metabolism of Sirolimus can be decreased when combined with Olaparib.,decrease,no risk
Sirolimus,Olutasidenib,The therapeutic efficacy of Sirolimus can be decreased when used in combination with Olutasidenib.,decrease,no risk
Sirolimus,Omadacycline,The serum concentration of Sirolimus can be increased when it is combined with Omadacycline.,increase,no risk
Sirolimus,Omaveloxolone,The serum concentration of Sirolimus can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Sirolimus,Ombitasvir,The serum concentration of Sirolimus can be increased when it is combined with Ombitasvir.,increase,no risk
Sirolimus,Ondansetron,The metabolism of Sirolimus can be decreased when combined with Ondansetron.,decrease,no risk
Sirolimus,Oritavancin,The metabolism of Sirolimus can be increased when combined with Oritavancin.,increase,no risk
Sirolimus,Orphenadrine,The metabolism of Sirolimus can be decreased when combined with Orphenadrine.,decrease,no risk
Sirolimus,Osilodrostat,The metabolism of Sirolimus can be decreased when combined with Osilodrostat.,decrease,no risk
Sirolimus,Osimertinib,The metabolism of Sirolimus can be decreased when combined with Osimertinib.,decrease,no risk
Sirolimus,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Sirolimus.,increase,no risk
Sirolimus,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Sirolimus.,increase,risk
Sirolimus,Oxcarbazepine,The metabolism of Sirolimus can be increased when combined with Oxcarbazepine.,increase,no risk
Sirolimus,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Sirolimus is combined with Oxetacaine.,increase,risk
Sirolimus,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Sirolimus.,decrease,no risk
Sirolimus,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Sirolimus is combined with Oxybuprocaine.,increase,risk
Sirolimus,Oxybutynin,The serum concentration of Sirolimus can be increased when it is combined with Oxybutynin.,increase,no risk
Sirolimus,Oxycodone,The metabolism of Sirolimus can be decreased when combined with Oxycodone.,decrease,no risk
Sirolimus,Ozanimod,The risk or severity of adverse effects can be increased when Sirolimus is combined with Ozanimod.,increase,risk
Sirolimus,Quetiapine,The metabolism of Sirolimus can be decreased when combined with Quetiapine.,decrease,no risk
Sirolimus,Quinapril,The risk or severity of adverse effects can be increased when Sirolimus is combined with Quinapril.,increase,risk
Sirolimus,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Sirolimus.,increase,no risk
Sirolimus,Quinine,The serum concentration of Quinine can be increased when it is combined with Sirolimus.,increase,no risk
Sirolimus,Quinupristin,The metabolism of Sirolimus can be decreased when combined with Quinupristin.,decrease,no risk
Sirolimus,Quizartinib,The serum concentration of Sirolimus can be increased when it is combined with Quizartinib.,increase,no risk
Sirolimus,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Sirolimus.,increase,risk
Sirolimus,Ubrogepant,The serum concentration of Sirolimus can be increased when it is combined with Ubrogepant.,increase,no risk
Sirolimus,Udenafil,The metabolism of Sirolimus can be decreased when combined with Udenafil.,decrease,no risk
Sirolimus,Umbralisib,The serum concentration of Sirolimus can be increased when it is combined with Umbralisib.,increase,no risk
Sirolimus,Umeclidinium,The serum concentration of Sirolimus can be increased when it is combined with Umeclidinium.,increase,no risk
Sirolimus,Upadacitinib,The risk or severity of adverse effects can be increased when Sirolimus is combined with Upadacitinib.,increase,risk
Sirolimus,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Sirolimus.,increase,risk
Sirolimus,Vadadustat,The serum concentration of Sirolimus can be increased when it is combined with Vadadustat.,increase,no risk
Sirolimus,Valbenazine,The metabolism of Sirolimus can be decreased when combined with Valbenazine.,decrease,no risk
Sirolimus,Valproic acid,The serum concentration of Sirolimus can be increased when it is combined with Valproic acid.,increase,no risk
Sirolimus,Valsartan,The risk or severity of angioedema can be increased when Valsartan is combined with Sirolimus.,increase,risk
Sirolimus,Vandetanib,The serum concentration of Sirolimus can be increased when it is combined with Vandetanib.,increase,no risk
Sirolimus,Vardenafil,The serum concentration of Sirolimus can be increased when it is combined with Vardenafil.,increase,no risk
Sirolimus,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Sirolimus.,increase,risk
Sirolimus,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Sirolimus.,decrease,no risk
Sirolimus,Vedolizumab,The risk or severity of adverse effects can be increased when Sirolimus is combined with Vedolizumab.,increase,risk
Sirolimus,Velpatasvir,The serum concentration of Sirolimus can be increased when it is combined with Velpatasvir.,increase,no risk
Sirolimus,Vemurafenib,The serum concentration of Sirolimus can be increased when it is combined with Vemurafenib.,increase,no risk
Sirolimus,Venetoclax,The serum concentration of Sirolimus can be increased when it is combined with Venetoclax.,increase,no risk
Sirolimus,Verapamil,The serum concentration of Sirolimus can be increased when it is combined with Verapamil.,increase,no risk
Sirolimus,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Sirolimus.,decrease,no risk
Sirolimus,Vilanterol,The risk or severity of adverse effects can be increased when Sirolimus is combined with Vilanterol.,increase,risk
Sirolimus,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Sirolimus.,decrease,no risk
Sirolimus,Viloxazine,The metabolism of Sirolimus can be decreased when combined with Viloxazine.,decrease,no risk
Sirolimus,Vinblastine,The metabolism of Sirolimus can be increased when combined with Vinblastine.,increase,no risk
Sirolimus,Vincristine,The metabolism of Sirolimus can be decreased when combined with Vincristine.,decrease,no risk
Sirolimus,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Sirolimus.,increase,risk
Sirolimus,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Sirolimus.,increase,no risk
Sirolimus,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Sirolimus.,increase,risk
Sirolimus,Vitamin E,The metabolism of Sirolimus can be increased when combined with Vitamin E.,increase,no risk
Sirolimus,Voclosporin,The serum concentration of Sirolimus can be increased when it is combined with Voclosporin.,increase,no risk
Sirolimus,Vonoprazan,The metabolism of Sirolimus can be decreased when combined with Vonoprazan.,decrease,no risk
Sirolimus,Vorapaxar,The serum concentration of Sirolimus can be increased when it is combined with Vorapaxar.,increase,no risk
Sirolimus,Voriconazole,The serum concentration of Sirolimus can be increased when it is combined with Voriconazole.,increase,no risk
Sirolimus,Vorinostat,The risk or severity of adverse effects can be increased when Sirolimus is combined with Vorinostat.,increase,risk
Sirolimus,Vortioxetine,The metabolism of Sirolimus can be decreased when combined with Vortioxetine.,decrease,no risk
Sirolimus,Voxelotor,The serum concentration of Sirolimus can be increased when it is combined with Voxelotor.,increase,no risk
Sirolimus,Voxilaprevir,The serum concentration of Sirolimus can be increased when it is combined with Voxilaprevir.,increase,no risk
Sirolimus,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Sirolimus.,increase,no risk
Sirolimus,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Sirolimus.,increase,risk
Sirolimus,Xylometazoline,Xylometazoline may increase the immunosuppressive activities of Sirolimus.,increase,no risk
Sirolimus,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Sirolimus.,increase,risk
Sirolimus,Zafirlukast,The serum concentration of Sirolimus can be increased when it is combined with Zafirlukast.,increase,no risk
Sirolimus,Zaleplon,The metabolism of Sirolimus can be decreased when combined with Zaleplon.,decrease,no risk
Sirolimus,Ziconotide,Ziconotide may increase the immunosuppressive activities of Sirolimus.,increase,no risk
Sirolimus,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Sirolimus.,increase,risk
Sirolimus,Zimelidine,The metabolism of Sirolimus can be decreased when combined with Zimelidine.,decrease,no risk
Sirolimus,Ziprasidone,The metabolism of Sirolimus can be decreased when combined with Ziprasidone.,decrease,no risk
Sirolimus,Zofenopril,The risk or severity of adverse effects can be increased when Sirolimus is combined with Zofenopril.,increase,risk
Sirolimus,Zonisamide,Zonisamide may increase the immunosuppressive activities of Sirolimus.,increase,no risk
Sirolimus,Zuclopenthixol,The metabolism of Sirolimus can be decreased when combined with Zuclopenthixol.,decrease,no risk
Emtricitabine,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Emtricitabine.,decrease,no risk
Emtricitabine,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Emtricitabine.,decrease,no risk
Emtricitabine,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Emtricitabine.,decrease,no risk
Emtricitabine,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Emtricitabine.,decrease,no risk
Emtricitabine,Brigatinib,The excretion of Emtricitabine can be decreased when combined with Brigatinib.,decrease,no risk
Emtricitabine,Ganciclovir,The risk or severity of cytopenia can be increased when Ganciclovir is combined with Emtricitabine.,increase,risk
Emtricitabine,Gilteritinib,The excretion of Emtricitabine can be decreased when combined with Gilteritinib.,decrease,no risk
Emtricitabine,Glasdegib,The excretion of Emtricitabine can be decreased when combined with Glasdegib.,decrease,no risk
Emtricitabine,Guanidine,The excretion of Emtricitabine can be decreased when combined with Guanidine.,decrease,no risk
Emtricitabine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Emtricitabine.,decrease,no risk
Emtricitabine,Nadolol,The excretion of Nadolol can be decreased when combined with Emtricitabine.,decrease,no risk
Emtricitabine,Valganciclovir,The risk or severity of cytopenia can be increased when Valganciclovir is combined with Emtricitabine.,increase,risk
Emtricitabine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Emtricitabine.,decrease,no risk
Emtricitabine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Emtricitabine.,decrease,no risk
Emtricitabine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Emtricitabine.,decrease,no risk
Chlorothiazide,Benorilate,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Benorilate.,decrease,no risk
Chlorothiazide,Benoxaprofen,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Benoxaprofen.,decrease,no risk
Chlorothiazide,Benserazide,Chlorothiazide may increase the excretion rate of Benserazide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Benzatropine,Chlorothiazide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Benzhydrocodone,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Benzhydrocodone.,decrease,no risk
Chlorothiazide,Benziodarone,The therapeutic efficacy of Benziodarone can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Benznidazole,Chlorothiazide may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Benzphetamine,Benzphetamine may decrease the antihypertensive activities of Chlorothiazide.,decrease,no risk
Chlorothiazide,Benzthiazide,The therapeutic efficacy of Chlorothiazide can be increased when used in combination with Benzthiazide.,increase,no risk
Chlorothiazide,Benzydamine,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Benzydamine.,decrease,no risk
Chlorothiazide,Benzylpenicillin,Chlorothiazide may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Chlorothiazide,Bepotastine,Chlorothiazide may increase the excretion rate of Bepotastine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Bepridil,The therapeutic efficacy of Bepridil can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Betamethasone,The risk or severity of electrolyte imbalance can be increased when Betamethasone is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Betamethasone phosphate,The risk or severity of electrolyte imbalance can be increased when Betamethasone phosphate is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Betaxolol,The therapeutic efficacy of Betaxolol can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Bethanidine,The therapeutic efficacy of Bethanidine can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Betrixaban,The therapeutic efficacy of Betrixaban can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Bexarotene,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Bexarotene.,increase,risk
Chlorothiazide,Bicisate,Chlorothiazide may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Bimatoprost,The therapeutic efficacy of Bimatoprost can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Biperiden,The serum concentration of Chlorothiazide can be increased when it is combined with Biperiden.,increase,no risk
Chlorothiazide,Bisacodyl,The risk or severity of dehydration can be increased when Chlorothiazide is combined with Bisacodyl.,increase,risk
Chlorothiazide,Bismuth subgallate,Chlorothiazide may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Bisoprolol,The therapeutic efficacy of Bisoprolol can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Bisoxatin,The risk or severity of dehydration can be increased when Chlorothiazide is combined with Bisoxatin.,increase,risk
Chlorothiazide,Bivalirudin,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Bleomycin,Chlorothiazide may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Blinatumomab,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Blinatumomab.,increase,risk
Chlorothiazide,Bortezomib,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Bortezomib.,increase,risk
Chlorothiazide,Bosentan,The therapeutic efficacy of Bosentan can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Bosutinib,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Bosutinib.,increase,risk
Chlorothiazide,Bretylium,The therapeutic efficacy of Bretylium can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Brexpiprazole,Brexpiprazole may decrease the antihypertensive activities of Chlorothiazide.,decrease,no risk
Chlorothiazide,Brimonidine,Brimonidine may increase the antihypertensive activities of Chlorothiazide.,increase,no risk
Chlorothiazide,Brivaracetam,Chlorothiazide may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Bromazepam,Chlorothiazide may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Brompheniramine,The serum concentration of Chlorothiazide can be increased when it is combined with Brompheniramine.,increase,no risk
Chlorothiazide,Buclizine,The serum concentration of Chlorothiazide can be increased when it is combined with Buclizine.,increase,no risk
Chlorothiazide,Budesonide,The risk or severity of electrolyte imbalance can be increased when Budesonide is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Bumadizone,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Bumadizone.,decrease,no risk
Chlorothiazide,Bumetanide,Chlorothiazide may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Buprenorphine,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Buprenorphine.,decrease,no risk
Chlorothiazide,Bupropion,Chlorothiazide may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Buspirone,Chlorothiazide may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Busulfan,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Busulfan.,increase,risk
Chlorothiazide,Butabarbital,The risk or severity of hypotension and orthostatic hypotension can be increased when Butabarbital is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Butalbital,The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Butobarbital,The serum concentration of Chlorothiazide can be increased when it is combined with Butobarbital.,increase,no risk
Chlorothiazide,Butorphanol,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Butorphanol.,decrease,no risk
Chlorothiazide,Butriptyline,Butriptyline may decrease the antihypertensive activities of Chlorothiazide.,decrease,no risk
Chlorothiazide,Butylscopolamine,The serum concentration of Chlorothiazide can be increased when it is combined with Butylscopolamine.,increase,no risk
Chlorothiazide,Gabapentin enacarbil,The therapeutic efficacy of Furosemide can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Gadobenic acid,Chlorothiazide may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Gadodiamide,Chlorothiazide may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Gadofosveset trisodium,Chlorothiazide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Gadopentetic acid,Chlorothiazide may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Gadoteric acid,Chlorothiazide may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Gadoteridol,Chlorothiazide may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Gallamine triethiodide,Chlorothiazide may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Ganciclovir,The serum concentration of Chlorothiazide can be increased when it is combined with Gallamine triethiodide.,increase,no risk
Chlorothiazide,Gemcitabine,Chlorothiazide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Gemfibrozil,Chlorothiazide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Gemtuzumab ozogamicin,Chlorothiazide may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Gimeracil,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Gemtuzumab ozogamicin.,increase,risk
Chlorothiazide,Gliclazide,Chlorothiazide may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Glimepiride,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Glipizide,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Gliquidone,The therapeutic efficacy of Glipizide can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Gluconic Acid,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Glyburide,The risk or severity of dehydration can be increased when Chlorothiazide is combined with Gluconic Acid.,increase,risk
Chlorothiazide,Glycerin,The therapeutic efficacy of Glyburide can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Glycerol phenylbutyrate,The risk or severity of dehydration can be increased when Chlorothiazide is combined with Glycerin.,increase,risk
Chlorothiazide,Glycol salicylate,Chlorothiazide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Glycopyrronium,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Chlorothiazide,Glymidine,The serum concentration of Chlorothiazide can be increased when it is combined with Glycopyrronium.,increase,no risk
Chlorothiazide,Golodirsen,The therapeutic efficacy of Glymidine can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Goserelin,Chlorothiazide may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Grepafloxacin,Chlorothiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Guanabenz,The excretion of Grepafloxacin can be decreased when combined with Chlorothiazide.,decrease,no risk
Chlorothiazide,Guanadrel,The therapeutic efficacy of Guanabenz can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Guanethidine,The therapeutic efficacy of Guanadrel can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Guanfacine,The therapeutic efficacy of Guanethidine can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Guanoxan,The therapeutic efficacy of Guanfacine can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Halcinonide,The therapeutic efficacy of Guanoxan can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Haloperidol,The risk or severity of electrolyte imbalance can be increased when Halcinonide is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Halothane,Chlorothiazide may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Heparin,Halothane may decrease the antihypertensive activities of Chlorothiazide.,decrease,no risk
Chlorothiazide,Hexafluronium,The therapeutic efficacy of Heparin can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Hexocyclium,The serum concentration of Chlorothiazide can be increased when it is combined with Hexafluronium.,increase,no risk
Chlorothiazide,Homatropine methylbromide,The serum concentration of Chlorothiazide can be increased when it is combined with Hexocyclium.,increase,no risk
Chlorothiazide,Hydralazine,The serum concentration of Chlorothiazide can be increased when it is combined with Homatropine methylbromide.,increase,no risk
Chlorothiazide,Hydrochlorothiazide,The therapeutic efficacy of Hydralazine can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Hydrocodone,The therapeutic efficacy of Hydrochlorothiazide can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Hydrocortisone,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Hydrocodone.,decrease,no risk
Chlorothiazide,Hydrocortisone acetate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Hydrocortisone butyrate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone acetate is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Hydrocortisone cypionate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone butyrate is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Hydrocortisone probutate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone cypionate is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Hydrocortisone succinate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone probutate is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Hydrocortisone valerate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone succinate is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone valerate is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Hydromorphone,The therapeutic efficacy of Chlorothiazide can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Chlorothiazide,Hydroxocobalamin,Chlorothiazide may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Hydroxyethyl Starch,Chlorothiazide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Hydroxyurea,Chlorothiazide may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Hyoscyamine,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Hydroxyurea.,increase,risk
Chlorothiazide,Ketamine,Chlorothiazide may increase the excretion rate of Ixazomib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Ketazolam,Chlorothiazide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Ketoprofen,Chlorothiazide may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Ketorolac,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Chlorothiazide.,increase,risk
Chlorothiazide,N-acetyltyrosine,Chlorothiazide may increase the excretion rate of Mycophenolic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Nabilone,Chlorothiazide may increase the excretion rate of N-acetyltyrosine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Nabumetone,The risk or severity of adverse effects can be increased when Nabilone is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Nadolol,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Nabumetone.,decrease,no risk
Chlorothiazide,Nadroparin,The therapeutic efficacy of Nadolol can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Nalbuphine,The therapeutic efficacy of Nadroparin can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Naldemedine,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Nalbuphine.,decrease,no risk
Chlorothiazide,Nalmefene,Chlorothiazide may increase the excretion rate of Naldemedine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Naloxegol,Chlorothiazide may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Naloxone,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Naloxegol.,decrease,no risk
Chlorothiazide,Naltrexone,Chlorothiazide may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Naphazoline,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Naltrexone.,decrease,no risk
Chlorothiazide,Naproxen,Naphazoline may decrease the antihypertensive activities of Chlorothiazide.,decrease,no risk
Chlorothiazide,Naratriptan,The therapeutic efficacy of Naproxen can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Nateglinide,Naratriptan may decrease the antihypertensive activities of Chlorothiazide.,decrease,no risk
Chlorothiazide,Naxitamab,The therapeutic efficacy of Nateglinide can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Nebivolol,Naxitamab may decrease the antihypertensive activities of Chlorothiazide.,decrease,no risk
Chlorothiazide,Nedaplatin,The therapeutic efficacy of Nebivolol can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Nedocromil,Chlorothiazide may increase the excretion rate of Nedaplatin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Nefazodone,Chlorothiazide may increase the excretion rate of Nedocromil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Nelarabine,The risk or severity of hyponatremia can be increased when Nefazodone is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Nesiritide,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Nelarabine.,increase,risk
Chlorothiazide,Nialamide,The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Nesiritide.,increase,risk
Chlorothiazide,Nicardipine,Nialamide may increase the hypotensive activities of Chlorothiazide.,increase,no risk
Chlorothiazide,Nicergoline,The therapeutic efficacy of Nicardipine can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Nicorandil,Nicergoline may decrease the antihypertensive activities of Chlorothiazide.,decrease,no risk
Chlorothiazide,Nicotine,Nicorandil may increase the hypotensive activities of Chlorothiazide.,increase,no risk
Chlorothiazide,Nifedipine,The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Nicotine.,increase,risk
Chlorothiazide,Nilotinib,Chlorothiazide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Nilutamide,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Nilotinib.,increase,risk
Chlorothiazide,Nilvadipine,Chlorothiazide may increase the excretion rate of Nilutamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Nimesulide,The therapeutic efficacy of Nilvadipine can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Nimodipine,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Nimesulide.,decrease,no risk
Chlorothiazide,Nisoldipine,The therapeutic efficacy of Nimodipine can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Nitrendipine,The therapeutic efficacy of Nisoldipine can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Nitric Oxide,The therapeutic efficacy of Nitrendipine can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Nitrofurantoin,Chlorothiazide may increase the excretion rate of Nitric Oxide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Nitroglycerin,Chlorothiazide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Nitroprusside,The therapeutic efficacy of Nitroglycerin can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Nitrous acid,The therapeutic efficacy of Nitroprusside can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Nitrous oxide,The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Nitrous acid.,increase,risk
Chlorothiazide,Norepinephrine,Nitrous oxide may decrease the antihypertensive activities of Chlorothiazide.,decrease,no risk
Chlorothiazide,Normethadone,The risk or severity of hypokalemia can be increased when Norepinephrine is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Nortriptyline,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Normethadone.,decrease,no risk
Chlorothiazide,Nylidrin,Nortriptyline may decrease the antihypertensive activities of Chlorothiazide.,decrease,no risk
Chlorothiazide,Obinutuzumab,Nylidrin may decrease the antihypertensive activities of Chlorothiazide.,decrease,no risk
Chlorothiazide,Octinoxate,Chlorothiazide may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Chlorothiazide,Olanzapine,Chlorothiazide may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Olaparib,The serum concentration of Chlorothiazide can be increased when it is combined with Olanzapine.,increase,no risk
Chlorothiazide,Oliceridine,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Olaparib.,increase,risk
Chlorothiazide,Olmesartan,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Oliceridine.,decrease,no risk
Chlorothiazide,Olodaterol,The therapeutic efficacy of Olmesartan can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Opicapone,The risk or severity of hypokalemia can be increased when Olodaterol is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Opium,The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Opicapone.,increase,risk
Chlorothiazide,Orciprenaline,Chlorothiazide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Orphenadrine,The risk or severity of hypokalemia can be increased when Orciprenaline is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Oseltamivir,The serum concentration of Chlorothiazide can be increased when it is combined with Orphenadrine.,increase,no risk
Chlorothiazide,Ouabain,Chlorothiazide may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Oxacillin,Chlorothiazide may increase the hypokalemic activities of Ouabain.,increase,no risk
Chlorothiazide,Oxaliplatin,Chlorothiazide may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Oxaprozin,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Oxaliplatin.,increase,risk
Chlorothiazide,Oxazepam,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Oxaprozin.,decrease,no risk
Chlorothiazide,Oxcarbazepine,Chlorothiazide may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Oxprenolol,The risk or severity of hyponatremia can be increased when Chlorothiazide is combined with Oxcarbazepine.,increase,risk
Chlorothiazide,Oxybenzone,The therapeutic efficacy of Oxprenolol can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Oxybutynin,Chlorothiazide may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Oxycodone,The serum concentration of Chlorothiazide can be increased when it is combined with Oxybutynin.,increase,no risk
Chlorothiazide,Oxymetazoline,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Oxycodone.,decrease,no risk
Chlorothiazide,Oxymorphone,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Chlorothiazide,Oxyphenbutazone,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Oxymorphone.,decrease,no risk
Chlorothiazide,Oxyphencyclimine,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Chlorothiazide,Oxyphenisatin acetate,The serum concentration of Chlorothiazide can be increased when it is combined with Oxyphencyclimine.,increase,no risk
Chlorothiazide,Oxyphenonium,The risk or severity of dehydration can be increased when Chlorothiazide is combined with Oxyphenisatin acetate.,increase,risk
Chlorothiazide,Oxyquinoline,The serum concentration of Chlorothiazide can be increased when it is combined with Oxyphenonium.,increase,no risk
Chlorothiazide,Quetiapine,Chlorothiazide may increase the excretion rate of Pyridoxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Quinapril,Quetiapine may increase the hypotensive activities of Chlorothiazide.,increase,no risk
Chlorothiazide,Quinidine,The therapeutic efficacy of Quinapril can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Quinine,Chlorothiazide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Quinupramine,The therapeutic efficacy of Quinine can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Udenafil,The serum concentration of Chlorothiazide can be increased when it is combined with Tubocurarine.,increase,no risk
Chlorothiazide,Ulobetasol,Udenafil may increase the antihypertensive activities of Chlorothiazide.,increase,no risk
Chlorothiazide,Umeclidinium,The risk or severity of electrolyte imbalance can be increased when Ulobetasol is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Unoprostone,The serum concentration of Chlorothiazide can be increased when it is combined with Umeclidinium.,increase,no risk
Chlorothiazide,Urokinase,The therapeutic efficacy of Unoprostone can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Vaborbactam,The therapeutic efficacy of Urokinase can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Vadadustat,Chlorothiazide may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Valaciclovir,The serum concentration of Vadadustat can be increased when it is combined with Chlorothiazide.,increase,no risk
Chlorothiazide,Valbenazine,Chlorothiazide may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Valdecoxib,Chlorothiazide may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Valganciclovir,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Valdecoxib.,decrease,no risk
Chlorothiazide,Valsartan,Chlorothiazide may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Vamorolone,The therapeutic efficacy of Valsartan can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Vancomycin,The risk or severity of electrolyte imbalance can be increased when Vamorolone is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Vardenafil,Chlorothiazide may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Varenicline,Vardenafil may increase the antihypertensive activities of Chlorothiazide.,increase,no risk
Chlorothiazide,Vecuronium,Chlorothiazide may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Venlafaxine,The serum concentration of Chlorothiazide can be increased when it is combined with Vecuronium.,increase,no risk
Chlorothiazide,Verapamil,Chlorothiazide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Vericiguat,Chlorothiazide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Vilanterol,The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Vericiguat.,increase,risk
Chlorothiazide,Vilazodone,The risk or severity of hypokalemia can be increased when Chlorothiazide is combined with Vilanterol.,increase,risk
Chlorothiazide,Vildagliptin,Vilazodone may decrease the antihypertensive activities of Chlorothiazide.,decrease,no risk
Chlorothiazide,Viloxazine,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Vinblastine,Chlorothiazide may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Vindesine,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Vinblastine.,increase,risk
Chlorothiazide,Vinorelbine,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Vindesine.,increase,risk
Chlorothiazide,Vitamin D,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Vinorelbine.,increase,risk
Chlorothiazide,Vorapaxar,The risk or severity of hypercalcemia can be increased when Chlorothiazide is combined with Vitamin D.,increase,risk
Chlorothiazide,Vorinostat,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Vortioxetine,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Vorinostat.,increase,risk
Chlorothiazide,Warfarin,Chlorothiazide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Xamoterol,Chlorothiazide may increase the excretion rate of Warfarin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Ximelagatran,Xamoterol may decrease the antihypertensive activities of Chlorothiazide.,decrease,no risk
Chlorothiazide,Xylometazoline,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Chlorothiazide.,decrease,no risk
Chlorothiazide,Yohimbine,Xylometazoline may decrease the antihypertensive activities of Chlorothiazide.,decrease,no risk
Chlorothiazide,Zalcitabine,Yohimbine may decrease the antihypertensive activities of Chlorothiazide.,decrease,no risk
Chlorothiazide,Zaleplon,The excretion of Zalcitabine can be decreased when combined with Chlorothiazide.,decrease,no risk
Chlorothiazide,Zanamivir,Chlorothiazide may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Ziconotide,Chlorothiazide may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorothiazide,Zidovudine,The risk or severity of CNS depression can be increased when Chlorothiazide is combined with Ziconotide.,increase,risk
Chlorothiazide,Zimelidine,The excretion of Zidovudine can be decreased when combined with Chlorothiazide.,decrease,no risk
Chlorothiazide,Ziprasidone,The risk or severity of hyponatremia can be increased when Zimelidine is combined with Chlorothiazide.,increase,risk
Chlorothiazide,Zofenopril,Ziprasidone may increase the antihypertensive activities of Chlorothiazide.,increase,no risk
Chlorothiazide,Zolmitriptan,The therapeutic efficacy of Zofenopril can be increased when used in combination with Chlorothiazide.,increase,no risk
Chlorothiazide,Zonisamide,Zolmitriptan may decrease the antihypertensive activities of Chlorothiazide.,decrease,no risk
Chlorothiazide,Zuclopenthixol,Chlorothiazide may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Quinapril,Ganciclovir,The excretion of Quinapril can be decreased when combined with Ganciclovir.,decrease,no risk
Quinapril,Gatifloxacin,Quinapril can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Quinapril,Gemfibrozil,The excretion of Quinapril can be decreased when combined with Gemfibrozil.,decrease,no risk
Quinapril,Gemifloxacin,Quinapril can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Quinapril,Glycol salicylate,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Glycol salicylate is combined with Quinapril.",increase,risk
Quinapril,Grepafloxacin,Quinapril can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Quinapril,Guanabenz,Guanabenz may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Guanadrel,Guanadrel may increase the hypotensive activities of Quinapril.,increase,no risk
Quinapril,Guanethidine,Quinapril may increase the hypotensive activities of Guanethidine.,increase,no risk
Quinapril,Guanfacine,Guanfacine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Guanidine,The excretion of Quinapril can be decreased when combined with Guanidine.,decrease,no risk
Quinapril,Guanoxan,Quinapril may increase the hypotensive activities of Guanoxan.,increase,no risk
Quinapril,Halothane,Halothane may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Heparin,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Heparin.,increase,risk
Quinapril,Holcus lanatus pollen,The risk or severity of adverse effects can be increased when Quinapril is combined with Holcus lanatus pollen.,increase,risk
Quinapril,Hydralazine,Quinapril may increase the hypotensive activities of Hydralazine.,increase,no risk
Quinapril,Hydroflumethiazide,The therapeutic efficacy of Quinapril can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Quinapril,Ketoconazole,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Ketoconazole.,increase,risk
Quinapril,Ketoprofen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketoprofen is combined with Quinapril.",increase,risk
Quinapril,Ketorolac,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketorolac is combined with Quinapril.",increase,risk
Quinapril,Koeleria macrantha pollen,The risk or severity of adverse effects can be increased when Quinapril is combined with Koeleria macrantha pollen.,increase,risk
Quinapril,Nabilone,The risk or severity of adverse effects can be increased when Nabilone is combined with Quinapril.,increase,risk
Quinapril,Nabumetone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Nabumetone is combined with Quinapril.",increase,risk
Quinapril,Nadolol,Quinapril may increase the hypotensive activities of Nadolol.,increase,no risk
Quinapril,Nadroparin,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Nadroparin.,increase,risk
Quinapril,Nalidixic acid,Quinapril can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Quinapril,Naphazoline,Naphazoline may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Naproxen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Naproxen is combined with Quinapril.",increase,risk
Quinapril,Naratriptan,Naratriptan may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Naxitamab,Naxitamab may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Nebivolol,Quinapril may increase the hypotensive activities of Nebivolol.,increase,no risk
Quinapril,Nefazodone,Nefazodone may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Nesiritide,The risk or severity of adverse effects can be increased when Quinapril is combined with Nesiritide.,increase,risk
Quinapril,Nialamide,Nialamide may increase the hypotensive activities of Quinapril.,increase,no risk
Quinapril,Nicardipine,Nicardipine may increase the hypotensive activities of Quinapril.,increase,no risk
Quinapril,Nicergoline,Nicergoline may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Nicorandil,Nicorandil may increase the vasodilatory activities of Quinapril.,increase,no risk
Quinapril,Nifedipine,The risk or severity of adverse effects can be increased when Quinapril is combined with Nifedipine.,increase,risk
Quinapril,Nilvadipine,Quinapril may increase the hypotensive activities of Nilvadipine.,increase,no risk
Quinapril,Nimesulide,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Nimesulide is combined with Quinapril.",increase,risk
Quinapril,Nimodipine,Nimodipine may increase the hypotensive activities of Quinapril.,increase,no risk
Quinapril,Nisoldipine,Nisoldipine may increase the hypotensive activities of Quinapril.,increase,no risk
Quinapril,Nitrendipine,Quinapril may increase the hypotensive activities of Nitrendipine.,increase,no risk
Quinapril,Nitric Oxide,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Quinapril.,increase,risk
Quinapril,Nitrofurantoin,The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Quinapril.,increase,risk
Quinapril,Nitroglycerin,Nitroglycerin may increase the hypotensive activities of Quinapril.,increase,no risk
Quinapril,Nitroprusside,Nitroprusside may increase the hypotensive activities of Quinapril.,increase,no risk
Quinapril,Nitrous acid,The risk or severity of adverse effects can be increased when Quinapril is combined with Nitrous acid.,increase,risk
Quinapril,Nitrous oxide,Nitrous oxide may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Norepinephrine,Norepinephrine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Norfloxacin,Quinapril can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Quinapril,Nortriptyline,Nortriptyline may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Novobiocin,The excretion of Quinapril can be decreased when combined with Novobiocin.,decrease,no risk
Quinapril,Nylidrin,Nylidrin may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Obinutuzumab,Quinapril may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Quinapril,Ofloxacin,Quinapril can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Quinapril,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Quinapril.,increase,risk
Quinapril,Olmesartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Quinapril is combined with Olmesartan.",increase,risk
Quinapril,Olodaterol,Olodaterol may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Olsalazine,The risk or severity of renal failure can be increased when Olsalazine is combined with Quinapril.,increase,risk
Quinapril,Omadacycline,Quinapril can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Quinapril,Opicapone,The risk or severity of adverse effects can be increased when Quinapril is combined with Opicapone.,increase,risk
Quinapril,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Ouabain,The excretion of Quinapril can be decreased when combined with Ouabain.,decrease,no risk
Quinapril,Oxaprozin,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxaprozin is combined with Quinapril.",increase,risk
Quinapril,Oxprenolol,Quinapril may increase the hypotensive activities of Oxprenolol.,increase,no risk
Quinapril,Oxymetazoline,The therapeutic efficacy of Quinapril can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Quinapril,Oxyphenbutazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Quinapril.",increase,risk
Quinapril,Oxytetracycline,Quinapril can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Quinapril,Quetiapine,Quetiapine may increase the hypotensive activities of Quinapril.,increase,no risk
Quinapril,Quinethazone,The risk or severity of hypotension can be increased when Quinethazone is combined with Quinapril.,increase,risk
Quinapril,Quinidine,The excretion of Quinapril can be decreased when combined with Quinidine.,decrease,no risk
Quinapril,Quinine,Quinine may increase the hypotensive activities of Quinapril.,increase,no risk
Quinapril,Quinupramine,Quinupramine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Udenafil,Udenafil may increase the antihypertensive activities of Quinapril.,increase,no risk
Quinapril,Unoprostone,Quinapril may increase the hypotensive activities of Unoprostone.,increase,no risk
Quinapril,Urochloa mutica pollen,The risk or severity of adverse effects can be increased when Quinapril is combined with Urochloa mutica pollen.,increase,risk
Quinapril,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Quinapril.,increase,risk
Quinapril,Vadadustat,The serum concentration of Quinapril can be increased when it is combined with Vadadustat.,increase,no risk
Quinapril,Valdecoxib,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valdecoxib is combined with Quinapril.",increase,risk
Quinapril,Valproic acid,The excretion of Quinapril can be decreased when combined with Valproic acid.,decrease,no risk
Quinapril,Valsartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Quinapril is combined with Valsartan.",increase,risk
Quinapril,Vardenafil,Vardenafil may increase the antihypertensive activities of Quinapril.,increase,no risk
Quinapril,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Quinapril.,increase,risk
Quinapril,Vericiguat,The risk or severity of adverse effects can be increased when Quinapril is combined with Vericiguat.,increase,risk
Quinapril,Vilanterol,Vilanterol may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Vilazodone,Vilazodone may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Vildagliptin,The risk or severity of angioedema can be increased when Vildagliptin is combined with Quinapril.,increase,risk
Quinapril,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Xamoterol,Xamoterol may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Yohimbine,Yohimbine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Zidovudine,The excretion of Quinapril can be decreased when combined with Zidovudine.,decrease,no risk
Quinapril,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Quinapril.,increase,no risk
Quinapril,Zofenopril,The risk or severity of angioedema can be increased when Quinapril is combined with Zofenopril.,increase,risk
Quinapril,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Quinapril,Zonisamide,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Zonisamide.,increase,risk
Quinapril,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Clomifene,Neratinib,The serum concentration of Clomifene can be increased when it is combined with Neratinib.,increase,no risk
Clomifene,Netupitant,The serum concentration of Clomifene can be increased when it is combined with Netupitant.,increase,no risk
Clomifene,Nilotinib,The serum concentration of Clomifene can be increased when it is combined with Nilotinib.,increase,no risk
Clomifene,Nintedanib,The serum concentration of Nintedanib can be increased when it is combined with Clomifene.,increase,no risk
Clomifene,Nirogacestat,The serum concentration of Clomifene can be increased when it is combined with Nirogacestat.,increase,no risk
Clomifene,Norgestimate,The serum concentration of Clomifene can be increased when it is combined with Norgestimate.,increase,no risk
Clomifene,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Clomifene.,increase,no risk
Clomifene,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Clomifene.,increase,no risk
Clomifene,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Clomifene.,increase,no risk
Clomifene,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Clomifene.,increase,no risk
Clomifene,Ospemifene,The risk or severity of adverse effects can be increased when Clomifene is combined with Ospemifene.,increase,risk
Clomifene,Quinidine,The serum concentration of Clomifene can be increased when it is combined with Quinidine.,increase,no risk
Clomifene,Quinine,The serum concentration of Clomifene can be increased when it is combined with Quinine.,increase,no risk
Clomifene,Quizartinib,The serum concentration of Clomifene can be increased when it is combined with Quizartinib.,increase,no risk
Clomifene,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Clomifene.,increase,no risk
Clomifene,Umbralisib,The serum concentration of Clomifene can be increased when it is combined with Umbralisib.,increase,no risk
Clomifene,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Clomifene.,increase,no risk
Clomifene,Vandetanib,The serum concentration of Clomifene can be increased when it is combined with Vandetanib.,increase,no risk
Clomifene,Vardenafil,The serum concentration of Clomifene can be increased when it is combined with Vardenafil.,increase,no risk
Clomifene,Velpatasvir,The serum concentration of Clomifene can be increased when it is combined with Velpatasvir.,increase,no risk
Clomifene,Vemurafenib,The serum concentration of Clomifene can be increased when it is combined with Vemurafenib.,increase,no risk
Clomifene,Venetoclax,The serum concentration of Clomifene can be increased when it is combined with Venetoclax.,increase,no risk
Clomifene,Verapamil,The serum concentration of Clomifene can be increased when it is combined with Verapamil.,increase,no risk
Clomifene,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Clomifene.,increase,no risk
Clomifene,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Clomifene.,increase,no risk
Clomifene,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Clomifene.,increase,no risk
Clomifene,Voclosporin,The serum concentration of Clomifene can be increased when it is combined with Voclosporin.,increase,no risk
Clomifene,Vorapaxar,The serum concentration of Clomifene can be increased when it is combined with Vorapaxar.,increase,no risk
Clomifene,Voxilaprevir,The serum concentration of Clomifene can be increased when it is combined with Voxilaprevir.,increase,no risk
Clomifene,Zonisamide,The serum concentration of Clomifene can be increased when it is combined with Zonisamide.,increase,no risk
Isosorbide dinitrate,Guanabenz,Isosorbide dinitrate may increase the hypotensive activities of Guanabenz.,increase,no risk
Isosorbide dinitrate,Guanadrel,Isosorbide dinitrate may increase the hypotensive activities of Guanadrel.,increase,no risk
Isosorbide dinitrate,Guanethidine,Isosorbide dinitrate may increase the hypotensive activities of Guanethidine.,increase,no risk
Isosorbide dinitrate,Guanfacine,The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Guanfacine.,increase,risk
Isosorbide dinitrate,Guanoxan,Isosorbide dinitrate may increase the hypotensive activities of Guanoxan.,increase,no risk
Isosorbide dinitrate,Halothane,The metabolism of Halothane can be decreased when combined with Isosorbide dinitrate.,decrease,no risk
Isosorbide dinitrate,Hydrochlorothiazide,The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Hydrochlorothiazide.,increase,risk
Isosorbide dinitrate,Hydroflumethiazide,The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Isosorbide dinitrate.,increase,risk
Isosorbide dinitrate,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Hydroxyurea.,increase,risk
Isosorbide dinitrate,Nabilone,The risk or severity of adverse effects can be increased when Nabilone is combined with Isosorbide dinitrate.,increase,risk
Isosorbide dinitrate,Nadolol,The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Nadolol.,increase,risk
Isosorbide dinitrate,Nebivolol,The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Nebivolol.,increase,risk
Isosorbide dinitrate,Nesiritide,The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Nesiritide.,increase,risk
Isosorbide dinitrate,Nialamide,Nialamide may increase the orthostatic hypotensive activities of Isosorbide dinitrate.,increase,no risk
Isosorbide dinitrate,Nicardipine,Nicardipine may increase the vasodilatory activities of Isosorbide dinitrate.,increase,no risk
Isosorbide dinitrate,Nicorandil,Nicorandil may increase the hypotensive activities of Isosorbide dinitrate.,increase,no risk
Isosorbide dinitrate,Nifedipine,Nifedipine may increase the vasodilatory activities of Isosorbide dinitrate.,increase,no risk
Isosorbide dinitrate,Nilvadipine,Nilvadipine may increase the vasodilatory activities of Isosorbide dinitrate.,increase,no risk
Isosorbide dinitrate,Nimesulide,Nimesulide may increase the vasodilatory activities of Isosorbide dinitrate.,increase,no risk
Isosorbide dinitrate,Nimodipine,Nimodipine may increase the vasodilatory activities of Isosorbide dinitrate.,increase,no risk
Isosorbide dinitrate,Nisoldipine,Nisoldipine may increase the vasodilatory activities of Isosorbide dinitrate.,increase,no risk
Isosorbide dinitrate,Nitrendipine,Nitrendipine may increase the vasodilatory activities of Isosorbide dinitrate.,increase,no risk
Isosorbide dinitrate,Nitric Oxide,The risk or severity of methemoglobinemia can be increased when Nitric Oxide is combined with Isosorbide dinitrate.,increase,risk
Isosorbide dinitrate,Nitrofurantoin,The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Isosorbide dinitrate.,increase,risk
Isosorbide dinitrate,Nitroglycerin,The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Isosorbide dinitrate.,increase,risk
Isosorbide dinitrate,Nitroprusside,The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Isosorbide dinitrate.,increase,risk
Isosorbide dinitrate,Nitrous acid,The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Nitrous acid.,increase,risk
Isosorbide dinitrate,Nitrous oxide,The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Nitrous oxide.,increase,risk
Isosorbide dinitrate,Nylidrin,Nylidrin may increase the vasodilatory activities of Isosorbide dinitrate.,increase,no risk
Isosorbide dinitrate,Obinutuzumab,The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Obinutuzumab.,increase,risk
Isosorbide dinitrate,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Isosorbide dinitrate.,increase,risk
Isosorbide dinitrate,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Isosorbide dinitrate.,increase,risk
Isosorbide dinitrate,Opicapone,The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Opicapone.,increase,risk
Isosorbide dinitrate,Oxprenolol,The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Oxprenolol.,increase,risk
Isosorbide dinitrate,Quetiapine,The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Quetiapine.,increase,risk
Isosorbide dinitrate,Quinapril,The risk or severity of adverse effects can be increased when Quinapril is combined with Isosorbide dinitrate.,increase,risk
Isosorbide dinitrate,Quinine,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Isosorbide dinitrate.,increase,risk
Isosorbide dinitrate,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Isosorbide dinitrate.,increase,risk
Isosorbide dinitrate,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Isosorbide dinitrate.,increase,risk
Isosorbide dinitrate,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Isosorbide dinitrate.,increase,risk
Isosorbide dinitrate,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Isosorbide dinitrate.,increase,risk
Isosorbide dinitrate,Verapamil,Verapamil may increase the vasodilatory activities of Isosorbide dinitrate.,increase,no risk
Isosorbide dinitrate,Vericiguat,The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Vericiguat.,increase,risk
Isosorbide dinitrate,Zofenopril,Isosorbide dinitrate may increase the hypotensive activities of Zofenopril.,increase,no risk
Isosorbide dinitrate,Zonisamide,Zonisamide may increase the vasodilatory activities of Isosorbide dinitrate.,increase,no risk
Isosorbide dinitrate,Zopiclone,The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Zopiclone.,increase,risk
Risedronic acid,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Ganciclovir.",increase,risk
Risedronic acid,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Gemfibrozil.",increase,risk
Risedronic acid,Gentamicin,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Gentamicin is combined with Risedronic acid.,increase,risk
Risedronic acid,Givosiran,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Givosiran is combined with Risedronic acid.,increase,risk
Risedronic acid,Glycol salicylate,The risk or severity of gastrointestinal bleeding can be increased when Glycol salicylate is combined with Risedronic acid.,increase,risk
Risedronic acid,Human calcitonin,The risk or severity of hypocalcemia can be increased when Human calcitonin is combined with Risedronic acid.,increase,risk
Risedronic acid,Hydrochlorothiazide,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Hydrochlorothiazide is combined with Risedronic acid.,increase,risk
Risedronic acid,Hydrotalcite,The serum concentration of Risedronic acid can be decreased when it is combined with Hydrotalcite.,decrease,no risk
Risedronic acid,Kanamycin,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Kanamycin is combined with Risedronic acid.,increase,risk
Risedronic acid,Ketoprofen,The risk or severity of gastrointestinal bleeding can be increased when Ketoprofen is combined with Risedronic acid.,increase,risk
Risedronic acid,Ketorolac,The risk or severity of gastrointestinal bleeding can be increased when Ketorolac is combined with Risedronic acid.,increase,risk
Risedronic acid,Nabumetone,The risk or severity of gastrointestinal bleeding can be increased when Nabumetone is combined with Risedronic acid.,increase,risk
Risedronic acid,Nafarelin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Risedronic acid.",increase,risk
Risedronic acid,Naltrexone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Risedronic acid.",increase,risk
Risedronic acid,Naproxen,The risk or severity of gastrointestinal bleeding can be increased when Naproxen is combined with Risedronic acid.,increase,risk
Risedronic acid,Neomycin,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Neomycin is combined with Risedronic acid.,increase,risk
Risedronic acid,Netilmicin,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Netilmicin is combined with Risedronic acid.,increase,risk
Risedronic acid,Niacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Risedronic acid.",increase,risk
Risedronic acid,Nimesulide,The risk or severity of gastrointestinal bleeding can be increased when Nimesulide is combined with Risedronic acid.,increase,risk
Risedronic acid,Nitroprusside,Nitroprusside can cause a decrease in the absorption of Risedronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Risedronic acid,Nizatidine,Nizatidine can cause an increase in the absorption of Risedronic acid resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Risedronic acid,Norfloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Norfloxacin.",increase,risk
Risedronic acid,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Ofloxacin.",increase,risk
Risedronic acid,Olanzapine,Olanzapine can cause an increase in the absorption of Risedronic acid resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Risedronic acid,Olsalazine,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Olsalazine is combined with Risedronic acid.,increase,risk
Risedronic acid,Omeprazole,Omeprazole can cause an increase in the absorption of Risedronic acid resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Risedronic acid,Oxaprozin,The risk or severity of gastrointestinal bleeding can be increased when Oxaprozin is combined with Risedronic acid.,increase,risk
Risedronic acid,Oxyphenbutazone,The risk or severity of gastrointestinal bleeding can be increased when Oxyphenbutazone is combined with Risedronic acid.,increase,risk
Risedronic acid,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Ubidecarenone.",increase,risk
Risedronic acid,Valaciclovir,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Valaciclovir is combined with Risedronic acid.,increase,risk
Risedronic acid,Valdecoxib,The risk or severity of gastrointestinal bleeding can be increased when Valdecoxib is combined with Risedronic acid.,increase,risk
Risedronic acid,Vancomycin,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Vancomycin is combined with Risedronic acid.,increase,risk
Risedronic acid,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Risedronic acid.",increase,risk
Risedronic acid,Zidovudine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Risedronic acid.",increase,risk
Risedronic acid,Zoledronic acid,The risk or severity of adverse effects can be increased when Zoledronic acid is combined with Risedronic acid.,increase,risk
Omapatrilat,Glycol salicylate,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Glycol salicylate is combined with Omapatrilat.",increase,risk
Omapatrilat,Guanabenz,Guanabenz may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Guanadrel,Omapatrilat may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Omapatrilat,Guanethidine,Omapatrilat may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Omapatrilat,Guanfacine,Omapatrilat may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Omapatrilat,Guanoxan,Omapatrilat may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Omapatrilat,Halothane,Halothane may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Heparin,The risk or severity of hyperkalemia can be increased when Omapatrilat is combined with Heparin.,increase,risk
Omapatrilat,Holcus lanatus pollen,The risk or severity of adverse effects can be increased when Omapatrilat is combined with Holcus lanatus pollen.,increase,risk
Omapatrilat,Hydralazine,Omapatrilat may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Omapatrilat,Hydrochlorothiazide,The therapeutic efficacy of Omapatrilat can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Omapatrilat,Hydroflumethiazide,The therapeutic efficacy of Omapatrilat can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Omapatrilat,Ketoconazole,The risk or severity of hyperkalemia can be increased when Omapatrilat is combined with Ketoconazole.,increase,risk
Omapatrilat,Ketoprofen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketoprofen is combined with Omapatrilat.",increase,risk
Omapatrilat,Ketorolac,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketorolac is combined with Omapatrilat.",increase,risk
Omapatrilat,Koeleria macrantha pollen,The risk or severity of adverse effects can be increased when Omapatrilat is combined with Koeleria macrantha pollen.,increase,risk
Omapatrilat,Nabilone,Nabilone may increase the hypotensive activities of Omapatrilat.,increase,no risk
Omapatrilat,Nabumetone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Nabumetone is combined with Omapatrilat.",increase,risk
Omapatrilat,Nadolol,Omapatrilat may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Omapatrilat,Nadroparin,The risk or severity of hyperkalemia can be increased when Omapatrilat is combined with Nadroparin.,increase,risk
Omapatrilat,Naphazoline,Naphazoline may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Naproxen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Naproxen is combined with Omapatrilat.",increase,risk
Omapatrilat,Naratriptan,Naratriptan may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Naxitamab,Naxitamab may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Nebivolol,Omapatrilat may decrease the antihypertensive activities of Nebivolol.,decrease,no risk
Omapatrilat,Nefazodone,Nefazodone may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Nesiritide,Nesiritide may increase the hypotensive activities of Omapatrilat.,increase,no risk
Omapatrilat,Nialamide,Nialamide may increase the hypotensive activities of Omapatrilat.,increase,no risk
Omapatrilat,Nicardipine,Omapatrilat may decrease the antihypertensive activities of Nicardipine.,decrease,no risk
Omapatrilat,Nicergoline,Nicergoline may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Nicorandil,Nicorandil may increase the vasodilatory activities of Omapatrilat.,increase,no risk
Omapatrilat,Nifedipine,The risk or severity of hyperkalemia can be increased when Omapatrilat is combined with Nifedipine.,increase,risk
Omapatrilat,Nilvadipine,Omapatrilat may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Omapatrilat,Nimesulide,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Nimesulide is combined with Omapatrilat.",increase,risk
Omapatrilat,Nimodipine,Omapatrilat may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Omapatrilat,Nisoldipine,Omapatrilat may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Omapatrilat,Nitrendipine,Omapatrilat may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Omapatrilat,Nitric Oxide,Nitric Oxide may increase the hypotensive activities of Omapatrilat.,increase,no risk
Omapatrilat,Nitrofurantoin,The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Omapatrilat.,increase,risk
Omapatrilat,Nitroglycerin,Omapatrilat may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Omapatrilat,Nitroprusside,Omapatrilat may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Omapatrilat,Nitrous acid,Nitrous acid may increase the hypotensive activities of Omapatrilat.,increase,no risk
Omapatrilat,Nitrous oxide,Nitrous oxide may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Norepinephrine,Norepinephrine may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Nortriptyline,Nortriptyline may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Nylidrin,Nylidrin may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Obinutuzumab,Omapatrilat may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Omapatrilat,Olanzapine,Olanzapine may increase the hypotensive activities of Omapatrilat.,increase,no risk
Omapatrilat,Olmesartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Omapatrilat is combined with Olmesartan.",increase,risk
Omapatrilat,Olodaterol,Olodaterol may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Olsalazine,The risk or severity of renal failure can be increased when Olsalazine is combined with Omapatrilat.,increase,risk
Omapatrilat,Opicapone,Opicapone may increase the hypotensive activities of Omapatrilat.,increase,no risk
Omapatrilat,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Oxaprozin,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxaprozin is combined with Omapatrilat.",increase,risk
Omapatrilat,Oxprenolol,Omapatrilat may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Omapatrilat,Oxymetazoline,The therapeutic efficacy of Omapatrilat can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Omapatrilat,Oxyphenbutazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Omapatrilat.",increase,risk
Omapatrilat,Quetiapine,Quetiapine may increase the hypotensive activities of Omapatrilat.,increase,no risk
Omapatrilat,Quinapril,The risk or severity of angioedema can be increased when Quinapril is combined with Omapatrilat.,increase,risk
Omapatrilat,Quinethazone,The risk or severity of hypotension can be increased when Quinethazone is combined with Omapatrilat.,increase,risk
Omapatrilat,Quinidine,Quinidine may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Quinine,Quinine may increase the hypotensive activities of Omapatrilat.,increase,no risk
Omapatrilat,Quinupramine,Quinupramine may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Udenafil,Udenafil may increase the antihypertensive activities of Omapatrilat.,increase,no risk
Omapatrilat,Unoprostone,Omapatrilat may increase the hypotensive activities of Unoprostone.,increase,no risk
Omapatrilat,Urochloa mutica pollen,The risk or severity of adverse effects can be increased when Omapatrilat is combined with Urochloa mutica pollen.,increase,risk
Omapatrilat,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Omapatrilat.,increase,risk
Omapatrilat,Valdecoxib,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valdecoxib is combined with Omapatrilat.",increase,risk
Omapatrilat,Valsartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Omapatrilat is combined with Valsartan.",increase,risk
Omapatrilat,Vardenafil,Vardenafil may increase the antihypertensive activities of Omapatrilat.,increase,no risk
Omapatrilat,Verapamil,Verapamil may increase the hypotensive activities of Omapatrilat.,increase,no risk
Omapatrilat,Vericiguat,Vericiguat may increase the hypotensive activities of Omapatrilat.,increase,no risk
Omapatrilat,Vilanterol,Vilanterol may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Vilazodone,Vilazodone may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Vildagliptin,The risk or severity of angioedema can be increased when Vildagliptin is combined with Omapatrilat.,increase,risk
Omapatrilat,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Xamoterol,Xamoterol may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Yohimbine,Yohimbine may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Omapatrilat.,increase,no risk
Omapatrilat,Zofenopril,The risk or severity of angioedema can be increased when Omapatrilat is combined with Zofenopril.,increase,risk
Omapatrilat,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Omapatrilat,Zonisamide,The risk or severity of hyperkalemia can be increased when Omapatrilat is combined with Zonisamide.,increase,risk
Omapatrilat,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Omapatrilat.,decrease,no risk
Bumetanide,Betaxolol,The risk or severity of adverse effects can be increased when Betaxolol is combined with Bumetanide.,increase,risk
Bumetanide,Bethanidine,Bumetanide may increase the hypotensive activities of Bethanidine.,increase,no risk
Bumetanide,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Bumetanide.,decrease,no risk
Bumetanide,Bezafibrate,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bumetanide is combined with Bezafibrate.",increase,risk
Bumetanide,Bicisate,Bumetanide may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Bisacodyl,The risk or severity of dehydration can be increased when Bumetanide is combined with Bisacodyl.,increase,risk
Bumetanide,Bismuth subgallate,Bumetanide may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Bismuth subsalicylate,The risk or severity of adverse effects can be increased when Bumetanide is combined with Bismuth subsalicylate.,increase,risk
Bumetanide,Bisoprolol,Bumetanide may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Bisoxatin,The risk or severity of dehydration can be increased when Bumetanide is combined with Bisoxatin.,increase,risk
Bumetanide,Bleomycin,Bumetanide may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Bosentan,Bumetanide may increase the hypotensive activities of Bosentan.,increase,no risk
Bumetanide,Bretylium,The risk or severity of adverse effects can be increased when Bumetanide is combined with Bretylium.,increase,risk
Bumetanide,Brivaracetam,Bumetanide may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Bromazepam,Bumetanide may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Bumetanide.,decrease,no risk
Bumetanide,Bromotheophylline,Bromotheophylline may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Budesonide,The risk or severity of hypokalemia can be increased when Budesonide is combined with Bumetanide.,increase,risk
Bumetanide,Bumadizone,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Bumadizone.,decrease,no risk
Bumetanide,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Bumetanide.,increase,risk
Bumetanide,Buprenorphine,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Buprenorphine.,decrease,no risk
Bumetanide,Bupropion,Bumetanide may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Buspirone,Bumetanide may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Butabarbital,Butabarbital may increase the hypotensive activities of Bumetanide.,increase,no risk
Bumetanide,Butalbital,Butalbital may increase the hypotensive activities of Bumetanide.,increase,no risk
Bumetanide,Butorphanol,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Butorphanol.,decrease,no risk
Bumetanide,Gabapentin enacarbil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bumetanide is combined with Fusidic acid.",increase,risk
Bumetanide,Gadobenic acid,Bumetanide may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Gadodiamide,Bumetanide may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Gadofosveset trisodium,Bumetanide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Gadopentetic acid,Bumetanide may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Gadoteric acid,Bumetanide may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Gadoteridol,Bumetanide may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Gallamine triethiodide,Bumetanide may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Ganciclovir,Bumetanide may decrease the neuromuscular blocking activities of Gallamine triethiodide.,decrease,no risk
Bumetanide,Gemcitabine,The excretion of Bumetanide can be decreased when combined with Ganciclovir.,decrease,no risk
Bumetanide,Gemfibrozil,Bumetanide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Gentamicin,The excretion of Bumetanide can be decreased when combined with Gemfibrozil.,decrease,no risk
Bumetanide,Gimeracil,The serum concentration of Gentamicin can be increased when it is combined with Bumetanide.,increase,no risk
Bumetanide,Givosiran,Bumetanide may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Gliclazide,The risk or severity of nephrotoxicity can be increased when Bumetanide is combined with Givosiran.,increase,risk
Bumetanide,Glimepiride,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Bumetanide.,decrease,no risk
Bumetanide,Glipizide,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Bumetanide.,decrease,no risk
Bumetanide,Gliquidone,The therapeutic efficacy of Glipizide can be decreased when used in combination with Bumetanide.,decrease,no risk
Bumetanide,Gluconic Acid,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Bumetanide.,decrease,no risk
Bumetanide,Glyburide,The risk or severity of dehydration can be increased when Bumetanide is combined with Gluconic Acid.,increase,risk
Bumetanide,Glycerin,The therapeutic efficacy of Glyburide can be decreased when used in combination with Bumetanide.,decrease,no risk
Bumetanide,Glycerol phenylbutyrate,The risk or severity of dehydration can be increased when Bumetanide is combined with Glycerin.,increase,risk
Bumetanide,Glycol salicylate,Bumetanide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Glymidine,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Bumetanide,Golodirsen,The therapeutic efficacy of Glymidine can be decreased when used in combination with Bumetanide.,decrease,no risk
Bumetanide,Goserelin,Bumetanide may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Grepafloxacin,Bumetanide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Guanabenz,The excretion of Grepafloxacin can be decreased when combined with Bumetanide.,decrease,no risk
Bumetanide,Guanadrel,Bumetanide may increase the hypotensive activities of Guanabenz.,increase,no risk
Bumetanide,Guanethidine,Bumetanide may increase the hypotensive activities of Guanadrel.,increase,no risk
Bumetanide,Guanfacine,Bumetanide may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Guanidine,Bumetanide may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Guanoxan,The excretion of Bumetanide can be decreased when combined with Guanidine.,decrease,no risk
Bumetanide,Haloperidol,Bumetanide may increase the hypotensive activities of Guanoxan.,increase,no risk
Bumetanide,Halothane,Bumetanide may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Hydralazine,The risk or severity of adverse effects can be increased when Bumetanide is combined with Halothane.,increase,risk
Bumetanide,Hydrochlorothiazide,Bumetanide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Hydrocodone,The excretion of Hydrochlorothiazide can be decreased when combined with Bumetanide.,decrease,no risk
Bumetanide,Hydrocortisone,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Hydrocodone.,decrease,no risk
Bumetanide,Hydrocortisone butyrate,The excretion of Hydrocortisone can be decreased when combined with Bumetanide.,decrease,no risk
Bumetanide,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Bumetanide.,increase,risk
Bumetanide,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Bumetanide.,increase,risk
Bumetanide,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Bumetanide.,increase,risk
Bumetanide,Hydromorphone,Hydroflumethiazide may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Hydroxocobalamin,Bumetanide may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Hydroxyethyl Starch,Bumetanide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Kanamycin,Bumetanide may increase the excretion rate of Ixazomib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Ketamine,The serum concentration of Kanamycin can be increased when it is combined with Bumetanide.,increase,no risk
Bumetanide,Ketazolam,Bumetanide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Ketoprofen,Bumetanide may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Ketorolac,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Ketoprofen.,decrease,no risk
Bumetanide,N-acetyltyrosine,Bumetanide may increase the excretion rate of Mycophenolic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Nabilone,Bumetanide may increase the excretion rate of N-acetyltyrosine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Nabumetone,The risk or severity of adverse effects can be increased when Nabilone is combined with Bumetanide.,increase,risk
Bumetanide,Nadolol,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Nabumetone.,decrease,no risk
Bumetanide,Nafarelin,Bumetanide may increase the excretion rate of Nadolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Nalbuphine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Bumetanide.",increase,risk
Bumetanide,Naldemedine,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Nalbuphine.,decrease,no risk
Bumetanide,Nalmefene,Bumetanide may increase the excretion rate of Naldemedine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Naloxegol,Bumetanide may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Naloxone,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Naloxegol.,decrease,no risk
Bumetanide,Naltrexone,Bumetanide may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Naproxen,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Bumetanide.",increase,risk
Bumetanide,Nateglinide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Naproxen.,decrease,no risk
Bumetanide,Nebivolol,The therapeutic efficacy of Nateglinide can be decreased when used in combination with Bumetanide.,decrease,no risk
Bumetanide,Nedaplatin,The risk or severity of adverse effects can be increased when Bumetanide is combined with Nebivolol.,increase,risk
Bumetanide,Nedocromil,Bumetanide may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Bumetanide,Nefazodone,Bumetanide may increase the excretion rate of Nedocromil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Neomycin,Bumetanide may increase the excretion rate of Nefazodone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Nesiritide,The risk or severity of nephrotoxicity can be increased when Bumetanide is combined with Neomycin.,increase,risk
Bumetanide,Netilmicin,The risk or severity of adverse effects can be increased when Bumetanide is combined with Nesiritide.,increase,risk
Bumetanide,Niacin,The serum concentration of Netilmicin can be increased when it is combined with Bumetanide.,increase,no risk
Bumetanide,Nialamide,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Bumetanide.",increase,risk
Bumetanide,Nicardipine,Nialamide may increase the orthostatic hypotensive activities of Bumetanide.,increase,no risk
Bumetanide,Nicorandil,The risk or severity of adverse effects can be increased when Nicardipine is combined with Bumetanide.,increase,risk
Bumetanide,Nicotine,Nicorandil may increase the hypotensive activities of Bumetanide.,increase,no risk
Bumetanide,Nifedipine,The risk or severity of adverse effects can be increased when Bumetanide is combined with Nicotine.,increase,risk
Bumetanide,Nilutamide,Bumetanide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Nilvadipine,Bumetanide may increase the excretion rate of Nilutamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Nimesulide,The risk or severity of adverse effects can be increased when Bumetanide is combined with Nilvadipine.,increase,risk
Bumetanide,Nimodipine,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Nimesulide.,decrease,no risk
Bumetanide,Nisoldipine,The risk or severity of adverse effects can be increased when Nimodipine is combined with Bumetanide.,increase,risk
Bumetanide,Nitrendipine,Bumetanide may increase the excretion rate of Nisoldipine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Nitric Oxide,The risk or severity of adverse effects can be increased when Bumetanide is combined with Nitrendipine.,increase,risk
Bumetanide,Nitrofurantoin,Bumetanide may increase the excretion rate of Nitric Oxide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Nitroglycerin,Bumetanide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Nitroprusside,The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Bumetanide.,increase,risk
Bumetanide,Nitrous acid,Bumetanide may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Nizatidine,The risk or severity of adverse effects can be increased when Bumetanide is combined with Nitrous acid.,increase,risk
Bumetanide,Norepinephrine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Bumetanide.",increase,risk
Bumetanide,Norfloxacin,The risk or severity of hypokalemia can be increased when Norepinephrine is combined with Bumetanide.,increase,risk
Bumetanide,Normethadone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bumetanide is combined with Norfloxacin.",increase,risk
Bumetanide,Novobiocin,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Normethadone.,decrease,no risk
Bumetanide,Obinutuzumab,The excretion of Bumetanide can be decreased when combined with Novobiocin.,decrease,no risk
Bumetanide,Octinoxate,The risk or severity of adverse effects can be increased when Bumetanide is combined with Obinutuzumab.,increase,risk
Bumetanide,Ofloxacin,Bumetanide may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Olanzapine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bumetanide is combined with Ofloxacin.",increase,risk
Bumetanide,Oliceridine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Bumetanide.,increase,risk
Bumetanide,Olmesartan,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Oliceridine.,decrease,no risk
Bumetanide,Olodaterol,The risk or severity of adverse effects can be increased when Olmesartan is combined with Bumetanide.,increase,risk
Bumetanide,Olsalazine,The risk or severity of hypokalemia can be increased when Olodaterol is combined with Bumetanide.,increase,risk
Bumetanide,Opicapone,The risk or severity of nephrotoxicity can be increased when Bumetanide is combined with Olsalazine.,increase,risk
Bumetanide,Opium,The risk or severity of adverse effects can be increased when Bumetanide is combined with Opicapone.,increase,risk
Bumetanide,Orciprenaline,Bumetanide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Oseltamivir,The risk or severity of hypokalemia can be increased when Orciprenaline is combined with Bumetanide.,increase,risk
Bumetanide,Ouabain,The excretion of Oseltamivir can be decreased when combined with Bumetanide.,decrease,no risk
Bumetanide,Oxacillin,The risk or severity of adverse effects can be increased when Bumetanide is combined with Ouabain.,increase,risk
Bumetanide,Oxaliplatin,Bumetanide may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Bumetanide.,increase,risk
Bumetanide,Oxazepam,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Oxaprozin.,decrease,no risk
Bumetanide,Oxprenolol,Bumetanide may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Oxybenzone,The risk or severity of adverse effects can be increased when Bumetanide is combined with Oxprenolol.,increase,risk
Bumetanide,Oxycodone,Bumetanide may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Oxymorphone,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Oxycodone.,decrease,no risk
Bumetanide,Oxyphenbutazone,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Oxymorphone.,decrease,no risk
Bumetanide,Oxyphenisatin acetate,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Bumetanide,Oxyquinoline,The risk or severity of dehydration can be increased when Bumetanide is combined with Oxyphenisatin acetate.,increase,risk
Bumetanide,Oxytetracycline,Bumetanide may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Quetiapine,Bumetanide may increase the excretion rate of Pyridoxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Quinapril,Bumetanide may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Quinethazone,The excretion of Quinapril can be decreased when combined with Bumetanide.,decrease,no risk
Bumetanide,Quinidine,Quinethazone may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Quinine,Bumetanide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Bumetanide,Ubidecarenone,Bumetanide may decrease the neuromuscular blocking activities of Tubocurarine.,decrease,no risk
Bumetanide,Udenafil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bumetanide is combined with Ubidecarenone.",increase,risk
Bumetanide,Vaborbactam,The risk or severity of hypotension can be increased when Udenafil is combined with Bumetanide.,increase,risk
Bumetanide,Vadadustat,Bumetanide may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Valaciclovir,The serum concentration of Vadadustat can be increased when it is combined with Bumetanide.,increase,no risk
Bumetanide,Valbenazine,The excretion of Valaciclovir can be decreased when combined with Bumetanide.,decrease,no risk
Bumetanide,Valdecoxib,Bumetanide may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Valganciclovir,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Valdecoxib.,decrease,no risk
Bumetanide,Valproic acid,Bumetanide may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Valsartan,The excretion of Valproic acid can be decreased when combined with Bumetanide.,decrease,no risk
Bumetanide,Vamorolone,The risk or severity of adverse effects can be increased when Valsartan is combined with Bumetanide.,increase,risk
Bumetanide,Vancomycin,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Bumetanide.,increase,risk
Bumetanide,Vardenafil,Bumetanide may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Bumetanide,Varenicline,The risk or severity of hypotension can be increased when Vardenafil is combined with Bumetanide.,increase,risk
Bumetanide,Vecuronium,Bumetanide may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Venlafaxine,Bumetanide may decrease the neuromuscular blocking activities of Vecuronium.,decrease,no risk
Bumetanide,Verapamil,Bumetanide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Vericiguat,Bumetanide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Vilanterol,The risk or severity of adverse effects can be increased when Bumetanide is combined with Vericiguat.,increase,risk
Bumetanide,Vildagliptin,The risk or severity of hypokalemia can be increased when Bumetanide is combined with Vilanterol.,increase,risk
Bumetanide,Viloxazine,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Bumetanide.,decrease,no risk
Bumetanide,Vincristine,Bumetanide may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Vortioxetine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Bumetanide.",increase,risk
Bumetanide,Warfarin,Bumetanide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Zalcitabine,Bumetanide may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Bumetanide,Zaleplon,The excretion of Zalcitabine can be decreased when combined with Bumetanide.,decrease,no risk
Bumetanide,Zanamivir,Bumetanide may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Ziconotide,Bumetanide may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bumetanide,Zidovudine,The risk or severity of CNS depression can be increased when Bumetanide is combined with Ziconotide.,increase,risk
Bumetanide,Zofenopril,The excretion of Bumetanide can be decreased when combined with Zidovudine.,decrease,no risk
Bumetanide,Zoledronic acid,Bumetanide may increase the hypotensive activities of Zofenopril.,increase,no risk
Bumetanide,Zonisamide,The risk or severity of hypocalcemia can be increased when Bumetanide is combined with Zoledronic acid.,increase,risk
Mechlorethamine,Butobarbital,The therapeutic efficacy of Butobarbital can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Butylscopolamine,The therapeutic efficacy of Butylscopolamine can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Gallamine triethiodide,The risk or severity of bleeding can be increased when Fondaparinux is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Gemcitabine,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Glatiramer,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Glycopyrronium,The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Glatiramer.,increase,risk
Mechlorethamine,Golimumab,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Guselkumab,The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Golimumab.,increase,risk
Mechlorethamine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Guselkumab.,increase,risk
Mechlorethamine,Heparin,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Hepatitis A Vaccine,The risk or severity of bleeding can be increased when Heparin is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Hexafluronium,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Hexocyclium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Homatropine methylbromide,The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Hydrochlorothiazide,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Hydrocortisone,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Hydrocortisone acetate,The therapeutic efficacy of Mechlorethamine can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Mechlorethamine,Hydrocortisone butyrate,The therapeutic efficacy of Mechlorethamine can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Mechlorethamine,Hydrocortisone cypionate,The therapeutic efficacy of Mechlorethamine can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Mechlorethamine,Hydrocortisone succinate,The therapeutic efficacy of Mechlorethamine can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Mechlorethamine,Hydroflumethiazide,The therapeutic efficacy of Mechlorethamine can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Mechlorethamine,Hydroxychloroquine,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Hydroxyurea,The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Hydroxychloroquine.,increase,risk
Mechlorethamine,Hyoscyamine,The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Hydroxyurea.,increase,risk
Mechlorethamine,Janssen COVID-19 Vaccine,The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Ixekizumab.,increase,risk
Mechlorethamine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Nadolol,The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Mycophenolic acid.,increase,risk
Mechlorethamine,Nadroparin,Mechlorethamine may increase the bradycardic activities of Nadolol.,increase,no risk
Mechlorethamine,Natalizumab,The risk or severity of bleeding can be increased when Nadroparin is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Nebivolol,The risk or severity of immunosuppression can be increased when Mechlorethamine is combined with Natalizumab.,increase,risk
Mechlorethamine,Nelarabine,Mechlorethamine may increase the bradycardic activities of Nebivolol.,increase,no risk
Mechlorethamine,Nicardipine,The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Nelarabine.,increase,risk
Mechlorethamine,Nicotine,The therapeutic efficacy of Nicardipine can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Nilotinib,The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Nicotine.,increase,risk
Mechlorethamine,Nimesulide,The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Nilotinib.,increase,risk
Mechlorethamine,Nortriptyline,The risk or severity of bleeding can be increased when Nimesulide is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Nuvaxovid,The therapeutic efficacy of Nortriptyline can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Obinutuzumab,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Ocrelizumab,The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Obinutuzumab.,increase,risk
Mechlorethamine,Ofatumumab,Ocrelizumab may increase the immunosuppressive activities of Mechlorethamine.,increase,no risk
Mechlorethamine,Olanzapine,The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Ofatumumab.,increase,risk
Mechlorethamine,Olaparib,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Orphenadrine,The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Olaparib.,increase,risk
Mechlorethamine,Ouabain,The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Oxaliplatin,Ouabain may decrease the cardiotoxic activities of Mechlorethamine.,decrease,no risk
Mechlorethamine,Oxetacaine,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Oxprenolol,The risk or severity of methemoglobinemia can be increased when Mechlorethamine is combined with Oxetacaine.,increase,risk
Mechlorethamine,Oxybuprocaine,Mechlorethamine may increase the bradycardic activities of Oxprenolol.,increase,no risk
Mechlorethamine,Oxybutynin,The risk or severity of methemoglobinemia can be increased when Mechlorethamine is combined with Oxybuprocaine.,increase,risk
Mechlorethamine,Oxyphencyclimine,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Oxyphenonium,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Ozanimod,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Quetiapine,The risk or severity of bleeding can be increased when Protein S human is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Quinidine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Ublituximab,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Umeclidinium,The risk or severity of infection can be increased when Ublituximab is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Upadacitinib,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Urokinase,The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Upadacitinib.,increase,risk
Mechlorethamine,Vamorolone,The risk or severity of bleeding can be increased when Urokinase is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Varenicline,The therapeutic efficacy of Mechlorethamine can be decreased when used in combination with Vamorolone.,decrease,no risk
Mechlorethamine,Varicella zoster vaccine (live/attenuated),The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Varenicline.,increase,risk
Mechlorethamine,Varicella zoster vaccine (recombinant),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Vecuronium,The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Vedolizumab,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Vibrio cholerae CVD 103-HgR strain live antigen,The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Vedolizumab.,increase,risk
Mechlorethamine,Vilanterol,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Mechlorethamine.,decrease,no risk
Mechlorethamine,Vinblastine,The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Vilanterol.,increase,risk
Mechlorethamine,Vincristine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Vindesine,The risk or severity of adverse effects can be increased when Vincristine is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Vinorelbine,The risk or severity of adverse effects can be increased when Vindesine is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Voclosporin,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Vorapaxar,The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Voclosporin.,increase,risk
Mechlorethamine,Vorinostat,The risk or severity of bleeding can be increased when Vorapaxar is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Warfarin,The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Vorinostat.,increase,risk
Mechlorethamine,Ximelagatran,The risk or severity of bleeding can be increased when Warfarin is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Yellow fever vaccine,The risk or severity of bleeding can be increased when Ximelagatran is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Zidovudine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Mechlorethamine.,increase,risk
Mechlorethamine,Ziprasidone,The risk or severity of adverse effects can be increased when Zidovudine is combined with Mechlorethamine.,increase,risk
Granisetron,Gabapentin,The risk or severity of CNS depression can be increased when Granisetron is combined with Gabapentin.,increase,risk
Granisetron,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Granisetron is combined with Gabapentin enacarbil.,increase,risk
Granisetron,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Granisetron.,increase,risk
Granisetron,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Granisetron.,increase,risk
Granisetron,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Granisetron.,increase,risk
Granisetron,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Granisetron is combined with Ganaxolone.",increase,risk
Granisetron,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Granisetron.,increase,risk
Granisetron,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Gemifloxacin.,increase,risk
Granisetron,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Granisetron.,increase,risk
Granisetron,Gilteritinib,The therapeutic efficacy of Granisetron can be decreased when used in combination with Gilteritinib.,decrease,no risk
Granisetron,Glasdegib,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Glasdegib.,increase,risk
Granisetron,Glofitamab,The serum concentration of Granisetron can be increased when it is combined with Glofitamab.,increase,no risk
Granisetron,Glutethimide,The risk or severity of CNS depression can be increased when Granisetron is combined with Glutethimide.,increase,risk
Granisetron,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Granisetron.,increase,risk
Granisetron,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Grepafloxacin.,increase,risk
Granisetron,Guanfacine,The risk or severity of CNS depression can be increased when Granisetron is combined with Guanfacine.,increase,risk
Granisetron,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Granisetron.,increase,risk
Granisetron,Halofantrine,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Halofantrine.,increase,risk
Granisetron,Haloperidol,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Haloperidol.,increase,risk
Granisetron,Halothane,The risk or severity of CNS depression can be increased when Granisetron is combined with Halothane.,increase,risk
Granisetron,Hexafluronium,The risk or severity of CNS depression can be increased when Granisetron is combined with Hexafluronium.,increase,risk
Granisetron,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Granisetron.,increase,risk
Granisetron,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Granisetron.,increase,risk
Granisetron,Hydrocodone,Granisetron may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Granisetron,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Granisetron.,increase,risk
Granisetron,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Granisetron.,increase,risk
Granisetron,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Hydroxyzine.,increase,risk
Granisetron,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Granisetron.,increase,risk
Granisetron,Ketamine,The risk or severity of CNS depression can be increased when Granisetron is combined with Ketamine.,increase,risk
Granisetron,Ketazolam,The risk or severity of CNS depression can be increased when Granisetron is combined with Ketazolam.,increase,risk
Granisetron,Ketoconazole,The metabolism of Granisetron can be decreased when combined with Ketoconazole.,decrease,no risk
Granisetron,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Granisetron.,increase,no risk
Granisetron,Nalbuphine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Granisetron.,increase,risk
Granisetron,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Granisetron.,increase,risk
Granisetron,Naltrexone,The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Granisetron.,increase,risk
Granisetron,Naratriptan,The risk or severity of CNS depression can be increased when Granisetron is combined with Naratriptan.,increase,risk
Granisetron,Nefazodone,The metabolism of Granisetron can be decreased when combined with Nefazodone.,decrease,no risk
Granisetron,Nelfinavir,The metabolism of Granisetron can be decreased when combined with Nelfinavir.,decrease,no risk
Granisetron,Netupitant,The metabolism of Granisetron can be decreased when combined with Netupitant.,decrease,no risk
Granisetron,Nialamide,The risk or severity of CNS depression can be increased when Granisetron is combined with Nialamide.,increase,risk
Granisetron,Nicardipine,The metabolism of Granisetron can be decreased when combined with Nicardipine.,decrease,no risk
Granisetron,Nifedipine,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Nifedipine.,increase,risk
Granisetron,Nilotinib,The metabolism of Granisetron can be decreased when combined with Nilotinib.,decrease,no risk
Granisetron,Nilvadipine,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Nilvadipine.,increase,risk
Granisetron,Nimodipine,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Granisetron.,increase,risk
Granisetron,Nitrazepam,The risk or severity of CNS depression can be increased when Granisetron is combined with Nitrazepam.,increase,risk
Granisetron,Nitrendipine,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Granisetron.,increase,risk
Granisetron,Nitrous oxide,The risk or severity of CNS depression can be increased when Granisetron is combined with Nitrous oxide.,increase,risk
Granisetron,Nomifensine,The risk or severity of CNS depression can be increased when Granisetron is combined with Nomifensine.,increase,risk
Granisetron,Norfloxacin,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Granisetron.,increase,risk
Granisetron,Normethadone,The risk or severity of CNS depression can be increased when Granisetron is combined with Normethadone.,increase,risk
Granisetron,Nortriptyline,The risk or severity of CNS depression can be increased when Nortriptyline is combined with Granisetron.,increase,risk
Granisetron,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Granisetron.,increase,risk
Granisetron,Ofloxacin,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Ofloxacin.,increase,risk
Granisetron,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Granisetron.,increase,risk
Granisetron,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Granisetron is combined with Oliceridine.",increase,risk
Granisetron,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Granisetron.,increase,risk
Granisetron,Omaveloxolone,The serum concentration of Granisetron can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Granisetron,Ondansetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Ondansetron.,increase,risk
Granisetron,Opium,The risk or severity of CNS depression can be increased when Granisetron is combined with Opium.,increase,risk
Granisetron,Orphenadrine,Granisetron may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Granisetron,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Granisetron.,increase,risk
Granisetron,Oxatomide,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Oxatomide.,increase,risk
Granisetron,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Granisetron.,increase,risk
Granisetron,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Granisetron.,increase,risk
Granisetron,Oxitriptan,The risk or severity of CNS depression can be increased when Granisetron is combined with Oxitriptan.,increase,risk
Granisetron,Oxprenolol,The risk or severity of CNS depression can be increased when Granisetron is combined with Oxprenolol.,increase,risk
Granisetron,Oxybuprocaine,The risk or severity of CNS depression can be increased when Granisetron is combined with Oxybuprocaine.,increase,risk
Granisetron,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Granisetron.,increase,risk
Granisetron,Oxymorphone,The risk or severity of CNS depression can be increased when Granisetron is combined with Oxymorphone.,increase,risk
Granisetron,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Granisetron.,increase,risk
Granisetron,Quazepam,The risk or severity of CNS depression can be increased when Granisetron is combined with Quazepam.,increase,risk
Granisetron,Quetiapine,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Quetiapine.,increase,risk
Granisetron,Quinidine,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Quinidine.,increase,risk
Granisetron,Quinine,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Quinine.,increase,risk
Granisetron,Quinupramine,The risk or severity of CNS depression can be increased when Granisetron is combined with Quinupramine.,increase,risk
Granisetron,Quizartinib,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Quizartinib.,increase,risk
Granisetron,Urethane,The risk or severity of CNS depression can be increased when Granisetron is combined with Urethane.,increase,risk
Granisetron,Vadadustat,The serum concentration of Granisetron can be increased when it is combined with Vadadustat.,increase,no risk
Granisetron,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Granisetron is combined with Valproate bismuth.,increase,risk
Granisetron,Valproic acid,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Valproic acid.,increase,risk
Granisetron,Vandetanib,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Vandetanib.,increase,risk
Granisetron,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Granisetron.,increase,risk
Granisetron,Vecuronium,The risk or severity of CNS depression can be increased when Granisetron is combined with Vecuronium.,increase,risk
Granisetron,Vemurafenib,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Vemurafenib.,increase,risk
Granisetron,Venetoclax,The metabolism of Granisetron can be decreased when combined with Venetoclax.,decrease,no risk
Granisetron,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Granisetron is combined with Venlafaxine.,increase,risk
Granisetron,Verapamil,The metabolism of Granisetron can be decreased when combined with Verapamil.,decrease,no risk
Granisetron,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Granisetron.,increase,risk
Granisetron,Vigabatrin,The risk or severity of CNS depression can be increased when Granisetron is combined with Vigabatrin.,increase,risk
Granisetron,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Granisetron.,increase,risk
Granisetron,Vilazodone,The risk or severity of CNS depression can be increased when Granisetron is combined with Vilazodone.,increase,risk
Granisetron,Viloxazine,The metabolism of Granisetron can be decreased when combined with Viloxazine.,decrease,no risk
Granisetron,Voriconazole,The metabolism of Granisetron can be decreased when combined with Voriconazole.,decrease,no risk
Granisetron,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Granisetron.,increase,risk
Granisetron,Vortioxetine,The risk or severity of CNS depression can be increased when Granisetron is combined with Vortioxetine.,increase,risk
Granisetron,Warfarin,The risk or severity of adverse effects can be increased when Granisetron is combined with Warfarin.,increase,risk
Granisetron,Yohimbine,The risk or severity of CNS depression can be increased when Granisetron is combined with Yohimbine.,increase,risk
Granisetron,Zaleplon,The risk or severity of CNS depression can be increased when Granisetron is combined with Zaleplon.,increase,risk
Granisetron,Ziconotide,The risk or severity of CNS depression can be increased when Granisetron is combined with Ziconotide.,increase,risk
Granisetron,Zimelidine,The risk or severity of adverse effects can be increased when Granisetron is combined with Zimelidine.,increase,risk
Granisetron,Ziprasidone,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Ziprasidone.,increase,risk
Granisetron,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Granisetron.,increase,risk
Granisetron,Zolpidem,Granisetron may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Granisetron,Zonisamide,The risk or severity of CNS depression can be increased when Granisetron is combined with Zonisamide.,increase,risk
Granisetron,Zopiclone,The risk or severity of adverse effects can be increased when Granisetron is combined with Zopiclone.,increase,risk
Granisetron,Zotepine,The risk or severity of CNS depression can be increased when Granisetron is combined with Zotepine.,increase,risk
Granisetron,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Zuclopenthixol.,increase,risk
Granisetron,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Granisetron.,increase,risk
Dienestrol,Natalizumab,Dienestrol may increase the thrombogenic activities of Natalizumab.,increase,no risk
Dienestrol,Necitumumab,Dienestrol may increase the thrombogenic activities of Necitumumab.,increase,no risk
Dienestrol,Niacinamide ascorbate,The serum concentration of Niacinamide ascorbate can be decreased when it is combined with Dienestrol.,decrease,no risk
Dienestrol,Nivolumab,Dienestrol may increase the thrombogenic activities of Nivolumab.,increase,no risk
Dienestrol,Obiltoxaximab,Dienestrol may increase the thrombogenic activities of Obiltoxaximab.,increase,no risk
Dienestrol,Obinutuzumab,Dienestrol may increase the thrombogenic activities of Obinutuzumab.,increase,no risk
Dienestrol,Ocrelizumab,Dienestrol may increase the thrombogenic activities of Ocrelizumab.,increase,no risk
Dienestrol,Odesivimab,Dienestrol may increase the thrombogenic activities of Odesivimab.,increase,no risk
Dienestrol,Ofatumumab,Dienestrol may increase the thrombogenic activities of Ofatumumab.,increase,no risk
Dienestrol,Olaratumab,Dienestrol may increase the thrombogenic activities of Olaratumab.,increase,no risk
Dienestrol,Omalizumab,Dienestrol may increase the thrombogenic activities of Omalizumab.,increase,no risk
Dienestrol,Ombitasvir,The risk or severity of liver enzyme elevations can be increased when Dienestrol is combined with Ombitasvir.,increase,risk
Dienestrol,Ospemifene,The risk or severity of adverse effects can be increased when Dienestrol is combined with Ospemifene.,increase,risk
Dienestrol,Ublituximab,Dienestrol may increase the thrombogenic activities of Ublituximab.,increase,no risk
Dienestrol,Ustekinumab,Dienestrol may increase the thrombogenic activities of Ustekinumab.,increase,no risk
Dienestrol,Vedolizumab,Dienestrol may increase the thrombogenic activities of Vedolizumab.,increase,no risk
Dienestrol,Zinc ascorbate,The serum concentration of Zinc ascorbate can be decreased when it is combined with Dienestrol.,decrease,no risk
Sulfapyridine,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Sulfapyridine.,increase,no risk
Sulfapyridine,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Sulfapyridine.,increase,no risk
Sulfapyridine,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Sulfapyridine.,increase,no risk
Sulfapyridine,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Sulfapyridine.,increase,no risk
Sulfapyridine,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Sulfapyridine.,increase,no risk
Sulfapyridine,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Sulfapyridine.,increase,no risk
Sulfapyridine,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Halothane,The metabolism of Halothane can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Sulfapyridine is combined with Hydroxyurea.,increase,risk
Sulfapyridine,Ketamine,The metabolism of Ketamine can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sulfapyridine.,increase,risk
Sulfapyridine,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Nabilone,The metabolism of Nabilone can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Nabumetone,The metabolism of Nabumetone can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Naproxen,The metabolism of Naproxen can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Nateglinide,The therapeutic efficacy of Nateglinide can be increased when used in combination with Sulfapyridine.,increase,no risk
Sulfapyridine,Netupitant,The metabolism of Netupitant can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Niclosamide,The metabolism of Niclosamide can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Nicotine,The risk or severity of adverse effects can be increased when Sulfapyridine is combined with Nicotine.,increase,risk
Sulfapyridine,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Nitric Oxide,The risk or severity of methemoglobinemia can be increased when Nitric Oxide is combined with Sulfapyridine.,increase,risk
Sulfapyridine,Nitrofurantoin,The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Sulfapyridine.,increase,risk
Sulfapyridine,Nitroglycerin,The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Sulfapyridine.,increase,risk
Sulfapyridine,Nitroprusside,The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Sulfapyridine.,increase,risk
Sulfapyridine,Nitrous oxide,The risk or severity of methemoglobinemia can be increased when Sulfapyridine is combined with Nitrous oxide.,increase,risk
Sulfapyridine,Norgestimate,The metabolism of Norgestimate can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Quinine,The therapeutic efficacy of Quinine can be increased when used in combination with Sulfapyridine.,increase,no risk
Sulfapyridine,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Sulfapyridine.,increase,risk
Sulfapyridine,Valsartan,The metabolism of Valsartan can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Sulfapyridine.,increase,no risk
Sulfapyridine,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Warfarin,The metabolism of Warfarin can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Zileuton,The metabolism of Zileuton can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Sulfapyridine.,decrease,no risk
Sulfapyridine,Zopiclone,The risk or severity of methemoglobinemia can be increased when Sulfapyridine is combined with Zopiclone.,increase,risk
Oxybuprocaine,Brexucabtagene autoleucel,The risk or severity of methemoglobinemia can be increased when Brexucabtagene autoleucel is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Brigatinib,The risk or severity of methemoglobinemia can be increased when Brigatinib is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.,increase,no risk
Oxybuprocaine,Brivaracetam,The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Bromazepam,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Bromazepam.,increase,risk
Oxybuprocaine,Bromocriptine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Bromocriptine.,increase,risk
Oxybuprocaine,Bromperidol,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Bromperidol.,increase,risk
Oxybuprocaine,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Buprenorphine,Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Oxybuprocaine,Bupropion,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Bupropion.,increase,risk
Oxybuprocaine,Buserelin,The risk or severity of methemoglobinemia can be increased when Buserelin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Busulfan,The risk or severity of methemoglobinemia can be increased when Busulfan is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Butacaine,The risk or severity of methemoglobinemia can be increased when Oxybuprocaine is combined with Butacaine.,increase,risk
Oxybuprocaine,Butalbital,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Butamben,The risk or severity of methemoglobinemia can be increased when Oxybuprocaine is combined with Butamben.,increase,risk
Oxybuprocaine,Butaperazine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Butaperazine.,increase,risk
Oxybuprocaine,Butobarbital,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Butobarbital.,increase,risk
Oxybuprocaine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Butriptyline,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Butriptyline.,increase,risk
Oxybuprocaine,Gabapentin,The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Gabapentin enacarbil.,increase,risk
Oxybuprocaine,Galantamine,Galantamine may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Oxybuprocaine,Gallamine triethiodide,Gallamine triethiodide may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Oxybuprocaine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Oxybuprocaine is combined with Ganaxolone.",increase,risk
Oxybuprocaine,Gatifloxacin,The risk or severity of methemoglobinemia can be increased when Gatifloxacin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Gefitinib,The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Gemcitabine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Gemifloxacin,The risk or severity of methemoglobinemia can be increased when Gemifloxacin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Gemtuzumab ozogamicin,The risk or severity of methemoglobinemia can be increased when Gemtuzumab ozogamicin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Gentamicin,The risk or severity of methemoglobinemia can be increased when Gentamicin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Gepirone,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Gepirone.,increase,risk
Oxybuprocaine,Gilteritinib,The risk or severity of methemoglobinemia can be increased when Gilteritinib is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Ginkgo biloba,Ginkgo biloba may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Oxybuprocaine,Glasdegib,The risk or severity of methemoglobinemia can be increased when Glasdegib is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Glutethimide,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Glutethimide.,increase,risk
Oxybuprocaine,Goserelin,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Gramicidin D,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Grepafloxacin,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Guanfacine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Guanfacine.,increase,risk
Oxybuprocaine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Halofantrine,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Halothane,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Halothane.,increase,risk
Oxybuprocaine,Hetacillin,The risk or severity of methemoglobinemia can be increased when Hetacillin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Hexafluronium,Hexafluronium may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Oxybuprocaine,Huperzine A,Huperzine A may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Oxybuprocaine,Hyaluronidase,Hyaluronidase can cause an increase in the absorption of Oxybuprocaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Oxybuprocaine,Hyaluronidase (human recombinant),Hyaluronidase (human recombinant) can cause an increase in the absorption of Oxybuprocaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Oxybuprocaine,Hyaluronidase (ovine),Hyaluronidase (ovine) can cause an increase in the absorption of Oxybuprocaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Oxybuprocaine,Hydrocodone,Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Oxybuprocaine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Hydroxychloroquine,The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Hydroxyprogesterone caproate,The risk or severity of methemoglobinemia can be increased when Hydroxyprogesterone caproate is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.,increase,no risk
Oxybuprocaine,Kanamycin,The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Ketamine,Ketamine may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Oxybuprocaine,Ketazolam,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Ketazolam.,increase,risk
Oxybuprocaine,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.,increase,no risk
Oxybuprocaine,Nafcillin,The risk or severity of methemoglobinemia can be increased when Nafcillin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Nalbuphine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Nalidixic acid,The risk or severity of methemoglobinemia can be increased when Nalidixic acid is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Naratriptan,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Naratriptan.,increase,risk
Oxybuprocaine,Natamycin,The risk or severity of methemoglobinemia can be increased when Natamycin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Naxitamab,The risk or severity of methemoglobinemia can be increased when Naxitamab is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Necitumumab,The risk or severity of methemoglobinemia can be increased when Necitumumab is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Nedaplatin,The risk or severity of methemoglobinemia can be increased when Nedaplatin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Nefazodone,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Nefazodone.,increase,risk
Oxybuprocaine,Nelarabine,The risk or severity of methemoglobinemia can be increased when Nelarabine is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Neomycin,The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Neostigmine,Neostigmine may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Oxybuprocaine,Neratinib,The risk or severity of methemoglobinemia can be increased when Neratinib is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Netilmicin,The risk or severity of methemoglobinemia can be increased when Netilmicin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Nialamide,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Nialamide.,increase,risk
Oxybuprocaine,Nilotinib,The risk or severity of methemoglobinemia can be increased when Nilotinib is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Nilutamide,The risk or severity of methemoglobinemia can be increased when Nilutamide is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Nintedanib,The risk or severity of methemoglobinemia can be increased when Nintedanib is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Niraparib,The risk or severity of methemoglobinemia can be increased when Niraparib is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Nitrazepam,The risk or severity of methemoglobinemia can be increased when Nitrazepam is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Nitrofurantoin,The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Nitrous oxide,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Nitrous oxide.,increase,risk
Oxybuprocaine,Nivolumab,The risk or severity of methemoglobinemia can be increased when Nivolumab is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Nizatidine,Nizatidine may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Oxybuprocaine,Nomifensine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Nomifensine.,increase,risk
Oxybuprocaine,Norfloxacin,The risk or severity of methemoglobinemia can be increased when Norfloxacin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Normethadone,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Normethadone.,increase,risk
Oxybuprocaine,Nortriptyline,The risk or severity of CNS depression can be increased when Nortriptyline is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Novobiocin,The risk or severity of methemoglobinemia can be increased when Novobiocin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Obinutuzumab,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Octreotide,The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Ofatumumab,The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Ofloxacin,The risk or severity of methemoglobinemia can be increased when Ofloxacin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Olaparib,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Olaratumab,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Oxybuprocaine is combined with Oliceridine.",increase,risk
Oxybuprocaine,Olutasidenib,The risk or severity of methemoglobinemia can be increased when Olutasidenib is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Omacetaxine mepesuccinate,The risk or severity of methemoglobinemia can be increased when Omacetaxine mepesuccinate is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Omadacycline,The risk or severity of methemoglobinemia can be increased when Omadacycline is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Ondansetron,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Ondansetron.,increase,risk
Oxybuprocaine,Opium,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Opium.,increase,risk
Oxybuprocaine,Oritavancin,The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Orphenadrine,Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Oxybuprocaine,Osimertinib,The risk or severity of methemoglobinemia can be increased when Osimertinib is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Oxacillin,The risk or severity of methemoglobinemia can be increased when Oxacillin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Oxaliplatin,The risk or severity of methemoglobinemia can be increased when Oxaliplatin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Oxcarbazepine,The risk or severity of methemoglobinemia can be increased when Oxcarbazepine is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Oxybuprocaine is combined with Oxetacaine.,increase,risk
Oxybuprocaine,Oxitriptan,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Oxitriptan.,increase,risk
Oxybuprocaine,Oxprenolol,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Oxprenolol.,increase,risk
Oxybuprocaine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Oxymorphone.,increase,risk
Oxybuprocaine,Oxytetracycline,The risk or severity of methemoglobinemia can be increased when Oxytetracycline is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Quazepam,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Quazepam.,increase,risk
Oxybuprocaine,Quetiapine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Quetiapine.,increase,risk
Oxybuprocaine,Quinidine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Quinine,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Quinupramine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Quinupramine.,increase,risk
Oxybuprocaine,Quinupristin,The risk or severity of methemoglobinemia can be increased when Quinupristin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Quizartinib,The risk or severity of methemoglobinemia can be increased when Quizartinib is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Umbralisib,The risk or severity of methemoglobinemia can be increased when Umbralisib is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Uracil mustard,The risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Urethane,The risk or severity of methemoglobinemia can be increased when Urethane is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Valrubicin,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Vancomycin,The risk or severity of methemoglobinemia can be increased when Vancomycin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Vandetanib,The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Vecuronium,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Vecuronium.,increase,risk
Oxybuprocaine,Vemurafenib,The risk or severity of methemoglobinemia can be increased when Vemurafenib is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Venetoclax,The risk or severity of methemoglobinemia can be increased when Venetoclax is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Vigabatrin,The risk or severity of methemoglobinemia can be increased when Vigabatrin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Vilazodone,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Vilazodone.,increase,risk
Oxybuprocaine,Viloxazine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Viloxazine.,increase,risk
Oxybuprocaine,Vinblastine,The risk or severity of methemoglobinemia can be increased when Vinblastine is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Vincristine,The risk or severity of methemoglobinemia can be increased when Vincristine is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Vindesine,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Vinflunine,The risk or severity of methemoglobinemia can be increased when Vinflunine is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Vinorelbine,The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Viomycin,The risk or severity of methemoglobinemia can be increased when Viomycin is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Vismodegib,The risk or severity of methemoglobinemia can be increased when Vismodegib is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Vorinostat,The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Vortioxetine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Vortioxetine.,increase,risk
Oxybuprocaine,Yohimbine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Yohimbine.,increase,risk
Oxybuprocaine,Zaleplon,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Zanubrutinib,The risk or severity of methemoglobinemia can be increased when Zanubrutinib is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Ziconotide,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Ziconotide.,increase,risk
Oxybuprocaine,Zimelidine,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Zimelidine.,increase,risk
Oxybuprocaine,Ziprasidone,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Ziprasidone.,increase,risk
Oxybuprocaine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Zolpidem,Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Oxybuprocaine,Zonisamide,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Oxybuprocaine.,increase,risk
Oxybuprocaine,Zopiclone,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Zopiclone.,increase,risk
Oxybuprocaine,Zotepine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Zotepine.,increase,risk
Oxybuprocaine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Zuclopenthixol.,increase,risk
Oxybuprocaine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Oxybuprocaine.,increase,risk
Iron Dextran,Benazepril,The risk or severity of adverse effects can be increased when Benazepril is combined with Iron Dextran.,increase,risk
Iron Dextran,Gatifloxacin,Iron Dextran can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iron Dextran,Gemifloxacin,Iron Dextran can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iron Dextran,Grepafloxacin,Iron Dextran can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iron Dextran,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iron Dextran,Nalidixic acid,Iron Dextran can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iron Dextran,Nizatidine,Nizatidine can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iron Dextran,Norfloxacin,Iron Dextran can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iron Dextran,Ofloxacin,Iron Dextran can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iron Dextran,Omadacycline,Omadacycline can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iron Dextran,Omeprazole,The absorption of Iron Dextran can be decreased when combined with Omeprazole.,decrease,no risk
Iron Dextran,Oxytetracycline,Oxytetracycline can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iron Dextran,Quinapril,The risk or severity of adverse effects can be increased when Quinapril is combined with Iron Dextran.,increase,risk
Iron Dextran,Vadadustat,The serum concentration of Vadadustat can be decreased when it is combined with Iron Dextran.,decrease,no risk
Iron Dextran,Vonoprazan,Vonoprazan can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iron Dextran,Zofenopril,The risk or severity of adverse effects can be increased when Zofenopril is combined with Iron Dextran.,increase,risk
Testolactone,Gabapentin enacarbil,Testolactone may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Testolactone,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Gadodiamide,Gadodiamide may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Gadofosveset trisodium,Testolactone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Testolactone,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Gadoteric acid,Testolactone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Testolactone,Gadoteridol,Gadoteridol may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Ganciclovir,Testolactone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Testolactone,Gemcitabine,Gemcitabine may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Gemfibrozil,Testolactone may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Testolactone,Gentamicin,Testolactone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Testolactone,Gimeracil,Testolactone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Testolactone,Givosiran,Givosiran may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Glipizide,Testolactone may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Testolactone,Glycerol phenylbutyrate,Testolactone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Testolactone,Golodirsen,Testolactone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Testolactone,Goserelin,Goserelin may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Guanethidine,Testolactone may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Testolactone,Guanfacine,Testolactone may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Testolactone,Haloperidol,Haloperidol may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Hydralazine,Testolactone may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Testolactone,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Testolactone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Testolactone,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Testolactone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Testolactone,Hydromorphone,Hydromorphone may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Hydroxyethyl Starch,Testolactone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Testolactone,Kanamycin,Testolactone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Testolactone,Ketamine,Testolactone may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Testolactone,Ketazolam,Testolactone may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Testolactone,Ketoprofen,Ketoprofen may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Ketorolac,Ketorolac may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,N-acetyltyrosine,Testolactone may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Testolactone,Nabumetone,Nabumetone may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Nadolol,Testolactone may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Testolactone,Naldemedine,Testolactone may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Testolactone,Nalmefene,Testolactone may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Testolactone,Naloxone,Testolactone may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Testolactone,Naproxen,Naproxen may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Nateglinide,Nateglinide may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Nedaplatin,Testolactone may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Testolactone,Nedocromil,Nedocromil may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Nefazodone,Testolactone may decrease the excretion rate of Nefazodone which could result in a higher serum level.,decrease,no risk
Testolactone,Neomycin,Testolactone may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Testolactone,Netilmicin,Testolactone may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Testolactone,Nicorandil,Testolactone may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Testolactone,Nifedipine,Testolactone may decrease the excretion rate of Nifedipine which could result in a higher serum level.,decrease,no risk
Testolactone,Nilutamide,Nilutamide may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Nimesulide,Nimesulide may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Nisoldipine,Nisoldipine may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Nitroprusside,Nitroprusside may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Octinoxate,Testolactone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Testolactone,Olsalazine,Olsalazine may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Opium,Testolactone may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Testolactone,Oseltamivir,Oseltamivir may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Oxacillin,Oxacillin may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Oxaprozin,Oxaprozin may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Oxazepam,Oxazepam may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Testolactone is combined with Oxetacaine.,increase,risk
Testolactone,Oxybenzone,Testolactone may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Testolactone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Testolactone is combined with Oxybuprocaine.,increase,risk
Testolactone,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Oxyquinoline,Testolactone may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Testolactone,Quetiapine,Testolactone may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Testolactone,Quinethazone,Quinethazone may increase the excretion rate of Testolactone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Testolactone,Quinidine,Testolactone may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Testolactone,Vaborbactam,Testolactone may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Testolactone,Valaciclovir,Valaciclovir may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Valbenazine,Testolactone may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Testolactone,Valdecoxib,Valdecoxib may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Valganciclovir,Testolactone may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Testolactone,Vancomycin,Testolactone may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Testolactone,Varenicline,Testolactone may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Testolactone,Venlafaxine,Venlafaxine may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Verapamil,Verapamil may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Vilanterol,Testolactone may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Testolactone,Viloxazine,Testolactone may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Testolactone,Vortioxetine,Testolactone may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Testolactone,Warfarin,Testolactone may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Testolactone,Zaleplon,Testolactone may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Testolactone,Zanamivir,Zanamivir may decrease the excretion rate of Testolactone which could result in a higher serum level.,decrease,no risk
Testolactone,Zonisamide,Zonisamide may increase the excretion rate of Testolactone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Benzylpenicilloyl polylysine,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Benzylpenicilloyl polylysine.,increase,no risk
Benzylpenicilloyl polylysine,Gatifloxacin,The serum concentration of Gatifloxacin can be increased when it is combined with Benzylpenicilloyl polylysine.,increase,no risk
Benzylpenicilloyl polylysine,Gemifloxacin,The serum concentration of Gemifloxacin can be increased when it is combined with Benzylpenicilloyl polylysine.,increase,no risk
Benzylpenicilloyl polylysine,Gentamicin,The serum concentration of Gentamicin can be decreased when it is combined with Benzylpenicilloyl polylysine.,decrease,no risk
Benzylpenicilloyl polylysine,Gestrinone,The therapeutic efficacy of Gestrinone can be decreased when used in combination with Benzylpenicilloyl polylysine.,decrease,no risk
Benzylpenicilloyl polylysine,Grepafloxacin,The serum concentration of Grepafloxacin can be increased when it is combined with Benzylpenicilloyl polylysine.,increase,no risk
Benzylpenicilloyl polylysine,Guanabenz,Guanabenz may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Guanfacine,Guanfacine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Hydroxyprogesterone caproate,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Benzylpenicilloyl polylysine.,decrease,no risk
Benzylpenicilloyl polylysine,Hydroxyzine,Hydroxyzine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Kanamycin,The serum concentration of Kanamycin can be decreased when it is combined with Benzylpenicilloyl polylysine.,decrease,no risk
Benzylpenicilloyl polylysine,Ketotifen,Ketotifen may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Nalidixic acid,The serum concentration of Nalidixic acid can be increased when it is combined with Benzylpenicilloyl polylysine.,increase,no risk
Benzylpenicilloyl polylysine,Naphazoline,Naphazoline may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Nebivolol,Nebivolol may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Neomycin,The serum concentration of Neomycin can be decreased when it is combined with Benzylpenicilloyl polylysine.,decrease,no risk
Benzylpenicilloyl polylysine,Netilmicin,The serum concentration of Netilmicin can be decreased when it is combined with Benzylpenicilloyl polylysine.,decrease,no risk
Benzylpenicilloyl polylysine,Nizatidine,Nizatidine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Nomegestrol,The therapeutic efficacy of Nomegestrol can be decreased when used in combination with Benzylpenicilloyl polylysine.,decrease,no risk
Benzylpenicilloyl polylysine,Nomegestrol acetate,The therapeutic efficacy of Nomegestrol acetate can be decreased when used in combination with Benzylpenicilloyl polylysine.,decrease,no risk
Benzylpenicilloyl polylysine,Norelgestromin,The therapeutic efficacy of Norelgestromin can be decreased when used in combination with Benzylpenicilloyl polylysine.,decrease,no risk
Benzylpenicilloyl polylysine,Norepinephrine,Norepinephrine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Norethisterone,The therapeutic efficacy of Norethisterone can be decreased when used in combination with Benzylpenicilloyl polylysine.,decrease,no risk
Benzylpenicilloyl polylysine,Norethynodrel,The therapeutic efficacy of Norethynodrel can be decreased when used in combination with Benzylpenicilloyl polylysine.,decrease,no risk
Benzylpenicilloyl polylysine,Norfloxacin,The serum concentration of Norfloxacin can be increased when it is combined with Benzylpenicilloyl polylysine.,increase,no risk
Benzylpenicilloyl polylysine,Norgestimate,The therapeutic efficacy of Norgestimate can be decreased when used in combination with Benzylpenicilloyl polylysine.,decrease,no risk
Benzylpenicilloyl polylysine,Norgestrel,The therapeutic efficacy of Norgestrel can be decreased when used in combination with Benzylpenicilloyl polylysine.,decrease,no risk
Benzylpenicilloyl polylysine,Nortriptyline,Nortriptyline may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Nylidrin,Nylidrin may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Ofloxacin,The serum concentration of Ofloxacin can be increased when it is combined with Benzylpenicilloyl polylysine.,increase,no risk
Benzylpenicilloyl polylysine,Olanzapine,Olanzapine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Olodaterol,Olodaterol may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Omadacycline,The therapeutic efficacy of Benzylpenicilloyl polylysine can be decreased when used in combination with Omadacycline.,decrease,no risk
Benzylpenicilloyl polylysine,Orciprenaline,Orciprenaline may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Orphenadrine,Orphenadrine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Oxatomide,Oxatomide may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Benzylpenicilloyl polylysine is combined with Oxetacaine.,increase,risk
Benzylpenicilloyl polylysine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Benzylpenicilloyl polylysine is combined with Oxybuprocaine.,increase,risk
Benzylpenicilloyl polylysine,Oxymetazoline,Oxymetazoline may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Oxytetracycline,The therapeutic efficacy of Benzylpenicilloyl polylysine can be decreased when used in combination with Oxytetracycline.,decrease,no risk
Benzylpenicilloyl polylysine,Quetiapine,Quetiapine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Ulipristal,The therapeutic efficacy of Ulipristal can be decreased when used in combination with Benzylpenicilloyl polylysine.,decrease,no risk
Benzylpenicilloyl polylysine,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Benzylpenicilloyl polylysine.,increase,no risk
Benzylpenicilloyl polylysine,Vibegron,Vibegron may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Benzylpenicilloyl polylysine.,decrease,no risk
Benzylpenicilloyl polylysine,Vilanterol,Vilanterol may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Warfarin,Benzylpenicilloyl polylysine may increase the anticoagulant activities of Warfarin.,increase,no risk
Benzylpenicilloyl polylysine,Xamoterol,Xamoterol may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Xylometazoline,Xylometazoline may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Ziprasidone,Ziprasidone may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzylpenicilloyl polylysine,Zuclopenthixol,Zuclopenthixol may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Rimexolone,Nateglinide,The risk or severity of hyperglycemia can be increased when Rimexolone is combined with Nateglinide.,increase,risk
Rimexolone,Nirogacestat,The serum concentration of Nirogacestat can be decreased when it is combined with Rimexolone.,decrease,no risk
Rimexolone,Olaparib,The metabolism of Olaparib can be increased when combined with Rimexolone.,increase,no risk
Rimexolone,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Rimexolone.,decrease,no risk
Rimexolone,Olutasidenib,The therapeutic efficacy of Olutasidenib can be decreased when used in combination with Rimexolone.,decrease,no risk
Rimexolone,Omaveloxolone,The therapeutic efficacy of Omaveloxolone can be decreased when used in combination with Rimexolone.,decrease,no risk
Rimexolone,Osilodrostat,The serum concentration of Osilodrostat can be decreased when it is combined with Rimexolone.,decrease,no risk
Rimexolone,Quinine,The risk or severity of hyperglycemia can be increased when Rimexolone is combined with Quinine.,increase,risk
Rimexolone,Quizartinib,The serum concentration of Quizartinib can be decreased when it is combined with Rimexolone.,decrease,no risk
Rimexolone,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Rimexolone.,increase,risk
Rimexolone,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Rimexolone.,decrease,no risk
Rimexolone,Vadadustat,The serum concentration of Rimexolone can be increased when it is combined with Vadadustat.,increase,no risk
Rimexolone,Valbenazine,The serum concentration of Valbenazine can be decreased when it is combined with Rimexolone.,decrease,no risk
Rimexolone,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Rimexolone.,decrease,no risk
Rimexolone,Vildagliptin,The risk or severity of hyperglycemia can be increased when Rimexolone is combined with Vildagliptin.,increase,risk
Rimexolone,Viloxazine,The metabolism of Rimexolone can be decreased when combined with Viloxazine.,decrease,no risk
Rimexolone,Voclosporin,The metabolism of Voclosporin can be increased when combined with Rimexolone.,increase,no risk
Rimexolone,Voriconazole,The serum concentration of Rimexolone can be increased when it is combined with Voriconazole.,increase,no risk
Rimexolone,Voxelotor,The serum concentration of Voxelotor can be decreased when it is combined with Rimexolone.,decrease,no risk
Rimexolone,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Rimexolone.,decrease,no risk
Triazolam,Benzocaine,The risk or severity of CNS depression can be increased when Triazolam is combined with Benzocaine.,increase,risk
Triazolam,Benzphetamine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Triazolam.,increase,risk
Triazolam,Benzthiazide,Benzthiazide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triazolam,Benzydamine,Benzydamine may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Benzyl alcohol,The risk or severity of CNS depression can be increased when Triazolam is combined with Benzyl alcohol.,increase,risk
Triazolam,Bepotastine,Triazolam may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Triazolam,Berotralstat,The metabolism of Triazolam can be decreased when combined with Berotralstat.,decrease,no risk
Triazolam,Betamethasone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Triazolam.",increase,risk
Triazolam,Betamethasone phosphate,The metabolism of Triazolam can be increased when combined with Betamethasone phosphate.,increase,no risk
Triazolam,Bezafibrate,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Bezafibrate.",increase,risk
Triazolam,Bicisate,Triazolam may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Triazolam,Bimekizumab,The metabolism of Triazolam can be increased when combined with Bimekizumab.,increase,no risk
Triazolam,Bismuth subgallate,Triazolam may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Triazolam,Bisoprolol,Bisoprolol may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Bisoxatin,Triazolam may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Triazolam,Bleomycin,Bleomycin may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Boceprevir,The metabolism of Triazolam can be decreased when combined with Boceprevir.,decrease,no risk
Triazolam,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Triazolam.,increase,risk
Triazolam,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Triazolam.,increase,risk
Triazolam,Brexanolone,The risk or severity of CNS depression can be increased when Triazolam is combined with Brexanolone.,increase,risk
Triazolam,Brexpiprazole,The risk or severity of CNS depression can be increased when Triazolam is combined with Brexpiprazole.,increase,risk
Triazolam,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Triazolam.,increase,no risk
Triazolam,Brivaracetam,The risk or severity of CNS depression can be increased when Triazolam is combined with Brivaracetam.,increase,risk
Triazolam,Bromazepam,The risk or severity of CNS depression can be increased when Triazolam is combined with Bromazepam.,increase,risk
Triazolam,Bromocriptine,The risk or severity of CNS depression can be increased when Triazolam is combined with Bromocriptine.,increase,risk
Triazolam,Bromotheophylline,The therapeutic efficacy of Triazolam can be decreased when used in combination with Bromotheophylline.,decrease,no risk
Triazolam,Bromperidol,The risk or severity of CNS depression can be increased when Triazolam is combined with Bromperidol.,increase,risk
Triazolam,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Triazolam.,increase,risk
Triazolam,Budesonide,The metabolism of Triazolam can be increased when combined with Budesonide.,increase,no risk
Triazolam,Bumadizone,Bumadizone may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Bumetanide,Bumetanide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triazolam,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Triazolam.,increase,risk
Triazolam,Buprenorphine,Triazolam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Triazolam,Bupropion,The risk or severity of CNS depression can be increased when Triazolam is combined with Bupropion.,increase,risk
Triazolam,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Triazolam.,increase,risk
Triazolam,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Triazolam.,increase,risk
Triazolam,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Triazolam.,increase,risk
Triazolam,Butaperazine,The risk or severity of CNS depression can be increased when Triazolam is combined with Butaperazine.,increase,risk
Triazolam,Butobarbital,The risk or severity of CNS depression can be increased when Triazolam is combined with Butobarbital.,increase,risk
Triazolam,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Triazolam.,increase,risk
Triazolam,Butriptyline,The risk or severity of CNS depression can be increased when Triazolam is combined with Butriptyline.,increase,risk
Triazolam,Gabapentin,The risk or severity of CNS depression can be increased when Triazolam is combined with Gabapentin.,increase,risk
Triazolam,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Triazolam is combined with Gabapentin enacarbil.,increase,risk
Triazolam,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Gadodiamide,Gadodiamide may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Gadofosveset trisodium,Triazolam may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Triazolam,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Gadoteric acid,Triazolam may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Triazolam,Gadoteridol,Gadoteridol may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Triazolam.,increase,risk
Triazolam,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Triazolam is combined with Ganaxolone.",increase,risk
Triazolam,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Ganciclovir.",increase,risk
Triazolam,Gefitinib,The metabolism of Triazolam can be decreased when combined with Gefitinib.,decrease,no risk
Triazolam,Gemcitabine,Gemcitabine may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Gemfibrozil.",increase,risk
Triazolam,Gentamicin,Triazolam may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Triazolam,Gepirone,The risk or severity of CNS depression can be increased when Triazolam is combined with Gepirone.,increase,risk
Triazolam,Gimeracil,Triazolam may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Triazolam,Givosiran,Givosiran may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Glipizide,Triazolam may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Triazolam,Glofitamab,The serum concentration of Triazolam can be increased when it is combined with Glofitamab.,increase,no risk
Triazolam,Glutethimide,The risk or severity of CNS depression can be increased when Triazolam is combined with Glutethimide.,increase,risk
Triazolam,Glyburide,The metabolism of Glyburide can be decreased when combined with Triazolam.,decrease,no risk
Triazolam,Glycerol phenylbutyrate,Triazolam may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Triazolam,Golimumab,The metabolism of Triazolam can be increased when combined with Golimumab.,increase,no risk
Triazolam,Golodirsen,Triazolam may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Triazolam,Goserelin,Goserelin may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Triazolam.,increase,risk
Triazolam,Guanethidine,Triazolam may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Triazolam,Guanfacine,The risk or severity of CNS depression can be increased when Triazolam is combined with Guanfacine.,increase,risk
Triazolam,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Triazolam.,increase,risk
Triazolam,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Triazolam.,decrease,no risk
Triazolam,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Triazolam.,increase,risk
Triazolam,Halothane,The risk or severity of CNS depression can be increased when Triazolam is combined with Halothane.,increase,risk
Triazolam,Hexafluronium,The risk or severity of CNS depression can be increased when Triazolam is combined with Hexafluronium.,increase,risk
Triazolam,Hydralazine,Triazolam may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Triazolam,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triazolam,Hydrocodone,Triazolam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Triazolam,Hydrocortisone,The metabolism of Triazolam can be decreased when combined with Hydrocortisone.,decrease,no risk
Triazolam,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Triazolam.,decrease,no risk
Triazolam,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Triazolam.,decrease,no risk
Triazolam,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Triazolam.,decrease,no risk
Triazolam,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Triazolam.,decrease,no risk
Triazolam,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triazolam,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Triazolam.,increase,risk
Triazolam,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Hydroxyethyl Starch,Triazolam may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Triazolam,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Triazolam.,decrease,no risk
Triazolam,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Triazolam.,increase,no risk
Triazolam,Kanamycin,Triazolam may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Triazolam,Ketamine,The risk or severity of CNS depression can be increased when Triazolam is combined with Ketamine.,increase,risk
Triazolam,Ketazolam,The risk or severity of CNS depression can be increased when Triazolam is combined with Ketazolam.,increase,risk
Triazolam,Ketoconazole,The metabolism of Triazolam can be decreased when combined with Ketoconazole.,decrease,no risk
Triazolam,Ketoprofen,Ketoprofen may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Ketorolac,Ketorolac may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,N-acetyltyrosine,Triazolam may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Triazolam,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Triazolam.,increase,no risk
Triazolam,Nabumetone,Nabumetone may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Nadolol,Triazolam may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Triazolam,Nafarelin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Triazolam.",increase,risk
Triazolam,Nalbuphine,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Triazolam.,increase,risk
Triazolam,Naldemedine,Triazolam may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Triazolam,Nalmefene,Triazolam may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Triazolam,Naloxegol,The risk or severity of adverse effects can be increased when Naloxegol is combined with Triazolam.,increase,risk
Triazolam,Naloxone,Triazolam may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Triazolam,Naltrexone,The risk or severity of adverse effects can be increased when Naltrexone is combined with Triazolam.,increase,risk
Triazolam,Naphazoline,The risk or severity of CNS depression can be increased when Naphazoline is combined with Triazolam.,increase,risk
Triazolam,Naproxen,Naproxen may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Naratriptan,The risk or severity of CNS depression can be increased when Triazolam is combined with Naratriptan.,increase,risk
Triazolam,Nateglinide,Nateglinide may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Nedaplatin,Triazolam may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Triazolam,Nedocromil,Nedocromil may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Nefazodone,The metabolism of Triazolam can be decreased when combined with Nefazodone.,decrease,no risk
Triazolam,Nelfinavir,The metabolism of Triazolam can be decreased when combined with Nelfinavir.,decrease,no risk
Triazolam,Neomycin,Triazolam may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Triazolam,Netilmicin,Triazolam may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Triazolam,Netupitant,The metabolism of Triazolam can be decreased when combined with Netupitant.,decrease,no risk
Triazolam,Nevirapine,The metabolism of Triazolam can be decreased when combined with Nevirapine.,decrease,no risk
Triazolam,Niacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Triazolam.",increase,risk
Triazolam,Nialamide,The risk or severity of CNS depression can be increased when Triazolam is combined with Nialamide.,increase,risk
Triazolam,Nicardipine,The metabolism of Triazolam can be decreased when combined with Nicardipine.,decrease,no risk
Triazolam,Nicorandil,Triazolam may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Triazolam,Nifedipine,Triazolam may decrease the excretion rate of Nifedipine which could result in a higher serum level.,decrease,no risk
Triazolam,Nilotinib,The metabolism of Triazolam can be decreased when combined with Nilotinib.,decrease,no risk
Triazolam,Nilutamide,Nilutamide may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Nilvadipine,The metabolism of Triazolam can be decreased when combined with Nilvadipine.,decrease,no risk
Triazolam,Nimesulide,Nimesulide may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Nisoldipine,Nisoldipine may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Nitrazepam,The risk or severity of CNS depression can be increased when Triazolam is combined with Nitrazepam.,increase,risk
Triazolam,Nitrendipine,The metabolism of Nitrendipine can be decreased when combined with Triazolam.,decrease,no risk
Triazolam,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Nitroprusside,Nitroprusside may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Nitrous oxide,The risk or severity of CNS depression can be increased when Triazolam is combined with Nitrous oxide.,increase,risk
Triazolam,Nizatidine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Triazolam.",increase,risk
Triazolam,Nomifensine,The risk or severity of CNS depression can be increased when Triazolam is combined with Nomifensine.,increase,risk
Triazolam,Norethisterone,The metabolism of Triazolam can be decreased when combined with Norethisterone.,decrease,no risk
Triazolam,Norfloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Norfloxacin.",increase,risk
Triazolam,Normethadone,The risk or severity of adverse effects can be increased when Normethadone is combined with Triazolam.,increase,risk
Triazolam,Nortriptyline,The risk or severity of CNS depression can be increased when Nortriptyline is combined with Triazolam.,increase,risk
Triazolam,Octinoxate,Triazolam may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Triazolam,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Ofloxacin.",increase,risk
Triazolam,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Triazolam.,increase,risk
Triazolam,Olaparib,The metabolism of Olaparib can be decreased when combined with Triazolam.,decrease,no risk
Triazolam,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Triazolam is combined with Oliceridine.",increase,risk
Triazolam,Olsalazine,Olsalazine may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Olutasidenib,The therapeutic efficacy of Triazolam can be decreased when used in combination with Olutasidenib.,decrease,no risk
Triazolam,Omaveloxolone,The serum concentration of Triazolam can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Triazolam,Ondansetron,The risk or severity of CNS depression can be increased when Triazolam is combined with Ondansetron.,increase,risk
Triazolam,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Triazolam.,increase,risk
Triazolam,Orphenadrine,Triazolam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Triazolam,Oseltamivir,Oseltamivir may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Osilodrostat,The metabolism of Triazolam can be decreased when combined with Osilodrostat.,decrease,no risk
Triazolam,Oxacillin,Oxacillin may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Oxaprozin,Oxaprozin may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Triazolam.,increase,risk
Triazolam,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Triazolam.,increase,risk
Triazolam,Oxitriptan,The risk or severity of CNS depression can be increased when Triazolam is combined with Oxitriptan.,increase,risk
Triazolam,Oxprenolol,The risk or severity of CNS depression can be increased when Triazolam is combined with Oxprenolol.,increase,risk
Triazolam,Oxtriphylline,The therapeutic efficacy of Triazolam can be decreased when used in combination with Oxtriphylline.,decrease,no risk
Triazolam,Oxybenzone,Triazolam may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Triazolam,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Triazolam.,increase,risk
Triazolam,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Triazolam.,decrease,no risk
Triazolam,Oxycodone,The risk or severity of adverse effects can be increased when Oxycodone is combined with Triazolam.,increase,risk
Triazolam,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Triazolam.,increase,risk
Triazolam,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Triazolam which could result in a higher serum level.,decrease,no risk
Triazolam,Oxyquinoline,Triazolam may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ethanol,Bepridil,Ethanol may increase the hypotensive activities of Bepridil.,increase,no risk
Ethanol,Berotralstat,The metabolism of Ethanol can be decreased when combined with Berotralstat.,decrease,no risk
Ethanol,Betamethasone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Ethanol.",increase,risk
Ethanol,Betaxolol,Ethanol may increase the hypotensive activities of Betaxolol.,increase,no risk
Ethanol,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Ethanol.,decrease,no risk
Ethanol,Bezafibrate,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ethanol is combined with Bezafibrate.",increase,risk
Ethanol,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Ethanol.,increase,no risk
Ethanol,Bifonazole,The metabolism of Ethanol can be decreased when combined with Bifonazole.,decrease,no risk
Ethanol,Bimekizumab,The metabolism of Ethanol can be increased when combined with Bimekizumab.,increase,no risk
Ethanol,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Ethanol.,decrease,no risk
Ethanol,Bismuth subcitrate potassium,Ethanol may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Ethanol,Bismuth subgallate,Ethanol may increase the neurotoxic activities of Bismuth subgallate.,increase,no risk
Ethanol,Bismuth subnitrate,Ethanol may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Ethanol,Bisoprolol,Ethanol may increase the hypotensive activities of Bisoprolol.,increase,no risk
Ethanol,Boceprevir,The metabolism of Ethanol can be decreased when combined with Boceprevir.,decrease,no risk
Ethanol,Bortezomib,The metabolism of Bortezomib can be increased when combined with Ethanol.,increase,no risk
Ethanol,Bosentan,The metabolism of Bosentan can be decreased when combined with Ethanol.,decrease,no risk
Ethanol,Bosutinib,The metabolism of Bosutinib can be increased when combined with Ethanol.,increase,no risk
Ethanol,Botulinum toxin type A,Botulinum toxin type A may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Botulinum toxin type B,Botulinum toxin type B may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Ethanol.,increase,no risk
Ethanol,Bretylium,Ethanol may increase the hypotensive activities of Bretylium.,increase,no risk
Ethanol,Brexanolone,Brexanolone may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Brexpiprazole,Brexpiprazole may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Brigatinib,The metabolism of Brigatinib can be increased when combined with Ethanol.,increase,no risk
Ethanol,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Brivaracetam,Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Bromazepam,Bromazepam may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Bromocriptine,Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Ethanol.,decrease,no risk
Ethanol,Bromperidol,Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Brompheniramine,Brompheniramine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Bumadizone,The risk or severity of gastrointestinal irritation can be increased when Ethanol is combined with Bumadizone.,increase,risk
Ethanol,Bumetanide,Ethanol may increase the hypotensive activities of Bumetanide.,increase,no risk
Ethanol,Bupivacaine,Bupivacaine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Buprenorphine,Ethanol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Ethanol,Bupropion,The risk or severity of adverse effects can be increased when Ethanol is combined with Bupropion.,increase,risk
Ethanol,Buspirone,Buspirone may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Busulfan,The metabolism of Busulfan can be increased when combined with Ethanol.,increase,no risk
Ethanol,Butabarbital,Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Butalbital,Butalbital may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Butaperazine,Butaperazine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Butobarbital,Butobarbital may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Butorphanol,Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Butriptyline,Butriptyline may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Gabapentin,Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Gabapentin enacarbil,Gabapentin enacarbil may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Gallamine triethiodide,Gallamine triethiodide may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Ganaxolone,Ganaxolone may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ethanol is combined with Ganciclovir.",increase,risk
Ethanol,Gatifloxacin,The metabolism of Ethanol can be decreased when combined with Gatifloxacin.,decrease,no risk
Ethanol,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ethanol is combined with Gemfibrozil.",increase,risk
Ethanol,Gemifloxacin,The metabolism of Ethanol can be decreased when combined with Gemifloxacin.,decrease,no risk
Ethanol,Gepirone,Gepirone may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Gestrinone,The metabolism of Gestrinone can be increased when combined with Ethanol.,increase,no risk
Ethanol,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Ethanol.,increase,no risk
Ethanol,Givosiran,The serum concentration of Ethanol can be increased when it is combined with Givosiran.,increase,no risk
Ethanol,Gliclazide,The risk or severity of adverse effects can be increased when Gliclazide is combined with Ethanol.,increase,risk
Ethanol,Glimepiride,The risk or severity of adverse effects can be increased when Glimepiride is combined with Ethanol.,increase,risk
Ethanol,Glipizide,The risk or severity of adverse effects can be increased when Glipizide is combined with Ethanol.,increase,risk
Ethanol,Gliquidone,The risk or severity of adverse effects can be increased when Gliquidone is combined with Ethanol.,increase,risk
Ethanol,Glofitamab,The serum concentration of Ethanol can be increased when it is combined with Glofitamab.,increase,no risk
Ethanol,Glutethimide,Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Glyburide,The risk or severity of adverse effects can be increased when Glyburide is combined with Ethanol.,increase,risk
Ethanol,Glycerin,The metabolism of Ethanol can be increased when combined with Glycerin.,increase,no risk
Ethanol,Glycol salicylate,The risk or severity of gastrointestinal irritation can be increased when Ethanol is combined with Glycol salicylate.,increase,risk
Ethanol,Golimumab,The metabolism of Ethanol can be increased when combined with Golimumab.,increase,no risk
Ethanol,Granisetron,Granisetron may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Grepafloxacin,The metabolism of Ethanol can be decreased when combined with Grepafloxacin.,decrease,no risk
Ethanol,Griseofulvin,The risk or severity of adverse effects can be increased when Griseofulvin is combined with Ethanol.,increase,risk
Ethanol,Guanabenz,The metabolism of Ethanol can be decreased when combined with Guanabenz.,decrease,no risk
Ethanol,Guanfacine,Ethanol may increase the central nervous system depressant (CNS depressant) activities of Guanfacine.,increase,no risk
Ethanol,Halazepam,Halazepam may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Haloperidol,Haloperidol may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Halothane,Halothane may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Hexafluronium,Hexafluronium may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Hydralazine,Ethanol may increase the hypotensive activities of Hydralazine.,increase,no risk
Ethanol,Hydrochlorothiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Ethanol is combined with Hydrochlorothiazide.,increase,risk
Ethanol,Hydroflumethiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Ethanol is combined with Hydroflumethiazide.,increase,risk
Ethanol,Hydromorphone,Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Ethanol.,increase,no risk
Ethanol,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Ketamine,Ketamine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Ketazolam,Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Ketoconazole,The risk or severity of adverse effects can be increased when Ketoconazole is combined with Ethanol.,increase,risk
Ethanol,Ketoprofen,The risk or severity of gastrointestinal irritation can be increased when Ethanol is combined with Ketoprofen.,increase,risk
Ethanol,Ketorolac,The risk or severity of gastrointestinal irritation can be increased when Ethanol is combined with Ketorolac.,increase,risk
Ethanol,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Nabumetone,The risk or severity of gastrointestinal irritation can be increased when Ethanol is combined with Nabumetone.,increase,risk
Ethanol,Nadolol,Ethanol may increase the hypotensive activities of Nadolol.,increase,no risk
Ethanol,Nafarelin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Ethanol.",increase,risk
Ethanol,Nafcillin,The metabolism of Ethanol can be increased when combined with Nafcillin.,increase,no risk
Ethanol,Nalbuphine,Nalbuphine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Nalidixic acid,The metabolism of Ethanol can be decreased when combined with Nalidixic acid.,decrease,no risk
Ethanol,Naloxegol,The risk or severity of adverse effects can be increased when Ethanol is combined with Naloxegol.,increase,risk
Ethanol,Naltrexone,The risk or severity of adverse effects can be increased when Ethanol is combined with Naltrexone.,increase,risk
Ethanol,Naphazoline,The risk or severity of CNS depression can be increased when Naphazoline is combined with Ethanol.,increase,risk
Ethanol,Naproxen,The risk or severity of gastrointestinal irritation can be increased when Ethanol is combined with Naproxen.,increase,risk
Ethanol,Naratriptan,Naratriptan may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Ethanol.,decrease,no risk
Ethanol,Naxitamab,Ethanol may increase the neurotoxic activities of Naxitamab.,increase,no risk
Ethanol,Nebivolol,Ethanol may increase the hypotensive activities of Nebivolol.,increase,no risk
Ethanol,Nefazodone,Nefazodone may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Nelfinavir,The metabolism of Ethanol can be decreased when combined with Nelfinavir.,decrease,no risk
Ethanol,Neomycin,Ethanol may increase the neurotoxic activities of Neomycin.,increase,no risk
Ethanol,Neratinib,The metabolism of Neratinib can be increased when combined with Ethanol.,increase,no risk
Ethanol,Nesiritide,Ethanol may increase the hypotensive activities of Nesiritide.,increase,no risk
Ethanol,Netupitant,The metabolism of Ethanol can be decreased when combined with Netupitant.,decrease,no risk
Ethanol,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Ethanol.,decrease,no risk
Ethanol,Niacin,The risk or severity of adverse effects can be increased when Ethanol is combined with Niacin.,increase,risk
Ethanol,Nialamide,Nialamide may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Nicardipine,Ethanol may increase the hypotensive activities of Nicardipine.,increase,no risk
Ethanol,Niclosamide,The metabolism of Ethanol can be decreased when combined with Niclosamide.,decrease,no risk
Ethanol,Nicotine,The metabolism of Ethanol can be increased when combined with Nicotine.,increase,no risk
Ethanol,Nifedipine,Ethanol may increase the hypotensive activities of Nifedipine.,increase,no risk
Ethanol,Nilotinib,The metabolism of Ethanol can be decreased when combined with Nilotinib.,decrease,no risk
Ethanol,Nilutamide,The metabolism of Nilutamide can be decreased when combined with Ethanol.,decrease,no risk
Ethanol,Nilvadipine,Ethanol may increase the hypotensive activities of Nilvadipine.,increase,no risk
Ethanol,Nimesulide,The risk or severity of gastrointestinal irritation can be increased when Ethanol is combined with Nimesulide.,increase,risk
Ethanol,Nimodipine,Ethanol may increase the hypotensive activities of Nimodipine.,increase,no risk
Ethanol,Nintedanib,The metabolism of Nintedanib can be increased when combined with Ethanol.,increase,no risk
Ethanol,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Ethanol.,decrease,no risk
Ethanol,Nisoldipine,Ethanol may increase the hypotensive activities of Nisoldipine.,increase,no risk
Ethanol,Nitrazepam,Nitrazepam may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,increase,no risk
Ethanol,Nitrendipine,Ethanol may increase the hypotensive activities of Nitrendipine.,increase,no risk
Ethanol,Nitric Oxide,Ethanol may increase the hypotensive activities of Nitric Oxide.,increase,no risk
Remifentanil,Buprenorphine,Remifentanil may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Remifentanil,Bupropion,The risk or severity of CNS depression can be increased when Remifentanil is combined with Bupropion.,increase,risk
Remifentanil,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Remifentanil.,increase,risk
Remifentanil,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Remifentanil.,increase,risk
Remifentanil,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Remifentanil.,increase,risk
Remifentanil,Butaperazine,The risk or severity of hypotension and CNS depression can be increased when Butaperazine is combined with Remifentanil.,increase,risk
Remifentanil,Butobarbital,The risk or severity of adverse effects can be increased when Butobarbital is combined with Remifentanil.,increase,risk
Remifentanil,Butorphanol,The therapeutic efficacy of Remifentanil can be decreased when used in combination with Butorphanol.,decrease,no risk
Remifentanil,Butriptyline,The risk or severity of CNS depression can be increased when Remifentanil is combined with Butriptyline.,increase,risk
Remifentanil,Butylscopolamine,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Remifentanil.,increase,risk
Didanosine,Gabapentin enacarbil,Didanosine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Didanosine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Gadodiamide,Gadodiamide may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Gadofosveset trisodium,Didanosine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Didanosine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Gadoteric acid,Didanosine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Didanosine,Gadoteridol,Gadoteridol may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Ganciclovir,The risk or severity of cytopenia can be increased when Ganciclovir is combined with Didanosine.,increase,risk
Didanosine,Gatifloxacin,Didanosine can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Didanosine,Gemcitabine,Gemcitabine may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Gemfibrozil,Didanosine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Didanosine,Gemifloxacin,Didanosine can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Didanosine,Gentamicin,Didanosine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Didanosine,Gimeracil,Didanosine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Didanosine,Givosiran,Givosiran may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Glipizide,Didanosine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Didanosine,Glyburide,The excretion of Didanosine can be decreased when combined with Glyburide.,decrease,no risk
Didanosine,Glycerol phenylbutyrate,Didanosine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Didanosine,Golodirsen,Didanosine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Didanosine,Goserelin,Goserelin may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Grepafloxacin,Didanosine can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Didanosine,Guanethidine,Didanosine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Didanosine,Guanfacine,Didanosine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Didanosine,Haloperidol,Haloperidol may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Didanosine.,decrease,no risk
Didanosine,Hydralazine,Didanosine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Didanosine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Didanosine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Didanosine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Didanosine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Didanosine,Hydromorphone,Hydromorphone may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Hydroxyethyl Starch,Didanosine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Didanosine,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Didanosine.,increase,risk
Didanosine,Kanamycin,Didanosine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Didanosine,Ketamine,Didanosine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Didanosine,Ketazolam,Didanosine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Didanosine,Ketoconazole,Didanosine can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Didanosine,Ketoprofen,Ketoprofen may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Ketorolac,Ketorolac may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,N-acetyltyrosine,Didanosine may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Didanosine,Nabumetone,Nabumetone may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Nadolol,Didanosine may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Didanosine,Nafcillin,The excretion of Didanosine can be decreased when combined with Nafcillin.,decrease,no risk
Didanosine,Naldemedine,Didanosine may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Didanosine,Nalidixic acid,Didanosine can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Didanosine,Nalmefene,Didanosine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Didanosine,Naloxone,Didanosine may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Didanosine,Naproxen,Naproxen may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Nateglinide,Nateglinide may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Naxitamab,Didanosine may increase the neurotoxic activities of Naxitamab.,increase,no risk
Didanosine,Nedaplatin,Didanosine may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Didanosine,Nedocromil,Nedocromil may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Nefazodone,Didanosine may decrease the excretion rate of Nefazodone which could result in a higher serum level.,decrease,no risk
Didanosine,Neomycin,Didanosine may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Didanosine,Netilmicin,Didanosine may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Didanosine,Nicorandil,Didanosine may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Didanosine,Nifedipine,Didanosine may decrease the excretion rate of Nifedipine which could result in a higher serum level.,decrease,no risk
Didanosine,Nilutamide,Nilutamide may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Nimesulide,Nimesulide may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Nisoldipine,Nisoldipine may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Nitroprusside,Nitroprusside may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Norfloxacin,Didanosine can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Didanosine,Nortriptyline,Nortriptyline may increase the neurotoxic activities of Didanosine.,increase,no risk
Didanosine,Novobiocin,The excretion of Didanosine can be decreased when combined with Novobiocin.,decrease,no risk
Didanosine,Octinoxate,Didanosine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Didanosine,Ofloxacin,Didanosine can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Didanosine,Olsalazine,Olsalazine may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Omadacycline,Didanosine can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Didanosine,Opium,Didanosine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Didanosine,Oseltamivir,Oseltamivir may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Oteseconazole,Didanosine can cause a decrease in the absorption of Oteseconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Didanosine,Oxacillin,Oxacillin may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Oxaprozin,Oxaprozin may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Oxazepam,Oxazepam may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Oxybenzone,Didanosine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Didanosine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Oxyquinoline,Didanosine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Didanosine,Oxytetracycline,Didanosine can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Didanosine,Quetiapine,Didanosine may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Didanosine,Quinethazone,Quinethazone may increase the excretion rate of Didanosine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Didanosine,Quinidine,Didanosine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Didanosine,Quinupramine,Didanosine may increase the neurotoxic activities of Quinupramine.,increase,no risk
Didanosine,Vaborbactam,Didanosine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Didanosine,Valaciclovir,Valaciclovir may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Valbenazine,Didanosine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Didanosine,Valdecoxib,Valdecoxib may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Valganciclovir,The risk or severity of cytopenia can be increased when Valganciclovir is combined with Didanosine.,increase,risk
Didanosine,Valproate bismuth,Didanosine may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Didanosine,Valproic acid,The excretion of Didanosine can be decreased when combined with Valproic acid.,decrease,no risk
Didanosine,Vancomycin,Didanosine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Didanosine,Varenicline,Didanosine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Didanosine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Didanosine.,decrease,no risk
Didanosine,Venlafaxine,Venlafaxine may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Verapamil,Verapamil may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Didanosine.,decrease,no risk
Didanosine,Vilanterol,Didanosine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Didanosine,Viloxazine,Didanosine may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Didanosine,Vincristine,Vincristine may increase the neurotoxic activities of Didanosine.,increase,no risk
Didanosine,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Didanosine.,increase,no risk
Didanosine,Viomycin,Didanosine may increase the neurotoxic activities of Viomycin.,increase,no risk
Didanosine,Voriconazole,Didanosine can cause a decrease in the absorption of Voriconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Didanosine,Vortioxetine,Didanosine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Didanosine,Warfarin,Didanosine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Didanosine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Didanosine.,decrease,no risk
Didanosine,Zaleplon,Didanosine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Didanosine,Zanamivir,Zanamivir may decrease the excretion rate of Didanosine which could result in a higher serum level.,decrease,no risk
Didanosine,Ziprasidone,Ziprasidone may increase the neurotoxic activities of Didanosine.,increase,no risk
Didanosine,Zonisamide,Zonisamide may increase the excretion rate of Didanosine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Didanosine,Zotepine,Didanosine may increase the neurotoxic activities of Zotepine.,increase,no risk
Didanosine,Zuclopenthixol,Didanosine may increase the neurotoxic activities of Zuclopenthixol.,increase,no risk
Bitolterol,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Bitolterol.,increase,risk
Bitolterol,Glycopyrronium,The risk or severity of Tachycardia can be increased when Bitolterol is combined with Glycopyrronium.,increase,risk
Bitolterol,Guanabenz,Bitolterol may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Bitolterol,Guanadrel,Bitolterol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Bitolterol,Guanethidine,Bitolterol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Bitolterol,Guanfacine,Bitolterol may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Bitolterol,Guanoxan,Bitolterol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Bitolterol,Halothane,The risk or severity of hypertension can be increased when Bitolterol is combined with Halothane.,increase,risk
Bitolterol,Hexocyclium,The risk or severity of Tachycardia can be increased when Bitolterol is combined with Hexocyclium.,increase,risk
Bitolterol,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Bitolterol.,increase,risk
Bitolterol,Hydralazine,Bitolterol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Bitolterol,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Bitolterol is combined with Hydrochlorothiazide.,increase,risk
Bitolterol,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Bitolterol.,increase,risk
Bitolterol,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Bitolterol.,increase,risk
Bitolterol,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Bitolterol.,increase,risk
Bitolterol,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Bitolterol.,increase,risk
Bitolterol,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Bitolterol.,increase,risk
Bitolterol,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Bitolterol is combined with Hydroflumethiazide.,increase,risk
Bitolterol,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Bitolterol.,increase,risk
Bitolterol,Ketamine,The risk or severity of Tachycardia can be increased when Bitolterol is combined with Ketamine.,increase,risk
Bitolterol,Ketoprofen,The risk or severity of hypertension can be increased when Bitolterol is combined with Ketoprofen.,increase,risk
Bitolterol,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Bitolterol.,increase,risk
Bitolterol,Nabilone,The risk or severity of Tachycardia can be increased when Nabilone is combined with Bitolterol.,increase,risk
Bitolterol,Nabumetone,The risk or severity of hypertension can be increased when Nabumetone is combined with Bitolterol.,increase,risk
Bitolterol,Nadolol,Nadolol may decrease the bronchodilatory activities of Bitolterol.,decrease,no risk
Bitolterol,Naphazoline,The risk or severity of hypertension can be increased when Bitolterol is combined with Naphazoline.,increase,risk
Bitolterol,Naproxen,The risk or severity of hypertension can be increased when Naproxen is combined with Bitolterol.,increase,risk
Bitolterol,Naratriptan,The risk or severity of hypertension can be increased when Bitolterol is combined with Naratriptan.,increase,risk
Bitolterol,Naxitamab,The risk or severity of hypertension can be increased when Bitolterol is combined with Naxitamab.,increase,risk
Bitolterol,Nebivolol,The therapeutic efficacy of Bitolterol can be decreased when used in combination with Nebivolol.,decrease,no risk
Bitolterol,Nefazodone,Nefazodone may increase the tachycardic activities of Bitolterol.,increase,no risk
Bitolterol,Nialamide,The risk or severity of hypertension can be increased when Bitolterol is combined with Nialamide.,increase,risk
Bitolterol,Nicardipine,The therapeutic efficacy of Bitolterol can be decreased when used in combination with Nicardipine.,decrease,no risk
Bitolterol,Nicergoline,Nicergoline may increase the hypertensive and vasoconstricting activities of Bitolterol.,increase,no risk
Bitolterol,Nicorandil,Bitolterol may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Bitolterol,Nicotine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Bitolterol.,increase,risk
Bitolterol,Nilvadipine,Bitolterol may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Bitolterol,Nimesulide,The risk or severity of hypertension can be increased when Bitolterol is combined with Nimesulide.,increase,risk
Bitolterol,Nimodipine,Bitolterol may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Bitolterol,Nisoldipine,Bitolterol may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Bitolterol,Nitrendipine,Bitolterol may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Bitolterol,Nitroglycerin,Bitolterol may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Bitolterol,Nitroprusside,Bitolterol may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Bitolterol,Nitrous oxide,The risk or severity of hypertension can be increased when Bitolterol is combined with Nitrous oxide.,increase,risk
Bitolterol,Norepinephrine,The risk or severity of adverse effects can be increased when Norepinephrine is combined with Bitolterol.,increase,risk
Bitolterol,Nortriptyline,The therapeutic efficacy of Bitolterol can be decreased when used in combination with Nortriptyline.,decrease,no risk
Bitolterol,Nylidrin,The risk or severity of hypertension can be increased when Bitolterol is combined with Nylidrin.,increase,risk
Bitolterol,Olanzapine,The therapeutic efficacy of Bitolterol can be decreased when used in combination with Olanzapine.,decrease,no risk
Bitolterol,Olmesartan,Bitolterol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Bitolterol,Olodaterol,The risk or severity of adverse effects can be increased when Bitolterol is combined with Olodaterol.,increase,risk
Bitolterol,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Bitolterol.,increase,risk
Bitolterol,Orphenadrine,The risk or severity of Tachycardia can be increased when Bitolterol is combined with Orphenadrine.,increase,risk
Bitolterol,Oxaprozin,The risk or severity of hypertension can be increased when Bitolterol is combined with Oxaprozin.,increase,risk
Bitolterol,Oxprenolol,Oxprenolol may decrease the bronchodilatory activities of Bitolterol.,decrease,no risk
Bitolterol,Oxtriphylline,The risk or severity of hypokalemia can be increased when Oxtriphylline is combined with Bitolterol.,increase,risk
Bitolterol,Oxybutynin,The risk or severity of Tachycardia can be increased when Bitolterol is combined with Oxybutynin.,increase,risk
Bitolterol,Oxymetazoline,The risk or severity of hypertension can be increased when Bitolterol is combined with Oxymetazoline.,increase,risk
Bitolterol,Oxyphenbutazone,The risk or severity of hypertension can be increased when Bitolterol is combined with Oxyphenbutazone.,increase,risk
Bitolterol,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Bitolterol.,increase,risk
Bitolterol,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Bitolterol.,increase,risk
Bitolterol,Quetiapine,The therapeutic efficacy of Bitolterol can be decreased when used in combination with Quetiapine.,decrease,no risk
Bitolterol,Quinapril,Bitolterol may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Bitolterol,Quinethazone,Bitolterol may increase the hypokalemic activities of Quinethazone.,increase,no risk
Bitolterol,Quinidine,The therapeutic efficacy of Bitolterol can be decreased when used in combination with Quinidine.,decrease,no risk
Bitolterol,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Bitolterol.,increase,risk
Bitolterol,Umeclidinium,The risk or severity of Tachycardia can be increased when Bitolterol is combined with Umeclidinium.,increase,risk
Bitolterol,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Bitolterol.,increase,risk
Bitolterol,Valsartan,Bitolterol may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Bitolterol,Vamorolone,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Bitolterol.,increase,risk
Bitolterol,Venlafaxine,Venlafaxine may increase the tachycardic activities of Bitolterol.,increase,no risk
Bitolterol,Verapamil,The therapeutic efficacy of Bitolterol can be decreased when used in combination with Verapamil.,decrease,no risk
Bitolterol,Vilanterol,The risk or severity of adverse effects can be increased when Bitolterol is combined with Vilanterol.,increase,risk
Bitolterol,Vilazodone,The risk or severity of hypertension can be increased when Bitolterol is combined with Vilazodone.,increase,risk
Bitolterol,Vortioxetine,The risk or severity of hypertension can be increased when Bitolterol is combined with Vortioxetine.,increase,risk
Bitolterol,Xamoterol,The risk or severity of hypertension can be increased when Bitolterol is combined with Xamoterol.,increase,risk
Bitolterol,Xylometazoline,The risk or severity of hypertension can be increased when Bitolterol is combined with Xylometazoline.,increase,risk
Bitolterol,Yohimbine,The risk or severity of hypertension can be increased when Bitolterol is combined with Yohimbine.,increase,risk
Bitolterol,Ziprasidone,The therapeutic efficacy of Bitolterol can be decreased when used in combination with Ziprasidone.,decrease,no risk
Bitolterol,Zofenopril,Bitolterol may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Bitolterol,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Bitolterol.,increase,risk
Bitolterol,Zuclopenthixol,The therapeutic efficacy of Bitolterol can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Methdilazine,Benzphetamine,Benzphetamine may decrease the sedative activities of Methdilazine.,decrease,no risk
Methdilazine,Benzylpenicilloyl polylysine,Methdilazine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Methdilazine,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Methdilazine.,decrease,no risk
Methdilazine,Brexanolone,The therapeutic efficacy of Brexanolone can be decreased when used in combination with Methdilazine.,decrease,no risk
Methdilazine,Brivaracetam,The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Methdilazine.,decrease,no risk
Methdilazine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Methdilazine.,increase,risk
Methdilazine,Butalbital,The therapeutic efficacy of Butalbital can be decreased when used in combination with Methdilazine.,decrease,no risk
Methdilazine,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Methdilazine.,decrease,no risk
Methdilazine,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Methdilazine.,decrease,no risk
Methdilazine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Methdilazine.,decrease,no risk
Methdilazine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Methdilazine.,decrease,no risk
Methdilazine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Methdilazine.,decrease,no risk
Methdilazine,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Methdilazine.,increase,risk
Methdilazine,Hyoscyamine,Methdilazine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Methdilazine,Nitrazepam,The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Methdilazine.,decrease,no risk
Methdilazine,Norepinephrine,The therapeutic efficacy of Norepinephrine can be increased when used in combination with Methdilazine.,increase,no risk
Methdilazine,Oxcarbazepine,The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Methdilazine.,decrease,no risk
Methdilazine,Valproic acid,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Methdilazine.,decrease,no risk
Methdilazine,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Methdilazine.,decrease,no risk
Methdilazine,Zaleplon,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Methdilazine.,decrease,no risk
Methdilazine,Zonisamide,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Methdilazine.,decrease,no risk
Etacrynic acid,Bleomycin,Etacrynic acid may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Bosentan,Etacrynic acid may increase the hypotensive activities of Bosentan.,increase,no risk
Etacrynic acid,Botulinum toxin type A,The therapeutic efficacy of Botulinum toxin type A can be increased when used in combination with Etacrynic acid.,increase,no risk
Etacrynic acid,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Botulinum toxin type B.,increase,risk
Etacrynic acid,Bretylium,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Bretylium.,increase,risk
Etacrynic acid,Brivaracetam,Etacrynic acid may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Bromazepam,Etacrynic acid may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Etacrynic acid.,decrease,no risk
Etacrynic acid,Budesonide,The risk or severity of hypokalemia can be increased when Budesonide is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Bumadizone,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Bumadizone.,decrease,no risk
Etacrynic acid,Bumetanide,The risk or severity of nephrotoxicity can be increased when Bumetanide is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Buprenorphine,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Buprenorphine.,decrease,no risk
Etacrynic acid,Bupropion,Etacrynic acid may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Buspirone,Etacrynic acid may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Butabarbital,Butabarbital may increase the hypotensive activities of Etacrynic acid.,increase,no risk
Etacrynic acid,Butalbital,Butalbital may increase the hypotensive activities of Etacrynic acid.,increase,no risk
Etacrynic acid,Butorphanol,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Butorphanol.,decrease,no risk
Etacrynic acid,Gabapentin enacarbil,Furosemide may increase the ototoxic activities of Etacrynic acid.,increase,no risk
Etacrynic acid,Gadobenic acid,Etacrynic acid may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Gadodiamide,Etacrynic acid may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Gadofosveset trisodium,Etacrynic acid may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Gadopentetic acid,Etacrynic acid may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Gadoteric acid,Etacrynic acid may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Gadoteridol,Etacrynic acid may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Gallamine triethiodide,Etacrynic acid may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Ganciclovir,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Etacrynic acid.,increase,no risk
Etacrynic acid,Gemcitabine,Etacrynic acid may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Gemfibrozil,Etacrynic acid may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Gentamicin,Etacrynic acid may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Gimeracil,The serum concentration of Gentamicin can be increased when it is combined with Etacrynic acid.,increase,no risk
Etacrynic acid,Givosiran,Etacrynic acid may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Gliclazide,The risk or severity of nephrotoxicity can be increased when Etacrynic acid is combined with Givosiran.,increase,risk
Etacrynic acid,Glimepiride,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Etacrynic acid.,decrease,no risk
Etacrynic acid,Glipizide,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Etacrynic acid.,decrease,no risk
Etacrynic acid,Gliquidone,The therapeutic efficacy of Glipizide can be decreased when used in combination with Etacrynic acid.,decrease,no risk
Etacrynic acid,Gluconic Acid,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Etacrynic acid.,decrease,no risk
Etacrynic acid,Glyburide,The risk or severity of dehydration can be increased when Etacrynic acid is combined with Gluconic Acid.,increase,risk
Etacrynic acid,Glycerin,The therapeutic efficacy of Glyburide can be decreased when used in combination with Etacrynic acid.,decrease,no risk
Etacrynic acid,Glycerol phenylbutyrate,The risk or severity of dehydration can be increased when Etacrynic acid is combined with Glycerin.,increase,risk
Etacrynic acid,Glycol salicylate,Etacrynic acid may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Glymidine,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Etacrynic acid,Golodirsen,The therapeutic efficacy of Glymidine can be decreased when used in combination with Etacrynic acid.,decrease,no risk
Etacrynic acid,Goserelin,Etacrynic acid may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Grepafloxacin,Etacrynic acid may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Guanabenz,The excretion of Grepafloxacin can be decreased when combined with Etacrynic acid.,decrease,no risk
Etacrynic acid,Guanadrel,Etacrynic acid may increase the hypotensive activities of Guanabenz.,increase,no risk
Etacrynic acid,Guanethidine,Etacrynic acid may increase the hypotensive activities of Guanadrel.,increase,no risk
Etacrynic acid,Guanfacine,Etacrynic acid may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Guanoxan,Etacrynic acid may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Haloperidol,Etacrynic acid may increase the hypotensive activities of Guanoxan.,increase,no risk
Etacrynic acid,Halothane,Etacrynic acid may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Hydralazine,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Halothane.,increase,risk
Etacrynic acid,Hydrochlorothiazide,Etacrynic acid may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Hydrocodone,The risk or severity of nephrotoxicity can be increased when Etacrynic acid is combined with Hydrochlorothiazide.,increase,risk
Etacrynic acid,Hydrocortisone,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Hydrocodone.,decrease,no risk
Etacrynic acid,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Hydromorphone,The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Hydroxocobalamin,Etacrynic acid may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Hydroxyethyl Starch,Etacrynic acid may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Kanamycin,Etacrynic acid may increase the excretion rate of Ixazomib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Ketamine,The serum concentration of Kanamycin can be increased when it is combined with Etacrynic acid.,increase,no risk
Etacrynic acid,Ketazolam,Etacrynic acid may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Ketoprofen,Etacrynic acid may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Ketorolac,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Ketoprofen.,decrease,no risk
Etacrynic acid,N-acetyltyrosine,Etacrynic acid may increase the excretion rate of Mycophenolic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Nabilone,Etacrynic acid may increase the excretion rate of N-acetyltyrosine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Nabumetone,The risk or severity of adverse effects can be increased when Nabilone is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Nadolol,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Nabumetone.,decrease,no risk
Etacrynic acid,Nalbuphine,Etacrynic acid may increase the excretion rate of Nadolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Naldemedine,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Nalbuphine.,decrease,no risk
Etacrynic acid,Nalmefene,Etacrynic acid may increase the excretion rate of Naldemedine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Naloxegol,Etacrynic acid may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Naloxone,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Naloxegol.,decrease,no risk
Etacrynic acid,Naltrexone,Etacrynic acid may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Naproxen,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Naltrexone.,decrease,no risk
Etacrynic acid,Nateglinide,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Naproxen.,decrease,no risk
Etacrynic acid,Nebivolol,The therapeutic efficacy of Nateglinide can be decreased when used in combination with Etacrynic acid.,decrease,no risk
Etacrynic acid,Nedaplatin,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Nebivolol.,increase,risk
Etacrynic acid,Nedocromil,Etacrynic acid may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Etacrynic acid,Nefazodone,Etacrynic acid may increase the excretion rate of Nedocromil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Neomycin,Etacrynic acid may increase the excretion rate of Nefazodone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Nesiritide,The risk or severity of nephrotoxicity can be increased when Etacrynic acid is combined with Neomycin.,increase,risk
Etacrynic acid,Netilmicin,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Nesiritide.,increase,risk
Etacrynic acid,Nialamide,The serum concentration of Netilmicin can be increased when it is combined with Etacrynic acid.,increase,no risk
Etacrynic acid,Nicardipine,Nialamide may increase the orthostatic hypotensive activities of Etacrynic acid.,increase,no risk
Etacrynic acid,Nicorandil,The risk or severity of adverse effects can be increased when Nicardipine is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Nicotine,Nicorandil may increase the hypotensive activities of Etacrynic acid.,increase,no risk
Etacrynic acid,Nifedipine,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Nicotine.,increase,risk
Etacrynic acid,Nilutamide,Etacrynic acid may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Nilvadipine,Etacrynic acid may increase the excretion rate of Nilutamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Nimesulide,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Nilvadipine.,increase,risk
Etacrynic acid,Nimodipine,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Nimesulide.,decrease,no risk
Etacrynic acid,Nisoldipine,The risk or severity of adverse effects can be increased when Nimodipine is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Nitrendipine,Etacrynic acid may increase the excretion rate of Nisoldipine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Nitric Oxide,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Nitrendipine.,increase,risk
Etacrynic acid,Nitrofurantoin,Etacrynic acid may increase the excretion rate of Nitric Oxide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Nitroglycerin,Etacrynic acid may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Nitroprusside,The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Nitrous acid,Etacrynic acid may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Norepinephrine,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Nitrous acid.,increase,risk
Etacrynic acid,Normethadone,The risk or severity of hypokalemia can be increased when Norepinephrine is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Obinutuzumab,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Normethadone.,decrease,no risk
Etacrynic acid,Octinoxate,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Obinutuzumab.,increase,risk
Etacrynic acid,Olanzapine,Etacrynic acid may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Oliceridine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Olmesartan,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Oliceridine.,decrease,no risk
Etacrynic acid,Olodaterol,The risk or severity of adverse effects can be increased when Olmesartan is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Olsalazine,The risk or severity of hypokalemia can be increased when Olodaterol is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Opicapone,The risk or severity of nephrotoxicity can be increased when Etacrynic acid is combined with Olsalazine.,increase,risk
Etacrynic acid,Opium,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Opicapone.,increase,risk
Etacrynic acid,Orciprenaline,Etacrynic acid may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Oseltamivir,The risk or severity of hypokalemia can be increased when Orciprenaline is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Ouabain,Etacrynic acid may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Oxacillin,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Ouabain.,increase,risk
Etacrynic acid,Oxaliplatin,Etacrynic acid may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Oxazepam,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Oxaprozin.,decrease,no risk
Etacrynic acid,Oxprenolol,Etacrynic acid may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Oxybenzone,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Oxprenolol.,increase,risk
Etacrynic acid,Oxycodone,Etacrynic acid may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Oxymorphone,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Oxycodone.,decrease,no risk
Etacrynic acid,Oxyphenbutazone,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Oxymorphone.,decrease,no risk
Etacrynic acid,Oxyphenisatin acetate,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Etacrynic acid,Oxyquinoline,The risk or severity of dehydration can be increased when Etacrynic acid is combined with Oxyphenisatin acetate.,increase,risk
Etacrynic acid,Oxytetracycline,Etacrynic acid may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Quetiapine,Etacrynic acid may increase the excretion rate of Pyridoxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Quinapril,Etacrynic acid may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Quinidine,The risk or severity of adverse effects can be increased when Quinapril is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Quinine,Etacrynic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Etacrynic acid,Udenafil,The therapeutic efficacy of Tubocurarine can be increased when used in combination with Etacrynic acid.,increase,no risk
Etacrynic acid,Vaborbactam,The risk or severity of hypotension can be increased when Udenafil is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Vadadustat,Etacrynic acid may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Valaciclovir,The serum concentration of Vadadustat can be increased when it is combined with Etacrynic acid.,increase,no risk
Etacrynic acid,Valbenazine,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Valdecoxib,Etacrynic acid may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Valganciclovir,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Valdecoxib.,decrease,no risk
Etacrynic acid,Valsartan,Etacrynic acid may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Vamorolone,The risk or severity of adverse effects can be increased when Valsartan is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Vancomycin,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Vardenafil,Etacrynic acid may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Etacrynic acid,Varenicline,The risk or severity of hypotension can be increased when Vardenafil is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Vecuronium,Etacrynic acid may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Venlafaxine,The therapeutic efficacy of Vecuronium can be increased when used in combination with Etacrynic acid.,increase,no risk
Etacrynic acid,Verapamil,Etacrynic acid may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Vericiguat,Etacrynic acid may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Vilanterol,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Vericiguat.,increase,risk
Etacrynic acid,Vildagliptin,The risk or severity of hypokalemia can be increased when Etacrynic acid is combined with Vilanterol.,increase,risk
Etacrynic acid,Viloxazine,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Etacrynic acid.,decrease,no risk
Etacrynic acid,Viomycin,Etacrynic acid may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Vortioxetine,The risk or severity of neuromuscular blockade can be increased when Etacrynic acid is combined with Viomycin.,increase,risk
Etacrynic acid,Warfarin,Etacrynic acid may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Zalcitabine,The protein binding of Warfarin can be decreased when combined with Etacrynic acid.,decrease,no risk
Etacrynic acid,Zaleplon,The excretion of Zalcitabine can be decreased when combined with Etacrynic acid.,decrease,no risk
Etacrynic acid,Zanamivir,Etacrynic acid may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Ziconotide,Etacrynic acid may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Zidovudine,The risk or severity of CNS depression can be increased when Etacrynic acid is combined with Ziconotide.,increase,risk
Etacrynic acid,Zofenopril,The excretion of Zidovudine can be decreased when combined with Etacrynic acid.,decrease,no risk
Etacrynic acid,Zoledronic acid,Etacrynic acid may increase the hypotensive activities of Zofenopril.,increase,no risk
Etacrynic acid,Zonisamide,The risk or severity of hypocalcemia can be increased when Etacrynic acid is combined with Zoledronic acid.,increase,risk
Ondansetron,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Ondansetron.,increase,risk
Ondansetron,Bimekizumab,The metabolism of Ondansetron can be increased when combined with Bimekizumab.,increase,no risk
Ondansetron,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Biperiden,The metabolism of Ondansetron can be decreased when combined with Biperiden.,decrease,no risk
Ondansetron,Boceprevir,The metabolism of Ondansetron can be decreased when combined with Boceprevir.,decrease,no risk
Ondansetron,Bortezomib,The metabolism of Ondansetron can be decreased when combined with Bortezomib.,decrease,no risk
Ondansetron,Bosentan,The metabolism of Ondansetron can be increased when combined with Bosentan.,increase,no risk
Ondansetron,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Ondansetron.,increase,risk
Ondansetron,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Ondansetron.,increase,risk
Ondansetron,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Ondansetron.,increase,risk
Ondansetron,Brexanolone,The risk or severity of CNS depression can be increased when Ondansetron is combined with Brexanolone.,increase,risk
Ondansetron,Brexpiprazole,The risk or severity of CNS depression can be increased when Ondansetron is combined with Brexpiprazole.,increase,risk
Ondansetron,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Ondansetron.,increase,no risk
Ondansetron,Brivaracetam,The risk or severity of CNS depression can be increased when Ondansetron is combined with Brivaracetam.,increase,risk
Ondansetron,Bromazepam,The risk or severity of CNS depression can be increased when Ondansetron is combined with Bromazepam.,increase,risk
Ondansetron,Bromocriptine,The risk or severity of CNS depression can be increased when Ondansetron is combined with Bromocriptine.,increase,risk
Ondansetron,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Bromperidol,The risk or severity of CNS depression can be increased when Ondansetron is combined with Bromperidol.,increase,risk
Ondansetron,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Ondansetron.,increase,risk
Ondansetron,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Ondansetron.,increase,risk
Ondansetron,Budesonide,The metabolism of Ondansetron can be increased when combined with Budesonide.,increase,no risk
Ondansetron,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Ondansetron.,increase,risk
Ondansetron,Buprenorphine,Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Ondansetron,Bupropion,The metabolism of Ondansetron can be decreased when combined with Bupropion.,decrease,no risk
Ondansetron,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Ondansetron.,increase,risk
Ondansetron,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Ondansetron.,increase,risk
Ondansetron,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Ondansetron.,increase,risk
Ondansetron,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Ondansetron.,increase,risk
Ondansetron,Butaperazine,The risk or severity of CNS depression can be increased when Ondansetron is combined with Butaperazine.,increase,risk
Ondansetron,Butobarbital,The risk or severity of CNS depression can be increased when Ondansetron is combined with Butobarbital.,increase,risk
Ondansetron,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Ondansetron.,increase,risk
Ondansetron,Butriptyline,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Butriptyline.,increase,risk
Ondansetron,Gabapentin,The risk or severity of CNS depression can be increased when Ondansetron is combined with Gabapentin.,increase,risk
Ondansetron,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Ondansetron is combined with Gabapentin enacarbil.,increase,risk
Ondansetron,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Ondansetron.,increase,risk
Ondansetron,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Ondansetron.,increase,risk
Ondansetron,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Ondansetron.,increase,risk
Ondansetron,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Ondansetron is combined with Ganaxolone.",increase,risk
Ondansetron,Gatifloxacin,The metabolism of Ondansetron can be decreased when combined with Gatifloxacin.,decrease,no risk
Ondansetron,Gefitinib,The metabolism of Ondansetron can be decreased when combined with Gefitinib.,decrease,no risk
Ondansetron,Gemfibrozil,The metabolism of Ondansetron can be decreased when combined with Gemfibrozil.,decrease,no risk
Ondansetron,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Gemifloxacin.,increase,risk
Ondansetron,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Ondansetron.,increase,risk
Ondansetron,Gilteritinib,The therapeutic efficacy of Ondansetron can be decreased when used in combination with Gilteritinib.,decrease,no risk
Ondansetron,Ginkgo biloba,The metabolism of Ondansetron can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ondansetron,Givosiran,The serum concentration of Ondansetron can be increased when it is combined with Givosiran.,increase,no risk
Ondansetron,Glasdegib,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Glasdegib.,increase,risk
Ondansetron,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Glimepiride,The metabolism of Ondansetron can be decreased when combined with Glimepiride.,decrease,no risk
Ondansetron,Glipizide,The metabolism of Glipizide can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Glofitamab,The serum concentration of Ondansetron can be increased when it is combined with Glofitamab.,increase,no risk
Ondansetron,Glutethimide,The risk or severity of CNS depression can be increased when Ondansetron is combined with Glutethimide.,increase,risk
Ondansetron,Glyburide,The metabolism of Ondansetron can be decreased when combined with Glyburide.,decrease,no risk
Ondansetron,Glycerol phenylbutyrate,The metabolism of Ondansetron can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Ondansetron,Golimumab,The metabolism of Ondansetron can be increased when combined with Golimumab.,increase,no risk
Ondansetron,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ondansetron.,increase,risk
Ondansetron,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Ondansetron.,increase,risk
Ondansetron,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Grepafloxacin.,increase,risk
Ondansetron,Guanabenz,The metabolism of Ondansetron can be decreased when combined with Guanabenz.,decrease,no risk
Ondansetron,Guanfacine,The risk or severity of CNS depression can be increased when Ondansetron is combined with Guanfacine.,increase,risk
Ondansetron,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Ondansetron.,increase,risk
Ondansetron,Halofantrine,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Halofantrine.,increase,risk
Ondansetron,Haloperidol,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Haloperidol.,increase,risk
Ondansetron,Halothane,The risk or severity of CNS depression can be increased when Ondansetron is combined with Halothane.,increase,risk
Ondansetron,Hexafluronium,The risk or severity of CNS depression can be increased when Ondansetron is combined with Hexafluronium.,increase,risk
Ondansetron,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Ondansetron.,increase,risk
Ondansetron,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Ondansetron.,increase,risk
Ondansetron,Hydrocodone,Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Ondansetron,Hydrocortisone,The metabolism of Ondansetron can be decreased when combined with Hydrocortisone.,decrease,no risk
Ondansetron,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Ondansetron.,increase,risk
Ondansetron,Hydroxychloroquine,The metabolism of Ondansetron can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Ondansetron,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Hydroxyzine.,increase,risk
Ondansetron,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ondansetron.,increase,risk
Ondansetron,Ketamine,The risk or severity of CNS depression can be increased when Ondansetron is combined with Ketamine.,increase,risk
Ondansetron,Ketazolam,The risk or severity of CNS depression can be increased when Ondansetron is combined with Ketazolam.,increase,risk
Ondansetron,Ketoconazole,The metabolism of Ondansetron can be decreased when combined with Ketoconazole.,decrease,no risk
Ondansetron,Ketorolac,The metabolism of Ondansetron can be decreased when combined with Ketorolac.,decrease,no risk
Ondansetron,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Ondansetron.,increase,no risk
Ondansetron,Nabumetone,The metabolism of Ondansetron can be decreased when combined with Nabumetone.,decrease,no risk
Ondansetron,Nadolol,The metabolism of Nadolol can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Nafcillin,The metabolism of Ondansetron can be increased when combined with Nafcillin.,increase,no risk
Ondansetron,Nalbuphine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Ondansetron.,increase,risk
Ondansetron,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Ondansetron.,increase,risk
Ondansetron,Naltrexone,The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Ondansetron.,increase,risk
Ondansetron,Naphazoline,The risk or severity of CNS depression can be increased when Naphazoline is combined with Ondansetron.,increase,risk
Ondansetron,Naproxen,The metabolism of Ondansetron can be decreased when combined with Naproxen.,decrease,no risk
Ondansetron,Naratriptan,The risk or severity of CNS depression can be increased when Ondansetron is combined with Naratriptan.,increase,risk
Ondansetron,Nateglinide,The metabolism of Ondansetron can be decreased when combined with Nateglinide.,decrease,no risk
Ondansetron,Nebivolol,The metabolism of Nebivolol can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Nefazodone,The metabolism of Ondansetron can be decreased when combined with Nefazodone.,decrease,no risk
Ondansetron,Nelfinavir,The metabolism of Ondansetron can be decreased when combined with Nelfinavir.,decrease,no risk
Ondansetron,Netupitant,The metabolism of Ondansetron can be decreased when combined with Netupitant.,decrease,no risk
Ondansetron,Nevirapine,The metabolism of Ondansetron can be decreased when combined with Nevirapine.,decrease,no risk
Ondansetron,Niacin,The metabolism of Ondansetron can be decreased when combined with Niacin.,decrease,no risk
Ondansetron,Nialamide,The risk or severity of CNS depression can be increased when Ondansetron is combined with Nialamide.,increase,risk
Ondansetron,Nicardipine,The metabolism of Ondansetron can be decreased when combined with Nicardipine.,decrease,no risk
Ondansetron,Nicergoline,The metabolism of Ondansetron can be decreased when combined with Nicergoline.,decrease,no risk
Ondansetron,Niclosamide,The metabolism of Ondansetron can be decreased when combined with Niclosamide.,decrease,no risk
Ondansetron,Nifedipine,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Nifedipine.,increase,risk
Ondansetron,Nilotinib,The metabolism of Ondansetron can be decreased when combined with Nilotinib.,decrease,no risk
Ondansetron,Nilutamide,The metabolism of Ondansetron can be decreased when combined with Nilutamide.,decrease,no risk
Ondansetron,Nilvadipine,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Nilvadipine.,increase,risk
Ondansetron,Nimodipine,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Ondansetron.,increase,risk
Ondansetron,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Nisoldipine,The metabolism of Ondansetron can be decreased when combined with Nisoldipine.,decrease,no risk
Ondansetron,Nitrazepam,The risk or severity of CNS depression can be increased when Ondansetron is combined with Nitrazepam.,increase,risk
Ondansetron,Nitrendipine,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Ondansetron.,increase,risk
Ondansetron,Nitrous oxide,The risk or severity of CNS depression can be increased when Ondansetron is combined with Nitrous oxide.,increase,risk
Ondansetron,Nomifensine,The risk or severity of CNS depression can be increased when Ondansetron is combined with Nomifensine.,increase,risk
Ondansetron,Norethisterone,The metabolism of Ondansetron can be decreased when combined with Norethisterone.,decrease,no risk
Ondansetron,Norfloxacin,The metabolism of Ondansetron can be decreased when combined with Norfloxacin.,decrease,no risk
Ondansetron,Norgestimate,The metabolism of Norgestimate can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Normethadone,The risk or severity of CNS depression can be increased when Ondansetron is combined with Normethadone.,increase,risk
Ondansetron,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Noscapine,The metabolism of Ondansetron can be decreased when combined with Noscapine.,decrease,no risk
Ondansetron,Obeticholic acid,The metabolism of Ondansetron can be decreased when combined with Obeticholic acid.,decrease,no risk
Ondansetron,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Ondansetron.,increase,risk
Ondansetron,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Ofloxacin.,increase,risk
Ondansetron,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Ondansetron.,increase,risk
Ondansetron,Olaparib,The metabolism of Olaparib can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Ondansetron is combined with Oliceridine.",increase,risk
Ondansetron,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Ondansetron.,increase,risk
Ondansetron,Omaveloxolone,The serum concentration of Ondansetron can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Ondansetron,Opium,The risk or severity of CNS depression can be increased when Ondansetron is combined with Opium.,increase,risk
Ondansetron,Oritavancin,The metabolism of Ondansetron can be decreased when combined with Oritavancin.,decrease,no risk
Ondansetron,Orphenadrine,Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Ondansetron,Osilodrostat,The metabolism of Ondansetron can be decreased when combined with Osilodrostat.,decrease,no risk
Ondansetron,Osimertinib,The serum concentration of Ondansetron can be decreased when it is combined with Osimertinib.,decrease,no risk
Ondansetron,Ospemifene,The metabolism of Ondansetron can be decreased when combined with Ospemifene.,decrease,no risk
Ondansetron,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Ondansetron.,increase,risk
Ondansetron,Oxamniquine,The metabolism of Ondansetron can be decreased when combined with Oxamniquine.,decrease,no risk
Ondansetron,Oxandrolone,The metabolism of Ondansetron can be decreased when combined with Oxandrolone.,decrease,no risk
Ondansetron,Oxatomide,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Oxatomide.,increase,risk
Ondansetron,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Ondansetron.,increase,risk
Ondansetron,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Ondansetron.,increase,risk
Ondansetron,Oxitriptan,The risk or severity of CNS depression can be increased when Ondansetron is combined with Oxitriptan.,increase,risk
Ondansetron,Oxprenolol,The risk or severity of CNS depression can be increased when Ondansetron is combined with Oxprenolol.,increase,risk
Ondansetron,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Ondansetron.,increase,risk
Ondansetron,Oxybutynin,The metabolism of Ondansetron can be decreased when combined with Oxybutynin.,decrease,no risk
Ondansetron,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Ondansetron.,increase,risk
Ondansetron,Oxymorphone,The risk or severity of CNS depression can be increased when Ondansetron is combined with Oxymorphone.,increase,risk
Ondansetron,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Ondansetron.,increase,risk
Ondansetron,Quazepam,The risk or severity of CNS depression can be increased when Ondansetron is combined with Quazepam.,increase,risk
Ondansetron,Quetiapine,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Quetiapine.,increase,risk
Ondansetron,Quinidine,The metabolism of Quinidine can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Quinine,The metabolism of Ondansetron can be decreased when combined with Quinine.,decrease,no risk
Ondansetron,Quinupramine,The risk or severity of CNS depression can be increased when Ondansetron is combined with Quinupramine.,increase,risk
Ondansetron,Quizartinib,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Quizartinib.,increase,risk
Ondansetron,Udenafil,The metabolism of Udenafil can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Urethane,The risk or severity of CNS depression can be increased when Ondansetron is combined with Urethane.,increase,risk
Ondansetron,Vadadustat,The serum concentration of Ondansetron can be increased when it is combined with Vadadustat.,increase,no risk
Ondansetron,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Valdecoxib,The metabolism of Ondansetron can be decreased when combined with Valdecoxib.,decrease,no risk
Ondansetron,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Valproate bismuth.,increase,risk
Ondansetron,Valproic acid,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Valproic acid.,increase,risk
Ondansetron,Valsartan,The metabolism of Ondansetron can be decreased when combined with Valsartan.,decrease,no risk
Ondansetron,Vandetanib,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Vandetanib.,increase,risk
Ondansetron,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Ondansetron.,increase,risk
Ondansetron,Vecuronium,The risk or severity of CNS depression can be increased when Ondansetron is combined with Vecuronium.,increase,risk
Ondansetron,Vemurafenib,The serum concentration of Ondansetron can be increased when it is combined with Vemurafenib.,increase,no risk
Ondansetron,Venetoclax,The metabolism of Ondansetron can be decreased when combined with Venetoclax.,decrease,no risk
Ondansetron,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Venlafaxine.,increase,risk
Ondansetron,Verapamil,The metabolism of Ondansetron can be decreased when combined with Verapamil.,decrease,no risk
Ondansetron,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ondansetron.,increase,risk
Ondansetron,Vigabatrin,The risk or severity of CNS depression can be increased when Ondansetron is combined with Vigabatrin.,increase,risk
Ondansetron,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Ondansetron.,increase,risk
Ondansetron,Vilazodone,The metabolism of Ondansetron can be decreased when combined with Vilazodone.,decrease,no risk
Ondansetron,Viloxazine,The metabolism of Ondansetron can be decreased when combined with Viloxazine.,decrease,no risk
Ondansetron,Vinblastine,The metabolism of Ondansetron can be decreased when combined with Vinblastine.,decrease,no risk
Ondansetron,Vincristine,The metabolism of Vincristine can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Vinorelbine,The metabolism of Ondansetron can be decreased when combined with Vinorelbine.,decrease,no risk
Ondansetron,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Voriconazole,The metabolism of Ondansetron can be decreased when combined with Voriconazole.,decrease,no risk
Ondansetron,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Ondansetron.,increase,risk
Ondansetron,Vortioxetine,The risk or severity of CNS depression can be increased when Ondansetron is combined with Vortioxetine.,increase,risk
Ondansetron,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Warfarin,The metabolism of Ondansetron can be decreased when combined with Warfarin.,decrease,no risk
Ondansetron,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Yohimbine,The therapeutic efficacy of Ondansetron can be increased when used in combination with Yohimbine.,increase,no risk
Ondansetron,Zafirlukast,The metabolism of Ondansetron can be decreased when combined with Zafirlukast.,decrease,no risk
Ondansetron,Zaleplon,The risk or severity of CNS depression can be increased when Ondansetron is combined with Zaleplon.,increase,risk
Ondansetron,Ziconotide,The risk or severity of CNS depression can be increased when Ondansetron is combined with Ziconotide.,increase,risk
Ondansetron,Zidovudine,The metabolism of Ondansetron can be decreased when combined with Zidovudine.,decrease,no risk
Ondansetron,Zileuton,The metabolism of Ondansetron can be decreased when combined with Zileuton.,decrease,no risk
Ondansetron,Zimelidine,The risk or severity of adverse effects can be increased when Ondansetron is combined with Zimelidine.,increase,risk
Ondansetron,Ziprasidone,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Ziprasidone.,increase,risk
Ondansetron,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Ondansetron.,increase,risk
Ondansetron,Zolpidem,Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Ondansetron,Zonisamide,The risk or severity of CNS depression can be increased when Ondansetron is combined with Zonisamide.,increase,risk
Ondansetron,Zopiclone,The risk or severity of adverse effects can be increased when Ondansetron is combined with Zopiclone.,increase,risk
Ondansetron,Zotepine,The risk or severity of CNS depression can be increased when Ondansetron is combined with Zotepine.,increase,risk
Ondansetron,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Zuclopenthixol.,increase,risk
Ondansetron,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Ondansetron.,increase,risk
Bimatoprost,Nabumetone,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Nabumetone.,decrease,no risk
Bimatoprost,Nadolol,Bimatoprost may increase the hypotensive activities of Nadolol.,increase,no risk
Bimatoprost,Naproxen,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Naproxen.,decrease,no risk
Bimatoprost,Nebivolol,Bimatoprost may increase the hypotensive activities of Nebivolol.,increase,no risk
Bimatoprost,Nicardipine,Nicardipine may increase the hypotensive activities of Bimatoprost.,increase,no risk
Bimatoprost,Nicorandil,Bimatoprost may increase the hypotensive activities of Nicorandil.,increase,no risk
Bimatoprost,Nilvadipine,Bimatoprost may increase the hypotensive activities of Nilvadipine.,increase,no risk
Bimatoprost,Nimesulide,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Nimesulide.,decrease,no risk
Bimatoprost,Nimodipine,Nimodipine may increase the hypotensive activities of Bimatoprost.,increase,no risk
Bimatoprost,Nisoldipine,Nisoldipine may increase the hypotensive activities of Bimatoprost.,increase,no risk
Bimatoprost,Nitrendipine,Bimatoprost may increase the hypotensive activities of Nitrendipine.,increase,no risk
Bimatoprost,Nitroglycerin,Nitroglycerin may increase the hypotensive activities of Bimatoprost.,increase,no risk
Bimatoprost,Nitroprusside,Nitroprusside may increase the hypotensive activities of Bimatoprost.,increase,no risk
Bimatoprost,Olmesartan,Olmesartan may increase the hypotensive activities of Bimatoprost.,increase,no risk
Bimatoprost,Oxaprozin,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Oxaprozin.,decrease,no risk
Bimatoprost,Oxprenolol,Bimatoprost may increase the hypotensive activities of Oxprenolol.,increase,no risk
Bimatoprost,Oxyphenbutazone,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Bimatoprost,Quetiapine,Quetiapine may increase the hypotensive activities of Bimatoprost.,increase,no risk
Bimatoprost,Quinapril,Quinapril may increase the hypotensive activities of Bimatoprost.,increase,no risk
Bimatoprost,Quinine,Quinine may increase the hypotensive activities of Bimatoprost.,increase,no risk
Bimatoprost,Unoprostone,Bimatoprost may increase the hypotensive activities of Unoprostone.,increase,no risk
Bimatoprost,Valdecoxib,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Valdecoxib.,decrease,no risk
Bimatoprost,Valsartan,Valsartan may increase the hypotensive activities of Bimatoprost.,increase,no risk
Bimatoprost,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Bimatoprost.,increase,no risk
Bimatoprost,Zofenopril,Bimatoprost may increase the hypotensive activities of Zofenopril.,increase,no risk
Tiagabine,Gabapentin,The risk or severity of CNS depression can be increased when Tiagabine is combined with Gabapentin.,increase,risk
Tiagabine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Tiagabine is combined with Gabapentin enacarbil.,increase,risk
Tiagabine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Tiagabine.,increase,risk
Tiagabine,Gamolenic acid,The therapeutic efficacy of Tiagabine can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Tiagabine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Tiagabine is combined with Ganaxolone.",increase,risk
Tiagabine,Ganciclovir,The therapeutic efficacy of Tiagabine can be decreased when used in combination with Ganciclovir.,decrease,no risk
Tiagabine,Gemfibrozil,The metabolism of Tiagabine can be decreased when combined with Gemfibrozil.,decrease,no risk
Tiagabine,Gepirone,The risk or severity of CNS depression can be increased when Tiagabine is combined with Gepirone.,increase,risk
Tiagabine,Gestrinone,The metabolism of Gestrinone can be increased when combined with Tiagabine.,increase,no risk
Tiagabine,Glecaprevir,The metabolism of Tiagabine can be decreased when combined with Glecaprevir.,decrease,no risk
Tiagabine,Glofitamab,The serum concentration of Tiagabine can be increased when it is combined with Glofitamab.,increase,no risk
Tiagabine,Glutethimide,The risk or severity of CNS depression can be increased when Tiagabine is combined with Glutethimide.,increase,risk
Tiagabine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Tiagabine.,increase,risk
Tiagabine,Guanfacine,The risk or severity of CNS depression can be increased when Tiagabine is combined with Guanfacine.,increase,risk
Tiagabine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Tiagabine.,increase,risk
Tiagabine,Halofantrine,The therapeutic efficacy of Tiagabine can be decreased when used in combination with Halofantrine.,decrease,no risk
Tiagabine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Tiagabine.,increase,risk
Tiagabine,Halothane,The risk or severity of CNS depression can be increased when Tiagabine is combined with Halothane.,increase,risk
Tiagabine,Hexafluronium,The risk or severity of CNS depression can be increased when Tiagabine is combined with Hexafluronium.,increase,risk
Tiagabine,Hydrocodone,Tiagabine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Tiagabine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Tiagabine.,increase,risk
Tiagabine,Hydroxychloroquine,The therapeutic efficacy of Tiagabine can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Tiagabine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Tiagabine.,increase,no risk
Tiagabine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tiagabine.,increase,no risk
Tiagabine,Ketamine,The risk or severity of CNS depression can be increased when Tiagabine is combined with Ketamine.,increase,risk
Tiagabine,Ketazolam,The risk or severity of CNS depression can be increased when Tiagabine is combined with Ketazolam.,increase,risk
Tiagabine,Ketoconazole,The metabolism of Tiagabine can be decreased when combined with Ketoconazole.,decrease,no risk
Tiagabine,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Tiagabine.,increase,no risk
Tiagabine,Nalbuphine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Tiagabine.,increase,risk
Tiagabine,Nalidixic acid,The therapeutic efficacy of Tiagabine can be decreased when used in combination with Nalidixic acid.,decrease,no risk
Tiagabine,Naratriptan,The risk or severity of CNS depression can be increased when Tiagabine is combined with Naratriptan.,increase,risk
Tiagabine,Nefazodone,The metabolism of Tiagabine can be decreased when combined with Nefazodone.,decrease,no risk
Tiagabine,Nelfinavir,The metabolism of Tiagabine can be decreased when combined with Nelfinavir.,decrease,no risk
Tiagabine,Netupitant,The metabolism of Tiagabine can be decreased when combined with Netupitant.,decrease,no risk
Tiagabine,Nialamide,The risk or severity of CNS depression can be increased when Tiagabine is combined with Nialamide.,increase,risk
Tiagabine,Nicardipine,The metabolism of Tiagabine can be decreased when combined with Nicardipine.,decrease,no risk
Tiagabine,Nilotinib,The metabolism of Tiagabine can be decreased when combined with Nilotinib.,decrease,no risk
Tiagabine,Nilvadipine,The metabolism of Tiagabine can be decreased when combined with Nilvadipine.,decrease,no risk
Tiagabine,Nitrazepam,The risk or severity of CNS depression can be increased when Tiagabine is combined with Nitrazepam.,increase,risk
Tiagabine,Nitrous oxide,The risk or severity of CNS depression can be increased when Tiagabine is combined with Nitrous oxide.,increase,risk
Tiagabine,Nomegestrol,The metabolism of Nomegestrol can be increased when combined with Tiagabine.,increase,no risk
Tiagabine,Nomegestrol acetate,The metabolism of Nomegestrol acetate can be increased when combined with Tiagabine.,increase,no risk
Tiagabine,Nomifensine,The risk or severity of CNS depression can be increased when Tiagabine is combined with Nomifensine.,increase,risk
Tiagabine,Nonoxynol-9,The metabolism of Nonoxynol-9 can be increased when combined with Tiagabine.,increase,no risk
Tiagabine,Norelgestromin,The metabolism of Norelgestromin can be increased when combined with Tiagabine.,increase,no risk
Tiagabine,Norethisterone,The metabolism of Norethisterone can be increased when combined with Tiagabine.,increase,no risk
Tiagabine,Norethynodrel,The metabolism of Norethynodrel can be increased when combined with Tiagabine.,increase,no risk
Tiagabine,Norgestimate,The metabolism of Norgestimate can be increased when combined with Tiagabine.,increase,no risk
Tiagabine,Norgestrel,The metabolism of Norgestrel can be increased when combined with Tiagabine.,increase,no risk
Tiagabine,Normethadone,The risk or severity of CNS depression can be increased when Tiagabine is combined with Normethadone.,increase,risk
Tiagabine,Nortriptyline,The risk or severity of CNS depression can be increased when Nortriptyline is combined with Tiagabine.,increase,risk
Tiagabine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Tiagabine.,increase,risk
Tiagabine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Tiagabine is combined with Oliceridine.",increase,risk
Tiagabine,Omaveloxolone,The serum concentration of Tiagabine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Tiagabine,Ombitasvir,The metabolism of Tiagabine can be decreased when combined with Ombitasvir.,decrease,no risk
Tiagabine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Tiagabine.,increase,risk
Tiagabine,Opium,The risk or severity of CNS depression can be increased when Tiagabine is combined with Opium.,increase,risk
Tiagabine,Orlistat,Orlistat can cause a decrease in the absorption of Tiagabine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Tiagabine,Orphenadrine,Tiagabine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Tiagabine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Tiagabine.,increase,risk
Tiagabine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Tiagabine.,increase,risk
Tiagabine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tiagabine is combined with Oxetacaine.,increase,risk
Tiagabine,Oxitriptan,The risk or severity of CNS depression can be increased when Tiagabine is combined with Oxitriptan.,increase,risk
Tiagabine,Oxprenolol,The risk or severity of CNS depression can be increased when Tiagabine is combined with Oxprenolol.,increase,risk
Tiagabine,Oxtriphylline,Tiagabine may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tiagabine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Tiagabine is combined with Oxybuprocaine.,increase,risk
Tiagabine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Tiagabine.,increase,risk
Tiagabine,Oxymorphone,The risk or severity of CNS depression can be increased when Tiagabine is combined with Oxymorphone.,increase,risk
Tiagabine,Quazepam,The risk or severity of CNS depression can be increased when Tiagabine is combined with Quazepam.,increase,risk
Tiagabine,Quetiapine,The risk or severity of CNS depression can be increased when Tiagabine is combined with Quetiapine.,increase,risk
Tiagabine,Quinidine,The therapeutic efficacy of Tiagabine can be decreased when used in combination with Quinidine.,decrease,no risk
Tiagabine,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Tiagabine.,increase,risk
Tiagabine,Quinupramine,The risk or severity of CNS depression can be increased when Tiagabine is combined with Quinupramine.,increase,risk
Tiagabine,Quizartinib,The metabolism of Tiagabine can be decreased when combined with Quizartinib.,decrease,no risk
Tiagabine,Ulipristal,The metabolism of Ulipristal can be increased when combined with Tiagabine.,increase,no risk
Tiagabine,Urethane,The risk or severity of CNS depression can be increased when Tiagabine is combined with Urethane.,increase,risk
Tiagabine,Vadadustat,The serum concentration of Tiagabine can be increased when it is combined with Vadadustat.,increase,no risk
Tiagabine,Valganciclovir,The therapeutic efficacy of Tiagabine can be decreased when used in combination with Valganciclovir.,decrease,no risk
Tiagabine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Tiagabine.,increase,risk
Tiagabine,Vecuronium,The risk or severity of CNS depression can be increased when Tiagabine is combined with Vecuronium.,increase,risk
Tiagabine,Venetoclax,The metabolism of Tiagabine can be decreased when combined with Venetoclax.,decrease,no risk
Tiagabine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Tiagabine.,increase,risk
Tiagabine,Verapamil,The metabolism of Tiagabine can be decreased when combined with Verapamil.,decrease,no risk
Tiagabine,Vigabatrin,The risk or severity of CNS depression can be increased when Tiagabine is combined with Vigabatrin.,increase,risk
Tiagabine,Vilazodone,The risk or severity of CNS depression can be increased when Tiagabine is combined with Vilazodone.,increase,risk
Tiagabine,Viloxazine,The metabolism of Tiagabine can be decreased when combined with Viloxazine.,decrease,no risk
Tiagabine,Voriconazole,The metabolism of Tiagabine can be decreased when combined with Voriconazole.,decrease,no risk
Tiagabine,Vortioxetine,The risk or severity of CNS depression can be increased when Tiagabine is combined with Vortioxetine.,increase,risk
Tiagabine,Yohimbine,The risk or severity of CNS depression can be increased when Tiagabine is combined with Yohimbine.,increase,risk
Tiagabine,Zaleplon,The risk or severity of CNS depression can be increased when Tiagabine is combined with Zaleplon.,increase,risk
Tiagabine,Ziconotide,The risk or severity of CNS depression can be increased when Tiagabine is combined with Ziconotide.,increase,risk
Tiagabine,Zidovudine,The metabolism of Tiagabine can be increased when combined with Zidovudine.,increase,no risk
Tiagabine,Zimelidine,The risk or severity of adverse effects can be increased when Tiagabine is combined with Zimelidine.,increase,risk
Tiagabine,Ziprasidone,The risk or severity of adverse effects can be increased when Tiagabine is combined with Ziprasidone.,increase,risk
Tiagabine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Tiagabine.,increase,risk
Tiagabine,Zolpidem,Tiagabine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Tiagabine,Zonisamide,The risk or severity of CNS depression can be increased when Tiagabine is combined with Zonisamide.,increase,risk
Tiagabine,Zopiclone,The risk or severity of adverse effects can be increased when Tiagabine is combined with Zopiclone.,increase,risk
Tiagabine,Zotepine,The risk or severity of CNS depression can be increased when Tiagabine is combined with Zotepine.,increase,risk
Tiagabine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Tiagabine is combined with Zuclopenthixol.,increase,risk
Tiagabine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Tiagabine.,increase,risk
Cocaine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Benzocaine.,increase,risk
Cocaine,Benzonatate,The serum concentration of Cocaine can be increased when it is combined with Benzonatate.,increase,no risk
Cocaine,Benzphetamine,The risk or severity of serotonin syndrome can be increased when Benzphetamine is combined with Cocaine.,increase,risk
Cocaine,Benzthiazide,The serum concentration of Benzthiazide can be increased when it is combined with Cocaine.,increase,no risk
Cocaine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Benzyl alcohol.,increase,risk
Cocaine,Benzylpenicillin,The risk or severity of methemoglobinemia can be increased when Benzylpenicillin is combined with Cocaine.,increase,risk
Cocaine,Benzylpenicilloyl polylysine,The risk or severity of methemoglobinemia can be increased when Benzylpenicilloyl polylysine is combined with Cocaine.,increase,risk
Cocaine,Bepridil,The risk or severity of QTc prolongation can be increased when Cocaine is combined with Bepridil.,increase,risk
Cocaine,Berotralstat,The risk or severity of QTc prolongation can be increased when Berotralstat is combined with Cocaine.,increase,risk
Cocaine,Besifloxacin,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Cocaine.,increase,risk
Cocaine,Betaine,Betaine may increase the neuromuscular blocking activities of Cocaine.,increase,no risk
Cocaine,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Bethanidine,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Cocaine.,increase,risk
Cocaine,Bevacizumab,The risk or severity of methemoglobinemia can be increased when Bevacizumab is combined with Cocaine.,increase,risk
Cocaine,Bexarotene,The risk or severity of methemoglobinemia can be increased when Bexarotene is combined with Cocaine.,increase,risk
Cocaine,Bicalutamide,The risk or severity of methemoglobinemia can be increased when Bicalutamide is combined with Cocaine.,increase,risk
Cocaine,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Cocaine.,increase,risk
Cocaine,Binimetinib,The risk or severity of methemoglobinemia can be increased when Binimetinib is combined with Cocaine.,increase,risk
Cocaine,Biperiden,The risk or severity of adverse effects can be increased when Biperiden is combined with Cocaine.,increase,risk
Cocaine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Cocaine.,decrease,no risk
Cocaine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Cocaine.,decrease,no risk
Cocaine,Bleomycin,The risk or severity of methemoglobinemia can be increased when Bleomycin is combined with Cocaine.,increase,risk
Cocaine,Blinatumomab,The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Cocaine.,increase,risk
Cocaine,Bortezomib,The risk or severity of methemoglobinemia can be increased when Bortezomib is combined with Cocaine.,increase,risk
Cocaine,Bortezomib D-mannitol,The risk or severity of methemoglobinemia can be increased when Bortezomib D-mannitol is combined with Cocaine.,increase,risk
Cocaine,Bosutinib,The risk or severity of methemoglobinemia can be increased when Bosutinib is combined with Cocaine.,increase,risk
Cocaine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Cocaine is combined with Botulinum toxin type A.,increase,risk
Cocaine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Cocaine is combined with Botulinum toxin type B.,increase,risk
Cocaine,Brentuximab vedotin,The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Cocaine.,increase,risk
Cocaine,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Cocaine.,increase,risk
Cocaine,Brexanolone,The risk or severity of methemoglobinemia can be increased when Brexanolone is combined with Cocaine.,increase,risk
Cocaine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Brexucabtagene autoleucel,The risk or severity of methemoglobinemia can be increased when Brexucabtagene autoleucel is combined with Cocaine.,increase,risk
Cocaine,Brigatinib,The risk or severity of methemoglobinemia can be increased when Brigatinib is combined with Cocaine.,increase,risk
Cocaine,Brivaracetam,The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Cocaine.,increase,risk
Cocaine,Bromocriptine,The risk or severity of Tachycardia can be increased when Cocaine is combined with Bromocriptine.,increase,risk
Cocaine,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Cocaine.,increase,risk
Cocaine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Cocaine.,increase,risk
Cocaine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Cocaine.,increase,risk
Cocaine,Buprenorphine,The risk or severity of adverse effects can be increased when Cocaine is combined with Buprenorphine.,increase,risk
Cocaine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Cocaine.,increase,risk
Cocaine,Buserelin,The risk or severity of methemoglobinemia can be increased when Buserelin is combined with Cocaine.,increase,risk
Cocaine,Buspirone,The metabolism of Buspirone can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Busulfan,The risk or severity of methemoglobinemia can be increased when Busulfan is combined with Cocaine.,increase,risk
Cocaine,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Cocaine.,increase,risk
Cocaine,Butacaine,The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Butacaine.,increase,risk
Cocaine,Butalbital,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Cocaine.,increase,risk
Cocaine,Butamben,The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Butamben.,increase,risk
Cocaine,Butobarbital,The risk or severity of adverse effects can be increased when Cocaine is combined with Butobarbital.,increase,risk
Cocaine,Butorphanol,The risk or severity of adverse effects can be increased when Cocaine is combined with Butorphanol.,increase,risk
Cocaine,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Cocaine.,increase,risk
Cocaine,Butylscopolamine,The risk or severity of adverse effects can be increased when Cocaine is combined with Butylscopolamine.,increase,risk
Cocaine,Gabapentin,The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Cocaine.,increase,risk
Cocaine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Cocaine.,increase,risk
Cocaine,Galantamine,Galantamine may increase the neuromuscular blocking activities of Cocaine.,increase,no risk
Cocaine,Gallamine triethiodide,Gallamine triethiodide may increase the neuromuscular blocking activities of Cocaine.,increase,no risk
Cocaine,Ganaxolone,The risk or severity of methemoglobinemia can be increased when Ganaxolone is combined with Cocaine.,increase,risk
Cocaine,Gatifloxacin,The risk or severity of methemoglobinemia can be increased when Gatifloxacin is combined with Cocaine.,increase,risk
Cocaine,Gefitinib,The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Cocaine.,increase,risk
Cocaine,Gemcitabine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Cocaine.,increase,risk
Cocaine,Gemifloxacin,The risk or severity of methemoglobinemia can be increased when Gemifloxacin is combined with Cocaine.,increase,risk
Cocaine,Gemtuzumab ozogamicin,The risk or severity of methemoglobinemia can be increased when Gemtuzumab ozogamicin is combined with Cocaine.,increase,risk
Cocaine,Gentamicin,The risk or severity of methemoglobinemia can be increased when Gentamicin is combined with Cocaine.,increase,risk
Cocaine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Cocaine.,increase,risk
Cocaine,Gilteritinib,The risk or severity of methemoglobinemia can be increased when Gilteritinib is combined with Cocaine.,increase,risk
Cocaine,Ginkgo biloba,Ginkgo biloba may increase the neuromuscular blocking activities of Cocaine.,increase,no risk
Cocaine,Glasdegib,The risk or severity of QTc prolongation can be increased when Cocaine is combined with Glasdegib.,increase,risk
Cocaine,Glofitamab,The serum concentration of Cocaine can be increased when it is combined with Glofitamab.,increase,no risk
Cocaine,Glucagon,Cocaine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Cocaine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Cocaine.,decrease,no risk
Cocaine,Glycopyrronium,The risk or severity of adverse effects can be increased when Cocaine is combined with Glycopyrronium.,increase,risk
Cocaine,Goserelin,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Cocaine.,increase,risk
Cocaine,Gramicidin D,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Cocaine.,increase,risk
Cocaine,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Cocaine.,increase,risk
Cocaine,Grepafloxacin,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Cocaine.,increase,risk
Cocaine,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Cocaine.,increase,risk
Cocaine,Guanfacine,The risk or severity of Tachycardia can be increased when Cocaine is combined with Guanfacine.,increase,risk
Cocaine,Halofantrine,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Cocaine.,increase,risk
Cocaine,Haloperidol,The risk or severity of QTc prolongation can be increased when Cocaine is combined with Haloperidol.,increase,risk
Cocaine,Hetacillin,The risk or severity of methemoglobinemia can be increased when Hetacillin is combined with Cocaine.,increase,risk
Cocaine,Hexafluronium,Hexafluronium may increase the neuromuscular blocking activities of Cocaine.,increase,no risk
Cocaine,Hexocyclium,The risk or severity of adverse effects can be increased when Cocaine is combined with Hexocyclium.,increase,risk
Cocaine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Cocaine.,increase,risk
Cocaine,Homatropine,The risk or severity of adverse effects can be increased when Cocaine is combined with Homatropine.,increase,risk
Cocaine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Cocaine.,increase,risk
Cocaine,Huperzine A,Huperzine A may increase the neuromuscular blocking activities of Cocaine.,increase,no risk
Cocaine,Hydralazine,The therapeutic efficacy of Hydralazine can be decreased when used in combination with Cocaine.,decrease,no risk
Cocaine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Cocaine.,increase,risk
Cocaine,Hydrocodone,The risk or severity of serotonin syndrome can be increased when Hydrocodone is combined with Cocaine.,increase,risk
Cocaine,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Cocaine.,increase,no risk
Cocaine,Hydromorphone,The risk or severity of adverse effects can be increased when Cocaine is combined with Hydromorphone.,increase,risk
Cocaine,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Cocaine.,increase,risk
Cocaine,Hydroxyprogesterone caproate,The risk or severity of methemoglobinemia can be increased when Hydroxyprogesterone caproate is combined with Cocaine.,increase,risk
Cocaine,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Cocaine.,increase,risk
Cocaine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Cocaine is combined with Hydroxyzine.,increase,risk
Cocaine,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Cocaine.,increase,risk
Cocaine,Kanamycin,The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Cocaine.,increase,risk
Cocaine,Ketamine,Ketamine may increase the neuromuscular blocking activities of Cocaine.,increase,no risk
Cocaine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Cocaine.,increase,risk
Cocaine,Nabilone,Cocaine may increase the tachycardic activities of Nabilone.,increase,no risk
Cocaine,Nadolol,The metabolism of Nadolol can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Nafcillin,The risk or severity of methemoglobinemia can be increased when Nafcillin is combined with Cocaine.,increase,risk
Cocaine,Nalbuphine,The risk or severity of adverse effects can be increased when Cocaine is combined with Nalbuphine.,increase,risk
Cocaine,Nalidixic acid,The risk or severity of methemoglobinemia can be increased when Nalidixic acid is combined with Cocaine.,increase,risk
Cocaine,Naloxegol,The risk or severity of adverse effects can be increased when Cocaine is combined with Naloxegol.,increase,risk
Cocaine,Naltrexone,The risk or severity of adverse effects can be increased when Cocaine is combined with Naltrexone.,increase,risk
Cocaine,Naphazoline,The risk or severity of Tachycardia can be increased when Cocaine is combined with Naphazoline.,increase,risk
Cocaine,Naratriptan,The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Naratriptan.,increase,risk
Cocaine,Natamycin,The risk or severity of methemoglobinemia can be increased when Natamycin is combined with Cocaine.,increase,risk
Cocaine,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Naxitamab,The risk or severity of methemoglobinemia can be increased when Naxitamab is combined with Cocaine.,increase,risk
Cocaine,Nebivolol,The metabolism of Nebivolol can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Necitumumab,The risk or severity of methemoglobinemia can be increased when Necitumumab is combined with Cocaine.,increase,risk
Cocaine,Nedaplatin,The risk or severity of methemoglobinemia can be increased when Nedaplatin is combined with Cocaine.,increase,risk
Cocaine,Nefazodone,The metabolism of Nefazodone can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Nelarabine,The risk or severity of methemoglobinemia can be increased when Nelarabine is combined with Cocaine.,increase,risk
Cocaine,Nelfinavir,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Cocaine.,increase,risk
Cocaine,Neomycin,The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Cocaine.,increase,risk
Cocaine,Neostigmine,Neostigmine may increase the neuromuscular blocking activities of Cocaine.,increase,no risk
Cocaine,Neratinib,The risk or severity of methemoglobinemia can be increased when Neratinib is combined with Cocaine.,increase,risk
Cocaine,Netilmicin,The risk or severity of methemoglobinemia can be increased when Netilmicin is combined with Cocaine.,increase,risk
Cocaine,Netupitant,The metabolism of Netupitant can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Nialamide,The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Nialamide.,increase,risk
Cocaine,Nicardipine,The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Cocaine.,increase,risk
Cocaine,Nicergoline,The metabolism of Nicergoline can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Nicotine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Cocaine.,increase,risk
Cocaine,Nifedipine,The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Cocaine.,increase,risk
Cocaine,Nilotinib,The risk or severity of methemoglobinemia can be increased when Nilotinib is combined with Cocaine.,increase,risk
Cocaine,Nilutamide,The risk or severity of methemoglobinemia can be increased when Nilutamide is combined with Cocaine.,increase,risk
Cocaine,Nilvadipine,The risk or severity of QTc prolongation can be increased when Nilvadipine is combined with Cocaine.,increase,risk
Cocaine,Nimodipine,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Cocaine.,increase,risk
Cocaine,Nintedanib,The risk or severity of methemoglobinemia can be increased when Nintedanib is combined with Cocaine.,increase,risk
Cocaine,Niraparib,The risk or severity of methemoglobinemia can be increased when Niraparib is combined with Cocaine.,increase,risk
Cocaine,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Nitrazepam,The risk or severity of methemoglobinemia can be increased when Nitrazepam is combined with Cocaine.,increase,risk
Cocaine,Nitrendipine,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Cocaine.,increase,risk
Cocaine,Nitrofurantoin,The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Cocaine.,increase,risk
Cocaine,Nivolumab,The risk or severity of methemoglobinemia can be increased when Nivolumab is combined with Cocaine.,increase,risk
Cocaine,Nizatidine,Nizatidine may increase the neuromuscular blocking activities of Cocaine.,increase,no risk
Cocaine,Norepinephrine,The risk or severity of Tachycardia can be increased when Norepinephrine is combined with Cocaine.,increase,risk
Cocaine,Norfloxacin,The risk or severity of methemoglobinemia can be increased when Norfloxacin is combined with Cocaine.,increase,risk
Cocaine,Normethadone,The risk or severity of adverse effects can be increased when Cocaine is combined with Normethadone.,increase,risk
Cocaine,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Novobiocin,The risk or severity of methemoglobinemia can be increased when Novobiocin is combined with Cocaine.,increase,risk
Cocaine,Nylidrin,The risk or severity of Tachycardia can be increased when Cocaine is combined with Nylidrin.,increase,risk
Cocaine,Obinutuzumab,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Cocaine.,increase,risk
Cocaine,Octreotide,The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Cocaine.,increase,risk
Cocaine,Ofatumumab,The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Cocaine.,increase,risk
Cocaine,Ofloxacin,The risk or severity of methemoglobinemia can be increased when Ofloxacin is combined with Cocaine.,increase,risk
Cocaine,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Cocaine.,increase,risk
Cocaine,Olaparib,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Cocaine.,increase,risk
Cocaine,Olaratumab,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Cocaine.,increase,risk
Cocaine,Oliceridine,The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Oliceridine.,increase,risk
Cocaine,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Cocaine.,increase,risk
Cocaine,Olutasidenib,The risk or severity of methemoglobinemia can be increased when Olutasidenib is combined with Cocaine.,increase,risk
Cocaine,Omacetaxine mepesuccinate,The risk or severity of methemoglobinemia can be increased when Omacetaxine mepesuccinate is combined with Cocaine.,increase,risk
Cocaine,Omadacycline,The risk or severity of methemoglobinemia can be increased when Omadacycline is combined with Cocaine.,increase,risk
Cocaine,Omaveloxolone,The serum concentration of Cocaine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Cocaine,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Cocaine.,increase,risk
Cocaine,Opium,The risk or severity of adverse effects can be increased when Cocaine is combined with Opium.,increase,risk
Cocaine,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Cocaine.,increase,risk
Cocaine,Oritavancin,The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Cocaine.,increase,risk
Cocaine,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Cocaine.,increase,risk
Cocaine,Osimertinib,The risk or severity of methemoglobinemia can be increased when Osimertinib is combined with Cocaine.,increase,risk
Cocaine,Oxacillin,The risk or severity of methemoglobinemia can be increased when Oxacillin is combined with Cocaine.,increase,risk
Cocaine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Cocaine.,increase,risk
Cocaine,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Cocaine.,increase,risk
Cocaine,Oxcarbazepine,The risk or severity of methemoglobinemia can be increased when Oxcarbazepine is combined with Cocaine.,increase,risk
Cocaine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Oxetacaine.,increase,risk
Cocaine,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Oxybuprocaine is combined with Cocaine.,increase,risk
Cocaine,Oxybutynin,The risk or severity of adverse effects can be increased when Cocaine is combined with Oxybutynin.,increase,risk
Cocaine,Oxycodone,The risk or severity of adverse effects can be increased when Cocaine is combined with Oxycodone.,increase,risk
Cocaine,Oxymetazoline,The risk or severity of Tachycardia can be increased when Cocaine is combined with Oxymetazoline.,increase,risk
Cocaine,Oxymorphone,The risk or severity of adverse effects can be increased when Cocaine is combined with Oxymorphone.,increase,risk
Cocaine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Cocaine.,increase,risk
Cocaine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Cocaine.,decrease,no risk
Cocaine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Cocaine.,increase,risk
Cocaine,Oxytetracycline,The risk or severity of methemoglobinemia can be increased when Oxytetracycline is combined with Cocaine.,increase,risk
Cocaine,Oxytocin,The risk or severity of hypertension can be increased when Cocaine is combined with Oxytocin.,increase,risk
Cocaine,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Cocaine.,increase,risk
Cocaine,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Cocaine.,increase,no risk
Cocaine,Quinidine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Cocaine.,increase,risk
Cocaine,Quinine,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Cocaine.,increase,risk
Cocaine,Quinupramine,The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Quinupramine.,increase,risk
Cocaine,Quinupristin,The risk or severity of methemoglobinemia can be increased when Quinupristin is combined with Cocaine.,increase,risk
Cocaine,Quizartinib,The risk or severity of QTc prolongation can be increased when Cocaine is combined with Quizartinib.,increase,risk
Cocaine,Umbralisib,The risk or severity of methemoglobinemia can be increased when Umbralisib is combined with Cocaine.,increase,risk
Cocaine,Umeclidinium,The risk or severity of adverse effects can be increased when Cocaine is combined with Umeclidinium.,increase,risk
Cocaine,Uracil mustard,The risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Cocaine.,increase,risk
Cocaine,Urethane,The risk or severity of methemoglobinemia can be increased when Urethane is combined with Cocaine.,increase,risk
Cocaine,Vadadustat,The serum concentration of Cocaine can be increased when it is combined with Vadadustat.,increase,no risk
Cocaine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Valproate bismuth.,increase,risk
Cocaine,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Cocaine.,increase,risk
Cocaine,Valrubicin,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Cocaine.,increase,risk
Cocaine,Vancomycin,The risk or severity of methemoglobinemia can be increased when Vancomycin is combined with Cocaine.,increase,risk
Cocaine,Vandetanib,The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Cocaine.,increase,risk
Cocaine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Cocaine.,increase,risk
Cocaine,Vecuronium,The risk or severity of adverse effects can be increased when Cocaine is combined with Vecuronium.,increase,risk
Cocaine,Vemurafenib,The risk or severity of methemoglobinemia can be increased when Vemurafenib is combined with Cocaine.,increase,risk
Cocaine,Venetoclax,The risk or severity of methemoglobinemia can be increased when Venetoclax is combined with Cocaine.,increase,risk
Cocaine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Venlafaxine.,increase,risk
Cocaine,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Cocaine.,increase,risk
Cocaine,Vigabatrin,The risk or severity of methemoglobinemia can be increased when Vigabatrin is combined with Cocaine.,increase,risk
Cocaine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Cocaine.,increase,risk
Cocaine,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Viloxazine,The metabolism of Cocaine can be decreased when combined with Viloxazine.,decrease,no risk
Cocaine,Vinblastine,The risk or severity of methemoglobinemia can be increased when Vinblastine is combined with Cocaine.,increase,risk
Cocaine,Vincristine,The risk or severity of methemoglobinemia can be increased when Vincristine is combined with Cocaine.,increase,risk
Cocaine,Vindesine,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Cocaine.,increase,risk
Cocaine,Vinflunine,The risk or severity of methemoglobinemia can be increased when Vinflunine is combined with Cocaine.,increase,risk
Cocaine,Vinorelbine,The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Cocaine.,increase,risk
Cocaine,Viomycin,The risk or severity of methemoglobinemia can be increased when Viomycin is combined with Cocaine.,increase,risk
Cocaine,Vismodegib,The risk or severity of methemoglobinemia can be increased when Vismodegib is combined with Cocaine.,increase,risk
Cocaine,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Cocaine.,increase,risk
Cocaine,Vorinostat,The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Cocaine.,increase,risk
Cocaine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Xamoterol,The risk or severity of Tachycardia can be increased when Cocaine is combined with Xamoterol.,increase,risk
Cocaine,Xylometazoline,The risk or severity of Tachycardia can be increased when Cocaine is combined with Xylometazoline.,increase,risk
Cocaine,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Zaleplon,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Cocaine.,increase,risk
Cocaine,Zanubrutinib,The risk or severity of methemoglobinemia can be increased when Zanubrutinib is combined with Cocaine.,increase,risk
Cocaine,Zimelidine,The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Zimelidine.,increase,risk
Cocaine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Cocaine is combined with Ziprasidone.,increase,risk
Cocaine,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Cocaine.,increase,risk
Cocaine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Zonisamide,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Cocaine.,increase,risk
Cocaine,Zotepine,The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Zotepine.,increase,risk
Cocaine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Cocaine is combined with Zuclopenthixol.,increase,risk
Quinidine,Bacitracin,Bacitracin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Baclofen,Baclofen may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Balsalazide,Balsalazide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Baricitinib,The serum concentration of Baricitinib can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Beclomethasone dipropionate,The metabolism of Quinidine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Quinidine,Bedaquiline,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Bedaquiline.,increase,risk
Quinidine,Belantamab mafodotin,Quinidine may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.,decrease,no risk
Quinidine,Belinostat,The serum concentration of Belinostat can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Belladonna,The risk or severity of adverse effects can be increased when Quinidine is combined with Belladonna.,increase,risk
Quinidine,Belumosudil,The serum concentration of Quinidine can be increased when it is combined with Belumosudil.,increase,no risk
Quinidine,Belzutifan,The serum concentration of Quinidine can be decreased when it is combined with Belzutifan.,decrease,no risk
Quinidine,Bemiparin,The therapeutic efficacy of Bemiparin can be increased when used in combination with Quinidine.,increase,no risk
Quinidine,Benazepril,Quinidine may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Quinidine,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Quinidine,Benorilate,Benorilate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Benserazide,Benserazide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Benzatropine,The metabolism of Benzatropine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Benzhydrocodone,The risk or severity of adverse effects can be increased when Quinidine is combined with Benzhydrocodone.,increase,risk
Quinidine,Benznidazole,Benznidazole may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Benzocaine.,increase,risk
Quinidine,Benzphetamine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Benzphetamine.,decrease,no risk
Quinidine,Benzthiazide,Benzthiazide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Quinidine,Benzydamine,Benzydamine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Benzyl alcohol.,increase,risk
Quinidine,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Bepotastine,Bepotastine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Bepridil,Quinidine may increase the arrhythmogenic activities of Bepridil.,increase,no risk
Quinidine,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Betaine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Betaine.,decrease,no risk
Quinidine,Betamethasone,The metabolism of Quinidine can be increased when combined with Betamethasone.,increase,no risk
Quinidine,Betamethasone phosphate,The metabolism of Quinidine can be increased when combined with Betamethasone phosphate.,increase,no risk
Quinidine,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Quinidine.,increase,no risk
Quinidine,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Bexarotene,The metabolism of Quinidine can be increased when combined with Bexarotene.,increase,no risk
Quinidine,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Bicisate,Bicisate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Bifonazole,The metabolism of Quinidine can be decreased when combined with Bifonazole.,decrease,no risk
Quinidine,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Quinidine.,increase,risk
Quinidine,Bimekizumab,The metabolism of Quinidine can be increased when combined with Bimekizumab.,increase,no risk
Quinidine,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Bioallethrin,Quinidine may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Quinidine,Biperiden,The risk or severity of adverse effects can be increased when Biperiden is combined with Quinidine.,increase,risk
Quinidine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Bismuth subgallate,Bismuth subgallate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Bismuth subnitrate,Bismuth subnitrate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Bisoprolol,The therapeutic efficacy of Quinidine can be increased when used in combination with Bisoprolol.,increase,no risk
Quinidine,Bisoxatin,Bisoxatin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Bivalirudin,The therapeutic efficacy of Bivalirudin can be increased when used in combination with Quinidine.,increase,no risk
Quinidine,Bleomycin,Bleomycin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Boceprevir,The metabolism of Quinidine can be decreased when combined with Boceprevir.,decrease,no risk
Quinidine,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Bosentan,The metabolism of Quinidine can be increased when combined with Bosentan.,increase,no risk
Quinidine,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Quinidine is combined with Botulinum toxin type A.,increase,risk
Quinidine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Quinidine is combined with Botulinum toxin type B.,increase,risk
Quinidine,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Bretylium,Quinidine may increase the arrhythmogenic activities of Bretylium.,increase,no risk
Quinidine,Brexanolone,The therapeutic efficacy of Brexanolone can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Brivaracetam,Brivaracetam may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Bromocriptine,"Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bromocriptine.",increase,no risk
Quinidine,Bromotheophylline,The serum concentration of Bromotheophylline can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Quinidine.,increase,risk
Quinidine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Quinidine.,increase,risk
Quinidine,Budesonide,The metabolism of Quinidine can be increased when combined with Budesonide.,increase,no risk
Quinidine,Bumadizone,Bumadizone may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Bumetanide,Bumetanide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Bupivacaine.,increase,risk
Quinidine,Buprenorphine,The risk or severity of adverse effects can be increased when Quinidine is combined with Buprenorphine.,increase,risk
Quinidine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Quinidine.,increase,risk
Quinidine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Quinidine.,increase,risk
Quinidine,Buspirone,The metabolism of Quinidine can be decreased when combined with Buspirone.,decrease,no risk
Quinidine,Busulfan,The metabolism of Busulfan can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Butabarbital,Butabarbital may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Butacaine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Butacaine.,increase,risk
Quinidine,Butalbital,The metabolism of Quinidine can be increased when combined with Butalbital.,increase,no risk
Quinidine,Butamben,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Butamben.,increase,risk
Quinidine,Butaperazine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Butaperazine.,increase,risk
Quinidine,Butobarbital,The risk or severity of adverse effects can be increased when Quinidine is combined with Butobarbital.,increase,risk
Quinidine,Butorphanol,The risk or severity of adverse effects can be increased when Quinidine is combined with Butorphanol.,increase,risk
Quinidine,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Quinidine.,increase,risk
Quinidine,Butylscopolamine,The risk or severity of adverse effects can be increased when Quinidine is combined with Butylscopolamine.,increase,risk
Quinidine,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Quinidine.,increase,risk
Quinidine,Gadodiamide,Gadodiamide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Gadoteric acid,Gadoteric acid may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Gadoteridol,Gadoteridol may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Galantamine,The metabolism of Galantamine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Quinidine.,increase,no risk
Quinidine,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Ganciclovir,Ganciclovir may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Quinidine.,increase,risk
Quinidine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Quinidine.,increase,risk
Quinidine,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Quinidine.,increase,risk
Quinidine,Gimeracil,Gimeracil may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Ginkgo biloba,The metabolism of Quinidine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Quinidine,Givosiran,Givosiran may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Glasdegib,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Glasdegib.,increase,risk
Quinidine,Glecaprevir,The serum concentration of Quinidine can be increased when it is combined with Glecaprevir.,increase,no risk
Quinidine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Glimepiride,Quinidine may decrease the excretion rate of Glimepiride which could result in a higher serum level.,decrease,no risk
Quinidine,Glipizide,Glipizide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Glofitamab,The serum concentration of Quinidine can be increased when it is combined with Glofitamab.,increase,no risk
Quinidine,Glucagon,Quinidine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Quinidine,Glyburide,The metabolism of Quinidine can be decreased when combined with Glyburide.,decrease,no risk
Quinidine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Glycerol phenylbutyrate,The metabolism of Quinidine can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Quinidine,Glycopyrronium,The risk or severity of adverse effects can be increased when Quinidine is combined with Glycopyrronium.,increase,risk
Quinidine,Glycyrrhizic acid,Quinidine may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Quinidine,Golimumab,The metabolism of Quinidine can be increased when combined with Golimumab.,increase,no risk
Quinidine,Golodirsen,Golodirsen may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Quinidine.,increase,risk
Quinidine,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Quinidine.,increase,risk
Quinidine,Grapefruit,The serum concentration of Quinidine can be increased when it is combined with Grapefruit.,increase,no risk
Quinidine,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Quinidine.,increase,risk
Quinidine,Griseofulvin,The metabolism of Quinidine can be increased when combined with Griseofulvin.,increase,no risk
Quinidine,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Guanadrel,Quinidine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Quinidine,Guanethidine,Guanethidine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Guanfacine,Guanfacine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Guanoxan,Quinidine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Quinidine,Halofantrine,"The risk or severity of QTc prolongation, ventricular arrhythmias, torsade de pointes, and convulsion can be increased when Quinidine is combined with Halofantrine.",increase,risk
Quinidine,Haloperidol,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Haloperidol.,increase,risk
Quinidine,Halothane,The metabolism of Halothane can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Heparin,The therapeutic efficacy of Heparin can be increased when used in combination with Quinidine.,increase,no risk
Quinidine,Hexafluronium,The risk or severity of adverse effects can be increased when Quinidine is combined with Hexafluronium.,increase,risk
Quinidine,Hexocyclium,The risk or severity of adverse effects can be increased when Quinidine is combined with Hexocyclium.,increase,risk
Quinidine,Histamine,The serum concentration of Histamine can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Quinidine.,increase,risk
Quinidine,Homatropine,The risk or severity of adverse effects can be increased when Quinidine is combined with Homatropine.,increase,risk
Quinidine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Quinidine.,increase,risk
Quinidine,Huperzine A,The therapeutic efficacy of Quinidine can be decreased when used in combination with Huperzine A.,decrease,no risk
Quinidine,Hydralazine,The serum concentration of Quinidine can be increased when it is combined with Hydralazine.,increase,no risk
Quinidine,Hydrochlorothiazide,Hydrochlorothiazide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Hydrocortamate,The metabolism of Quinidine can be increased when combined with Hydrocortamate.,increase,no risk
Quinidine,Hydrocortisone,The metabolism of Quinidine can be increased when combined with Hydrocortisone.,increase,no risk
Quinidine,Hydrocortisone acetate,The metabolism of Quinidine can be increased when combined with Hydrocortisone acetate.,increase,no risk
Quinidine,Hydrocortisone butyrate,The metabolism of Quinidine can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Quinidine,Hydrocortisone cypionate,The metabolism of Quinidine can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Quinidine,Hydrocortisone phosphate,The metabolism of Quinidine can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Quinidine,Hydrocortisone succinate,The metabolism of Quinidine can be increased when combined with Hydrocortisone succinate.,increase,no risk
Quinidine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Quinidine,Hydromorphone,The risk or severity of adverse effects can be increased when Quinidine is combined with Hydromorphone.,increase,risk
Quinidine,Hydrotalcite,Hydrotalcite may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Quinidine.,increase,risk
Quinidine,Hydroxyethyl Starch,Hydroxyethyl Starch may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Hydroxyzine.,increase,risk
Quinidine,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Quinidine.,increase,no risk
Quinidine,Kanamycin,Kanamycin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Kaolin,Kaolin can cause a decrease in the absorption of Quinidine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Quinidine,Ketamine,Ketamine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Ketazolam,The serum concentration of Quinidine can be increased when it is combined with Ketazolam.,increase,no risk
Quinidine,Ketoconazole,The metabolism of Quinidine can be decreased when combined with Ketoconazole.,decrease,no risk
Quinidine,Ketoprofen,Ketoprofen may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Ketorolac,Ketorolac may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,N-acetyltyrosine,N-acetyltyrosine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Nabilone,The risk or severity of Tachycardia and drowsiness can be increased when Quinidine is combined with Nabilone.,increase,risk
Quinidine,Nabumetone,The metabolism of Nabumetone can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Nadolol,Quinidine may increase the arrhythmogenic activities of Nadolol.,increase,no risk
Quinidine,Nadroparin,The therapeutic efficacy of Nadroparin can be increased when used in combination with Quinidine.,increase,no risk
Quinidine,Nafcillin,The metabolism of Quinidine can be increased when combined with Nafcillin.,increase,no risk
Quinidine,Nalbuphine,The risk or severity of adverse effects can be increased when Quinidine is combined with Nalbuphine.,increase,risk
Quinidine,Naldemedine,Naldemedine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Quinidine.,increase,risk
Quinidine,Nalmefene,Nalmefene may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Naloxegol,The serum concentration of Naloxegol can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Naloxone,Naloxone may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Naltrexone,The risk or severity of adverse effects can be increased when Quinidine is combined with Naltrexone.,increase,risk
Quinidine,Naphazoline,The risk or severity of Cardiac Arrhythmia can be increased when Naphazoline is combined with Quinidine.,increase,risk
Quinidine,Naproxen,The metabolism of Naproxen can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Naratriptan,The risk or severity of hypertension can be increased when Quinidine is combined with Naratriptan.,increase,risk
Quinidine,Nateglinide,The metabolism of Quinidine can be decreased when combined with Nateglinide.,decrease,no risk
Quinidine,Naxitamab,The risk or severity of hypertension can be increased when Quinidine is combined with Naxitamab.,increase,risk
Quinidine,Nebivolol,Quinidine may increase the arrhythmogenic activities of Nebivolol.,increase,no risk
Quinidine,Nedaplatin,Quinidine may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Quinidine,Nedocromil,Nedocromil may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Nefazodone,The metabolism of Quinidine can be decreased when combined with Nefazodone.,decrease,no risk
Quinidine,Nelfinavir,The metabolism of Quinidine can be decreased when combined with Nelfinavir.,decrease,no risk
Quinidine,Neomycin,Neomycin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Neostigmine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Neostigmine.,decrease,no risk
Quinidine,Neratinib,The serum concentration of Quinidine can be increased when it is combined with Neratinib.,increase,no risk
Quinidine,Netilmicin,Netilmicin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Netupitant,The serum concentration of Quinidine can be increased when it is combined with Netupitant.,increase,no risk
Quinidine,Nevirapine,The metabolism of Quinidine can be decreased when combined with Nevirapine.,decrease,no risk
Quinidine,Niacin,The serum concentration of Quinidine can be increased when it is combined with Niacin.,increase,no risk
Quinidine,Nialamide,The risk or severity of hypertension can be increased when Quinidine is combined with Nialamide.,increase,risk
Quinidine,Nicardipine,Nicardipine may increase the arrhythmogenic activities of Quinidine.,increase,no risk
Quinidine,Nicergoline,"Nicergoline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.",increase,no risk
Quinidine,Niclosamide,The metabolism of Niclosamide can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Nicorandil,Quinidine may increase the arrhythmogenic activities of Nicorandil.,increase,no risk
Quinidine,Nicotine,The risk or severity of adverse effects can be increased when Quinidine is combined with Nicotine.,increase,risk
Quinidine,Nifedipine,Quinidine may increase the arrhythmogenic activities of Nifedipine.,increase,no risk
Quinidine,Nilotinib,The metabolism of Quinidine can be decreased when combined with Nilotinib.,decrease,no risk
Quinidine,Nilutamide,Nilutamide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Nilvadipine,Quinidine may increase the arrhythmogenic activities of Nilvadipine.,increase,no risk
Quinidine,Nimesulide,Quinidine may increase the arrhythmogenic activities of Nimesulide.,increase,no risk
Quinidine,Nimodipine,Nimodipine may increase the arrhythmogenic activities of Quinidine.,increase,no risk
Quinidine,Nintedanib,The metabolism of Quinidine can be decreased when combined with Nintedanib.,decrease,no risk
Quinidine,Nirogacestat,The serum concentration of Quinidine can be increased when it is combined with Nirogacestat.,increase,no risk
Quinidine,Nisoldipine,Nisoldipine may increase the arrhythmogenic activities of Quinidine.,increase,no risk
Quinidine,Nitrazepam,The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Nitrendipine,Quinidine may increase the arrhythmogenic activities of Nitrendipine.,increase,no risk
Quinidine,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Nitroglycerin,Quinidine may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Quinidine,Nitroprusside,Nitroprusside may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Nitrous oxide,The risk or severity of hypertension can be increased when Quinidine is combined with Nitrous oxide.,increase,risk
Quinidine,Nizatidine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Nizatidine.,decrease,no risk
Quinidine,Norepinephrine,The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Norethisterone,The metabolism of Quinidine can be decreased when combined with Norethisterone.,decrease,no risk
Quinidine,Norfloxacin,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Quinidine.,increase,risk
Quinidine,Norgestimate,The serum concentration of Quinidine can be increased when it is combined with Norgestimate.,increase,no risk
Quinidine,Normethadone,The risk or severity of adverse effects can be increased when Quinidine is combined with Normethadone.,increase,risk
Quinidine,Nortriptyline,"Nortriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.",increase,no risk
Quinidine,Noscapine,The serum concentration of Quinidine can be increased when it is combined with Noscapine.,increase,no risk
Quinidine,Nylidrin,Quinidine may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Quinidine,Obeticholic acid,The risk or severity of adverse effects can be increased when Quinidine is combined with Obeticholic acid.,increase,risk
Quinidine,Octinoxate,Octinoxate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Octreotide,The serum concentration of Quinidine can be increased when it is combined with Octreotide.,increase,no risk
Quinidine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Quinidine.,increase,risk
Quinidine,Olanzapine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.",increase,no risk
Quinidine,Olaparib,The metabolism of Olaparib can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Olmesartan,The risk or severity of liver damage can be increased when Olmesartan is combined with Quinidine.,increase,risk
Quinidine,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Olsalazine,Olsalazine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Olutasidenib,The metabolism of Quinidine can be increased when combined with Olutasidenib.,increase,no risk
Quinidine,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Omaveloxolone,The serum concentration of Quinidine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Quinidine,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Ondansetron,The metabolism of Quinidine can be decreased when combined with Ondansetron.,decrease,no risk
Quinidine,Opicapone,The serum concentration of Opicapone can be decreased when it is combined with Quinidine.,decrease,no risk
Quinidine,Opium,The risk or severity of adverse effects can be increased when Quinidine is combined with Opium.,increase,risk
Quinidine,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Oritavancin,The metabolism of Quinidine can be increased when combined with Oritavancin.,increase,no risk
Quinidine,Orphenadrine,The metabolism of Quinidine can be decreased when combined with Orphenadrine.,decrease,no risk
Quinidine,Oseltamivir,Oseltamivir may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Osilodrostat,The metabolism of Quinidine can be decreased when combined with Osilodrostat.,decrease,no risk
Quinidine,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Oxacillin,Oxacillin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Quinidine.,increase,risk
Quinidine,Oxaprozin,Oxaprozin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Quinidine.,increase,risk
Quinidine,Oxazepam,Oxazepam may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Oxcarbazepine,The metabolism of Quinidine can be increased when combined with Oxcarbazepine.,increase,no risk
Quinidine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Oxetacaine.,increase,risk
Quinidine,Oxprenolol,Quinidine may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Quinidine,Oxtriphylline,The serum concentration of Oxtriphylline can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Oxybenzone,Oxybenzone may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Oxybuprocaine.,increase,risk
Quinidine,Oxybutynin,The serum concentration of Quinidine can be increased when it is combined with Oxybutynin.,increase,no risk
Quinidine,Oxycodone,The risk or severity of adverse effects can be increased when Quinidine is combined with Oxycodone.,increase,risk
Quinidine,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Oxymorphone,The risk or severity of adverse effects can be increased when Quinidine is combined with Oxymorphone.,increase,risk
Quinidine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Quinidine.,increase,risk
Quinidine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Quinidine.,increase,risk
Quinidine,Oxyquinoline,Oxyquinoline may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Quinidine.,increase,risk
Quinidine,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Quetiapine,"Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.",increase,no risk
Quinidine,Quinapril,The excretion of Quinapril can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Quinethazone,Quinethazone may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Quinidine,Quinine,The serum concentration of Quinidine can be increased when it is combined with Quinine.,increase,no risk
Quinidine,Quinupramine,The risk or severity of adverse effects can be increased when Quinidine is combined with Quinupramine.,increase,risk
Quinidine,Quinupristin,The metabolism of Quinidine can be decreased when combined with Quinupristin.,decrease,no risk
Quinidine,Quizartinib,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Quizartinib.,increase,risk
Quinidine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Udenafil,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Quinidine.,increase,risk
Quinidine,Umbralisib,The serum concentration of Quinidine can be increased when it is combined with Umbralisib.,increase,no risk
Quinidine,Umeclidinium,The risk or severity of adverse effects can be increased when Quinidine is combined with Umeclidinium.,increase,risk
Quinidine,Urokinase,The therapeutic efficacy of Urokinase can be increased when used in combination with Quinidine.,increase,no risk
Quinidine,Ursodeoxycholic acid,Quinidine may decrease the excretion rate of Ursodeoxycholic acid which could result in a higher serum level.,decrease,no risk
Quinidine,Vaborbactam,Vaborbactam may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Valaciclovir,Valaciclovir may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Valdecoxib,Valdecoxib may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Valganciclovir,Valganciclovir may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Valproic acid,The serum concentration of Quinidine can be increased when it is combined with Valproic acid.,increase,no risk
Quinidine,Valsartan,The metabolism of Valsartan can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Vancomycin,Vancomycin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Vandetanib,The serum concentration of Quinidine can be increased when it is combined with Vandetanib.,increase,no risk
Quinidine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Varenicline,The excretion of Varenicline can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Quinidine.,increase,no risk
Quinidine,Velpatasvir,The serum concentration of Quinidine can be increased when it is combined with Velpatasvir.,increase,no risk
Quinidine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Quinidine.,increase,risk
Quinidine,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Verapamil,Verapamil may increase the hypotensive activities of Quinidine.,increase,no risk
Quinidine,Vernakalant,Quinidine may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Quinidine,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Quinidine.,increase,risk
Quinidine,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Viloxazine,The metabolism of Quinidine can be decreased when combined with Viloxazine.,decrease,no risk
Quinidine,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Vincristine,The excretion of Vincristine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Vindesine,The metabolism of Vindesine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Viomycin,The risk or severity of neuromuscular blockade can be increased when Quinidine is combined with Viomycin.,increase,risk
Quinidine,Vitamin E,The metabolism of Quinidine can be increased when combined with Vitamin E.,increase,no risk
Quinidine,Voclosporin,The serum concentration of Quinidine can be increased when it is combined with Voclosporin.,increase,no risk
Quinidine,Vorapaxar,The therapeutic efficacy of Vorapaxar can be increased when used in combination with Quinidine.,increase,no risk
Quinidine,Voriconazole,The risk or severity of QTc prolongation and torsade de pointes can be increased when Voriconazole is combined with Quinidine.,increase,risk
Quinidine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Quinidine.,increase,risk
Quinidine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Voxelotor,The serum concentration of Quinidine can be increased when it is combined with Voxelotor.,increase,no risk
Quinidine,Voxilaprevir,The serum concentration of Quinidine can be increased when it is combined with Voxilaprevir.,increase,no risk
Quinidine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Ximelagatran,The therapeutic efficacy of Ximelagatran can be increased when used in combination with Quinidine.,increase,no risk
Quinidine,Xylometazoline,Quinidine may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Quinidine,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Zafirlukast,The serum concentration of Quinidine can be increased when it is combined with Zafirlukast.,increase,no risk
Quinidine,Zaleplon,The metabolism of Quinidine can be decreased when combined with Zaleplon.,decrease,no risk
Quinidine,Zanamivir,Zanamivir may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Ziconotide,Quinidine may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Quinidine,Zidovudine,The excretion of Zidovudine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Zileuton,The metabolism of Zileuton can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Zimelidine,The metabolism of Quinidine can be decreased when combined with Zimelidine.,decrease,no risk
Quinidine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Ziprasidone.,increase,risk
Quinidine,Zofenopril,Quinidine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Quinidine,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Zonisamide,Quinidine may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Quinidine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Zotepine,The metabolism of Zotepine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Zuclopenthixol,"Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Zuclopenthixol.",increase,no risk
Zonisamide,Bacitracin,Bacitracin may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Zonisamide,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Zonisamide.,increase,no risk
Zonisamide,Balsalazide,The risk or severity of adverse effects can be increased when Balsalazide is combined with Zonisamide.,increase,risk
Zonisamide,Baricitinib,Zonisamide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Beclomethasone dipropionate,The metabolism of Zonisamide can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Zonisamide,Bedaquiline,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Bedaquiline.,increase,risk
Zonisamide,Belantamab mafodotin,The serum concentration of Belantamab mafodotin can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Belinostat,The serum concentration of Belinostat can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Belzutifan,The serum concentration of Belzutifan can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Bemiparin,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Bemiparin.,increase,risk
Zonisamide,Benazepril,The risk or severity of hyperkalemia can be increased when Benazepril is combined with Zonisamide.,increase,risk
Zonisamide,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Benorilate,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Benorilate.,increase,risk
Zonisamide,Benoxaprofen,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Benoxaprofen.,increase,risk
Zonisamide,Benperidol,The risk or severity of CNS depression can be increased when Zonisamide is combined with Benperidol.,increase,risk
Zonisamide,Benserazide,Zonisamide may increase the excretion rate of Benserazide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Benzatropine,Zonisamide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Benzhydrocodone,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Benzhydrocodone.,decrease,no risk
Zonisamide,Benznidazole,Zonisamide may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Benzocaine,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Benzocaine.,increase,risk
Zonisamide,Benzphetamine,Zonisamide may decrease the excretion rate of Benzphetamine which could result in a higher serum level.,decrease,no risk
Zonisamide,Benzthiazide,Benzthiazide may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Benzydamine,Zonisamide may increase the excretion rate of Benzydamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Benzyl alcohol.,increase,risk
Zonisamide,Benzylpenicillin,Zonisamide may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Zonisamide,Bepotastine,Zonisamide may increase the excretion rate of Bepotastine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Bepridil,Zonisamide may increase the arrhythmogenic activities of Bepridil.,increase,no risk
Zonisamide,Beractant,Zonisamide may increase the bradycardic activities of Beractant.,increase,no risk
Zonisamide,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Betamethasone,The metabolism of Zonisamide can be increased when combined with Betamethasone.,increase,no risk
Zonisamide,Betamethasone phosphate,The metabolism of Zonisamide can be increased when combined with Betamethasone phosphate.,increase,no risk
Zonisamide,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Zonisamide,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Zonisamide.,increase,no risk
Zonisamide,Bicisate,Zonisamide may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Bifonazole,The therapeutic efficacy of Bifonazole can be increased when used in combination with Zonisamide.,increase,no risk
Zonisamide,Bilastine,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Bilastine.,increase,risk
Zonisamide,Bimekizumab,The metabolism of Zonisamide can be increased when combined with Bimekizumab.,increase,no risk
Zonisamide,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Bioallethrin,Zonisamide may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Zonisamide,Bisacodyl,The risk or severity of dehydration can be increased when Zonisamide is combined with Bisacodyl.,increase,risk
Zonisamide,Bismuth subgallate,Zonisamide may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Bismuth subsalicylate,The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Zonisamide.,increase,risk
Zonisamide,Bisoprolol,The therapeutic efficacy of Zonisamide can be increased when used in combination with Bisoprolol.,increase,no risk
Zonisamide,Bisoxatin,The risk or severity of dehydration can be increased when Zonisamide is combined with Bisoxatin.,increase,risk
Zonisamide,Bleomycin,Zonisamide may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Boceprevir,The serum concentration of Zonisamide can be increased when it is combined with Boceprevir.,increase,no risk
Zonisamide,Borage oil,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Borage oil.,decrease,no risk
Zonisamide,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Zonisamide.,increase,risk
Zonisamide,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Zonisamide.,increase,risk
Zonisamide,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Bretylium,Zonisamide may increase the arrhythmogenic activities of Bretylium.,increase,no risk
Zonisamide,Brexanolone,The risk or severity of CNS depression can be increased when Zonisamide is combined with Brexanolone.,increase,risk
Zonisamide,Brexpiprazole,The risk or severity of CNS depression can be increased when Zonisamide is combined with Brexpiprazole.,increase,risk
Zonisamide,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Zonisamide.,increase,no risk
Zonisamide,Brinzolamide,The risk or severity of adverse effects can be increased when Brinzolamide is combined with Zonisamide.,increase,risk
Zonisamide,Brivaracetam,The risk or severity of CNS depression can be increased when Zonisamide is combined with Brivaracetam.,increase,risk
Zonisamide,Bromazepam,The risk or severity of CNS depression can be increased when Zonisamide is combined with Bromazepam.,increase,risk
Zonisamide,Bromocriptine,The risk or severity of CNS depression can be increased when Zonisamide is combined with Bromocriptine.,increase,risk
Zonisamide,Bromotheophylline,Zonisamide may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Bromperidol,The risk or severity of CNS depression can be increased when Zonisamide is combined with Bromperidol.,increase,risk
Zonisamide,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Zonisamide.,increase,risk
Zonisamide,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Zonisamide.,increase,risk
Zonisamide,Budesonide,Zonisamide may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Bumadizone,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Bumadizone.,increase,risk
Zonisamide,Bumetanide,Bumetanide may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Bupivacaine.,increase,risk
Zonisamide,Buprenorphine,Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Zonisamide,Bupropion,The risk or severity of CNS depression can be increased when Zonisamide is combined with Bupropion.,increase,risk
Zonisamide,Buserelin,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Buserelin.,increase,risk
Zonisamide,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Zonisamide.,increase,risk
Zonisamide,Butabarbital,The metabolism of Zonisamide can be increased when combined with Butabarbital.,increase,no risk
Zonisamide,Butacaine,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Butacaine.,increase,risk
Zonisamide,Butalbital,The metabolism of Zonisamide can be increased when combined with Butalbital.,increase,no risk
Zonisamide,Butamben,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Butamben.,increase,risk
Zonisamide,Butaperazine,The risk or severity of CNS depression can be increased when Zonisamide is combined with Butaperazine.,increase,risk
Zonisamide,Butobarbital,The risk or severity of CNS depression can be increased when Zonisamide is combined with Butobarbital.,increase,risk
Zonisamide,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Zonisamide.,increase,risk
Zonisamide,Butriptyline,The risk or severity of CNS depression can be increased when Zonisamide is combined with Butriptyline.,increase,risk
Zonisamide,Gabapentin,The risk or severity of CNS depression can be increased when Zonisamide is combined with Gabapentin.,increase,risk
Zonisamide,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Zonisamide is combined with Gabapentin enacarbil.,increase,risk
Zonisamide,Gadobenic acid,Zonisamide may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Gadodiamide,Zonisamide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Gadofosveset trisodium,Zonisamide may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Gadopentetic acid,Zonisamide may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Gadoteric acid,Zonisamide may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Gadoteridol,Zonisamide may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Galantamine,Galantamine may increase the bradycardic activities of Zonisamide.,increase,no risk
Zonisamide,Gallamine triethiodide,Zonisamide may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Zonisamide,Gamolenic acid,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Zonisamide,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Zonisamide is combined with Ganaxolone.",increase,risk
Zonisamide,Ganciclovir,Zonisamide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Gatifloxacin.,increase,risk
Zonisamide,Gefitinib,The metabolism of Zonisamide can be decreased when combined with Gefitinib.,decrease,no risk
Zonisamide,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Gemfibrozil,The metabolism of Zonisamide can be decreased when combined with Gemfibrozil.,decrease,no risk
Zonisamide,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Gemifloxacin.,increase,risk
Zonisamide,Gentamicin,Zonisamide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Zonisamide,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Zonisamide.,increase,risk
Zonisamide,Gestrinone,The metabolism of Gestrinone can be increased when combined with Zonisamide.,increase,no risk
Zonisamide,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Gimeracil,Zonisamide may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Givosiran,Givosiran may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Zonisamide,Glasdegib,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Glasdegib.,increase,risk
Zonisamide,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Zonisamide.,increase,no risk
Zonisamide,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Zonisamide.,increase,no risk
Zonisamide,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Zonisamide.,increase,no risk
Zonisamide,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Zonisamide.,increase,no risk
Zonisamide,Glofitamab,The serum concentration of Zonisamide can be increased when it is combined with Glofitamab.,increase,no risk
Zonisamide,Gluconic Acid,The risk or severity of dehydration can be increased when Zonisamide is combined with Gluconic Acid.,increase,risk
Zonisamide,Glutethimide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Glutethimide.,increase,risk
Zonisamide,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Zonisamide.,increase,no risk
Zonisamide,Glycerin,The risk or severity of dehydration can be increased when Zonisamide is combined with Glycerin.,increase,risk
Zonisamide,Glycerol phenylbutyrate,Zonisamide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Zonisamide.,increase,no risk
Zonisamide,Golimumab,The metabolism of Zonisamide can be increased when combined with Golimumab.,increase,no risk
Zonisamide,Golodirsen,Zonisamide may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Goserelin,Zonisamide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Zonisamide.,increase,risk
Zonisamide,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Grepafloxacin.,increase,risk
Zonisamide,Guanethidine,Zonisamide may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Guanfacine,The risk or severity of CNS depression can be increased when Zonisamide is combined with Guanfacine.,increase,risk
Zonisamide,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Zonisamide.,increase,risk
Zonisamide,Halofantrine,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Halofantrine.,increase,risk
Zonisamide,Haloperidol,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Haloperidol.,increase,risk
Zonisamide,Halothane,The risk or severity of CNS depression can be increased when Zonisamide is combined with Halothane.,increase,risk
Zonisamide,Heparin,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Heparin.,increase,risk
Zonisamide,Hexafluronium,The risk or severity of CNS depression can be increased when Zonisamide is combined with Hexafluronium.,increase,risk
Zonisamide,Histrelin,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Histrelin.,increase,risk
Zonisamide,Hydralazine,Zonisamide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Hydrocodone,Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Zonisamide,Hydrocortisone,The metabolism of Zonisamide can be decreased when combined with Hydrocortisone.,decrease,no risk
Zonisamide,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Zonisamide.,decrease,no risk
Zonisamide,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Zonisamide.,decrease,no risk
Zonisamide,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Zonisamide.,decrease,no risk
Zonisamide,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Zonisamide.,decrease,no risk
Zonisamide,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Zonisamide.,increase,risk
Zonisamide,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Zonisamide.,increase,risk
Zonisamide,Hydroxocobalamin,Zonisamide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Hydroxychloroquine,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Zonisamide,Hydroxyethyl Starch,Zonisamide may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Zonisamide.,increase,no risk
Zonisamide,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Hydroxyzine.,increase,risk
Zonisamide,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Zonisamide,Kanamycin,Zonisamide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Zonisamide,Ketamine,The risk or severity of CNS depression can be increased when Zonisamide is combined with Ketamine.,increase,risk
Zonisamide,Ketazolam,The risk or severity of CNS depression can be increased when Zonisamide is combined with Ketazolam.,increase,risk
Zonisamide,Ketoconazole,The metabolism of Zonisamide can be decreased when combined with Ketoconazole.,decrease,no risk
Zonisamide,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Zonisamide.,increase,risk
Zonisamide,Ketorolac,The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Zonisamide.,increase,risk
Zonisamide,N-acetyltyrosine,Zonisamide may increase the excretion rate of N-acetyltyrosine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Zonisamide.,increase,no risk
Zonisamide,Nabumetone,The risk or severity of hyperkalemia can be increased when Nabumetone is combined with Zonisamide.,increase,risk
Zonisamide,Nadolol,Zonisamide may increase the arrhythmogenic activities of Nadolol.,increase,no risk
Zonisamide,Nadroparin,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Nadroparin.,increase,risk
Zonisamide,Nafcillin,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Nafcillin.,decrease,no risk
Zonisamide,Nalbuphine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Zonisamide.,increase,risk
Zonisamide,Naldemedine,Zonisamide may increase the excretion rate of Naldemedine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Nalidixic acid,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Nalidixic acid.,decrease,no risk
Zonisamide,Nalmefene,Zonisamide may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Naloxegol,The serum concentration of Naloxegol can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Naloxone,Zonisamide may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Naltrexone,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Naltrexone.,decrease,no risk
Zonisamide,Naproxen,The risk or severity of hyperkalemia can be increased when Naproxen is combined with Zonisamide.,increase,risk
Zonisamide,Naratriptan,The metabolism of Naratriptan can be decreased when combined with Zonisamide.,decrease,no risk
Zonisamide,Nateglinide,The therapeutic efficacy of Nateglinide can be increased when used in combination with Zonisamide.,increase,no risk
Zonisamide,Nebivolol,Zonisamide may increase the arrhythmogenic activities of Nebivolol.,increase,no risk
Zonisamide,Nedaplatin,Zonisamide may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Zonisamide,Nedocromil,Zonisamide may increase the excretion rate of Nedocromil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Nefazodone,The metabolism of Zonisamide can be decreased when combined with Nefazodone.,decrease,no risk
Zonisamide,Nelfinavir,The metabolism of Zonisamide can be decreased when combined with Nelfinavir.,decrease,no risk
Zonisamide,Neomycin,Zonisamide may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Zonisamide,Netilmicin,Zonisamide may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Zonisamide,Netupitant,The metabolism of Zonisamide can be decreased when combined with Netupitant.,decrease,no risk
Zonisamide,Nevirapine,The metabolism of Zonisamide can be decreased when combined with Nevirapine.,decrease,no risk
Zonisamide,Nialamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Nialamide.,increase,risk
Zonisamide,Nicardipine,Nicardipine may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Zonisamide,Nicergoline,The risk or severity of hypotension can be increased when Nicergoline is combined with Zonisamide.,increase,risk
Zonisamide,Nicorandil,Zonisamide may increase the arrhythmogenic activities of Nicorandil.,increase,no risk
Zonisamide,Nicotine,The risk or severity of adverse effects can be increased when Zonisamide is combined with Nicotine.,increase,risk
Zonisamide,Nifedipine,Zonisamide may increase the arrhythmogenic activities of Nifedipine.,increase,no risk
Zonisamide,Nilotinib,The metabolism of Zonisamide can be decreased when combined with Nilotinib.,decrease,no risk
Zonisamide,Nilutamide,Zonisamide may increase the excretion rate of Nilutamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Nilvadipine,Zonisamide may increase the arrhythmogenic activities of Nilvadipine.,increase,no risk
Zonisamide,Nimesulide,Zonisamide may increase the arrhythmogenic activities of Nimesulide.,increase,no risk
Zonisamide,Nimodipine,Nimodipine may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Zonisamide,Nintedanib,The serum concentration of Nintedanib can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Nisoldipine,Nisoldipine may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Zonisamide,Nitrazepam,The risk or severity of CNS depression can be increased when Zonisamide is combined with Nitrazepam.,increase,risk
Zonisamide,Nitrendipine,Zonisamide may increase the arrhythmogenic activities of Nitrendipine.,increase,no risk
Zonisamide,Nitric Oxide,Zonisamide may increase the excretion rate of Nitric Oxide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Nitrofurantoin,Zonisamide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Nitroglycerin,Zonisamide may increase the vasodilatory activities of Nitroglycerin.,increase,no risk
Zonisamide,Nitroprusside,Zonisamide may increase the hypotensive activities of Nitroprusside.,increase,no risk
Zonisamide,Nitrous oxide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Nitrous oxide.,increase,risk
Zonisamide,Nomegestrol,The metabolism of Nomegestrol can be increased when combined with Zonisamide.,increase,no risk
Zonisamide,Nomegestrol acetate,The metabolism of Nomegestrol acetate can be increased when combined with Zonisamide.,increase,no risk
Zonisamide,Nomifensine,The risk or severity of CNS depression can be increased when Zonisamide is combined with Nomifensine.,increase,risk
Zonisamide,Nonoxynol-9,The metabolism of Nonoxynol-9 can be increased when combined with Zonisamide.,increase,no risk
Zonisamide,Norelgestromin,The metabolism of Norelgestromin can be increased when combined with Zonisamide.,increase,no risk
Zonisamide,Norepinephrine,The risk or severity of Cardiac Arrhythmia can be increased when Norepinephrine is combined with Zonisamide.,increase,risk
Zonisamide,Norethisterone,The metabolism of Norethisterone can be increased when combined with Zonisamide.,increase,no risk
Zonisamide,Norethynodrel,The metabolism of Norethynodrel can be increased when combined with Zonisamide.,increase,no risk
Zonisamide,Norfloxacin,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Norfloxacin.,increase,risk
Zonisamide,Norgestimate,The metabolism of Norgestimate can be increased when combined with Zonisamide.,increase,no risk
Zonisamide,Norgestrel,The metabolism of Norgestrel can be increased when combined with Zonisamide.,increase,no risk
Zonisamide,Normethadone,The risk or severity of CNS depression can be increased when Zonisamide is combined with Normethadone.,increase,risk
Zonisamide,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Nylidrin,Zonisamide may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Zonisamide,Octinoxate,Zonisamide may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Zonisamide.,increase,no risk
Zonisamide,Ofloxacin,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Ofloxacin.,increase,risk
Zonisamide,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Zonisamide.,increase,risk
Zonisamide,Olaparib,The metabolism of Olaparib can be decreased when combined with Zonisamide.,decrease,no risk
Zonisamide,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Zonisamide is combined with Oliceridine.",increase,risk
Zonisamide,Olmesartan,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Zonisamide.,increase,risk
Zonisamide,Olodaterol,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Olodaterol.,increase,risk
Zonisamide,Olsalazine,The risk or severity of adverse effects can be increased when Olsalazine is combined with Zonisamide.,increase,risk
Zonisamide,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Omaveloxolone,The serum concentration of Zonisamide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Zonisamide,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Omeprazole,The metabolism of Zonisamide can be decreased when combined with Omeprazole.,decrease,no risk
Zonisamide,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Zonisamide.,increase,risk
Zonisamide,Opium,The risk or severity of CNS depression can be increased when Zonisamide is combined with Opium.,increase,risk
Zonisamide,Oritavancin,The metabolism of Zonisamide can be decreased when combined with Oritavancin.,decrease,no risk
Zonisamide,Orlistat,Orlistat can cause a decrease in the absorption of Zonisamide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Zonisamide,Orphenadrine,Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Zonisamide,Oseltamivir,Zonisamide may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Osilodrostat,The metabolism of Zonisamide can be decreased when combined with Osilodrostat.,decrease,no risk
Zonisamide,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Oteseconazole,The therapeutic efficacy of Oteseconazole can be increased when used in combination with Zonisamide.,increase,no risk
Zonisamide,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Oxacillin,Zonisamide may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Zonisamide.,increase,risk
Zonisamide,Oxaprozin,Zonisamide may increase the excretion rate of Oxaprozin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Oxatomide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Oxatomide.,increase,risk
Zonisamide,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Zonisamide.,increase,risk
Zonisamide,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Zonisamide.,increase,risk
Zonisamide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Oxetacaine.,increase,risk
Zonisamide,Oxitriptan,The risk or severity of CNS depression can be increased when Zonisamide is combined with Oxitriptan.,increase,risk
Zonisamide,Oxprenolol,Zonisamide may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Zonisamide,Oxtriphylline,Zonisamide may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Oxybenzone,Zonisamide may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Oxybuprocaine.,increase,risk
Zonisamide,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Zonisamide.,decrease,no risk
Zonisamide,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Zonisamide.,increase,risk
Zonisamide,Oxymorphone,The risk or severity of CNS depression can be increased when Zonisamide is combined with Oxymorphone.,increase,risk
Zonisamide,Oxyphenbutazone,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Oxyphenbutazone.,increase,risk
Zonisamide,Oxyphenisatin acetate,The risk or severity of dehydration can be increased when Zonisamide is combined with Oxyphenisatin acetate.,increase,risk
Zonisamide,Oxyquinoline,Zonisamide may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Zonisamide.,increase,risk
Zonisamide,Quazepam,The risk or severity of CNS depression can be increased when Zonisamide is combined with Quazepam.,increase,risk
Zonisamide,Quetiapine,The risk or severity of CNS depression can be increased when Zonisamide is combined with Quetiapine.,increase,risk
Zonisamide,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Zonisamide.,increase,risk
Zonisamide,Quinethazone,Quinethazone may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Quinidine,Quinidine may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Zonisamide,Quinine,The excretion of Quinine can be decreased when combined with Zonisamide.,decrease,no risk
Zonisamide,Quinupramine,The risk or severity of CNS depression can be increased when Zonisamide is combined with Quinupramine.,increase,risk
Zonisamide,Quizartinib,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Quizartinib.,increase,risk
Paricalcitol,Hydrochlorothiazide,The risk or severity of hypercalcemia can be increased when Hydrochlorothiazide is combined with Paricalcitol.,increase,risk
Paricalcitol,Hydrocortisone,The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Paricalcitol,Hydrocortisone acetate,The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Paricalcitol,Hydrocortisone butyrate,The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Paricalcitol,Hydrocortisone cypionate,The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Paricalcitol,Hydrocortisone succinate,The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Paricalcitol,Hydroflumethiazide,The risk or severity of hypercalcemia can be increased when Hydroflumethiazide is combined with Paricalcitol.,increase,risk
Paricalcitol,Hydrotalcite,The serum concentration of Hydrotalcite can be increased when it is combined with Paricalcitol.,increase,no risk
Paricalcitol,Ketoconazole,The metabolism of Paricalcitol can be decreased when combined with Ketoconazole.,decrease,no risk
Paricalcitol,Nefazodone,The metabolism of Paricalcitol can be decreased when combined with Nefazodone.,decrease,no risk
Paricalcitol,Nelfinavir,The metabolism of Paricalcitol can be decreased when combined with Nelfinavir.,decrease,no risk
Paricalcitol,Netupitant,The metabolism of Paricalcitol can be decreased when combined with Netupitant.,decrease,no risk
Paricalcitol,Nicardipine,The metabolism of Paricalcitol can be decreased when combined with Nicardipine.,decrease,no risk
Paricalcitol,Nilotinib,The metabolism of Paricalcitol can be decreased when combined with Nilotinib.,decrease,no risk
Paricalcitol,Nilvadipine,The metabolism of Paricalcitol can be decreased when combined with Nilvadipine.,decrease,no risk
Paricalcitol,Omaveloxolone,The serum concentration of Paricalcitol can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Paricalcitol,Orlistat,Orlistat can cause a decrease in the absorption of Paricalcitol resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Paricalcitol,Ouabain,The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Paricalcitol is combined with Ouabain.,increase,risk
Paricalcitol,Quinethazone,The risk or severity of hypokalemia can be increased when Paricalcitol is combined with Quinethazone.,increase,risk
Paricalcitol,Vadadustat,The serum concentration of Paricalcitol can be increased when it is combined with Vadadustat.,increase,no risk
Paricalcitol,Vamorolone,The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Vamorolone.,decrease,no risk
Paricalcitol,Venetoclax,The metabolism of Paricalcitol can be decreased when combined with Venetoclax.,decrease,no risk
Paricalcitol,Verapamil,The metabolism of Paricalcitol can be decreased when combined with Verapamil.,decrease,no risk
Paricalcitol,Viloxazine,The metabolism of Paricalcitol can be decreased when combined with Viloxazine.,decrease,no risk
Paricalcitol,Vitamin D,The risk or severity of adverse effects can be increased when Paricalcitol is combined with Vitamin D.,increase,risk
Paricalcitol,Voriconazole,The metabolism of Paricalcitol can be decreased when combined with Voriconazole.,decrease,no risk
Paricalcitol,Zimelidine,The metabolism of Paricalcitol can be decreased when combined with Zimelidine.,decrease,no risk
Paricalcitol,Ziprasidone,The metabolism of Paricalcitol can be decreased when combined with Ziprasidone.,decrease,no risk
Tinidazole,Gabapentin enacarbil,Tinidazole may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Tinidazole,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Gadodiamide,Gadodiamide may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Gadofosveset trisodium,Tinidazole may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Tinidazole,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Gadoteric acid,Tinidazole may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Tinidazole,Gadoteridol,Gadoteridol may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Tinidazole.,increase,no risk
Tinidazole,Ganciclovir,Tinidazole may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Tinidazole,Gemcitabine,Gemcitabine may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Gemfibrozil,Tinidazole may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Tinidazole,Gentamicin,Tinidazole may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Tinidazole,Gimeracil,Tinidazole may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Tinidazole,Givosiran,Givosiran may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Glimepiride,Glimepiride may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Glipizide,Tinidazole may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Tinidazole,Glofitamab,The serum concentration of Tinidazole can be increased when it is combined with Glofitamab.,increase,no risk
Tinidazole,Glyburide,Glyburide may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Glycerol phenylbutyrate,Tinidazole may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Tinidazole,Glycyrrhizic acid,Tinidazole may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Tinidazole,Golodirsen,Tinidazole may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Tinidazole,Goserelin,Goserelin may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Guanethidine,Tinidazole may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Tinidazole,Guanfacine,Tinidazole may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Tinidazole,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Tinidazole.,increase,no risk
Tinidazole,Hydralazine,Tinidazole may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Tinidazole,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Tinidazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tinidazole,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Tinidazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tinidazole,Hydromorphone,Hydromorphone may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Hydroxyethyl Starch,Tinidazole may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Tinidazole,Kanamycin,Tinidazole may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Tinidazole,Ketamine,Tinidazole may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Tinidazole,Ketazolam,Tinidazole may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Tinidazole,Ketoconazole,The metabolism of Tinidazole can be decreased when combined with Ketoconazole.,decrease,no risk
Tinidazole,Ketoprofen,Ketoprofen may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Ketorolac,Ketorolac may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,N-acetyltyrosine,Tinidazole may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Tinidazole,Nabumetone,Nabumetone may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Nadolol,Tinidazole may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Tinidazole,Naldemedine,Tinidazole may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Tinidazole,Nalmefene,Tinidazole may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Tinidazole,Naloxone,Tinidazole may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Tinidazole,Naproxen,Naproxen may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Nateglinide,Nateglinide may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Nedaplatin,Tinidazole may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Tinidazole,Nedocromil,Nedocromil may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Nefazodone,The metabolism of Tinidazole can be decreased when combined with Nefazodone.,decrease,no risk
Tinidazole,Nelfinavir,The metabolism of Tinidazole can be decreased when combined with Nelfinavir.,decrease,no risk
Tinidazole,Neomycin,Tinidazole may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Tinidazole,Netilmicin,Tinidazole may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Tinidazole,Netupitant,The metabolism of Tinidazole can be decreased when combined with Netupitant.,decrease,no risk
Tinidazole,Nicardipine,The metabolism of Tinidazole can be decreased when combined with Nicardipine.,decrease,no risk
Tinidazole,Nicorandil,Tinidazole may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Tinidazole,Nifedipine,Tinidazole may decrease the excretion rate of Nifedipine which could result in a higher serum level.,decrease,no risk
Tinidazole,Nilotinib,The metabolism of Tinidazole can be decreased when combined with Nilotinib.,decrease,no risk
Tinidazole,Nilutamide,Nilutamide may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Nilvadipine,The metabolism of Tinidazole can be decreased when combined with Nilvadipine.,decrease,no risk
Tinidazole,Nimesulide,Nimesulide may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Nisoldipine,Nisoldipine may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Nitrendipine,Tinidazole may decrease the excretion rate of Nitrendipine which could result in a higher serum level.,decrease,no risk
Tinidazole,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Nitroprusside,Nitroprusside may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Octinoxate,Tinidazole may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Tinidazole,Ofloxacin,Tinidazole may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Tinidazole,Olmesartan,Olmesartan may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Olsalazine,Olsalazine may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Omaveloxolone,The serum concentration of Tinidazole can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Tinidazole,Opium,Tinidazole may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Tinidazole,Oseltamivir,Oseltamivir may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Oxacillin,Oxacillin may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Oxaprozin,Oxaprozin may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Oxazepam,Oxazepam may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tinidazole is combined with Oxetacaine.,increase,risk
Tinidazole,Oxybenzone,Tinidazole may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Tinidazole,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Tinidazole is combined with Oxybuprocaine.,increase,risk
Tinidazole,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Oxyquinoline,Tinidazole may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Tinidazole,Quetiapine,Tinidazole may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Tinidazole,Quinethazone,Quinethazone may increase the excretion rate of Tinidazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tinidazole,Quinidine,Tinidazole may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Tinidazole,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Vaborbactam,Tinidazole may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Tinidazole,Vadadustat,The serum concentration of Tinidazole can be increased when it is combined with Vadadustat.,increase,no risk
Tinidazole,Valaciclovir,Valaciclovir may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Valbenazine,Tinidazole may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Tinidazole,Valdecoxib,Valdecoxib may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Valganciclovir,Tinidazole may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Tinidazole,Vancomycin,Tinidazole may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Tinidazole,Varenicline,Tinidazole may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Tinidazole,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Tinidazole.,increase,no risk
Tinidazole,Venetoclax,The metabolism of Tinidazole can be decreased when combined with Venetoclax.,decrease,no risk
Tinidazole,Venlafaxine,Venlafaxine may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Verapamil,The metabolism of Tinidazole can be decreased when combined with Verapamil.,decrease,no risk
Tinidazole,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Tinidazole.,decrease,no risk
Tinidazole,Vilanterol,Tinidazole may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Tinidazole,Viloxazine,The metabolism of Tinidazole can be decreased when combined with Viloxazine.,decrease,no risk
Tinidazole,Vinblastine,Vinblastine may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Vincristine,Vincristine may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Voriconazole,The metabolism of Tinidazole can be decreased when combined with Voriconazole.,decrease,no risk
Tinidazole,Vortioxetine,Tinidazole may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Tinidazole,Warfarin,Tinidazole may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Tinidazole,Zaleplon,Tinidazole may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Tinidazole,Zanamivir,Zanamivir may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Zimelidine,The metabolism of Tinidazole can be decreased when combined with Zimelidine.,decrease,no risk
Tinidazole,Ziprasidone,The metabolism of Tinidazole can be decreased when combined with Ziprasidone.,decrease,no risk
Tinidazole,Zonisamide,Zonisamide may increase the excretion rate of Tinidazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Repaglinide,Gatifloxacin,Fusidic acid may decrease the excretion rate of Repaglinide which could result in a higher serum level.,decrease,no risk
Repaglinide,Gefapixant,The therapeutic efficacy of Repaglinide can be increased when used in combination with Gatifloxacin.,increase,no risk
Repaglinide,Gemfibrozil,The therapeutic efficacy of Repaglinide can be increased when used in combination with Gefapixant.,increase,no risk
Repaglinide,Gemifloxacin,The serum concentration of Repaglinide can be increased when it is combined with Gemfibrozil.,increase,no risk
Repaglinide,Glasdegib,The therapeutic efficacy of Repaglinide can be increased when used in combination with Gemifloxacin.,increase,no risk
Repaglinide,Glecaprevir,The metabolism of Glasdegib can be decreased when combined with Repaglinide.,decrease,no risk
Repaglinide,Gliclazide,The excretion of Repaglinide can be decreased when combined with Glecaprevir.,decrease,no risk
Repaglinide,Glimepiride,The risk or severity of hypoglycemia can be increased when Repaglinide is combined with Gliclazide.,increase,risk
Repaglinide,Glipizide,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Repaglinide.,increase,risk
Repaglinide,Gliquidone,The risk or severity of hypoglycemia can be increased when Repaglinide is combined with Glipizide.,increase,risk
Repaglinide,Glofitamab,The risk or severity of hypoglycemia can be increased when Repaglinide is combined with Gliquidone.,increase,risk
Repaglinide,Glyburide,The serum concentration of Repaglinide can be increased when it is combined with Glofitamab.,increase,no risk
Repaglinide,Glycyrrhizic acid,Glyburide may decrease the excretion rate of Repaglinide which could result in a higher serum level.,decrease,no risk
Repaglinide,Glymidine,Repaglinide may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Repaglinide,Golimumab,The risk or severity of hypoglycemia can be increased when Repaglinide is combined with Glymidine.,increase,risk
Repaglinide,Goserelin,The metabolism of Repaglinide can be increased when combined with Golimumab.,increase,no risk
Repaglinide,Grepafloxacin,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Goserelin.,decrease,no risk
Repaglinide,Halcinonide,The therapeutic efficacy of Repaglinide can be increased when used in combination with Grepafloxacin.,increase,no risk
Repaglinide,Halofantrine,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Repaglinide.,increase,risk
Repaglinide,Haloperidol,The metabolism of Halofantrine can be decreased when combined with Repaglinide.,decrease,no risk
Repaglinide,Histrelin,The serum concentration of Haloperidol can be increased when it is combined with Repaglinide.,increase,no risk
Repaglinide,Hydrochlorothiazide,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Histrelin.,decrease,no risk
Repaglinide,Hydrocortisone,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Repaglinide,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Repaglinide.,increase,risk
Repaglinide,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Repaglinide.,increase,risk
Repaglinide,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Repaglinide.,increase,risk
Repaglinide,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Repaglinide.,increase,risk
Repaglinide,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Repaglinide.,increase,risk
Repaglinide,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Repaglinide.,increase,risk
Repaglinide,Hydroflumethiazide,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Repaglinide.,increase,risk
Repaglinide,Hydroxychloroquine,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Repaglinide,Hydroxyprogesterone caproate,The therapeutic efficacy of Repaglinide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Repaglinide,Ketamine,The serum concentration of Repaglinide can be increased when it is combined with Ixabepilone.,increase,no risk
Repaglinide,Ketoconazole,The metabolism of Ketamine can be decreased when combined with Repaglinide.,decrease,no risk
Repaglinide,Ketoprofen,The serum concentration of Repaglinide can be increased when it is combined with Ketoconazole.,increase,no risk
Repaglinide,Ketorolac,The metabolism of Repaglinide can be decreased when combined with Ketoprofen.,decrease,no risk
Repaglinide,Ketotifen,The metabolism of Repaglinide can be decreased when combined with Ketorolac.,decrease,no risk
Repaglinide,Nadolol,The metabolism of Repaglinide can be decreased when combined with Mycophenolate mofetil.,decrease,no risk
Repaglinide,Nalidixic acid,The therapeutic efficacy of Repaglinide can be increased when used in combination with Nadolol.,increase,no risk
Repaglinide,Nandrolone decanoate,The therapeutic efficacy of Repaglinide can be increased when used in combination with Nalidixic acid.,increase,no risk
Repaglinide,Nandrolone phenpropionate,Nandrolone decanoate may increase the hypoglycemic activities of Repaglinide.,increase,no risk
Repaglinide,Naproxen,Nandrolone phenpropionate may increase the hypoglycemic activities of Repaglinide.,increase,no risk
Repaglinide,Nateglinide,Naproxen may decrease the excretion rate of Repaglinide which could result in a higher serum level.,decrease,no risk
Repaglinide,Nebivolol,The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Repaglinide.,increase,risk
Repaglinide,Nefazodone,The therapeutic efficacy of Repaglinide can be increased when used in combination with Nebivolol.,increase,no risk
Repaglinide,Nelfinavir,The metabolism of Repaglinide can be decreased when combined with Nefazodone.,decrease,no risk
Repaglinide,Netupitant,The metabolism of Repaglinide can be decreased when combined with Nelfinavir.,decrease,no risk
Repaglinide,Niacin,The metabolism of Repaglinide can be decreased when combined with Netupitant.,decrease,no risk
Repaglinide,Nialamide,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Niacin.,decrease,no risk
Repaglinide,Nicardipine,Nialamide may increase the hypoglycemic activities of Repaglinide.,increase,no risk
Repaglinide,Nifedipine,The metabolism of Repaglinide can be decreased when combined with Nicardipine.,decrease,no risk
Repaglinide,Nilotinib,Repaglinide may decrease the excretion rate of Nifedipine which could result in a higher serum level.,decrease,no risk
Repaglinide,Nilutamide,The metabolism of Repaglinide can be decreased when combined with Nilotinib.,decrease,no risk
Repaglinide,Nilvadipine,The metabolism of Repaglinide can be decreased when combined with Nilutamide.,decrease,no risk
Repaglinide,Nimesulide,The metabolism of Repaglinide can be decreased when combined with Nilvadipine.,decrease,no risk
Repaglinide,Nimodipine,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Repaglinide.,increase,risk
Repaglinide,Nirogacestat,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Repaglinide.,increase,risk
Repaglinide,Nisoldipine,The metabolism of Repaglinide can be increased when combined with Nirogacestat.,increase,no risk
Repaglinide,Nitrendipine,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Repaglinide.,increase,risk
Repaglinide,Nitrofurantoin,Repaglinide may decrease the excretion rate of Nitrendipine which could result in a higher serum level.,decrease,no risk
Repaglinide,Norethisterone,Nitrofurantoin may decrease the excretion rate of Repaglinide which could result in a higher serum level.,decrease,no risk
Repaglinide,Norfloxacin,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Norethisterone.,decrease,no risk
Repaglinide,Norgestimate,The therapeutic efficacy of Repaglinide can be increased when used in combination with Norfloxacin.,increase,no risk
Repaglinide,Nortriptyline,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Norgestimate.,decrease,no risk
Repaglinide,Novobiocin,Nortriptyline may decrease the hypoglycemic activities of Repaglinide.,decrease,no risk
Repaglinide,Nylidrin,The excretion of Repaglinide can be decreased when combined with Novobiocin.,decrease,no risk
Repaglinide,Nystatin,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Repaglinide.,increase,risk
Repaglinide,Octreotide,The excretion of Repaglinide can be decreased when combined with Nystatin.,decrease,no risk
Repaglinide,Ofloxacin,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Octreotide.,decrease,no risk
Repaglinide,Olanzapine,The therapeutic efficacy of Repaglinide can be increased when used in combination with Ofloxacin.,increase,no risk
Repaglinide,Olmesartan,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Olanzapine.,decrease,no risk
Repaglinide,Olodaterol,Olmesartan may decrease the excretion rate of Repaglinide which could result in a higher serum level.,decrease,no risk
Repaglinide,Olsalazine,The metabolism of Olodaterol can be decreased when combined with Repaglinide.,decrease,no risk
Repaglinide,Omaveloxolone,Olsalazine may increase the hypoglycemic activities of Repaglinide.,increase,no risk
Repaglinide,Ombitasvir,The serum concentration of Repaglinide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Repaglinide,Ouabain,The metabolism of Ombitasvir can be decreased when combined with Repaglinide.,decrease,no risk
Repaglinide,Oxandrolone,The excretion of Repaglinide can be decreased when combined with Ouabain.,decrease,no risk
Repaglinide,Oxprenolol,Oxandrolone may increase the hypoglycemic activities of Repaglinide.,increase,no risk
Repaglinide,Oxybutynin,The therapeutic efficacy of Repaglinide can be increased when used in combination with Oxprenolol.,increase,no risk
Repaglinide,Oxymetholone,The metabolism of Repaglinide can be decreased when combined with Oxybutynin.,decrease,no risk
Repaglinide,Ozanimod,Oxymetholone may increase the hypoglycemic activities of Repaglinide.,increase,no risk
Anileridine,Halothane,The therapeutic efficacy of Halothane can be increased when used in combination with Anileridine.,increase,no risk
Anileridine,Ketamine,The therapeutic efficacy of Ketamine can be increased when used in combination with Anileridine.,increase,no risk
Anileridine,Nitrous oxide,The therapeutic efficacy of Nitrous oxide can be increased when used in combination with Anileridine.,increase,no risk
Anileridine,Urethane,The therapeutic efficacy of Urethane can be increased when used in combination with Anileridine.,increase,no risk
Phenformin,Galantamine,The metabolism of Phenformin can be decreased when combined with Fusidic acid.,decrease,no risk
Phenformin,Ganciclovir,The metabolism of Phenformin can be decreased when combined with Galantamine.,decrease,no risk
Phenformin,Gatifloxacin,The risk or severity of adverse effects can be increased when Phenformin is combined with Ganciclovir.,increase,risk
Phenformin,Gefapixant,The therapeutic efficacy of Phenformin can be increased when used in combination with Gatifloxacin.,increase,no risk
Phenformin,Gefitinib,The therapeutic efficacy of Phenformin can be increased when used in combination with Gefapixant.,increase,no risk
Phenformin,Gemifloxacin,The metabolism of Phenformin can be decreased when combined with Gefitinib.,decrease,no risk
Phenformin,Gentamicin,The therapeutic efficacy of Phenformin can be increased when used in combination with Gemifloxacin.,increase,no risk
Phenformin,Gilteritinib,The serum concentration of Gentamicin can be increased when it is combined with Phenformin.,increase,no risk
Phenformin,Givosiran,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Phenformin.,increase,risk
Phenformin,Gliclazide,The serum concentration of Phenformin can be increased when it is combined with Givosiran.,increase,no risk
Phenformin,Glimepiride,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Phenformin.,increase,risk
Phenformin,Glipizide,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Phenformin.,increase,risk
Phenformin,Gliquidone,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Phenformin.,increase,risk
Phenformin,Glyburide,The risk or severity of hypoglycemia can be increased when Phenformin is combined with Gliquidone.,increase,risk
Phenformin,Glycerol phenylbutyrate,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Phenformin.,increase,risk
Phenformin,Glymidine,The metabolism of Phenformin can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Phenformin,Golimumab,The therapeutic efficacy of Phenformin can be increased when used in combination with Glymidine.,increase,no risk
Phenformin,Goserelin,The metabolism of Phenformin can be increased when combined with Golimumab.,increase,no risk
Phenformin,Grepafloxacin,The therapeutic efficacy of Phenformin can be decreased when used in combination with Goserelin.,decrease,no risk
Phenformin,Guanfacine,The therapeutic efficacy of Phenformin can be increased when used in combination with Grepafloxacin.,increase,no risk
Phenformin,Guanidine,The risk or severity of adverse effects can be increased when Phenformin is combined with Guanfacine.,increase,risk
Phenformin,Halcinonide,The risk or severity of adverse effects can be increased when Guanidine is combined with Phenformin.,increase,risk
Phenformin,Halofantrine,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Phenformin.,increase,risk
Phenformin,Haloperidol,The metabolism of Phenformin can be decreased when combined with Halofantrine.,decrease,no risk
Phenformin,Histamine,The serum concentration of Phenformin can be increased when it is combined with Haloperidol.,increase,no risk
Phenformin,Histrelin,The serum concentration of Histamine can be increased when it is combined with Phenformin.,increase,no risk
Phenformin,Hydrochlorothiazide,The therapeutic efficacy of Phenformin can be decreased when used in combination with Histrelin.,decrease,no risk
Phenformin,Hydrocortisone,The therapeutic efficacy of Phenformin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Phenformin,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Phenformin.,increase,risk
Phenformin,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Phenformin.,increase,risk
Phenformin,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Phenformin.,increase,risk
Phenformin,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Phenformin.,increase,risk
Phenformin,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Phenformin.,increase,risk
Phenformin,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Phenformin.,increase,risk
Phenformin,Hydroflumethiazide,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Phenformin.,increase,risk
Phenformin,Hydroxychloroquine,The therapeutic efficacy of Phenformin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Phenformin,Hydroxyprogesterone caproate,The therapeutic efficacy of Phenformin can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Phenformin,Hydroxyzine,The therapeutic efficacy of Phenformin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Phenformin,Ketoconazole,The metabolism of Istradefylline can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Ketotifen,The metabolism of Phenformin can be decreased when combined with Ketoconazole.,decrease,no risk
Phenformin,Nadolol,The therapeutic efficacy of Phenformin can be increased when used in combination with Moxifloxacin.,increase,no risk
Phenformin,Nalidixic acid,The therapeutic efficacy of Phenformin can be increased when used in combination with Nadolol.,increase,no risk
Phenformin,Nandrolone decanoate,The therapeutic efficacy of Phenformin can be increased when used in combination with Nalidixic acid.,increase,no risk
Phenformin,Nandrolone phenpropionate,Nandrolone decanoate may increase the hypoglycemic activities of Phenformin.,increase,no risk
Phenformin,Nateglinide,Nandrolone phenpropionate may increase the hypoglycemic activities of Phenformin.,increase,no risk
Phenformin,Nebivolol,The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Phenformin.,increase,risk
Phenformin,Nefazodone,The therapeutic efficacy of Phenformin can be increased when used in combination with Nebivolol.,increase,no risk
Phenformin,Nelfinavir,The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Phenformin.,increase,risk
Phenformin,Netupitant,The therapeutic efficacy of Phenformin can be decreased when used in combination with Nelfinavir.,decrease,no risk
Phenformin,Nevirapine,The metabolism of Netupitant can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Niacin,The risk or severity of adverse effects can be increased when Nevirapine is combined with Phenformin.,increase,risk
Phenformin,Nialamide,The therapeutic efficacy of Phenformin can be decreased when used in combination with Niacin.,decrease,no risk
Phenformin,Nicardipine,Nialamide may increase the hypoglycemic activities of Phenformin.,increase,no risk
Phenformin,Nicergoline,The metabolism of Phenformin can be decreased when combined with Nicardipine.,decrease,no risk
Phenformin,Nicotine,The metabolism of Phenformin can be decreased when combined with Nicergoline.,decrease,no risk
Phenformin,Nifedipine,The risk or severity of adverse effects can be increased when Nicotine is combined with Phenformin.,increase,risk
Phenformin,Nilotinib,The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Phenformin.,increase,risk
Phenformin,Nilvadipine,The therapeutic efficacy of Phenformin can be decreased when used in combination with Nilotinib.,decrease,no risk
Phenformin,Nimesulide,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Phenformin.,increase,risk
Phenformin,Nimodipine,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Phenformin.,increase,risk
Phenformin,Nirogacestat,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Phenformin.,increase,risk
Phenformin,Nisoldipine,The metabolism of Nirogacestat can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Nitrendipine,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Phenformin.,increase,risk
Phenformin,Norepinephrine,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Phenformin.,increase,risk
Phenformin,Norethisterone,The serum concentration of Norepinephrine can be increased when it is combined with Phenformin.,increase,no risk
Phenformin,Norfloxacin,The therapeutic efficacy of Phenformin can be decreased when used in combination with Norethisterone.,decrease,no risk
Phenformin,Norgestimate,The therapeutic efficacy of Phenformin can be increased when used in combination with Norfloxacin.,increase,no risk
Phenformin,Nortriptyline,The therapeutic efficacy of Phenformin can be decreased when used in combination with Norgestimate.,decrease,no risk
Phenformin,Nylidrin,The metabolism of Nortriptyline can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Octreotide,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Phenformin.,increase,risk
Phenformin,Ofloxacin,The therapeutic efficacy of Phenformin can be decreased when used in combination with Octreotide.,decrease,no risk
Phenformin,Olanzapine,The therapeutic efficacy of Phenformin can be increased when used in combination with Ofloxacin.,increase,no risk
Phenformin,Oliceridine,The therapeutic efficacy of Phenformin can be decreased when used in combination with Olanzapine.,decrease,no risk
Phenformin,Olsalazine,The metabolism of Oliceridine can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Ondansetron,Olsalazine may increase the hypoglycemic activities of Phenformin.,increase,no risk
Phenformin,Opium,The metabolism of Phenformin can be decreased when combined with Ondansetron.,decrease,no risk
Phenformin,Oritavancin,The metabolism of Opium can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Orphenadrine,The metabolism of Phenformin can be decreased when combined with Oritavancin.,decrease,no risk
Phenformin,Osilodrostat,The metabolism of Phenformin can be decreased when combined with Orphenadrine.,decrease,no risk
Phenformin,Ospemifene,The metabolism of Phenformin can be decreased when combined with Osilodrostat.,decrease,no risk
Phenformin,Oxaliplatin,The metabolism of Phenformin can be decreased when combined with Ospemifene.,decrease,no risk
Phenformin,Oxamniquine,The serum concentration of Oxaliplatin can be increased when it is combined with Phenformin.,increase,no risk
Phenformin,Oxandrolone,The metabolism of Phenformin can be decreased when combined with Oxamniquine.,decrease,no risk
Phenformin,Oxprenolol,Oxandrolone may increase the hypoglycemic activities of Phenformin.,increase,no risk
Phenformin,Oxybutynin,The therapeutic efficacy of Phenformin can be increased when used in combination with Oxprenolol.,increase,no risk
Phenformin,Oxycodone,The metabolism of Phenformin can be decreased when combined with Oxybutynin.,decrease,no risk
Phenformin,Oxymetholone,The metabolism of Phenformin can be decreased when combined with Oxycodone.,decrease,no risk
Phenformin,Oxymorphone,Oxymetholone may increase the hypoglycemic activities of Phenformin.,increase,no risk
Phenformin,Quetiapine,The therapeutic efficacy of Phenformin can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Phenformin,Quinethazone,The therapeutic efficacy of Phenformin can be decreased when used in combination with Quetiapine.,decrease,no risk
Phenformin,Quinidine,The therapeutic efficacy of Phenformin can be decreased when used in combination with Quinethazone.,decrease,no risk
Phenformin,Quinine,The metabolism of Phenformin can be decreased when combined with Quinidine.,decrease,no risk
Phenformin,Quinupramine,The metabolism of Phenformin can be decreased when combined with Quinine.,decrease,no risk
Phenformin,Ubidecarenone,The risk or severity of adverse effects can be increased when Phenformin is combined with Tubocurarine.,increase,risk
Phenformin,Udenafil,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Phenformin.,increase,risk
Phenformin,Ulobetasol,The therapeutic efficacy of Phenformin can be increased when used in combination with Udenafil.,increase,no risk
Phenformin,Umeclidinium,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Phenformin.,increase,risk
Phenformin,Valbenazine,The metabolism of Umeclidinium can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Valdecoxib,The metabolism of Valbenazine can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Vamorolone,The therapeutic efficacy of Phenformin can be increased when used in combination with Valdecoxib.,increase,no risk
Phenformin,Varenicline,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Phenformin.,increase,risk
Phenformin,Vemurafenib,The excretion of Varenicline can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Venlafaxine,The therapeutic efficacy of Phenformin can be increased when used in combination with Vemurafenib.,increase,no risk
Phenformin,Verapamil,The metabolism of Phenformin can be decreased when combined with Venlafaxine.,decrease,no risk
Phenformin,Vernakalant,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Phenformin.,increase,risk
Phenformin,Vilazodone,The metabolism of Vernakalant can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Vildagliptin,The metabolism of Phenformin can be decreased when combined with Vilazodone.,decrease,no risk
Phenformin,Viloxazine,The risk or severity of hypoglycemia can be increased when Phenformin is combined with Vildagliptin.,increase,risk
Phenformin,Vinblastine,The metabolism of Phenformin can be decreased when combined with Viloxazine.,decrease,no risk
Phenformin,Vinorelbine,The metabolism of Phenformin can be decreased when combined with Vinblastine.,decrease,no risk
Phenformin,Vorinostat,The metabolism of Phenformin can be decreased when combined with Vinorelbine.,decrease,no risk
Phenformin,Vortioxetine,The therapeutic efficacy of Phenformin can be decreased when used in combination with Vorinostat.,decrease,no risk
Phenformin,Xylometazoline,The metabolism of Vortioxetine can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Yohimbine,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Phenformin.,increase,risk
Phenformin,Ziconotide,The metabolism of Yohimbine can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Zimelidine,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Phenformin.,increase,risk
Phenformin,Ziprasidone,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Phenformin.,increase,risk
Phenformin,Zolpidem,The therapeutic efficacy of Phenformin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Phenformin,Zonisamide,The metabolism of Phenformin can be decreased when combined with Zolpidem.,decrease,no risk
Phenformin,Zuclopenthixol,The therapeutic efficacy of Phenformin can be increased when used in combination with Zonisamide.,increase,no risk
Amantadine,Bilastine,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Bilastine.,increase,risk
Amantadine,Biperiden,The risk or severity of adverse effects can be increased when Biperiden is combined with Amantadine.,increase,risk
Amantadine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Amantadine.,decrease,no risk
Amantadine,Bismuth subgallate,Amantadine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Amantadine,Bisoprolol,Bisoprolol may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Bisoxatin,Amantadine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Amantadine,Bleomycin,Bleomycin may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Amantadine.,increase,risk
Amantadine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Amantadine is combined with Botulinum toxin type A.,increase,risk
Amantadine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Amantadine is combined with Botulinum toxin type B.,increase,risk
Amantadine,Bretylium,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Bretylium.,increase,risk
Amantadine,Brexpiprazole,The therapeutic efficacy of Amantadine can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Amantadine,Brivaracetam,Amantadine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Amantadine,Bromazepam,Amantadine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Amantadine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amantadine,Brompheniramine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Amantadine.,increase,risk
Amantadine,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Amantadine.,increase,risk
Amantadine,Budesonide,Amantadine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Amantadine,Bumadizone,Bumadizone may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Bumetanide,Bumetanide may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amantadine,Buprenorphine,The risk or severity of adverse effects can be increased when Amantadine is combined with Buprenorphine.,increase,risk
Amantadine,Bupropion,The excretion of Amantadine can be decreased when combined with Bupropion.,decrease,no risk
Amantadine,Buserelin,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Buserelin.,increase,risk
Amantadine,Buspirone,The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Amantadine.,increase,risk
Amantadine,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Amantadine.,increase,risk
Amantadine,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Amantadine.,increase,risk
Amantadine,Butobarbital,The risk or severity of adverse effects can be increased when Amantadine is combined with Butobarbital.,increase,risk
Amantadine,Butorphanol,The risk or severity of adverse effects can be increased when Amantadine is combined with Butorphanol.,increase,risk
Amantadine,Butriptyline,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Butriptyline.,increase,risk
Amantadine,Butylscopolamine,The risk or severity of adverse effects can be increased when Amantadine is combined with Butylscopolamine.,increase,risk
Amantadine,Gabapentin enacarbil,Amantadine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Amantadine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Gadobenic acid.,increase,risk
Amantadine,Gadodiamide,Gadodiamide may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Gadofosveset trisodium,Amantadine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Amantadine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Gadoteric acid,Amantadine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Amantadine,Gadoteridol,Gadoteridol may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Galantamine,The therapeutic efficacy of Amantadine can be decreased when used in combination with Galantamine.,decrease,no risk
Amantadine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Amantadine.,increase,risk
Amantadine,Ganciclovir,The risk or severity of adverse effects can be increased when Amantadine is combined with Ganciclovir.,increase,risk
Amantadine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Gatifloxacin.,increase,risk
Amantadine,Gemcitabine,Gemcitabine may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Gemfibrozil,Amantadine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Amantadine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Gemifloxacin.,increase,risk
Amantadine,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Amantadine.,increase,no risk
Amantadine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Amantadine.,increase,risk
Amantadine,Gilteritinib,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Amantadine.,increase,risk
Amantadine,Gimeracil,Amantadine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Amantadine,Ginkgo biloba,The therapeutic efficacy of Amantadine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Amantadine,Givosiran,Givosiran may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Glasdegib,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Glasdegib.,increase,risk
Amantadine,Glipizide,Amantadine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Amantadine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Amantadine.,decrease,no risk
Amantadine,Glycerol phenylbutyrate,Amantadine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Amantadine,Glycopyrronium,Amantadine may increase the anticholinergic activities of Glycopyrronium.,increase,no risk
Amantadine,Golodirsen,Amantadine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Amantadine,Goserelin,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Goserelin.,increase,risk
Amantadine,Granisetron,The risk or severity of serotonin syndrome can be increased when Granisetron is combined with Amantadine.,increase,risk
Amantadine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Grepafloxacin.,increase,risk
Amantadine,Guanethidine,Amantadine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Amantadine,Guanfacine,The risk or severity of adverse effects can be increased when Amantadine is combined with Guanfacine.,increase,risk
Amantadine,Guanidine,The serum concentration of Amantadine can be increased when it is combined with Guanidine.,increase,no risk
Amantadine,Halofantrine,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Halofantrine.,increase,risk
Amantadine,Haloperidol,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Haloperidol.,increase,risk
Amantadine,Hexafluronium,The risk or severity of adverse effects can be increased when Amantadine is combined with Hexafluronium.,increase,risk
Amantadine,Hexocyclium,The risk or severity of adverse effects can be increased when Amantadine is combined with Hexocyclium.,increase,risk
Amantadine,Histamine,The serum concentration of Histamine can be increased when it is combined with Amantadine.,increase,no risk
Amantadine,Histrelin,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Histrelin.,increase,risk
Amantadine,Homatropine,The risk or severity of adverse effects can be increased when Amantadine is combined with Homatropine.,increase,risk
Amantadine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Amantadine.,increase,risk
Amantadine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Amantadine.,decrease,no risk
Amantadine,Huperzine A,The therapeutic efficacy of Amantadine can be decreased when used in combination with Huperzine A.,decrease,no risk
Amantadine,Hydralazine,Amantadine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Amantadine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amantadine,Hydrocodone,The risk or severity of serotonin syndrome can be increased when Hydrocodone is combined with Amantadine.,increase,risk
Amantadine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amantadine,Hydromorphone,The risk or severity of adverse effects can be increased when Amantadine is combined with Hydromorphone.,increase,risk
Amantadine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Hydroxychloroquine.,increase,risk
Amantadine,Hydroxyethyl Starch,Amantadine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Amantadine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Hydroxyzine.,increase,risk
Amantadine,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Amantadine.,increase,risk
Amantadine,Kanamycin,Amantadine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Amantadine,Ketamine,The therapeutic efficacy of Amantadine can be decreased when used in combination with Ketamine.,decrease,no risk
Amantadine,Ketazolam,Amantadine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Amantadine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Ketoconazole.,increase,risk
Amantadine,Ketoprofen,Ketoprofen may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Ketorolac,Ketorolac may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,N-acetyltyrosine,Amantadine may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Amantadine,Nabumetone,Nabumetone may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Nadolol,Amantadine may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Amantadine,Nalbuphine,The risk or severity of adverse effects can be increased when Amantadine is combined with Nalbuphine.,increase,risk
Amantadine,Naldemedine,Amantadine may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Amantadine,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Nalidixic acid.,increase,risk
Amantadine,Nalmefene,Amantadine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Amantadine,Naloxegol,The risk or severity of adverse effects can be increased when Amantadine is combined with Naloxegol.,increase,risk
Amantadine,Naloxone,Amantadine may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Amantadine,Naltrexone,The risk or severity of adverse effects can be increased when Amantadine is combined with Naltrexone.,increase,risk
Amantadine,Naproxen,Naproxen may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Naratriptan,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Naratriptan.,increase,risk
Amantadine,Nateglinide,Nateglinide may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Nedaplatin,Amantadine may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Amantadine,Nedocromil,Nedocromil may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Nefazodone,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Nefazodone.,increase,risk
Amantadine,Nelfinavir,The risk or severity of adverse effects can be increased when Nelfinavir is combined with Amantadine.,increase,risk
Amantadine,Neomycin,Amantadine may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Amantadine,Neostigmine,The therapeutic efficacy of Amantadine can be decreased when used in combination with Neostigmine.,decrease,no risk
Amantadine,Netilmicin,Amantadine may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Amantadine,Nevirapine,The risk or severity of adverse effects can be increased when Nevirapine is combined with Amantadine.,increase,risk
Amantadine,Nialamide,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Nialamide.,increase,risk
Amantadine,Nicardipine,The risk or severity of adverse effects can be increased when Nicardipine is combined with Amantadine.,increase,risk
Amantadine,Nicorandil,Amantadine may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Amantadine,Nicotine,The serum concentration of Amantadine can be increased when it is combined with Nicotine.,increase,no risk
Amantadine,Nifedipine,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Nifedipine.,increase,risk
Amantadine,Nilotinib,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Nilotinib.,increase,risk
Amantadine,Nilutamide,Nilutamide may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Nilvadipine,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Nilvadipine.,increase,risk
Amantadine,Nimesulide,Nimesulide may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Nimodipine,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Nimodipine.,increase,risk
Amantadine,Nisoldipine,Nisoldipine may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Nitrendipine,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Nitrendipine.,increase,risk
Amantadine,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Nitroprusside,Nitroprusside may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Nizatidine,The therapeutic efficacy of Amantadine can be decreased when used in combination with Nizatidine.,decrease,no risk
Amantadine,Norepinephrine,The serum concentration of Amantadine can be increased when it is combined with Norepinephrine.,increase,no risk
Amantadine,Norfloxacin,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Norfloxacin.,increase,risk
Amantadine,Normethadone,The risk or severity of adverse effects can be increased when Amantadine is combined with Normethadone.,increase,risk
Amantadine,Nortriptyline,The risk or severity of serotonin syndrome can be increased when Nortriptyline is combined with Amantadine.,increase,risk
Amantadine,Octinoxate,Amantadine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Amantadine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Amantadine.,increase,risk
Amantadine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Ofloxacin.,increase,risk
Amantadine,Olanzapine,The therapeutic efficacy of Amantadine can be decreased when used in combination with Olanzapine.,decrease,no risk
Amantadine,Oliceridine,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Oliceridine.,increase,risk
Amantadine,Olodaterol,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Olodaterol.,increase,risk
Amantadine,Olsalazine,Olsalazine may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Ondansetron,The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Amantadine.,increase,risk
Amantadine,Opium,The risk or severity of adverse effects can be increased when Amantadine is combined with Opium.,increase,risk
Amantadine,Orphenadrine,The risk or severity of adverse effects can be increased when Amantadine is combined with Orphenadrine.,increase,risk
Amantadine,Oseltamivir,Oseltamivir may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Oxacillin,Oxacillin may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Amantadine.,increase,risk
Amantadine,Oxaprozin,Oxaprozin may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Oxatomide,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Oxatomide.,increase,risk
Amantadine,Oxazepam,Oxazepam may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Oxprenolol,The serum concentration of Amantadine can be increased when it is combined with Oxprenolol.,increase,no risk
Amantadine,Oxybenzone,Amantadine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Amantadine,Oxybutynin,The risk or severity of adverse effects can be increased when Amantadine is combined with Oxybutynin.,increase,risk
Amantadine,Oxycodone,The risk or severity of adverse effects can be increased when Amantadine is combined with Oxycodone.,increase,risk
Amantadine,Oxymorphone,The risk or severity of adverse effects can be increased when Amantadine is combined with Oxymorphone.,increase,risk
Amantadine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Amantadine.,increase,risk
Amantadine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Amantadine.,decrease,no risk
Amantadine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Amantadine.,increase,risk
Amantadine,Oxyquinoline,Amantadine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Amantadine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Amantadine.,increase,risk
Amantadine,Quetiapine,The therapeutic efficacy of Amantadine can be decreased when used in combination with Quetiapine.,decrease,no risk
Amantadine,Quinethazone,Quinethazone may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amantadine,Quinidine,Amantadine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Amantadine,Quinine,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Quinine.,increase,risk
Amantadine,Quinupramine,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Quinupramine.,increase,risk
Amantadine,Quizartinib,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Quizartinib.,increase,risk
Amantadine,Umeclidinium,The risk or severity of adverse effects can be increased when Amantadine is combined with Umeclidinium.,increase,risk
Amantadine,Vaborbactam,Amantadine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Amantadine,Valaciclovir,Valaciclovir may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Valbenazine,Amantadine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Amantadine,Valdecoxib,Valdecoxib may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Valganciclovir,Amantadine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Amantadine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Valproate bismuth.,increase,risk
Amantadine,Valproic acid,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Valproic acid.,increase,risk
Amantadine,Vancomycin,Amantadine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Amantadine,Vandetanib,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Vandetanib.,increase,risk
Amantadine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Amantadine.,increase,risk
Amantadine,Varenicline,The excretion of Varenicline can be decreased when combined with Amantadine.,decrease,no risk
Amantadine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Amantadine.,decrease,no risk
Amantadine,Vecuronium,The risk or severity of adverse effects can be increased when Amantadine is combined with Vecuronium.,increase,risk
Amantadine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Amantadine.,increase,risk
Amantadine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Venlafaxine.,increase,risk
Amantadine,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Amantadine.,increase,risk
Amantadine,Vernakalant,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Vernakalant.,increase,risk
Amantadine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Amantadine.,decrease,no risk
Amantadine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Amantadine.,increase,risk
Amantadine,Vilazodone,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Vilazodone.,increase,risk
Amantadine,Viloxazine,Amantadine may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Amantadine,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Amantadine.,increase,risk
Amantadine,Vorinostat,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Vorinostat.,increase,risk
Amantadine,Vortioxetine,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Vortioxetine.,increase,risk
Amantadine,Warfarin,Amantadine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Amantadine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Amantadine.,decrease,no risk
Amantadine,Yohimbine,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Yohimbine.,increase,risk
Amantadine,Zaleplon,Amantadine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Amantadine,Zanamivir,Zanamivir may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Zimelidine,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Zimelidine.,increase,risk
Amantadine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Ziprasidone.,increase,risk
Amantadine,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Amantadine.,increase,risk
Amantadine,Zonisamide,Zonisamide may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amantadine,Zotepine,The therapeutic efficacy of Amantadine can be decreased when used in combination with Zotepine.,decrease,no risk
Amantadine,Zuclopenthixol,The therapeutic efficacy of Amantadine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Metronidazole,Buserelin,The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Buserelin.,increase,risk
Metronidazole,Buspirone,The metabolism of Metronidazole can be decreased when combined with Buspirone.,decrease,no risk
Metronidazole,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Metronidazole.,increase,no risk
Metronidazole,Butacaine,The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Butacaine.,increase,risk
Metronidazole,Butalbital,The therapeutic efficacy of Butalbital can be decreased when used in combination with Metronidazole.,decrease,no risk
Metronidazole,Butamben,The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Butamben.,increase,risk
Metronidazole,Butriptyline,The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Butriptyline.,increase,risk
Dinoprostone,Ganciclovir,The excretion of Dinoprostone can be decreased when combined with Ganciclovir.,decrease,no risk
Dinoprostone,Gemfibrozil,The excretion of Dinoprostone can be decreased when combined with Gemfibrozil.,decrease,no risk
Dinoprostone,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Dinoprostone.,increase,no risk
Dinoprostone,Glecaprevir,The excretion of Dinoprostone can be decreased when combined with Glecaprevir.,decrease,no risk
Dinoprostone,Glyburide,The excretion of Dinoprostone can be decreased when combined with Glyburide.,decrease,no risk
Dinoprostone,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Dinoprostone.,decrease,no risk
Dinoprostone,Guanfacine,The risk or severity of adverse effects can be increased when Dinoprostone is combined with Guanfacine.,increase,risk
Dinoprostone,Guanidine,The excretion of Dinoprostone can be decreased when combined with Guanidine.,decrease,no risk
Dinoprostone,Histamine,The serum concentration of Histamine can be increased when it is combined with Dinoprostone.,increase,no risk
Dinoprostone,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Dinoprostone.,decrease,no risk
Dinoprostone,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Dinoprostone.,decrease,no risk
Dinoprostone,Ketoconazole,The excretion of Dinoprostone can be decreased when combined with Ketoconazole.,decrease,no risk
Dinoprostone,Ketoprofen,The excretion of Dinoprostone can be decreased when combined with Ketoprofen.,decrease,no risk
Dinoprostone,Nafcillin,The excretion of Dinoprostone can be decreased when combined with Nafcillin.,decrease,no risk
Dinoprostone,Nalidixic acid,The excretion of Dinoprostone can be decreased when combined with Nalidixic acid.,decrease,no risk
Dinoprostone,Naproxen,The excretion of Dinoprostone can be decreased when combined with Naproxen.,decrease,no risk
Dinoprostone,Nateglinide,The excretion of Dinoprostone can be decreased when combined with Nateglinide.,decrease,no risk
Dinoprostone,Nelfinavir,The excretion of Dinoprostone can be decreased when combined with Nelfinavir.,decrease,no risk
Dinoprostone,Nicardipine,The excretion of Dinoprostone can be decreased when combined with Nicardipine.,decrease,no risk
Dinoprostone,Nilotinib,The excretion of Dinoprostone can be decreased when combined with Nilotinib.,decrease,no risk
Dinoprostone,Norepinephrine,The serum concentration of Norepinephrine can be increased when it is combined with Dinoprostone.,increase,no risk
Dinoprostone,Norfloxacin,The excretion of Dinoprostone can be decreased when combined with Norfloxacin.,decrease,no risk
Dinoprostone,Novobiocin,The excretion of Dinoprostone can be decreased when combined with Novobiocin.,decrease,no risk
Dinoprostone,Nystatin,The excretion of Dinoprostone can be decreased when combined with Nystatin.,decrease,no risk
Dinoprostone,Ofloxacin,The excretion of Dinoprostone can be decreased when combined with Ofloxacin.,decrease,no risk
Dinoprostone,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Dinoprostone.,decrease,no risk
Dinoprostone,Ouabain,The excretion of Dinoprostone can be decreased when combined with Ouabain.,decrease,no risk
Dinoprostone,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Dinoprostone.,increase,no risk
Dinoprostone,Oxyphenbutazone,The excretion of Dinoprostone can be decreased when combined with Oxyphenbutazone.,decrease,no risk
Dinoprostone,Oxytetracycline,The excretion of Dinoprostone can be decreased when combined with Oxytetracycline.,decrease,no risk
Dinoprostone,Oxytocin,The risk or severity of adverse effects can be increased when Dinoprostone is combined with Oxytocin.,increase,risk
Dinoprostone,Quinapril,The excretion of Quinapril can be decreased when combined with Dinoprostone.,decrease,no risk
Dinoprostone,Quinidine,The excretion of Dinoprostone can be decreased when combined with Quinidine.,decrease,no risk
Dinoprostone,Quinine,The risk or severity of adverse effects can be increased when Dinoprostone is combined with Quinine.,increase,risk
Dinoprostone,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Dinoprostone.,increase,no risk
Dinoprostone,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Dinoprostone.,decrease,no risk
Dinoprostone,Valproic acid,The excretion of Valproic acid can be decreased when combined with Dinoprostone.,decrease,no risk
Dinoprostone,Valsartan,The excretion of Dinoprostone can be decreased when combined with Valsartan.,decrease,no risk
Dinoprostone,Varenicline,The excretion of Varenicline can be decreased when combined with Dinoprostone.,decrease,no risk
Dinoprostone,Velpatasvir,The excretion of Dinoprostone can be decreased when combined with Velpatasvir.,decrease,no risk
Dinoprostone,Venetoclax,The excretion of Dinoprostone can be decreased when combined with Venetoclax.,decrease,no risk
Dinoprostone,Vinblastine,The excretion of Dinoprostone can be decreased when combined with Vinblastine.,decrease,no risk
Dinoprostone,Vincristine,The excretion of Dinoprostone can be decreased when combined with Vincristine.,decrease,no risk
Dinoprostone,Voxilaprevir,The excretion of Dinoprostone can be decreased when combined with Voxilaprevir.,decrease,no risk
Dinoprostone,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Dinoprostone.,decrease,no risk
Dinoprostone,Zidovudine,The excretion of Dinoprostone can be decreased when combined with Zidovudine.,decrease,no risk
Almotriptan,Benoxaprofen,The risk or severity of hypertension can be increased when Almotriptan is combined with Benoxaprofen.,increase,risk
Almotriptan,Benperidol,The risk or severity of adverse effects can be increased when Almotriptan is combined with Benperidol.,increase,risk
Almotriptan,Benserazide,Almotriptan may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Almotriptan,Benzatropine,Benzatropine may decrease the excretion rate of Almotriptan which could result in a higher serum level.,decrease,no risk
Almotriptan,Benznidazole,Almotriptan may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Almotriptan,Benzocaine,The risk or severity of CNS depression can be increased when Almotriptan is combined with Benzocaine.,increase,risk
Almotriptan,Benzphetamine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Almotriptan.,increase,risk
Almotriptan,Benzthiazide,Benzthiazide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Almotriptan,Benzydamine,The risk or severity of hypertension can be increased when Almotriptan is combined with Benzydamine.,increase,risk
Almotriptan,Benzyl alcohol,The risk or severity of CNS depression can be increased when Almotriptan is combined with Benzyl alcohol.,increase,risk
Almotriptan,Bepotastine,Almotriptan may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Almotriptan,Bepridil,The metabolism of Almotriptan can be decreased when combined with Bepridil.,decrease,no risk
Almotriptan,Berotralstat,The metabolism of Almotriptan can be decreased when combined with Berotralstat.,decrease,no risk
Almotriptan,Betamethasone,The metabolism of Almotriptan can be increased when combined with Betamethasone.,increase,no risk
Almotriptan,Betaxolol,Almotriptan may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Almotriptan,Bethanidine,Almotriptan may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Almotriptan,Bexarotene,The metabolism of Almotriptan can be decreased when combined with Bexarotene.,decrease,no risk
Almotriptan,Bezafibrate,The metabolism of Almotriptan can be decreased when combined with Bezafibrate.,decrease,no risk
Almotriptan,Bicisate,Almotriptan may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Almotriptan,Bimekizumab,The metabolism of Almotriptan can be increased when combined with Bimekizumab.,increase,no risk
Almotriptan,Biperiden,The metabolism of Almotriptan can be decreased when combined with Biperiden.,decrease,no risk
Almotriptan,Bismuth subgallate,Almotriptan may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Almotriptan,Bisoprolol,Almotriptan may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Almotriptan,Bisoxatin,Almotriptan may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Almotriptan,Bleomycin,Bleomycin may decrease the excretion rate of Almotriptan which could result in a higher serum level.,decrease,no risk
Almotriptan,Boceprevir,The metabolism of Almotriptan can be decreased when combined with Boceprevir.,decrease,no risk
Almotriptan,Bortezomib,The metabolism of Almotriptan can be decreased when combined with Bortezomib.,decrease,no risk
Almotriptan,Bosentan,Almotriptan may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Almotriptan,Bosutinib,The metabolism of Almotriptan can be decreased when combined with Bosutinib.,decrease,no risk
Almotriptan,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Almotriptan.,increase,risk
Almotriptan,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Almotriptan.,increase,risk
Almotriptan,Bretylium,Almotriptan may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Almotriptan,Brexanolone,The risk or severity of CNS depression can be increased when Almotriptan is combined with Brexanolone.,increase,risk
Almotriptan,Brexpiprazole,The risk or severity of adverse effects can be increased when Almotriptan is combined with Brexpiprazole.,increase,risk
Almotriptan,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Almotriptan.,decrease,no risk
Almotriptan,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.,increase,no risk
Almotriptan,Brivaracetam,The risk or severity of CNS depression can be increased when Almotriptan is combined with Brivaracetam.,increase,risk
Almotriptan,Bromazepam,The risk or severity of CNS depression can be increased when Almotriptan is combined with Bromazepam.,increase,risk
Almotriptan,Bromocriptine,Bromocriptine may increase the vasoconstricting activities of Almotriptan.,increase,no risk
Almotriptan,Bromotheophylline,Bromotheophylline may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Almotriptan,Bromperidol,The risk or severity of adverse effects can be increased when Almotriptan is combined with Bromperidol.,increase,risk
Almotriptan,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Almotriptan.,increase,risk
Almotriptan,Budesonide,Almotriptan may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Almotriptan,Bumadizone,The risk or severity of hypertension can be increased when Almotriptan is combined with Bumadizone.,increase,risk
Almotriptan,Bumetanide,Bumetanide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Almotriptan,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Almotriptan.,increase,risk
Almotriptan,Buprenorphine,Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Almotriptan,Bupropion,The metabolism of Almotriptan can be decreased when combined with Bupropion.,decrease,no risk
Almotriptan,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Almotriptan.,increase,risk
Almotriptan,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Almotriptan.,increase,risk
Almotriptan,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Almotriptan.,increase,risk
Almotriptan,Butaperazine,The risk or severity of adverse effects can be increased when Almotriptan is combined with Butaperazine.,increase,risk
Almotriptan,Butobarbital,The risk or severity of CNS depression can be increased when Almotriptan is combined with Butobarbital.,increase,risk
Almotriptan,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Almotriptan.,increase,risk
Almotriptan,Butriptyline,The risk or severity of CNS depression can be increased when Almotriptan is combined with Butriptyline.,increase,risk
Almotriptan,Gabapentin,The risk or severity of CNS depression can be increased when Almotriptan is combined with Gabapentin.,increase,risk
Almotriptan,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Almotriptan is combined with Gabapentin enacarbil.,increase,risk
Almotriptan,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Almotriptan which could result in a higher serum level.,decrease,no risk
Almotriptan,Gadodiamide,Gadodiamide may decrease the excretion rate of Almotriptan which could result in a higher serum level.,decrease,no risk
Almotriptan,Gadofosveset trisodium,Almotriptan may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Almotriptan,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Almotriptan which could result in a higher serum level.,decrease,no risk
Almotriptan,Gadoteric acid,Almotriptan may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Almotriptan,Gadoteridol,Gadoteridol may decrease the excretion rate of Almotriptan which could result in a higher serum level.,decrease,no risk
Almotriptan,Galantamine,The metabolism of Almotriptan can be decreased when combined with Galantamine.,decrease,no risk
Almotriptan,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Almotriptan.,increase,risk
Almotriptan,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Almotriptan is combined with Ganaxolone.",increase,risk
Almotriptan,Ganciclovir,Almotriptan may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Almotriptan,Gefitinib,The metabolism of Almotriptan can be decreased when combined with Gefitinib.,decrease,no risk
Almotriptan,Gemcitabine,Gemcitabine may decrease the excretion rate of Almotriptan which could result in a higher serum level.,decrease,no risk
Almotriptan,Gemfibrozil,The metabolism of Almotriptan can be decreased when combined with Gemfibrozil.,decrease,no risk
Almotriptan,Gentamicin,Almotriptan may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Almotriptan,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Almotriptan.,increase,risk
Almotriptan,Gilteritinib,The therapeutic efficacy of Almotriptan can be decreased when used in combination with Gilteritinib.,decrease,no risk
Almotriptan,Gimeracil,Almotriptan may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Almotriptan,Ginkgo biloba,The metabolism of Almotriptan can be decreased when combined with Ginkgo biloba.,decrease,no risk
Almotriptan,Givosiran,The serum concentration of Almotriptan can be increased when it is combined with Givosiran.,increase,no risk
Almotriptan,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Almotriptan.,decrease,no risk
Almotriptan,Glipizide,Almotriptan may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Almotriptan,Glofitamab,The serum concentration of Almotriptan can be increased when it is combined with Glofitamab.,increase,no risk
Almotriptan,Glutethimide,The risk or severity of CNS depression can be increased when Almotriptan is combined with Glutethimide.,increase,risk
Almotriptan,Glycerol phenylbutyrate,The metabolism of Almotriptan can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Almotriptan,Golimumab,The metabolism of Almotriptan can be increased when combined with Golimumab.,increase,no risk
Almotriptan,Golodirsen,Almotriptan may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Almotriptan,Goserelin,Goserelin may decrease the excretion rate of Almotriptan which could result in a higher serum level.,decrease,no risk
Almotriptan,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Almotriptan.,increase,risk
Almotriptan,Guanabenz,Almotriptan may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Almotriptan,Guanadrel,Almotriptan may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Almotriptan,Guanethidine,Almotriptan may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Almotriptan,Guanfacine,The risk or severity of CNS depression can be increased when Almotriptan is combined with Guanfacine.,increase,risk
Almotriptan,Guanoxan,Almotriptan may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Almotriptan,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Almotriptan.,increase,risk
Almotriptan,Halofantrine,The metabolism of Almotriptan can be decreased when combined with Halofantrine.,decrease,no risk
Almotriptan,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Almotriptan.,increase,risk
Almotriptan,Halothane,The risk or severity of CNS depression can be increased when Almotriptan is combined with Halothane.,increase,risk
Almotriptan,Hexafluronium,The risk or severity of CNS depression can be increased when Almotriptan is combined with Hexafluronium.,increase,risk
Almotriptan,Hydralazine,Almotriptan may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Almotriptan,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Almotriptan,Hydrocodone,Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Almotriptan,Hydrocortisone,The metabolism of Almotriptan can be increased when combined with Hydrocortisone.,increase,no risk
Almotriptan,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Almotriptan,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Almotriptan.,increase,risk
Almotriptan,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Almotriptan which could result in a higher serum level.,decrease,no risk
Almotriptan,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Almotriptan.,decrease,no risk
Almotriptan,Hydroxyethyl Starch,Almotriptan may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Almotriptan,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.,increase,no risk
Almotriptan,Kanamycin,Almotriptan may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Almotriptan,Ketamine,The risk or severity of CNS depression can be increased when Almotriptan is combined with Ketamine.,increase,risk
Almotriptan,Ketazolam,The risk or severity of CNS depression can be increased when Almotriptan is combined with Ketazolam.,increase,risk
Almotriptan,Ketoconazole,The metabolism of Almotriptan can be decreased when combined with Ketoconazole.,decrease,no risk
Almotriptan,Ketoprofen,The risk or severity of hypertension can be increased when Almotriptan is combined with Ketoprofen.,increase,risk
Almotriptan,Ketorolac,The metabolism of Almotriptan can be decreased when combined with Ketorolac.,decrease,no risk
Spectinomycin,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Spectinomycin.,decrease,no risk
Spectinomycin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Spectinomycin is combined with Benzocaine.,increase,risk
Spectinomycin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Spectinomycin is combined with Benzyl alcohol.,increase,risk
Spectinomycin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Spectinomycin is combined with Bupivacaine.,increase,risk
Spectinomycin,Butacaine,The risk or severity of methemoglobinemia can be increased when Spectinomycin is combined with Butacaine.,increase,risk
Spectinomycin,Butamben,The risk or severity of methemoglobinemia can be increased when Spectinomycin is combined with Butamben.,increase,risk
Spectinomycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Spectinomycin is combined with Oxetacaine.,increase,risk
Spectinomycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Spectinomycin is combined with Oxybuprocaine.,increase,risk
Spectinomycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Spectinomycin.,decrease,no risk
Spectinomycin,Warfarin,The risk or severity of bleeding can be increased when Spectinomycin is combined with Warfarin.,increase,risk
Ketotifen,Benzphetamine,Benzphetamine may decrease the sedative activities of Ketotifen.,decrease,no risk
Ketotifen,Benzylpenicilloyl polylysine,Ketotifen may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Ketotifen,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Ketotifen.,decrease,no risk
Ketotifen,Bexagliflozin,The risk or severity of thrombocytopenia can be increased when Bexagliflozin is combined with Ketotifen.,increase,risk
Ketotifen,Gliclazide,The risk or severity of thrombocytopenia can be increased when Gliclazide is combined with Ketotifen.,increase,risk
Ketotifen,Glimepiride,The risk or severity of thrombocytopenia can be increased when Glimepiride is combined with Ketotifen.,increase,risk
Ketotifen,Glipizide,The risk or severity of thrombocytopenia can be increased when Glipizide is combined with Ketotifen.,increase,risk
Ketotifen,Gliquidone,The risk or severity of thrombocytopenia can be increased when Gliquidone is combined with Ketotifen.,increase,risk
Ketotifen,Glyburide,The risk or severity of thrombocytopenia can be increased when Glyburide is combined with Ketotifen.,increase,risk
Ketotifen,Glymidine,The risk or severity of thrombocytopenia can be increased when Glymidine is combined with Ketotifen.,increase,risk
Ketotifen,Hyoscyamine,Ketotifen may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Ketotifen,Nateglinide,The risk or severity of thrombocytopenia can be increased when Nateglinide is combined with Ketotifen.,increase,risk
Ketotifen,Norepinephrine,The therapeutic efficacy of Norepinephrine can be increased when used in combination with Ketotifen.,increase,no risk
Ketotifen,Vildagliptin,The risk or severity of thrombocytopenia can be increased when Vildagliptin is combined with Ketotifen.,increase,risk
Buprenorphine,Betamethasone,The metabolism of Buprenorphine can be increased when combined with Betamethasone.,increase,no risk
Buprenorphine,Betamethasone phosphate,The metabolism of Buprenorphine can be increased when combined with Betamethasone phosphate.,increase,no risk
Buprenorphine,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Bexarotene,The metabolism of Buprenorphine can be decreased when combined with Bexarotene.,decrease,no risk
Buprenorphine,Bezafibrate,The metabolism of Buprenorphine can be decreased when combined with Bezafibrate.,decrease,no risk
Buprenorphine,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Bimekizumab,The metabolism of Buprenorphine can be increased when combined with Bimekizumab.,increase,no risk
Buprenorphine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Biperiden,The risk or severity of adverse effects can be increased when Biperiden is combined with Buprenorphine.,increase,risk
Buprenorphine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Buprenorphine.,decrease,no risk
Buprenorphine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Buprenorphine.,decrease,no risk
Buprenorphine,Boceprevir,The serum concentration of Buprenorphine can be increased when it is combined with Boceprevir.,increase,no risk
Buprenorphine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Bosentan,The metabolism of Buprenorphine can be increased when combined with Bosentan.,increase,no risk
Buprenorphine,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Botulinum toxin type A,Botulinum toxin type A may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Botulinum toxin type B,Botulinum toxin type B may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Brexanolone,Brexanolone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Brexpiprazole,Brexpiprazole may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Brivaracetam,Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Bromazepam,Bromazepam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Bromocriptine,Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Bromotheophylline,The therapeutic efficacy of Bromotheophylline can be decreased when used in combination with Buprenorphine.,decrease,no risk
Buprenorphine,Bromperidol,Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Brompheniramine,Brompheniramine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Buprenorphine.,increase,risk
Buprenorphine,Budesonide,The metabolism of Buprenorphine can be increased when combined with Budesonide.,increase,no risk
Buprenorphine,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Buprenorphine.,decrease,no risk
Buprenorphine,Bupivacaine,Bupivacaine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Bupropion,Bupropion may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Buspirone,Buspirone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Busulfan,The metabolism of Busulfan can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Butabarbital,Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Butalbital,Butalbital may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Butaperazine,Butaperazine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Butobarbital,Butobarbital may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Butorphanol,Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Butriptyline,Butriptyline may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Butylscopolamine,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Buprenorphine.,increase,risk
Buprenorphine,Gabapentin,Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Gabapentin enacarbil,Gabapentin enacarbil may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Galantamine,The metabolism of Galantamine can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Gallamine triethiodide,Gallamine triethiodide may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Ganaxolone,Ganaxolone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Gefitinib,Buprenorphine may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Buprenorphine,Gemfibrozil,The metabolism of Buprenorphine can be decreased when combined with Gemfibrozil.,decrease,no risk
Buprenorphine,Gepirone,Gepirone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Ginkgo biloba,The metabolism of Buprenorphine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Buprenorphine,Givosiran,The serum concentration of Buprenorphine can be increased when it is combined with Givosiran.,increase,no risk
Buprenorphine,Glasdegib,Buprenorphine may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Buprenorphine,Glecaprevir,Buprenorphine may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Buprenorphine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Glimepiride,The metabolism of Buprenorphine can be decreased when combined with Glimepiride.,decrease,no risk
Buprenorphine,Glipizide,The metabolism of Glipizide can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Glofitamab,The serum concentration of Buprenorphine can be increased when it is combined with Glofitamab.,increase,no risk
Buprenorphine,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Buprenorphine.,decrease,no risk
Buprenorphine,Glutethimide,Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Glyburide,Buprenorphine may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Buprenorphine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Buprenorphine.,decrease,no risk
Buprenorphine,Glycerol phenylbutyrate,The metabolism of Buprenorphine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Buprenorphine,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Buprenorphine.,increase,risk
Buprenorphine,Golimumab,The metabolism of Buprenorphine can be increased when combined with Golimumab.,increase,no risk
Buprenorphine,Granisetron,Granisetron may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Guanfacine,Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Halazepam,Halazepam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Halofantrine,The metabolism of Buprenorphine can be decreased when combined with Halofantrine.,decrease,no risk
Buprenorphine,Haloperidol,Haloperidol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Halothane,Halothane may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Hexafluronium,Hexafluronium may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Buprenorphine.,increase,risk
Buprenorphine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Buprenorphine.,increase,risk
Buprenorphine,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Buprenorphine.,decrease,no risk
Buprenorphine,Hydrocodone,The therapeutic efficacy of Hydrocodone can be decreased when used in combination with Buprenorphine.,decrease,no risk
Buprenorphine,Hydrocortisone,The metabolism of Buprenorphine can be increased when combined with Hydrocortisone.,increase,no risk
Buprenorphine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Buprenorphine.,decrease,no risk
Buprenorphine,Hydromorphone,Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Buprenorphine.,increase,risk
Buprenorphine,Ketamine,Ketamine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Ketazolam,Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Ketoconazole,The metabolism of Buprenorphine can be decreased when combined with Ketoconazole.,decrease,no risk
Buprenorphine,Ketoprofen,The metabolism of Buprenorphine can be decreased when combined with Ketoprofen.,decrease,no risk
Buprenorphine,Ketorolac,The metabolism of Buprenorphine can be decreased when combined with Ketorolac.,decrease,no risk
Levosimendan,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Levosimendan.,increase,risk
Levosimendan,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Levosimendan.,increase,risk
Levosimendan,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Levosimendan.,increase,risk
Levosimendan,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Gemifloxacin.,increase,risk
Levosimendan,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Levosimendan.,increase,risk
Levosimendan,Gilteritinib,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Gilteritinib.,increase,risk
Levosimendan,Glasdegib,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Glasdegib.,increase,risk
Levosimendan,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Levosimendan.,increase,risk
Levosimendan,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Levosimendan.,increase,risk
Levosimendan,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Grepafloxacin.,increase,risk
Levosimendan,Guanabenz,Levosimendan may increase the hypotensive activities of Guanabenz.,increase,no risk
Levosimendan,Guanadrel,Levosimendan may increase the hypotensive activities of Guanadrel.,increase,no risk
Levosimendan,Guanethidine,Levosimendan may increase the hypotensive activities of Guanethidine.,increase,no risk
Levosimendan,Guanfacine,The risk or severity of adverse effects can be increased when Levosimendan is combined with Guanfacine.,increase,risk
Levosimendan,Guanoxan,Levosimendan may increase the hypotensive activities of Guanoxan.,increase,no risk
Levosimendan,Halofantrine,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Halofantrine.,increase,risk
Levosimendan,Haloperidol,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Haloperidol.,increase,risk
Levosimendan,Halothane,The risk or severity of adverse effects can be increased when Levosimendan is combined with Halothane.,increase,risk
Levosimendan,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Levosimendan.,increase,risk
Levosimendan,Hydralazine,The risk or severity of adverse effects can be increased when Levosimendan is combined with Hydralazine.,increase,risk
Levosimendan,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Levosimendan.,increase,risk
Levosimendan,Hydroflumethiazide,The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Levosimendan.,increase,risk
Levosimendan,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Levosimendan.,increase,risk
Levosimendan,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Hydroxyzine.,increase,risk
Levosimendan,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Levosimendan.,increase,no risk
Levosimendan,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Levosimendan.,increase,risk
Levosimendan,Nabilone,The risk or severity of adverse effects can be increased when Nabilone is combined with Levosimendan.,increase,risk
Levosimendan,Nadolol,Levosimendan may increase the arrhythmogenic activities of Nadolol.,increase,no risk
Levosimendan,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Levosimendan.,increase,risk
Levosimendan,Nebivolol,Levosimendan may increase the arrhythmogenic activities of Nebivolol.,increase,no risk
Levosimendan,Nelfinavir,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Levosimendan.,increase,risk
Levosimendan,Nesiritide,The risk or severity of adverse effects can be increased when Levosimendan is combined with Nesiritide.,increase,risk
Levosimendan,Nialamide,Nialamide may increase the orthostatic hypotensive activities of Levosimendan.,increase,no risk
Levosimendan,Nicardipine,Nicardipine may increase the arrhythmogenic activities of Levosimendan.,increase,no risk
Levosimendan,Nicorandil,Nicorandil may increase the hypotensive activities of Levosimendan.,increase,no risk
Levosimendan,Nifedipine,Levosimendan may increase the arrhythmogenic activities of Nifedipine.,increase,no risk
Levosimendan,Nilotinib,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Nilotinib.,increase,risk
Levosimendan,Nilvadipine,Levosimendan may increase the arrhythmogenic activities of Nilvadipine.,increase,no risk
Levosimendan,Nimesulide,Levosimendan may increase the arrhythmogenic activities of Nimesulide.,increase,no risk
Levosimendan,Nimodipine,Nimodipine may increase the arrhythmogenic activities of Levosimendan.,increase,no risk
Levosimendan,Nisoldipine,Nisoldipine may increase the arrhythmogenic activities of Levosimendan.,increase,no risk
Levosimendan,Nitrendipine,Levosimendan may increase the arrhythmogenic activities of Nitrendipine.,increase,no risk
Levosimendan,Nitric Oxide,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Levosimendan.,increase,risk
Levosimendan,Nitroglycerin,The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Levosimendan.,increase,risk
Levosimendan,Nitroprusside,The risk or severity of adverse effects can be increased when Nitroprusside is combined with Levosimendan.,increase,risk
Levosimendan,Nitrous acid,The risk or severity of adverse effects can be increased when Levosimendan is combined with Nitrous acid.,increase,risk
Levosimendan,Norfloxacin,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Levosimendan.,increase,risk
Levosimendan,Nortriptyline,The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Levosimendan.,increase,risk
Levosimendan,Nylidrin,Levosimendan may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Levosimendan,Obinutuzumab,The risk or severity of adverse effects can be increased when Levosimendan is combined with Obinutuzumab.,increase,risk
Levosimendan,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Levosimendan.,increase,risk
Levosimendan,Ofloxacin,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Ofloxacin.,increase,risk
Levosimendan,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Levosimendan.,increase,risk
Levosimendan,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Levosimendan.,increase,risk
Levosimendan,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Levosimendan.,increase,risk
Levosimendan,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Levosimendan.,increase,risk
Levosimendan,Opicapone,The risk or severity of adverse effects can be increased when Levosimendan is combined with Opicapone.,increase,risk
Levosimendan,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Levosimendan.,increase,risk
Levosimendan,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Levosimendan.,increase,risk
Levosimendan,Oxatomide,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Oxatomide.,increase,risk
Levosimendan,Oxprenolol,Levosimendan may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Levosimendan,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Levosimendan.,increase,risk
Levosimendan,Quetiapine,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Quetiapine.,increase,risk
Levosimendan,Quinapril,The risk or severity of adverse effects can be increased when Quinapril is combined with Levosimendan.,increase,risk
Levosimendan,Quinidine,Quinidine may increase the arrhythmogenic activities of Levosimendan.,increase,no risk
Levosimendan,Quinine,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Quinine.,increase,risk
Levosimendan,Quizartinib,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Quizartinib.,increase,risk
Levosimendan,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Levosimendan.,increase,risk
Levosimendan,Valproic acid,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Valproic acid.,increase,risk
Levosimendan,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Levosimendan.,increase,risk
Levosimendan,Vandetanib,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Vandetanib.,increase,risk
Levosimendan,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Levosimendan.,increase,risk
Levosimendan,Vemurafenib,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Vemurafenib.,increase,risk
Levosimendan,Verapamil,Verapamil may increase the arrhythmogenic activities of Levosimendan.,increase,no risk
Levosimendan,Vericiguat,The risk or severity of adverse effects can be increased when Levosimendan is combined with Vericiguat.,increase,risk
Levosimendan,Vernakalant,Levosimendan may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Levosimendan,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Levosimendan.,increase,risk
Levosimendan,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Levosimendan.,increase,risk
Levosimendan,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Levosimendan.,increase,risk
Levosimendan,Xylometazoline,Levosimendan may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Levosimendan,Ziconotide,Levosimendan may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Levosimendan,Ziprasidone,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Ziprasidone.,increase,risk
Levosimendan,Zofenopril,Levosimendan may increase the hypotensive activities of Zofenopril.,increase,no risk
Levosimendan,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Levosimendan.,increase,no risk
Levosimendan,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Zuclopenthixol.,increase,risk
Ceforanide,Gabapentin enacarbil,Ceforanide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ceforanide,Gadobenic acid,Ceforanide may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Ceforanide,Gadodiamide,Ceforanide may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Ceforanide,Gadofosveset trisodium,Ceforanide may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ceforanide,Gadopentetic acid,Ceforanide may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Ceforanide,Gadoteric acid,Ceforanide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ceforanide,Gadoteridol,Ceforanide may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Ceforanide,Ganciclovir,Ceforanide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ceforanide,Gemcitabine,Ceforanide may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Ceforanide,Gemfibrozil,Ceforanide may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Ceforanide,Gentamicin,Ceforanide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ceforanide,Gimeracil,Ceforanide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ceforanide,Givosiran,The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Givosiran.,increase,risk
Ceforanide,Glipizide,Ceforanide may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Ceforanide,Glycerol phenylbutyrate,Ceforanide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ceforanide,Golodirsen,Ceforanide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ceforanide,Goserelin,Ceforanide may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Ceforanide,Guanethidine,Ceforanide may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Ceforanide,Guanfacine,Ceforanide may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Ceforanide,Haloperidol,Ceforanide may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Ceforanide,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Ceforanide.,decrease,no risk
Ceforanide,Hydralazine,Ceforanide may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Ceforanide,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Hydrochlorothiazide.,increase,risk
Ceforanide,Hydromorphone,Ceforanide may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Ceforanide,Hydroxocobalamin,Ceforanide may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Ceforanide,Hydroxyethyl Starch,Ceforanide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ceforanide,Kanamycin,Ceforanide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ceforanide,Ketamine,Ceforanide may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ceforanide,Ketazolam,Ceforanide may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Ceforanide,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Ketoprofen.,increase,risk
Ceforanide,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Ceforanide.,increase,risk
Ceforanide,N-acetyltyrosine,Ceforanide may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Ceforanide,Nabumetone,The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Ceforanide.,increase,risk
Ceforanide,Nadolol,Ceforanide may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Ceforanide,Nadroparin,The therapeutic efficacy of Nadroparin can be decreased when used in combination with Ceforanide.,decrease,no risk
Ceforanide,Naldemedine,Ceforanide may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Ceforanide,Nalmefene,Ceforanide may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Ceforanide,Naloxone,Ceforanide may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Ceforanide,Naproxen,The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Ceforanide.,increase,risk
Ceforanide,Nateglinide,Ceforanide may decrease the excretion rate of Nateglinide which could result in a higher serum level.,decrease,no risk
Ceforanide,Nedaplatin,Ceforanide may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Ceforanide,Nedocromil,Ceforanide may decrease the excretion rate of Nedocromil which could result in a higher serum level.,decrease,no risk
Ceforanide,Nefazodone,Ceforanide may decrease the excretion rate of Nefazodone which could result in a higher serum level.,decrease,no risk
Ceforanide,Neomycin,The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Neomycin.,increase,risk
Ceforanide,Netilmicin,Ceforanide may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Ceforanide,Nicorandil,Ceforanide may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Ceforanide,Nifedipine,Ceforanide may decrease the excretion rate of Nifedipine which could result in a higher serum level.,decrease,no risk
Ceforanide,Nilutamide,Ceforanide may decrease the excretion rate of Nilutamide which could result in a higher serum level.,decrease,no risk
Ceforanide,Nimesulide,The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Nimesulide.,increase,risk
Ceforanide,Nisoldipine,Ceforanide may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Ceforanide,Nitric Oxide,Ceforanide may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Ceforanide,Nitrofurantoin,Ceforanide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,decrease,no risk
Ceforanide,Nitroprusside,Ceforanide may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,decrease,no risk
Ceforanide,Octinoxate,Ceforanide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ceforanide,Olsalazine,The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Olsalazine.,increase,risk
Ceforanide,Opium,Ceforanide may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ceforanide,Oseltamivir,Ceforanide may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Ceforanide,Oxacillin,Ceforanide may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Ceforanide,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Ceforanide.,increase,risk
Ceforanide,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Oxaprozin.,increase,risk
Ceforanide,Oxazepam,Ceforanide may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Ceforanide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ceforanide is combined with Oxetacaine.,increase,risk
Ceforanide,Oxybenzone,Ceforanide may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Ceforanide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ceforanide is combined with Oxybuprocaine.,increase,risk
Ceforanide,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Oxyphenbutazone.,increase,risk
Ceforanide,Oxyquinoline,Ceforanide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ceforanide,Quetiapine,Ceforanide may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Ceforanide,Quinidine,Ceforanide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Ceforanide,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceforanide.,decrease,no risk
Ceforanide,Vaborbactam,Ceforanide may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ceforanide,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Ceforanide.,increase,risk
Ceforanide,Valbenazine,Ceforanide may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ceforanide,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Ceforanide.,increase,risk
Ceforanide,Valganciclovir,Ceforanide may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Ceforanide,Vancomycin,Ceforanide may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ceforanide,Varenicline,Ceforanide may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Ceforanide,Venlafaxine,Ceforanide may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Ceforanide,Verapamil,Ceforanide may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Ceforanide,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ceforanide.,decrease,no risk
Ceforanide,Vilanterol,Ceforanide may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Ceforanide,Viloxazine,Ceforanide may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Ceforanide,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Ceforanide.,decrease,no risk
Ceforanide,Vortioxetine,Ceforanide may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Ceforanide,Warfarin,Ceforanide may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Ceforanide,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Ceforanide.,decrease,no risk
Ceforanide,Zaleplon,Ceforanide may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Ceforanide,Zanamivir,Ceforanide may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Ceforanide,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Ceforanide is combined with Zoledronic acid.,increase,risk
Ceforanide,Zonisamide,Ceforanide may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Cyclobenzaprine,Gabapentin,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Gabapentin.,increase,risk
Cyclobenzaprine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Gabapentin enacarbil.,increase,risk
Cyclobenzaprine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Gallamine triethiodide.,increase,risk
Cyclobenzaprine,Ganaxolone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Ganaxolone.,increase,risk
Cyclobenzaprine,Gatifloxacin,The metabolism of Cyclobenzaprine can be decreased when combined with Gatifloxacin.,decrease,no risk
Cyclobenzaprine,Gemfibrozil,The metabolism of Cyclobenzaprine can be decreased when combined with Gemfibrozil.,decrease,no risk
Cyclobenzaprine,Gemifloxacin,The metabolism of Cyclobenzaprine can be decreased when combined with Gemifloxacin.,decrease,no risk
Cyclobenzaprine,Gepirone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Gepirone.,increase,risk
Cyclobenzaprine,Gilteritinib,The therapeutic efficacy of Cyclobenzaprine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Cyclobenzaprine,Givosiran,The serum concentration of Cyclobenzaprine can be increased when it is combined with Givosiran.,increase,no risk
Cyclobenzaprine,Glofitamab,The serum concentration of Cyclobenzaprine can be increased when it is combined with Glofitamab.,increase,no risk
Cyclobenzaprine,Glutethimide,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Glutethimide.,increase,risk
Cyclobenzaprine,Golimumab,The metabolism of Cyclobenzaprine can be increased when combined with Golimumab.,increase,no risk
Cyclobenzaprine,Granisetron,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Granisetron.,increase,risk
Cyclobenzaprine,Grepafloxacin,The metabolism of Cyclobenzaprine can be decreased when combined with Grepafloxacin.,decrease,no risk
Cyclobenzaprine,Guanabenz,The metabolism of Cyclobenzaprine can be decreased when combined with Guanabenz.,decrease,no risk
Cyclobenzaprine,Guanfacine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Guanfacine.,increase,risk
Cyclobenzaprine,Halazepam,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Halazepam.,increase,risk
Cyclobenzaprine,Haloperidol,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Haloperidol.,increase,risk
Cyclobenzaprine,Halothane,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Halothane.,increase,risk
Cyclobenzaprine,Hexafluronium,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Hexafluronium.,increase,risk
Cyclobenzaprine,Hydrocodone,Cyclobenzaprine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Cyclobenzaprine,Hydromorphone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Hydromorphone.,increase,risk
Cyclobenzaprine,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Cyclobenzaprine.,increase,risk
Cyclobenzaprine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cyclobenzaprine.,increase,no risk
Cyclobenzaprine,Ketamine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Ketamine.,increase,risk
Cyclobenzaprine,Ketazolam,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Ketazolam.,increase,risk
Cyclobenzaprine,Ketoconazole,The metabolism of Cyclobenzaprine can be decreased when combined with Ketoconazole.,decrease,no risk
Cyclobenzaprine,Nabilone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Nabilone.,increase,risk
Cyclobenzaprine,Nabumetone,The metabolism of Cyclobenzaprine can be decreased when combined with Nabumetone.,decrease,no risk
Cyclobenzaprine,Nafcillin,The metabolism of Cyclobenzaprine can be increased when combined with Nafcillin.,increase,no risk
Cyclobenzaprine,Nalbuphine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Nalbuphine.,increase,risk
Cyclobenzaprine,Nalidixic acid,The metabolism of Cyclobenzaprine can be decreased when combined with Nalidixic acid.,decrease,no risk
Cyclobenzaprine,Naloxegol,The risk or severity of respiratory depression can be increased when Naloxegol is combined with Cyclobenzaprine.,increase,risk
Cyclobenzaprine,Naltrexone,The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Cyclobenzaprine.,increase,risk
Cyclobenzaprine,Naproxen,The metabolism of Cyclobenzaprine can be decreased when combined with Naproxen.,decrease,no risk
Cyclobenzaprine,Naratriptan,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Naratriptan.,increase,risk
Cyclobenzaprine,Naxitamab,Cyclobenzaprine may increase the neurotoxic activities of Naxitamab.,increase,no risk
Cyclobenzaprine,Nefazodone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Nefazodone.,increase,risk
Cyclobenzaprine,Nelfinavir,The metabolism of Cyclobenzaprine can be decreased when combined with Nelfinavir.,decrease,no risk
Cyclobenzaprine,Neomycin,Cyclobenzaprine may increase the neurotoxic activities of Neomycin.,increase,no risk
Cyclobenzaprine,Netupitant,The metabolism of Cyclobenzaprine can be decreased when combined with Netupitant.,decrease,no risk
Cyclobenzaprine,Nevirapine,The metabolism of Cyclobenzaprine can be decreased when combined with Nevirapine.,decrease,no risk
Cyclobenzaprine,Nialamide,Cyclobenzaprine may increase the serotonergic activities of Nialamide.,increase,no risk
Cyclobenzaprine,Nicardipine,The metabolism of Cyclobenzaprine can be decreased when combined with Nicardipine.,decrease,no risk
Cyclobenzaprine,Niclosamide,The metabolism of Cyclobenzaprine can be decreased when combined with Niclosamide.,decrease,no risk
Cyclobenzaprine,Nifedipine,The metabolism of Nifedipine can be decreased when combined with Cyclobenzaprine.,decrease,no risk
Cyclobenzaprine,Nilotinib,The metabolism of Cyclobenzaprine can be decreased when combined with Nilotinib.,decrease,no risk
Cyclobenzaprine,Nilvadipine,The metabolism of Cyclobenzaprine can be decreased when combined with Nilvadipine.,decrease,no risk
Cyclobenzaprine,Nitrazepam,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Nitrazepam.,increase,risk
Cyclobenzaprine,Nitrous oxide,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Nitrous oxide.,increase,risk
Cyclobenzaprine,Nomifensine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Nomifensine.,increase,risk
Cyclobenzaprine,Norfloxacin,The metabolism of Cyclobenzaprine can be decreased when combined with Norfloxacin.,decrease,no risk
Cyclobenzaprine,Normethadone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Normethadone.,increase,risk
Cyclobenzaprine,Nortriptyline,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Nortriptyline.,increase,risk
Cyclobenzaprine,Obeticholic acid,The metabolism of Cyclobenzaprine can be decreased when combined with Obeticholic acid.,decrease,no risk
Cyclobenzaprine,Olanzapine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Olanzapine.,increase,risk
Cyclobenzaprine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Cyclobenzaprine is combined with Oliceridine.",increase,risk
Cyclobenzaprine,Omaveloxolone,The serum concentration of Cyclobenzaprine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Cyclobenzaprine,Ondansetron,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Ondansetron.,increase,risk
Cyclobenzaprine,Opium,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Opium.,increase,risk
Cyclobenzaprine,Orphenadrine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Orphenadrine.,increase,risk
Cyclobenzaprine,Osilodrostat,The metabolism of Cyclobenzaprine can be decreased when combined with Osilodrostat.,decrease,no risk
Cyclobenzaprine,Osimertinib,The serum concentration of Cyclobenzaprine can be decreased when it is combined with Osimertinib.,decrease,no risk
Cyclobenzaprine,Oxazepam,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Oxazepam.,increase,risk
Cyclobenzaprine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Oxcarbazepine.,increase,risk
Cyclobenzaprine,Oxitriptan,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Oxitriptan.,increase,risk
Cyclobenzaprine,Oxprenolol,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Oxprenolol.,increase,risk
Cyclobenzaprine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Cyclobenzaprine.,decrease,no risk
Cyclobenzaprine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Oxybuprocaine.,increase,risk
Cyclobenzaprine,Oxycodone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Oxycodone.,increase,risk
Cyclobenzaprine,Oxymorphone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Oxymorphone.,increase,risk
Cyclobenzaprine,Quazepam,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Quazepam.,increase,risk
Cyclobenzaprine,Quetiapine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Quetiapine.,increase,risk
Cyclobenzaprine,Quinidine,The metabolism of Cyclobenzaprine can be decreased when combined with Quinidine.,decrease,no risk
Cyclobenzaprine,Quinine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Quinine.,increase,risk
Cyclobenzaprine,Quinupramine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Quinupramine.,increase,risk
Cyclobenzaprine,Urethane,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Urethane.,increase,risk
Cyclobenzaprine,Vadadustat,The serum concentration of Cyclobenzaprine can be increased when it is combined with Vadadustat.,increase,no risk
Cyclobenzaprine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Cyclobenzaprine is combined with Valproate bismuth.,increase,risk
Cyclobenzaprine,Valproic acid,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Valproic acid.,increase,risk
Cyclobenzaprine,Vecuronium,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Vecuronium.,increase,risk
Cyclobenzaprine,Vemurafenib,The serum concentration of Cyclobenzaprine can be increased when it is combined with Vemurafenib.,increase,no risk
Cyclobenzaprine,Venetoclax,The metabolism of Cyclobenzaprine can be decreased when combined with Venetoclax.,decrease,no risk
Cyclobenzaprine,Venlafaxine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Venlafaxine.,increase,risk
Cyclobenzaprine,Verapamil,The metabolism of Cyclobenzaprine can be decreased when combined with Verapamil.,decrease,no risk
Cyclobenzaprine,Vigabatrin,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Vigabatrin.,increase,risk
Cyclobenzaprine,Vilazodone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Vilazodone.,increase,risk
Cyclobenzaprine,Viloxazine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Viloxazine.,increase,risk
Cyclobenzaprine,Vincristine,Vincristine may increase the neurotoxic activities of Cyclobenzaprine.,increase,no risk
Cyclobenzaprine,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Cyclobenzaprine.,increase,no risk
Cyclobenzaprine,Viomycin,Cyclobenzaprine may increase the neurotoxic activities of Viomycin.,increase,no risk
Cyclobenzaprine,Voriconazole,The metabolism of Cyclobenzaprine can be decreased when combined with Voriconazole.,decrease,no risk
Cyclobenzaprine,Vortioxetine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Vortioxetine.,increase,risk
Cyclobenzaprine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Cyclobenzaprine.,decrease,no risk
Cyclobenzaprine,Warfarin,The metabolism of Cyclobenzaprine can be decreased when combined with Warfarin.,decrease,no risk
Cyclobenzaprine,Yohimbine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Yohimbine.,increase,risk
Cyclobenzaprine,Zaleplon,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Zaleplon.,increase,risk
Cyclobenzaprine,Ziconotide,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Ziconotide.,increase,risk
Cyclobenzaprine,Zileuton,The metabolism of Cyclobenzaprine can be decreased when combined with Zileuton.,decrease,no risk
Cyclobenzaprine,Zimelidine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Zimelidine.,increase,risk
Cyclobenzaprine,Ziprasidone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Ziprasidone.,increase,risk
Cyclobenzaprine,Zolmitriptan,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Zolmitriptan.,increase,risk
Cyclobenzaprine,Zolpidem,Cyclobenzaprine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Cyclobenzaprine,Zonisamide,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Zonisamide.,increase,risk
Cyclobenzaprine,Zopiclone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Zopiclone.,increase,risk
Cyclobenzaprine,Zotepine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Zotepine.,increase,risk
Cyclobenzaprine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Zuclopenthixol.,increase,risk
Cyclobenzaprine,Zuranolone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Zuranolone.,increase,risk
Phenoxybenzamine,Ganciclovir,The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Ganciclovir.,increase,risk
Phenoxybenzamine,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Phenoxybenzamine.,increase,no risk
Phenoxybenzamine,Glycol salicylate,The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Phenoxybenzamine,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Guanadrel,Phenoxybenzamine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Phenoxybenzamine,Guanethidine,Phenoxybenzamine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Phenoxybenzamine,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Guanoxan,Phenoxybenzamine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Phenoxybenzamine,Halothane,Halothane may decrease the antihypertensive activities of Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Histamine,The serum concentration of Histamine can be increased when it is combined with Phenoxybenzamine.,increase,no risk
Phenoxybenzamine,Hydralazine,Phenoxybenzamine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Phenoxybenzamine,Hydrochlorothiazide,The therapeutic efficacy of Phenoxybenzamine can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Phenoxybenzamine,Hydroflumethiazide,The therapeutic efficacy of Phenoxybenzamine can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Phenoxybenzamine,Ketoprofen,The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Ketoprofen.,decrease,no risk
Phenoxybenzamine,Ketorolac,The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Ketorolac.,decrease,no risk
Phenoxybenzamine,Nabilone,The risk or severity of adverse effects can be increased when Nabilone is combined with Phenoxybenzamine.,increase,risk
Phenoxybenzamine,Nabumetone,The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Nabumetone.,decrease,no risk
Phenoxybenzamine,Nadolol,Nadolol may increase the orthostatic hypotensive activities of Phenoxybenzamine.,increase,no risk
Phenoxybenzamine,Naphazoline,The therapeutic efficacy of Naphazoline can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Naproxen,The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Naproxen.,decrease,no risk
Phenoxybenzamine,Naratriptan,Naratriptan may decrease the antihypertensive activities of Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Naxitamab,Naxitamab may decrease the antihypertensive activities of Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Nebivolol,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Nefazodone,"Phenoxybenzamine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Nefazodone.",increase,no risk
Phenoxybenzamine,Nesiritide,The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Nesiritide.,increase,risk
Phenoxybenzamine,Nialamide,Nialamide may increase the hypotensive activities of Phenoxybenzamine.,increase,no risk
Phenoxybenzamine,Nicardipine,"Nicardipine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Phenoxybenzamine.",increase,no risk
Phenoxybenzamine,Nicergoline,"Nicergoline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Phenoxybenzamine.",increase,no risk
Phenoxybenzamine,Nicorandil,Nicorandil may increase the hypotensive activities of Phenoxybenzamine.,increase,no risk
Phenoxybenzamine,Nifedipine,The risk or severity of hypotension can be increased when Phenoxybenzamine is combined with Nifedipine.,increase,risk
Phenoxybenzamine,Nilvadipine,Phenoxybenzamine may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Phenoxybenzamine,Nimesulide,The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Nimesulide.,decrease,no risk
Phenoxybenzamine,Nimodipine,Phenoxybenzamine may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Phenoxybenzamine,Nisoldipine,Phenoxybenzamine may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Phenoxybenzamine,Nitrendipine,Phenoxybenzamine may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Phenoxybenzamine,Nitric Oxide,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Phenoxybenzamine.,increase,risk
Phenoxybenzamine,Nitroglycerin,Phenoxybenzamine may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Phenoxybenzamine,Nitroprusside,Phenoxybenzamine may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Phenoxybenzamine,Nitrous acid,The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Nitrous acid.,increase,risk
Phenoxybenzamine,Nitrous oxide,Nitrous oxide may decrease the antihypertensive activities of Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Norepinephrine,The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Nortriptyline,"Nortriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Phenoxybenzamine.",increase,no risk
Phenoxybenzamine,Nylidrin,The therapeutic efficacy of Nylidrin can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Obinutuzumab,Phenoxybenzamine may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Phenoxybenzamine,Olanzapine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Phenoxybenzamine.",increase,no risk
Phenoxybenzamine,Olmesartan,Phenoxybenzamine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Phenoxybenzamine,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Opicapone,The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Opicapone.,increase,risk
Phenoxybenzamine,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Phenoxybenzamine.,increase,no risk
Phenoxybenzamine,Oxaprozin,The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Oxaprozin.,decrease,no risk
Phenoxybenzamine,Oxprenolol,Oxprenolol may increase the orthostatic hypotensive activities of Phenoxybenzamine.,increase,no risk
Phenoxybenzamine,Oxymetazoline,The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Phenoxybenzamine,Oxyphenbutazone,The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Phenoxybenzamine,Quetiapine,Quetiapine may increase the hypotensive activities of Phenoxybenzamine.,increase,no risk
Phenoxybenzamine,Quinapril,Phenoxybenzamine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Phenoxybenzamine,Quinidine,"Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Phenoxybenzamine.",increase,no risk
Phenoxybenzamine,Quinine,The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Quinine.,increase,risk
Phenoxybenzamine,Quinupramine,Quinupramine may decrease the antihypertensive activities of Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Udenafil,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Phenoxybenzamine.,increase,risk
Phenoxybenzamine,Unoprostone,Phenoxybenzamine may increase the hypotensive activities of Unoprostone.,increase,no risk
Phenoxybenzamine,Valdecoxib,The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Valdecoxib.,decrease,no risk
Phenoxybenzamine,Valsartan,Phenoxybenzamine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Phenoxybenzamine,Vardenafil,The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Phenoxybenzamine.,increase,risk
Phenoxybenzamine,Varenicline,The excretion of Varenicline can be decreased when combined with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Verapamil,The risk or severity of hypotension can be increased when Phenoxybenzamine is combined with Verapamil.,increase,risk
Phenoxybenzamine,Vericiguat,The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Vericiguat.,increase,risk
Phenoxybenzamine,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Vilazodone,Vilazodone may decrease the antihypertensive activities of Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Xylometazoline,The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Yohimbine,Yohimbine may decrease the antihypertensive activities of Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Ziconotide,The risk or severity of hypotension can be increased when Phenoxybenzamine is combined with Ziconotide.,increase,risk
Phenoxybenzamine,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Phenoxybenzamine.,increase,no risk
Phenoxybenzamine,Zofenopril,Phenoxybenzamine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Phenoxybenzamine,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Zonisamide,The risk or severity of hypotension can be increased when Phenoxybenzamine is combined with Zonisamide.,increase,risk
Phenoxybenzamine,Zuclopenthixol,"Phenoxybenzamine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Zuclopenthixol.",increase,no risk
Etretinate,Gestrinone,The therapeutic efficacy of Gestrinone can be decreased when used in combination with Etretinate.,decrease,no risk
Etretinate,Hydroxyprogesterone caproate,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Etretinate.,decrease,no risk
Etretinate,Nomegestrol acetate,The therapeutic efficacy of Nomegestrol acetate can be decreased when used in combination with Etretinate.,decrease,no risk
Etretinate,Norethisterone,The therapeutic efficacy of Norethisterone can be decreased when used in combination with Etretinate.,decrease,no risk
Etretinate,Norethynodrel,The therapeutic efficacy of Norethynodrel can be decreased when used in combination with Etretinate.,decrease,no risk
Etretinate,Norgestimate,The therapeutic efficacy of Norgestimate can be decreased when used in combination with Etretinate.,decrease,no risk
Etretinate,Norgestrel,The therapeutic efficacy of Norgestrel can be decreased when used in combination with Etretinate.,decrease,no risk
Etretinate,Omadacycline,The risk or severity of pseudotumor cerebri can be increased when Etretinate is combined with Omadacycline.,increase,risk
Etretinate,Oxytetracycline,The risk or severity of pseudotumor cerebri can be increased when Etretinate is combined with Oxytetracycline.,increase,risk
Etretinate,Valproic acid,Valproic acid may increase the Pseudotumor Cerebri activities of Etretinate.,increase,no risk
Etretinate,Vitamin A,The risk or severity of adverse effects can be increased when Vitamin A is combined with Etretinate.,increase,risk
Famotidine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Gadobenic acid.,increase,risk
Famotidine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Famotidine.,increase,risk
Famotidine,Ganciclovir,The excretion of Famotidine can be decreased when combined with Ganciclovir.,decrease,no risk
Famotidine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Gatifloxacin.,increase,risk
Famotidine,Gefitinib,Famotidine can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Famotidine,Gemfibrozil,The excretion of Famotidine can be decreased when combined with Gemfibrozil.,decrease,no risk
Famotidine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Gemifloxacin.,increase,risk
Famotidine,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Famotidine.,increase,no risk
Famotidine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Famotidine.,increase,risk
Famotidine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Gilteritinib.,increase,risk
Famotidine,Glasdegib,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Glasdegib.,increase,risk
Famotidine,Goserelin,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Goserelin.,increase,risk
Famotidine,Granisetron,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Granisetron.,increase,risk
Famotidine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Grepafloxacin.,increase,risk
Famotidine,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Guanidine,The excretion of Famotidine can be decreased when combined with Guanidine.,decrease,no risk
Famotidine,Halofantrine,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Halofantrine.,increase,risk
Famotidine,Haloperidol,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Haloperidol.,increase,risk
Famotidine,Histamine,The serum concentration of Histamine can be increased when it is combined with Famotidine.,increase,no risk
Famotidine,Histrelin,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Histrelin.,increase,risk
Famotidine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Famotidine.,decrease,no risk
Famotidine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Famotidine.,decrease,no risk
Famotidine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Famotidine.,decrease,no risk
Famotidine,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Hydroxychloroquine.,increase,risk
Famotidine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Hydroxyzine.,increase,risk
Famotidine,Hyoscyamine,Famotidine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Famotidine,Ketoconazole,Famotidine can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Famotidine,Ketoprofen,The excretion of Famotidine can be decreased when combined with Ketoprofen.,decrease,no risk
Famotidine,Nabumetone,The metabolism of Nabumetone can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Nadolol,The excretion of Nadolol can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Nalidixic acid.,increase,risk
Famotidine,Naproxen,The metabolism of Naproxen can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Nelfinavir,Famotidine can cause a decrease in the absorption of Nelfinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Famotidine,Nicardipine,The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Famotidine.,increase,risk
Famotidine,Nifedipine,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Nifedipine.,increase,risk
Famotidine,Nilotinib,Famotidine can cause a decrease in the absorption of Nilotinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Famotidine,Nilvadipine,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Nilvadipine.,increase,risk
Famotidine,Nimodipine,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Nimodipine.,increase,risk
Famotidine,Nirogacestat,The serum concentration of Nirogacestat can be decreased when it is combined with Famotidine.,decrease,no risk
Famotidine,Nitrendipine,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Nitrendipine.,increase,risk
Famotidine,Norepinephrine,The serum concentration of Norepinephrine can be increased when it is combined with Famotidine.,increase,no risk
Famotidine,Norfloxacin,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Norfloxacin.,increase,risk
Famotidine,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Famotidine.,increase,no risk
Famotidine,Novobiocin,The excretion of Famotidine can be decreased when combined with Novobiocin.,decrease,no risk
Famotidine,Octreotide,Famotidine can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Famotidine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Ofloxacin.,increase,risk
Famotidine,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Famotidine.,increase,risk
Famotidine,Olodaterol,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Olodaterol.,increase,risk
Famotidine,Ondansetron,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Ondansetron.,increase,risk
Famotidine,Orphenadrine,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Orphenadrine.,increase,risk
Famotidine,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Oteseconazole,Famotidine can cause a decrease in the absorption of Oteseconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Famotidine,Ouabain,The excretion of Famotidine can be decreased when combined with Ouabain.,decrease,no risk
Famotidine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Famotidine.,increase,risk
Famotidine,Oxatomide,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Oxatomide.,increase,risk
Famotidine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Oxytetracycline,The excretion of Famotidine can be decreased when combined with Oxytetracycline.,decrease,no risk
Famotidine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Famotidine.,increase,risk
Famotidine,Quetiapine,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Quetiapine.,increase,risk
Famotidine,Quinapril,The excretion of Quinapril can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Quinidine,The excretion of Famotidine can be decreased when combined with Quinidine.,decrease,no risk
Famotidine,Quinine,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Quinine.,increase,risk
Famotidine,Quizartinib,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Quizartinib.,increase,risk
Famotidine,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Famotidine.,increase,no risk
Famotidine,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Valproic acid,The excretion of Valproic acid can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Vandetanib,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Vandetanib.,increase,risk
Famotidine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Famotidine.,increase,risk
Famotidine,Varenicline,The excretion of Varenicline can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Famotidine.,increase,risk
Famotidine,Verapamil,The metabolism of Verapamil can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Vernakalant,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Vernakalant.,increase,risk
Famotidine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Famotidine.,increase,risk
Famotidine,Voriconazole,Famotidine can cause a decrease in the absorption of Voriconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Famotidine,Vorinostat,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Vorinostat.,increase,risk
Famotidine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Warfarin,The metabolism of Warfarin can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Zidovudine,The excretion of Famotidine can be decreased when combined with Zidovudine.,decrease,no risk
Famotidine,Zileuton,The metabolism of Zileuton can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Ziprasidone.,increase,risk
Famotidine,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Famotidine.,increase,risk
Famotidine,Zotepine,The metabolism of Zotepine can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Zuclopenthixol.,increase,risk
Azacitidine,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Azacitidine.,increase,risk
Azacitidine,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Azacitidine.,increase,risk
Azacitidine,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Azacitidine.,increase,risk
Azacitidine,Bicisate,Azacitidine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Azacitidine,Bimekizumab,The risk or severity of adverse effects can be increased when Azacitidine is combined with Bimekizumab.,increase,risk
Azacitidine,Bismuth subgallate,Azacitidine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Azacitidine,Bisoprolol,Bisoprolol may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Bisoxatin,Azacitidine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Azacitidine,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Azacitidine.,increase,risk
Azacitidine,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Azacitidine.,increase,risk
Azacitidine,Blinatumomab,The risk or severity of adverse effects can be increased when Azacitidine is combined with Blinatumomab.,increase,risk
Azacitidine,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Azacitidine.",decrease,no risk
Azacitidine,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Azacitidine.,increase,risk
Azacitidine,Bosutinib,The risk or severity of adverse effects can be increased when Azacitidine is combined with Bosutinib.,increase,risk
Azacitidine,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Azacitidine is combined with Brentuximab vedotin.,increase,risk
Azacitidine,Brivaracetam,Azacitidine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Azacitidine,Brodalumab,The risk or severity of adverse effects can be increased when Azacitidine is combined with Brodalumab.,increase,risk
Azacitidine,Bromazepam,Azacitidine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Azacitidine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azacitidine,Budesonide,The risk or severity of adverse effects can be increased when Azacitidine is combined with Budesonide.,increase,risk
Azacitidine,Bumadizone,Bumadizone may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Bumetanide,Bumetanide may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azacitidine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Azacitidine is combined with Bupivacaine.,increase,risk
Azacitidine,Bupropion,Azacitidine may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Azacitidine,Buspirone,Buspirone may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Busulfan,The risk or severity of adverse effects can be increased when Azacitidine is combined with Busulfan.,increase,risk
Azacitidine,Butabarbital,Butabarbital may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Butacaine,The risk or severity of methemoglobinemia can be increased when Azacitidine is combined with Butacaine.,increase,risk
Azacitidine,Butamben,The risk or severity of methemoglobinemia can be increased when Azacitidine is combined with Butamben.,increase,risk
Azacitidine,Gabapentin enacarbil,Azacitidine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Azacitidine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Gadodiamide,Gadodiamide may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Gadofosveset trisodium,Azacitidine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Azacitidine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Gadoteric acid,Azacitidine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Azacitidine,Gadoteridol,Gadoteridol may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Ganciclovir,Azacitidine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Azacitidine,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Azacitidine.,increase,risk
Azacitidine,Gemfibrozil,Azacitidine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Azacitidine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Azacitidine.,increase,risk
Azacitidine,Gentamicin,Azacitidine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Azacitidine,Gimeracil,Azacitidine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Azacitidine,Givosiran,Givosiran may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Glatiramer,The risk or severity of adverse effects can be increased when Azacitidine is combined with Glatiramer.,increase,risk
Azacitidine,Glipizide,Azacitidine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Azacitidine,Glycerol phenylbutyrate,Azacitidine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Azacitidine,Golimumab,The risk or severity of adverse effects can be increased when Azacitidine is combined with Golimumab.,increase,risk
Azacitidine,Golodirsen,Azacitidine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Azacitidine,Goserelin,Goserelin may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Guanethidine,Azacitidine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Guanfacine,Azacitidine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Azacitidine,Guselkumab,The risk or severity of adverse effects can be increased when Azacitidine is combined with Guselkumab.,increase,risk
Azacitidine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Azacitidine.,decrease,no risk
Azacitidine,Haloperidol,Haloperidol may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Azacitidine.,increase,risk
Azacitidine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Azacitidine.,decrease,no risk
Azacitidine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Azacitidine.,decrease,no risk
Azacitidine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Azacitidine.,increase,risk
Azacitidine,Hydralazine,Azacitidine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Azacitidine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azacitidine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Azacitidine is combined with Hydrocortisone acetate.,increase,risk
Azacitidine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Azacitidine is combined with Hydrocortisone butyrate.,increase,risk
Azacitidine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Azacitidine is combined with Hydrocortisone succinate.,increase,risk
Azacitidine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azacitidine,Hydromorphone,Hydromorphone may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Azacitidine is combined with Hydroxychloroquine.,increase,risk
Azacitidine,Hydroxyethyl Starch,Azacitidine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Azacitidine,Hydroxyurea,The risk or severity of adverse effects can be increased when Azacitidine is combined with Hydroxyurea.,increase,risk
Azacitidine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Azacitidine.,decrease,no risk
Azacitidine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Azacitidine.,decrease,no risk
Azacitidine,Kanamycin,Azacitidine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Azacitidine,Ketamine,Azacitidine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Azacitidine,Ketazolam,Azacitidine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Azacitidine,Ketoprofen,Ketoprofen may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Ketorolac,Ketorolac may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,N-acetyltyrosine,Azacitidine may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Azacitidine,Nabumetone,Nabumetone may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Nadolol,Azacitidine may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Azacitidine,Nadroparin,The risk or severity of bleeding can be increased when Nadroparin is combined with Azacitidine.,increase,risk
Azacitidine,Naldemedine,Azacitidine may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Azacitidine,Nalmefene,Azacitidine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Azacitidine,Naloxone,Azacitidine may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Azacitidine,Naproxen,Naproxen may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Natalizumab,The risk or severity of immunosuppression can be increased when Azacitidine is combined with Natalizumab.,increase,risk
Azacitidine,Nateglinide,Nateglinide may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Nedaplatin,Azacitidine may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Azacitidine,Nedocromil,Nedocromil may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Nefazodone,Azacitidine may decrease the excretion rate of Nefazodone which could result in a higher serum level.,decrease,no risk
Azacitidine,Nelarabine,The risk or severity of adverse effects can be increased when Azacitidine is combined with Nelarabine.,increase,risk
Azacitidine,Neomycin,Azacitidine may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Azacitidine,Netilmicin,Azacitidine may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Azacitidine,Nicorandil,Azacitidine may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Azacitidine,Nifedipine,Azacitidine may decrease the excretion rate of Nifedipine which could result in a higher serum level.,decrease,no risk
Azacitidine,Nilotinib,The risk or severity of adverse effects can be increased when Azacitidine is combined with Nilotinib.,increase,risk
Azacitidine,Nilutamide,Nilutamide may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Nimesulide,The risk or severity of bleeding can be increased when Nimesulide is combined with Azacitidine.,increase,risk
Azacitidine,Nisoldipine,Nisoldipine may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Nitroprusside,Nitroprusside may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Azacitidine.,decrease,no risk
Azacitidine,Obinutuzumab,The risk or severity of adverse effects can be increased when Azacitidine is combined with Obinutuzumab.,increase,risk
Azacitidine,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Azacitidine.,increase,no risk
Azacitidine,Octinoxate,Azacitidine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Azacitidine,Ofatumumab,The risk or severity of adverse effects can be increased when Azacitidine is combined with Ofatumumab.,increase,risk
Azacitidine,Olaparib,The risk or severity of adverse effects can be increased when Azacitidine is combined with Olaparib.,increase,risk
Azacitidine,Olsalazine,Olsalazine may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Opium,Azacitidine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Azacitidine,Oseltamivir,Oseltamivir may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Oxacillin,Oxacillin may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Azacitidine.,increase,risk
Azacitidine,Oxaprozin,Oxaprozin may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Oxazepam,Oxazepam may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Azacitidine is combined with Oxetacaine.,increase,risk
Azacitidine,Oxybenzone,Azacitidine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Azacitidine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Azacitidine is combined with Oxybuprocaine.,increase,risk
Azacitidine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Oxyquinoline,Azacitidine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Azacitidine,Ozanimod,The risk or severity of adverse effects can be increased when Azacitidine is combined with Ozanimod.,increase,risk
Misoprostol,Hydrotalcite,The risk or severity of adverse effects can be increased when Hydrotalcite is combined with Misoprostol.,increase,risk
Misoprostol,Oxytocin,The risk or severity of adverse effects can be increased when Misoprostol is combined with Oxytocin.,increase,risk
Colesevelam,Ketorolac,Colesevelam can cause a decrease in the absorption of Ketorolac resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Nabumetone,Colesevelam can cause a decrease in the absorption of Nabumetone resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Naproxen,Colesevelam can cause a decrease in the absorption of Naproxen resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Niacin,Colesevelam can cause a decrease in the absorption of Niacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Nimesulide,Colesevelam can cause a decrease in the absorption of Nimesulide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Nomegestrol acetate,Colesevelam can cause a decrease in the absorption of Nomegestrol acetate resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Norethisterone,The serum concentration of Norethisterone can be decreased when it is combined with Colesevelam.,decrease,no risk
Colesevelam,Norethynodrel,Colesevelam can cause a decrease in the absorption of Norethynodrel resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Norgestimate,Colesevelam can cause a decrease in the absorption of Norgestimate resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Norgestrel,Colesevelam can cause a decrease in the absorption of Norgestrel resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Obeticholic acid,Colesevelam can cause a decrease in the absorption of Obeticholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Odevixibat,The therapeutic efficacy of Odevixibat can be decreased when used in combination with Colesevelam.,decrease,no risk
Colesevelam,Olmesartan,Colesevelam can cause a decrease in the absorption of Olmesartan resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Omadacycline,Colesevelam can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Ouabain,Colesevelam can cause a decrease in the absorption of Ouabain resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Oxaprozin,Colesevelam can cause a decrease in the absorption of Oxaprozin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Oxyphenbutazone,Colesevelam can cause a decrease in the absorption of Oxyphenbutazone resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Oxytetracycline,Colesevelam can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Quinethazone,Colesevelam can cause a decrease in the absorption of Quinethazone resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Udenafil,Colesevelam can cause a decrease in the absorption of Udenafil resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Ursodeoxycholic acid,Colesevelam can cause a decrease in the absorption of Ursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Valdecoxib,Colesevelam can cause a decrease in the absorption of Valdecoxib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Vancomycin,The therapeutic efficacy of Vancomycin can be decreased when used in combination with Colesevelam.,decrease,no risk
Colesevelam,Vemurafenib,Colesevelam can cause a decrease in the absorption of Vemurafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Vitamin D,The serum concentration of Vitamin D can be decreased when it is combined with Colesevelam.,decrease,no risk
Colesevelam,Warfarin,Colesevelam can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Zonisamide,Colesevelam can cause a decrease in the absorption of Zonisamide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Metacycline.,increase,no risk
Metacycline,Gentamicin,The risk or severity of neuromuscular blockade can be increased when Gentamicin is combined with Metacycline.,increase,risk
Metacycline,Gestrinone,The serum concentration of Gestrinone can be decreased when it is combined with Metacycline.,decrease,no risk
Metacycline,Hetacillin,The therapeutic efficacy of Hetacillin can be decreased when used in combination with Metacycline.,decrease,no risk
Metacycline,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Metacycline.,decrease,no risk
Metacycline,Kanamycin,The risk or severity of neuromuscular blockade can be increased when Metacycline is combined with Kanamycin.,increase,risk
Metacycline,Nafcillin,The therapeutic efficacy of Nafcillin can be decreased when used in combination with Metacycline.,decrease,no risk
Metacycline,Neomycin,The risk or severity of neuromuscular blockade can be increased when Metacycline is combined with Neomycin.,increase,risk
Metacycline,Netilmicin,The risk or severity of neuromuscular blockade can be increased when Metacycline is combined with Netilmicin.,increase,risk
Metacycline,Nicotine,The risk or severity of adverse effects can be increased when Metacycline is combined with Nicotine.,increase,risk
Metacycline,Nomegestrol,The serum concentration of Nomegestrol can be decreased when it is combined with Metacycline.,decrease,no risk
Metacycline,Nomegestrol acetate,The serum concentration of Nomegestrol acetate can be decreased when it is combined with Metacycline.,decrease,no risk
Metacycline,Norelgestromin,The serum concentration of Norelgestromin can be decreased when it is combined with Metacycline.,decrease,no risk
Metacycline,Norethisterone,The serum concentration of Norethisterone can be decreased when it is combined with Metacycline.,decrease,no risk
Metacycline,Norethynodrel,The serum concentration of Norethynodrel can be decreased when it is combined with Metacycline.,decrease,no risk
Metacycline,Norgestimate,The serum concentration of Norgestimate can be decreased when it is combined with Metacycline.,decrease,no risk
Metacycline,Norgestrel,The serum concentration of Norgestrel can be decreased when it is combined with Metacycline.,decrease,no risk
Metacycline,Oxacillin,The therapeutic efficacy of Oxacillin can be decreased when used in combination with Metacycline.,decrease,no risk
Metacycline,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Metacycline is combined with Oxetacaine.,increase,risk
Metacycline,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Metacycline is combined with Oxybuprocaine.,increase,risk
Metacycline,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Metacycline.,increase,risk
Metacycline,Quinapril,Quinapril can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,Quinidine,The risk or severity of neuromuscular blockade can be increased when Quinidine is combined with Metacycline.,increase,risk
Metacycline,Quinine,The risk or severity of neuromuscular blockade can be increased when Quinine is combined with Metacycline.,increase,risk
Metacycline,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Metacycline.,decrease,no risk
Metacycline,Vancomycin,The risk or severity of neuromuscular blockade can be increased when Vancomycin is combined with Metacycline.,increase,risk
Metacycline,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Metacycline.,increase,no risk
Metacycline,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Metacycline.,decrease,no risk
Metacycline,Viomycin,The risk or severity of neuromuscular blockade can be increased when Metacycline is combined with Viomycin.,increase,risk
Metacycline,Vitamin A,The risk or severity of pseudotumor cerebri can be increased when Vitamin A is combined with Metacycline.,increase,risk
Metacycline,Warfarin,Metacycline may increase the anticoagulant activities of Warfarin.,increase,no risk
Metacycline,Zinc,Zinc can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Tipranavir,Benzphetamine,The metabolism of Benzphetamine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bepridil,"The risk or severity of QTc prolongation, torsade de pointes, and Cardiac Arrhythmia can be increased when Tipranavir is combined with Bepridil.",increase,risk
Tipranavir,Berotralstat,The serum concentration of Berotralstat can be decreased when it is combined with Tipranavir.,decrease,no risk
Tipranavir,Betamethasone,The metabolism of Betamethasone can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Bexagliflozin,The metabolism of Bexagliflozin can be increased when combined with Tipranavir.,increase,no risk
Tipranavir,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bimekizumab,The metabolism of Tipranavir can be increased when combined with Bimekizumab.,increase,no risk
Tipranavir,Binimetinib,The serum concentration of Binimetinib can be decreased when it is combined with Tipranavir.,decrease,no risk
Tipranavir,Biperiden,The metabolism of Tipranavir can be decreased when combined with Biperiden.,decrease,no risk
Tipranavir,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Tipranavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Tipranavir,Bisoprolol,The metabolism of Bisoprolol can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Bivalirudin.,increase,risk
Tipranavir,Boceprevir,The metabolism of Boceprevir can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bosentan,The serum concentration of Bosentan can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Budesonide,The metabolism of Budesonide can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bupropion,The metabolism of Tipranavir can be decreased when combined with Bupropion.,decrease,no risk
Tipranavir,Buspirone,The metabolism of Buspirone can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Busulfan,The metabolism of Busulfan can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Galantamine,The metabolism of Galantamine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Garlic,Garlic can cause a decrease in the absorption of Tipranavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Tipranavir,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Gemcitabine,The serum concentration of Gemcitabine can be decreased when it is combined with Tipranavir.,decrease,no risk
Tipranavir,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Givosiran,The serum concentration of Tipranavir can be increased when it is combined with Givosiran.,increase,no risk
Tipranavir,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Tipranavir.,decrease,no risk
Tipranavir,Glimepiride,Tipranavir may decrease the excretion rate of Glimepiride which could result in a higher serum level.,decrease,no risk
Tipranavir,Glipizide,Tipranavir may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Tipranavir,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Tipranavir.,decrease,no risk
Tipranavir,Glofitamab,The serum concentration of Tipranavir can be increased when it is combined with Glofitamab.,increase,no risk
Tipranavir,Glyburide,The metabolism of Glyburide can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Glycerol phenylbutyrate,The metabolism of Tipranavir can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Tipranavir,Glycyrrhizic acid,Tipranavir may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Tipranavir,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Tipranavir.,decrease,no risk
Tipranavir,Golimumab,The metabolism of Tipranavir can be increased when combined with Golimumab.,increase,no risk
Tipranavir,Granisetron,The metabolism of Granisetron can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Heparin.,increase,risk
Tipranavir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Tipranavir.,decrease,no risk
Tipranavir,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Tipranavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Tipranavir,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Ketamine,The metabolism of Ketamine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Ketoconazole,The metabolism of Ketoconazole can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Ketoprofen,The metabolism of Ketoprofen can be increased when combined with Tipranavir.,increase,no risk
Tipranavir,Nabilone,The metabolism of Nabilone can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nadolol,The metabolism of Nadolol can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nadroparin,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Nadroparin.,increase,risk
Tipranavir,Naloxegol,The serum concentration of Naloxegol can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Naloxone,The metabolism of Naloxone can be increased when combined with Tipranavir.,increase,no risk
Tipranavir,Naltrexone,The metabolism of Naltrexone can be increased when combined with Tipranavir.,increase,no risk
Tipranavir,Naproxen,Tipranavir may decrease the excretion rate of Naproxen which could result in a higher serum level.,decrease,no risk
Tipranavir,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nebivolol,The metabolism of Nebivolol can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nefazodone,The metabolism of Nefazodone can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nelfinavir,The metabolism of Tipranavir can be decreased when combined with Nelfinavir.,decrease,no risk
Tipranavir,Neratinib,The serum concentration of Neratinib can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Netupitant,The metabolism of Netupitant can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Niacin,The metabolism of Tipranavir can be decreased when combined with Niacin.,decrease,no risk
Tipranavir,Nicardipine,The metabolism of Nicardipine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nicergoline,The serum concentration of Nicergoline can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Nifedipine,The metabolism of Nifedipine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nilotinib,The metabolism of Nilotinib can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nilutamide,The metabolism of Nilutamide can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nilvadipine,The metabolism of Nilvadipine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nimesulide,Tipranavir may increase the antiplatelet activities of Nimesulide.,increase,no risk
Tipranavir,Nimodipine,The metabolism of Nimodipine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nintedanib,The metabolism of Nintedanib can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nirmatrelvir,The metabolism of Nirmatrelvir can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Nisoldipine,The metabolism of Nisoldipine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nitrazepam,The metabolism of Nitrazepam can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nitrendipine,The metabolism of Nitrendipine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nitrofurantoin,Tipranavir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,decrease,no risk
Tipranavir,Nizatidine,Nizatidine can cause a decrease in the absorption of Tipranavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Tipranavir,Nomegestrol,The metabolism of Nomegestrol can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nomegestrol acetate,The metabolism of Nomegestrol acetate can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Norelgestromin,The metabolism of Norelgestromin can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Norethisterone,The metabolism of Norethisterone can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Norethynodrel,The metabolism of Norethynodrel can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Norgestimate,The metabolism of Norgestimate can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Norgestrel,The metabolism of Norgestrel can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Nylidrin,The metabolism of Nylidrin can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Obeticholic acid,The risk or severity of adverse effects can be increased when Tipranavir is combined with Obeticholic acid.,increase,risk
Tipranavir,Ofloxacin,Tipranavir may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Tipranavir,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Olaparib,The metabolism of Olaparib can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Olmesartan,Olmesartan may decrease the excretion rate of Tipranavir which could result in a higher serum level.,decrease,no risk
Tipranavir,Olutasidenib,The therapeutic efficacy of Tipranavir can be decreased when used in combination with Olutasidenib.,decrease,no risk
Tipranavir,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Omeprazole,The metabolism of Omeprazole can be increased when combined with Tipranavir.,increase,no risk
Tipranavir,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Opium,The metabolism of Opium can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Oritavancin,The metabolism of Tipranavir can be decreased when combined with Oritavancin.,decrease,no risk
Tipranavir,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Ouabain,The excretion of Ouabain can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Oxamniquine,The metabolism of Tipranavir can be decreased when combined with Oxamniquine.,decrease,no risk
Tipranavir,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Quazepam,The metabolism of Quazepam can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Quinidine,The risk or severity of torsade de pointes and Cardiac Arrhythmia can be increased when Tipranavir is combined with Quinidine.,increase,risk
Tipranavir,Quinine,The risk or severity of torsade de pointes and Cardiac Arrhythmia can be increased when Tipranavir is combined with Quinine.,increase,risk
Tipranavir,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Tipranavir.,increase,no risk
Mesoridazine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Mesoridazine.,increase,risk
Mesoridazine,Buprenorphine,Mesoridazine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Mesoridazine,Bupropion,The metabolism of Mesoridazine can be decreased when combined with Bupropion.,decrease,no risk
Mesoridazine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Mesoridazine.,increase,risk
Mesoridazine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Mesoridazine.,increase,risk
Mesoridazine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Mesoridazine.,increase,risk
Mesoridazine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Mesoridazine.,increase,risk
Mesoridazine,Butaperazine,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Butaperazine.,increase,risk
Mesoridazine,Butobarbital,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Butobarbital.,increase,risk
Mesoridazine,Butorphanol,The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Butorphanol.,increase,risk
Mesoridazine,Butriptyline,The serum concentration of Butriptyline can be increased when it is combined with Mesoridazine.,increase,no risk
Mesoridazine,Gabapentin,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Gabapentin.,increase,risk
Mesoridazine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Gabapentin enacarbil.,increase,risk
Mesoridazine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Mesoridazine.,increase,risk
Mesoridazine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Mesoridazine.,increase,risk
Mesoridazine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Mesoridazine.,increase,risk
Mesoridazine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Mesoridazine is combined with Ganaxolone.",increase,risk
Mesoridazine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Mesoridazine.,increase,risk
Mesoridazine,Gefitinib,The metabolism of Mesoridazine can be decreased when combined with Gefitinib.,decrease,no risk
Mesoridazine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Gemifloxacin.,increase,risk
Mesoridazine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Mesoridazine.,increase,risk
Mesoridazine,Gilteritinib,The therapeutic efficacy of Mesoridazine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Mesoridazine,Givosiran,The serum concentration of Mesoridazine can be increased when it is combined with Givosiran.,increase,no risk
Mesoridazine,Glasdegib,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Glasdegib.,increase,risk
Mesoridazine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Mesoridazine.,decrease,no risk
Mesoridazine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Mesoridazine.,decrease,no risk
Mesoridazine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Mesoridazine.,decrease,no risk
Mesoridazine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Mesoridazine.,decrease,no risk
Mesoridazine,Glutethimide,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Glutethimide.,increase,risk
Mesoridazine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Mesoridazine.,decrease,no risk
Mesoridazine,Glycerol phenylbutyrate,The metabolism of Mesoridazine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Mesoridazine,Golimumab,The metabolism of Mesoridazine can be increased when combined with Golimumab.,increase,no risk
Mesoridazine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Mesoridazine.,increase,risk
Mesoridazine,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Mesoridazine.,increase,risk
Mesoridazine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Grepafloxacin.,increase,risk
Mesoridazine,Guanfacine,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Guanfacine.,increase,risk
Mesoridazine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Mesoridazine.,increase,risk
Mesoridazine,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Mesoridazine.,increase,risk
Mesoridazine,Haloperidol,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Haloperidol.,increase,risk
Mesoridazine,Halothane,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Halothane.,increase,risk
Mesoridazine,Hexafluronium,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Hexafluronium.,increase,risk
Mesoridazine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Mesoridazine.,increase,risk
Mesoridazine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Mesoridazine.,increase,risk
Mesoridazine,Hydrocodone,Mesoridazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Mesoridazine,Hydromorphone,The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Hydromorphone.,increase,risk
Mesoridazine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Mesoridazine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Mesoridazine.,increase,risk
Mesoridazine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Hydroxyzine.,increase,risk
Mesoridazine,Hyoscyamine,Mesoridazine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Mesoridazine,Ketamine,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Ketamine.,increase,risk
Mesoridazine,Ketazolam,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Ketazolam.,increase,risk
Mesoridazine,Ketoconazole,The metabolism of Mesoridazine can be decreased when combined with Ketoconazole.,decrease,no risk
Mesoridazine,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Mesoridazine.,increase,no risk
Mesoridazine,Nadolol,The serum concentration of Nadolol can be increased when it is combined with Mesoridazine.,increase,no risk
Mesoridazine,Nalbuphine,The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Nalbuphine.,increase,risk
Mesoridazine,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Mesoridazine.,increase,risk
Mesoridazine,Naloxegol,The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Naloxegol.,increase,risk
Mesoridazine,Naltrexone,The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Naltrexone.,increase,risk
Mesoridazine,Naratriptan,The risk or severity of adverse effects can be increased when Naratriptan is combined with Mesoridazine.,increase,risk
Mesoridazine,Nateglinide,The metabolism of Mesoridazine can be decreased when combined with Nateglinide.,decrease,no risk
Mesoridazine,Naxitamab,Mesoridazine may increase the neurotoxic activities of Naxitamab.,increase,no risk
Mesoridazine,Nebivolol,The serum concentration of Nebivolol can be increased when it is combined with Mesoridazine.,increase,no risk
Mesoridazine,Nefazodone,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Nefazodone.,increase,risk
Mesoridazine,Nelfinavir,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Mesoridazine.,increase,risk
Mesoridazine,Neomycin,Mesoridazine may increase the neurotoxic activities of Neomycin.,increase,no risk
Mesoridazine,Netupitant,The metabolism of Netupitant can be decreased when combined with Mesoridazine.,decrease,no risk
Mesoridazine,Nevirapine,The metabolism of Mesoridazine can be decreased when combined with Nevirapine.,decrease,no risk
Mesoridazine,Niacin,The metabolism of Mesoridazine can be decreased when combined with Niacin.,decrease,no risk
Mesoridazine,Nialamide,The risk or severity of extrapyramidal symptoms can be increased when Nialamide is combined with Mesoridazine.,increase,risk
Mesoridazine,Nicardipine,The metabolism of Mesoridazine can be decreased when combined with Nicardipine.,decrease,no risk
Mesoridazine,Nicergoline,The metabolism of Mesoridazine can be decreased when combined with Nicergoline.,decrease,no risk
Mesoridazine,Nifedipine,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Nifedipine.,increase,risk
Mesoridazine,Nilotinib,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Nilotinib.,increase,risk
Mesoridazine,Nilvadipine,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Nilvadipine.,increase,risk
Mesoridazine,Nimodipine,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Mesoridazine.,increase,risk
Mesoridazine,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Mesoridazine.,decrease,no risk
Mesoridazine,Nitrazepam,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Nitrazepam.,increase,risk
Mesoridazine,Nitrendipine,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Mesoridazine.,increase,risk
Mesoridazine,Nitrous oxide,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Nitrous oxide.,increase,risk
Mesoridazine,Nomifensine,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Nomifensine.,increase,risk
Mesoridazine,Norfloxacin,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Mesoridazine.,increase,risk
Mesoridazine,Normethadone,The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Normethadone.,increase,risk
Mesoridazine,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Mesoridazine.,increase,no risk
Mesoridazine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Mesoridazine.,increase,risk
Mesoridazine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Ofloxacin.,increase,risk
Mesoridazine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Mesoridazine.,increase,risk
Mesoridazine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Mesoridazine is combined with Oliceridine.",increase,risk
Mesoridazine,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Mesoridazine.,increase,risk
Mesoridazine,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Mesoridazine.,increase,risk
Mesoridazine,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Mesoridazine.,decrease,no risk
Mesoridazine,Opium,The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Opium.,increase,risk
Mesoridazine,Oritavancin,The metabolism of Mesoridazine can be decreased when combined with Oritavancin.,decrease,no risk
Mesoridazine,Orphenadrine,Mesoridazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Mesoridazine,Osilodrostat,The metabolism of Mesoridazine can be decreased when combined with Osilodrostat.,decrease,no risk
Mesoridazine,Ospemifene,The metabolism of Mesoridazine can be decreased when combined with Ospemifene.,decrease,no risk
Mesoridazine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Mesoridazine.,increase,risk
Mesoridazine,Oxamniquine,The metabolism of Mesoridazine can be decreased when combined with Oxamniquine.,decrease,no risk
Mesoridazine,Oxatomide,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Oxatomide.,increase,risk
Mesoridazine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Mesoridazine.,increase,risk
Mesoridazine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Mesoridazine.,increase,risk
Mesoridazine,Oxitriptan,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Oxitriptan.,increase,risk
Mesoridazine,Oxprenolol,The serum concentration of Oxprenolol can be increased when it is combined with Mesoridazine.,increase,no risk
Mesoridazine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Mesoridazine.,increase,risk
Mesoridazine,Oxybutynin,The metabolism of Mesoridazine can be decreased when combined with Oxybutynin.,decrease,no risk
Mesoridazine,Oxycodone,The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Oxycodone.,increase,risk
Mesoridazine,Oxymorphone,The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Oxymorphone.,increase,risk
Mesoridazine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Mesoridazine.,increase,risk
Mesoridazine,Quazepam,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Quazepam.,increase,risk
Mesoridazine,Quetiapine,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Quetiapine.,increase,risk
Mesoridazine,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Mesoridazine.,decrease,no risk
Mesoridazine,Quinidine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Mesoridazine.,increase,risk
Mesoridazine,Quinine,The metabolism of Mesoridazine can be decreased when combined with Quinine.,decrease,no risk
Mesoridazine,Quinupramine,The serum concentration of Quinupramine can be increased when it is combined with Mesoridazine.,increase,no risk
Mesoridazine,Quizartinib,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Quizartinib.,increase,risk
Mesoridazine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Mesoridazine.,decrease,no risk
Mesoridazine,Urethane,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Urethane.,increase,risk
Mesoridazine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Mesoridazine.,decrease,no risk
Mesoridazine,Valproate bismuth,Mesoridazine may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Mesoridazine,Valproic acid,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Valproic acid.,increase,risk
Mesoridazine,Vandetanib,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Vandetanib.,increase,risk
Mesoridazine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Mesoridazine.,increase,risk
Mesoridazine,Vecuronium,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Vecuronium.,increase,risk
Mesoridazine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Vemurafenib.,increase,risk
Mesoridazine,Venlafaxine,The metabolism of Mesoridazine can be decreased when combined with Venlafaxine.,decrease,no risk
Mesoridazine,Verapamil,The metabolism of Mesoridazine can be decreased when combined with Verapamil.,decrease,no risk
Mesoridazine,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Mesoridazine.,increase,risk
Mesoridazine,Vigabatrin,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Vigabatrin.,increase,risk
Mesoridazine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Mesoridazine.,increase,risk
Mesoridazine,Vilazodone,The metabolism of Mesoridazine can be decreased when combined with Vilazodone.,decrease,no risk
Mesoridazine,Viloxazine,The metabolism of Mesoridazine can be decreased when combined with Viloxazine.,decrease,no risk
Mesoridazine,Vinblastine,The metabolism of Mesoridazine can be decreased when combined with Vinblastine.,decrease,no risk
Mesoridazine,Vincristine,Vincristine may increase the neurotoxic activities of Mesoridazine.,increase,no risk
Mesoridazine,Vinorelbine,The metabolism of Mesoridazine can be decreased when combined with Vinorelbine.,decrease,no risk
Mesoridazine,Viomycin,Mesoridazine may increase the neurotoxic activities of Viomycin.,increase,no risk
Mesoridazine,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Mesoridazine.,increase,risk
Mesoridazine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Mesoridazine.,increase,risk
Mesoridazine,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Mesoridazine.,increase,risk
Mesoridazine,Warfarin,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Warfarin.,increase,risk
Mesoridazine,Yohimbine,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Yohimbine.,increase,risk
Mesoridazine,Zaleplon,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Zaleplon.,increase,risk
Mesoridazine,Ziconotide,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Ziconotide.,increase,risk
Mesoridazine,Zimelidine,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Zimelidine.,increase,risk
Mesoridazine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Ziprasidone.,increase,risk
Mesoridazine,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Mesoridazine.,increase,risk
Mesoridazine,Zolpidem,Mesoridazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Mesoridazine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Mesoridazine.,increase,risk
Mesoridazine,Zopiclone,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Zopiclone.,increase,risk
Mesoridazine,Zotepine,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Zotepine.,increase,risk
Mesoridazine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Zuclopenthixol.,increase,risk
Mesoridazine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Mesoridazine.,increase,risk
Maprotiline,Bacitracin,Bacitracin may decrease the excretion rate of Maprotiline which could result in a higher serum level.,decrease,no risk
Maprotiline,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Maprotiline.,increase,no risk
Maprotiline,Balsalazide,Balsalazide may decrease the excretion rate of Maprotiline which could result in a higher serum level.,decrease,no risk
Maprotiline,Baricitinib,Maprotiline may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Maprotiline,Bedaquiline,The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Bedaquiline.,increase,risk
Maprotiline,Belinostat,The metabolism of Maprotiline can be increased when combined with Belinostat.,increase,no risk
Maprotiline,Belladonna,The risk or severity of adverse effects can be increased when Maprotiline is combined with Belladonna.,increase,risk
Maprotiline,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Maprotiline.,decrease,no risk
Maprotiline,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Maprotiline,Benorilate,Benorilate may decrease the excretion rate of Maprotiline which could result in a higher serum level.,decrease,no risk
Maprotiline,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Maprotiline which could result in a higher serum level.,decrease,no risk
Maprotiline,Benperidol,The risk or severity of adverse effects can be increased when Maprotiline is combined with Benperidol.,increase,risk
Maprotiline,Benserazide,Maprotiline may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Maprotiline,Benzatropine,The risk or severity of adverse effects can be increased when Benzatropine is combined with Maprotiline.,increase,risk
Maprotiline,Benzhydrocodone,The risk or severity of adverse effects can be increased when Maprotiline is combined with Benzhydrocodone.,increase,risk
Maprotiline,Benznidazole,Maprotiline may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Maprotiline,Benzocaine,The risk or severity of CNS depression can be increased when Maprotiline is combined with Benzocaine.,increase,risk
Maprotiline,Benzphetamine,Benzphetamine may decrease the sedative activities of Maprotiline.,decrease,no risk
Maprotiline,Benzthiazide,Benzthiazide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Maprotiline,Benzydamine,Benzydamine may decrease the excretion rate of Maprotiline which could result in a higher serum level.,decrease,no risk
Maprotiline,Benzyl alcohol,The risk or severity of CNS depression can be increased when Maprotiline is combined with Benzyl alcohol.,increase,risk
Maprotiline,Benzylpenicilloyl polylysine,Maprotiline may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Maprotiline,Bepotastine,Maprotiline may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Maprotiline,Bepridil,The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Bepridil.,increase,risk
Maprotiline,Berotralstat,The metabolism of Maprotiline can be decreased when combined with Berotralstat.,decrease,no risk
Maprotiline,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Maprotiline.,decrease,no risk
Maprotiline,Betaine,The therapeutic efficacy of Maprotiline can be decreased when used in combination with Betaine.,decrease,no risk
Maprotiline,Betaxolol,The metabolism of Maprotiline can be decreased when combined with Betaxolol.,decrease,no risk
Maprotiline,Bethanidine,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Maprotiline.,increase,risk
Maprotiline,Bicisate,Maprotiline may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Maprotiline,Bilastine,The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Bilastine.,increase,risk
Maprotiline,Bimekizumab,The metabolism of Maprotiline can be increased when combined with Bimekizumab.,increase,no risk
Maprotiline,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Maprotiline.,decrease,no risk
Maprotiline,Biperiden,The metabolism of Maprotiline can be decreased when combined with Biperiden.,decrease,no risk
Maprotiline,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Maprotiline.,decrease,no risk
Maprotiline,Bismuth subgallate,Maprotiline may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Maprotiline,Bisoprolol,Bisoprolol may decrease the excretion rate of Maprotiline which could result in a higher serum level.,decrease,no risk
Maprotiline,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Maprotiline.,decrease,no risk
Maprotiline,Bleomycin,Bleomycin may decrease the excretion rate of Maprotiline which could result in a higher serum level.,decrease,no risk
Maprotiline,Bortezomib,The metabolism of Maprotiline can be decreased when combined with Bortezomib.,decrease,no risk
Maprotiline,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Maprotiline is combined with Botulinum toxin type A.,increase,risk
Maprotiline,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Maprotiline is combined with Botulinum toxin type B.,increase,risk
Maprotiline,Bretylium,The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Bretylium.,increase,risk
Maprotiline,Brexanolone,The risk or severity of CNS depression can be increased when Maprotiline is combined with Brexanolone.,increase,risk
Maprotiline,Brexpiprazole,The risk or severity of adverse effects can be increased when Maprotiline is combined with Brexpiprazole.,increase,risk
Maprotiline,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Maprotiline.,increase,no risk
Maprotiline,Brivaracetam,The risk or severity of CNS depression can be increased when Maprotiline is combined with Brivaracetam.,increase,risk
Maprotiline,Bromazepam,The risk or severity of CNS depression can be increased when Maprotiline is combined with Bromazepam.,increase,risk
Maprotiline,Bromocriptine,The risk or severity of adverse effects can be increased when Maprotiline is combined with Bromocriptine.,increase,risk
Maprotiline,Bromotheophylline,Bromotheophylline may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Maprotiline,Bromperidol,The risk or severity of adverse effects can be increased when Maprotiline is combined with Bromperidol.,increase,risk
Maprotiline,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Maprotiline.,increase,risk
Maprotiline,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Maprotiline.,increase,risk
Maprotiline,Budesonide,Maprotiline may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Maprotiline,Bumadizone,Bumadizone may decrease the excretion rate of Maprotiline which could result in a higher serum level.,decrease,no risk
Maprotiline,Bumetanide,Bumetanide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Maprotiline,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Maprotiline.,increase,risk
Maprotiline,Buprenorphine,Maprotiline may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Maprotiline,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Maprotiline.,increase,risk
Maprotiline,Buserelin,The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Buserelin.,increase,risk
Maprotiline,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Maprotiline.,increase,risk
Maprotiline,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Maprotiline.,increase,risk
Maprotiline,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Maprotiline.,increase,risk
Maprotiline,Butaperazine,The risk or severity of adverse effects can be increased when Maprotiline is combined with Butaperazine.,increase,risk
Maprotiline,Butobarbital,The risk or severity of CNS depression can be increased when Maprotiline is combined with Butobarbital.,increase,risk
Maprotiline,Butorphanol,The risk or severity of adverse effects can be increased when Maprotiline is combined with Butorphanol.,increase,risk
Maprotiline,Butriptyline,The risk or severity of CNS depression can be increased when Maprotiline is combined with Butriptyline.,increase,risk
Maprotiline,Butylscopolamine,The risk or severity of adverse effects can be increased when Maprotiline is combined with Butylscopolamine.,increase,risk
Oxymetazoline,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Glycopyrronium,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Glycopyrronium.,increase,risk
Oxymetazoline,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Halothane,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Halothane.,increase,risk
Oxymetazoline,Hexocyclium,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Hexocyclium.,increase,risk
Oxymetazoline,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Hyaluronidase,The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Hyaluronidase (human recombinant),The risk or severity of adverse effects can be increased when Hyaluronidase (human recombinant) is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Hyaluronidase (ovine),The risk or severity of adverse effects can be increased when Hyaluronidase (ovine) is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Hydralazine,The therapeutic efficacy of Hydralazine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Ketamine,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Ketamine.,increase,risk
Oxymetazoline,Ketoprofen,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Ketoprofen.,increase,risk
Oxymetazoline,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Nabilone,The risk or severity of Tachycardia can be increased when Nabilone is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Nabumetone,The risk or severity of hypertension can be increased when Nabumetone is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Nadolol,The risk or severity of cardiovascular complications can be increased when Nadolol is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Naphazoline,The absorption of Naphazoline can be decreased when combined with Oxymetazoline.,decrease,no risk
Oxymetazoline,Naproxen,The risk or severity of hypertension can be increased when Naproxen is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Naratriptan,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Naratriptan.,increase,risk
Oxymetazoline,Naxitamab,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Naxitamab.,increase,risk
Oxymetazoline,Nebivolol,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Nedocromil,The absorption of Nedocromil can be decreased when combined with Oxymetazoline.,decrease,no risk
Oxymetazoline,Nefazodone,Nefazodone may increase the tachycardic activities of Oxymetazoline.,increase,no risk
Oxymetazoline,Nialamide,The serum concentration of Oxymetazoline can be increased when it is combined with Nialamide.,increase,no risk
Oxymetazoline,Nicardipine,The therapeutic efficacy of Nicardipine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Nicergoline,Nicergoline may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Oxymetazoline,Nicorandil,The therapeutic efficacy of Nicorandil can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Nicotine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Nilvadipine,The therapeutic efficacy of Nilvadipine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Nimesulide,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Nimesulide.,increase,risk
Oxymetazoline,Nimodipine,The therapeutic efficacy of Nimodipine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Nisoldipine,The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Nitrendipine,The therapeutic efficacy of Nitrendipine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Nitroglycerin,The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Nitroprusside,Oxymetazoline may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Oxymetazoline,Nitrous oxide,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Nitrous oxide.,increase,risk
Oxymetazoline,Norepinephrine,Norepinephrine may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Oxymetazoline,Nortriptyline,Nortriptyline may increase the vasopressor activities of Oxymetazoline.,increase,no risk
Oxymetazoline,Nylidrin,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Nylidrin.,increase,risk
Oxymetazoline,Olanzapine,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Olanzapine.,decrease,no risk
Oxymetazoline,Olmesartan,The therapeutic efficacy of Olmesartan can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Olodaterol,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Olodaterol.,increase,risk
Oxymetazoline,Olopatadine,The absorption of Olopatadine can be decreased when combined with Oxymetazoline.,decrease,no risk
Oxymetazoline,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Orphenadrine,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Orphenadrine.,increase,risk
Oxymetazoline,Ouabain,The therapeutic efficacy of Ouabain can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Oxaprozin,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Oxaprozin.,increase,risk
Oxymetazoline,Oxprenolol,The risk or severity of cardiovascular complications can be increased when Oxprenolol is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Oxtriphylline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Oxtriphylline.,increase,risk
Oxymetazoline,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Oxybutynin.,increase,risk
Oxymetazoline,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Oxyphenbutazone.,increase,risk
Oxymetazoline,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Oxytocin,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Oxytocin.,increase,risk
Oxymetazoline,Quetiapine,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Quetiapine.,decrease,no risk
Oxymetazoline,Quinapril,The therapeutic efficacy of Quinapril can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Quinidine,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Quinidine.,decrease,no risk
Oxymetazoline,Quinupramine,Quinupramine may increase the vasopressor activities of Oxymetazoline.,increase,no risk
Oxymetazoline,Umeclidinium,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Umeclidinium.,increase,risk
Oxymetazoline,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Valsartan,The therapeutic efficacy of Valsartan can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Venlafaxine,Venlafaxine may increase the tachycardic activities of Oxymetazoline.,increase,no risk
Oxymetazoline,Verapamil,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Verapamil.,decrease,no risk
Oxymetazoline,Vilanterol,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Vilanterol.,increase,risk
Oxymetazoline,Vilazodone,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Vilazodone.,increase,risk
Oxymetazoline,Vitamin A,The absorption of Vitamin A can be decreased when combined with Oxymetazoline.,decrease,no risk
Oxymetazoline,Vortioxetine,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Vortioxetine.,increase,risk
Oxymetazoline,Xamoterol,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Xamoterol.,increase,risk
Oxymetazoline,Xylometazoline,The absorption of Xylometazoline can be decreased when combined with Oxymetazoline.,decrease,no risk
Oxymetazoline,Yohimbine,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Yohimbine.,increase,risk
Oxymetazoline,Zavegepant,The absorption of Zavegepant can be decreased when combined with Oxymetazoline.,decrease,no risk
Oxymetazoline,Ziprasidone,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Ziprasidone.,decrease,no risk
Oxymetazoline,Zofenopril,The therapeutic efficacy of Zofenopril can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Zuclopenthixol,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Salicylic acid,Bacitracin,The risk or severity of nephrotoxicity can be increased when Bacitracin is combined with Salicylic acid.,increase,risk
Salicylic acid,Baclofen,Salicylic acid may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Salicylic acid,Balsalazide,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Balsalazide.,increase,risk
Salicylic acid,Baricitinib,The serum concentration of Baricitinib can be increased when it is combined with Salicylic acid.,increase,no risk
Salicylic acid,Beclomethasone dipropionate,The risk or severity of gastrointestinal irritation can be increased when Beclomethasone dipropionate is combined with Salicylic acid.,increase,risk
Salicylic acid,Bemiparin,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Bemiparin.,increase,risk
Salicylic acid,Benazepril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Salicylic acid is combined with Benazepril.",increase,risk
Salicylic acid,Bendazac,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Bendazac.,increase,risk
Salicylic acid,Bendroflumethiazide,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Benorilate,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Benorilate.,increase,risk
Salicylic acid,Benoxaprofen,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Benoxaprofen.,increase,risk
Salicylic acid,Benserazide,Salicylic acid may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Salicylic acid,Benzatropine,Salicylic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Salicylic acid,Benznidazole,Salicylic acid may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Salicylic acid,Benzphetamine,The risk or severity of hypertension can be increased when Benzphetamine is combined with Salicylic acid.,increase,risk
Salicylic acid,Benzthiazide,The therapeutic efficacy of Benzthiazide can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Benzydamine,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Benzydamine.,increase,risk
Salicylic acid,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Salicylic acid.,decrease,no risk
Salicylic acid,Bepotastine,Salicylic acid may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Salicylic acid,Bepridil,The therapeutic efficacy of Bepridil can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Betamethasone,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Salicylic acid.,increase,risk
Salicylic acid,Betamethasone phosphate,The risk or severity of gastrointestinal irritation can be increased when Betamethasone phosphate is combined with Salicylic acid.,increase,risk
Salicylic acid,Betaxolol,Salicylic acid may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Salicylic acid,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Salicylic acid.,increase,risk
Salicylic acid,Betulinic Acid,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Betulinic Acid.,increase,risk
Salicylic acid,Bexagliflozin,Salicylic acid may increase the hypoglycemic activities of Bexagliflozin.,increase,no risk
Salicylic acid,Bexarotene,The metabolism of Salicylic acid can be decreased when combined with Bexarotene.,decrease,no risk
Salicylic acid,Bicisate,Salicylic acid may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Salicylic acid,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Bimekizumab,The metabolism of Salicylic acid can be increased when combined with Bimekizumab.,increase,no risk
Salicylic acid,Bismuth subgallate,Salicylic acid may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Salicylic acid,Bismuth subsalicylate,"The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Salicylic acid is combined with Bismuth subsalicylate.",increase,risk
Salicylic acid,Bisoprolol,Salicylic acid may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Salicylic acid,Bisoxatin,Salicylic acid may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Salicylic acid,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Bivalirudin.,increase,risk
Salicylic acid,Bleomycin,Salicylic acid may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Salicylic acid,Bortezomib,The metabolism of Salicylic acid can be decreased when combined with Bortezomib.,decrease,no risk
Salicylic acid,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Brexpiprazole,The risk or severity of hypertension can be increased when Salicylic acid is combined with Brexpiprazole.,increase,risk
Salicylic acid,Brinzolamide,The risk or severity of electrolyte abnormality can be increased when Brinzolamide is combined with Salicylic acid.,increase,risk
Salicylic acid,Brivaracetam,Salicylic acid may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Salicylic acid,Bromazepam,Salicylic acid may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Salicylic acid,Bromfenac,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Bromfenac.,increase,risk
Salicylic acid,Bromocriptine,Salicylic acid may increase the hypoglycemic activities of Bromocriptine.,increase,no risk
Salicylic acid,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Salicylic acid.,increase,risk
Salicylic acid,Bufexamac,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Bufexamac.,increase,risk
Salicylic acid,Bumadizone,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Bumadizone.,increase,risk
Salicylic acid,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Buprenorphine,The metabolism of Salicylic acid can be decreased when combined with Buprenorphine.,decrease,no risk
Salicylic acid,Bupropion,Salicylic acid may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Salicylic acid,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Salicylic acid.,increase,risk
Salicylic acid,Butabarbital,Salicylic acid may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Salicylic acid,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Salicylic acid.,increase,risk
Salicylic acid,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when Furosemide is combined with Salicylic acid.,increase,risk
Salicylic acid,Gadobenic acid,Salicylic acid may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Salicylic acid,Gadodiamide,Salicylic acid may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Salicylic acid,Gadofosveset trisodium,Salicylic acid may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Salicylic acid,Gadopentetic acid,Salicylic acid may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Salicylic acid,Gadoteric acid,Salicylic acid may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Salicylic acid,Gadoteridol,Salicylic acid may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Salicylic acid,Ganciclovir,Salicylic acid may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Salicylic acid,Gatifloxacin,Salicylic acid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Salicylic acid,Gemcitabine,Salicylic acid may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Salicylic acid,Gemfibrozil,Salicylic acid may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Salicylic acid,Gemifloxacin,The metabolism of Salicylic acid can be decreased when combined with Gemfibrozil.,decrease,no risk
Salicylic acid,Gentamicin,Salicylic acid may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Salicylic acid,Gimeracil,Salicylic acid may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Salicylic acid,Ginkgo biloba,Salicylic acid may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Salicylic acid,Givosiran,The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Salicylic acid.,increase,risk
Salicylic acid,Gliclazide,The risk or severity of nephrotoxicity can be increased when Salicylic acid is combined with Givosiran.,increase,risk
Salicylic acid,Glimepiride,Salicylic acid may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Salicylic acid,Glipizide,Salicylic acid may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Salicylic acid,Gliquidone,Salicylic acid may increase the hypoglycemic activities of Glipizide.,increase,no risk
Salicylic acid,Glofitamab,Salicylic acid may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Salicylic acid,Glyburide,The serum concentration of Salicylic acid can be increased when it is combined with Glofitamab.,increase,no risk
Salicylic acid,Glycerol phenylbutyrate,Salicylic acid may increase the hypoglycemic activities of Glyburide.,increase,no risk
Salicylic acid,Glycol salicylate,Salicylic acid may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Salicylic acid,Glymidine,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Glycol salicylate.,increase,risk
Salicylic acid,Golimumab,Salicylic acid may increase the hypoglycemic activities of Glymidine.,increase,no risk
Salicylic acid,Golodirsen,The metabolism of Salicylic acid can be increased when combined with Golimumab.,increase,no risk
Salicylic acid,Goserelin,Salicylic acid may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Salicylic acid,Grepafloxacin,Salicylic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Salicylic acid,Guanabenz,Salicylic acid may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Salicylic acid,Guanadrel,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Guanethidine,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Guanfacine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Guanoxan,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Haloperidol,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Halothane,The therapeutic efficacy of Haloperidol can be increased when used in combination with Salicylic acid.,increase,no risk
Salicylic acid,Heparin,The risk or severity of hypertension can be increased when Salicylic acid is combined with Halothane.,increase,risk
Salicylic acid,Hyaluronidase,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Heparin.,increase,risk
Salicylic acid,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Hydralazine,The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Hydrochlorothiazide,Salicylic acid may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Salicylic acid,Hydrocortisone,The excretion of Hydrochlorothiazide can be decreased when combined with Salicylic acid.,decrease,no risk
Salicylic acid,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Salicylic acid.,increase,risk
Salicylic acid,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Salicylic acid.,increase,risk
Salicylic acid,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Salicylic acid.,increase,risk
Salicylic acid,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Salicylic acid.,increase,risk
Salicylic acid,Hydroflumethiazide,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Salicylic acid.,increase,risk
Salicylic acid,Hydromorphone,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Hydroxocobalamin,Salicylic acid may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Salicylic acid,Hydroxyethyl Starch,Salicylic acid may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Salicylic acid,Kanamycin,Salicylic acid may decrease the excretion rate of Ixazomib which could result in a higher serum level.,decrease,no risk
Salicylic acid,Ketamine,Salicylic acid may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Salicylic acid,Ketazolam,Salicylic acid may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Salicylic acid,Ketoconazole,Salicylic acid may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Salicylic acid,Ketoprofen,The risk or severity of hyperkalemia can be increased when Salicylic acid is combined with Ketoconazole.,increase,risk
Salicylic acid,Ketorolac,The risk or severity of bleeding and gastrointestinal bleeding can be increased when Salicylic acid is combined with Ketoprofen.,increase,risk
Salicylic acid,N-acetyltyrosine,Salicylic acid may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Salicylic acid,Nabilone,Salicylic acid may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Salicylic acid,Nabumetone,The metabolism of Salicylic acid can be decreased when combined with Nabilone.,decrease,no risk
Salicylic acid,Nadolol,The risk or severity of adverse effects can be increased when Nabumetone is combined with Salicylic acid.,increase,risk
Salicylic acid,Nadroparin,Salicylic acid may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Salicylic acid,Naldemedine,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Nadroparin.,increase,risk
Salicylic acid,Nalidixic acid,Salicylic acid may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Salicylic acid,Nalmefene,Salicylic acid may increase the neuroexcitatory activities of Nalidixic acid.,increase,no risk
Salicylic acid,Naloxone,Salicylic acid may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Salicylic acid,Naphazoline,Salicylic acid may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Salicylic acid,Naproxen,The risk or severity of hypertension can be increased when Salicylic acid is combined with Naphazoline.,increase,risk
Salicylic acid,Naratriptan,The risk or severity of adverse effects can be increased when Naproxen is combined with Salicylic acid.,increase,risk
Salicylic acid,Nateglinide,The risk or severity of hypertension can be increased when Salicylic acid is combined with Naratriptan.,increase,risk
Salicylic acid,Naxitamab,Salicylic acid may increase the hypoglycemic activities of Nateglinide.,increase,no risk
Salicylic acid,Nebivolol,The risk or severity of hypertension can be increased when Salicylic acid is combined with Naxitamab.,increase,risk
Salicylic acid,Nedaplatin,Salicylic acid may decrease the antihypertensive activities of Nebivolol.,decrease,no risk
Salicylic acid,Nedocromil,Salicylic acid may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Salicylic acid,Nefazodone,Salicylic acid may decrease the excretion rate of Nedocromil which could result in a higher serum level.,decrease,no risk
Salicylic acid,Neomycin,The risk or severity of gastrointestinal bleeding can be increased when Nefazodone is combined with Salicylic acid.,increase,risk
Salicylic acid,Nepafenac,The risk or severity of nephrotoxicity can be increased when Salicylic acid is combined with Neomycin.,increase,risk
Salicylic acid,Netilmicin,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Nepafenac.,increase,risk
Salicylic acid,Netupitant,Salicylic acid may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Salicylic acid,Nevirapine,The metabolism of Netupitant can be decreased when combined with Salicylic acid.,decrease,no risk
Salicylic acid,Nialamide,The metabolism of Salicylic acid can be decreased when combined with Nevirapine.,decrease,no risk
Salicylic acid,Nicardipine,The risk or severity of hypertension can be increased when Salicylic acid is combined with Nialamide.,increase,risk
Salicylic acid,Nicergoline,The metabolism of Salicylic acid can be decreased when combined with Nicardipine.,decrease,no risk
Salicylic acid,Niclosamide,The risk or severity of hypertension can be increased when Nicergoline is combined with Salicylic acid.,increase,risk
Salicylic acid,Nicorandil,The metabolism of Niclosamide can be decreased when combined with Salicylic acid.,decrease,no risk
Salicylic acid,Nifedipine,The therapeutic efficacy of Nicorandil can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Nilutamide,The risk or severity of hyperkalemia can be increased when Salicylic acid is combined with Nifedipine.,increase,risk
Salicylic acid,Nilvadipine,The metabolism of Salicylic acid can be decreased when combined with Nilutamide.,decrease,no risk
Salicylic acid,Nimesulide,The therapeutic efficacy of Nilvadipine can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Nimodipine,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Nimesulide.,increase,risk
Salicylic acid,Nirogacestat,The therapeutic efficacy of Nimodipine can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Nisoldipine,The metabolism of Nirogacestat can be decreased when combined with Salicylic acid.,decrease,no risk
Salicylic acid,Nitrendipine,The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Nitric Oxide,The therapeutic efficacy of Nitrendipine can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Nitrofurantoin,Salicylic acid may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Salicylic acid,Nitroglycerin,The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Salicylic acid.,increase,risk
Salicylic acid,Nitroprusside,The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Nitrous oxide,The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Norepinephrine,The risk or severity of hypertension can be increased when Salicylic acid is combined with Nitrous oxide.,increase,risk
Salicylic acid,Norfloxacin,The risk or severity of hypertension can be increased when Norepinephrine is combined with Salicylic acid.,increase,risk
Salicylic acid,Norgestimate,Salicylic acid may increase the neuroexcitatory activities of Norfloxacin.,increase,no risk
Salicylic acid,Nortriptyline,The metabolism of Norgestimate can be decreased when combined with Salicylic acid.,decrease,no risk
Salicylic acid,Noscapine,The risk or severity of gastrointestinal bleeding can be increased when Nortriptyline is combined with Salicylic acid.,increase,risk
Salicylic acid,Nylidrin,The metabolism of Salicylic acid can be decreased when combined with Noscapine.,decrease,no risk
Salicylic acid,Octinoxate,The risk or severity of hypertension can be increased when Salicylic acid is combined with Nylidrin.,increase,risk
Salicylic acid,Ofloxacin,Salicylic acid may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Salicylic acid,Olanzapine,Salicylic acid may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Salicylic acid,Olmesartan,The metabolism of Salicylic acid can be decreased when combined with Olanzapine.,decrease,no risk
Salicylic acid,Olodaterol,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Salicylic acid.",increase,risk
Salicylic acid,Olsalazine,The risk or severity of hypertension can be increased when Salicylic acid is combined with Olodaterol.,increase,risk
Salicylic acid,Omacetaxine mepesuccinate,The risk or severity of nephrotoxicity can be increased when Salicylic acid is combined with Olsalazine.,increase,risk
Salicylic acid,Ondansetron,The risk or severity of bleeding can be increased when Salicylic acid is combined with Omacetaxine mepesuccinate.,increase,risk
Salicylic acid,Opium,The metabolism of Salicylic acid can be decreased when combined with Ondansetron.,decrease,no risk
Salicylic acid,Orciprenaline,Salicylic acid may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Salicylic acid,Oritavancin,The risk or severity of hypertension can be increased when Orciprenaline is combined with Salicylic acid.,increase,risk
Salicylic acid,Oseltamivir,The metabolism of Salicylic acid can be decreased when combined with Oritavancin.,decrease,no risk
Salicylic acid,Ospemifene,The excretion of Oseltamivir can be decreased when combined with Salicylic acid.,decrease,no risk
Salicylic acid,Ouabain,The metabolism of Ospemifene can be decreased when combined with Salicylic acid.,decrease,no risk
Salicylic acid,Oxacillin,The serum concentration of Ouabain can be decreased when it is combined with Salicylic acid.,decrease,no risk
Salicylic acid,Oxaliplatin,Salicylic acid may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Salicylic acid,Oxandrolone,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Salicylic acid.,increase,risk
Salicylic acid,Oxaprozin,The metabolism of Salicylic acid can be decreased when combined with Oxandrolone.,decrease,no risk
Salicylic acid,Oxazepam,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Oxaprozin.,increase,risk
Salicylic acid,Oxprenolol,Salicylic acid may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Salicylic acid,Oxybenzone,Salicylic acid may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Salicylic acid,Oxymetazoline,Salicylic acid may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Salicylic acid,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Salicylic acid.,increase,risk
Salicylic acid,Oxyquinoline,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Oxyphenbutazone.,increase,risk
Salicylic acid,Oxytetracycline,Salicylic acid may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Salicylic acid,Quetiapine,Salicylic acid may decrease the excretion rate of Pyridoxine which could result in a higher serum level.,decrease,no risk
Salicylic acid,Quinapril,The risk or severity of hypertension can be increased when Salicylic acid is combined with Quetiapine.,increase,risk
Salicylic acid,Quinethazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Salicylic acid is combined with Quinapril.",increase,risk
Salicylic acid,Quinidine,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Quinine,Salicylic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Salicylic acid,Quinupramine,Salicylic acid may increase the hypoglycemic activities of Quinine.,increase,no risk
Salicylic acid,Unoprostone,Salicylic acid may increase the neuroexcitatory activities of Trovafloxacin.,increase,no risk
Salicylic acid,Urokinase,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Vaborbactam,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Urokinase.,increase,risk
Salicylic acid,Vadadustat,Salicylic acid may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Salicylic acid,Valaciclovir,The serum concentration of Vadadustat can be increased when it is combined with Salicylic acid.,increase,no risk
Salicylic acid,Valbenazine,The excretion of Valaciclovir can be decreased when combined with Salicylic acid.,decrease,no risk
Salicylic acid,Valdecoxib,Salicylic acid may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Salicylic acid,Valganciclovir,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Salicylic acid.,increase,risk
Salicylic acid,Valproic acid,Salicylic acid may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Salicylic acid,Valsartan,The serum concentration of Valproic acid can be increased when it is combined with Salicylic acid.,increase,no risk
Salicylic acid,Vamorolone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Salicylic acid.",increase,risk
Salicylic acid,Vancomycin,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Salicylic acid.,increase,risk
Salicylic acid,Vardenafil,Salicylic acid may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Salicylic acid,Varenicline,The metabolism of Salicylic acid can be decreased when combined with Vardenafil.,decrease,no risk
Salicylic acid,Varicella zoster vaccine (live/attenuated),Salicylic acid may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Salicylic acid,Vemurafenib,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Varicella zoster vaccine (live/attenuated).,increase,risk
Salicylic acid,Venlafaxine,The metabolism of Salicylic acid can be decreased when combined with Vemurafenib.,decrease,no risk
Salicylic acid,Verapamil,Venlafaxine may increase the antiplatelet activities of Salicylic acid.,increase,no risk
Salicylic acid,Vilanterol,The risk or severity of bleeding can be increased when Verapamil is combined with Salicylic acid.,increase,risk
Salicylic acid,Vilazodone,The risk or severity of hypertension can be increased when Salicylic acid is combined with Vilanterol.,increase,risk
Salicylic acid,Vildagliptin,The risk or severity of hypertension can be increased when Salicylic acid is combined with Vilazodone.,increase,risk
Salicylic acid,Viloxazine,Salicylic acid may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Salicylic acid,Vorapaxar,Salicylic acid may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Salicylic acid,Voriconazole,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Vorapaxar.,increase,risk
Salicylic acid,Vortioxetine,The serum concentration of Salicylic acid can be increased when it is combined with Voriconazole.,increase,no risk
Diethylpropion,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Diethylpropion.,increase,risk
Diethylpropion,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Diethylpropion.,increase,risk
Diethylpropion,Butaperazine,Butaperazine may decrease the stimulatory activities of Diethylpropion.,decrease,no risk
Diethylpropion,Butobarbital,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Butobarbital.,increase,risk
Diethylpropion,Butorphanol,Diethylpropion may increase the analgesic activities of Butorphanol.,increase,no risk
Diethylpropion,Butriptyline,Diethylpropion may decrease the sedative activities of Butriptyline.,decrease,no risk
Diethylpropion,Butylscopolamine,The risk or severity of Tachycardia can be increased when Diethylpropion is combined with Butylscopolamine.,increase,risk
Diethylpropion,Gabapentin,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Gabapentin.,increase,risk
Diethylpropion,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Gabapentin enacarbil.,increase,risk
Diethylpropion,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Diethylpropion.,increase,risk
Diethylpropion,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Diethylpropion is combined with Ganaxolone.",increase,risk
Diethylpropion,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Diethylpropion.,increase,risk
Diethylpropion,Glutamic acid,The serum concentration of Diethylpropion can be decreased when it is combined with Glutamic acid.,decrease,no risk
Diethylpropion,Glutethimide,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Glutethimide.,increase,risk
Diethylpropion,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Diethylpropion.,decrease,no risk
Diethylpropion,Glycopyrronium,The risk or severity of Tachycardia can be increased when Diethylpropion is combined with Glycopyrronium.,increase,risk
Diethylpropion,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Diethylpropion.,increase,risk
Diethylpropion,Guanabenz,Diethylpropion may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Diethylpropion,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Diethylpropion.,decrease,no risk
Diethylpropion,Guanethidine,The serum concentration of Diethylpropion can be decreased when it is combined with Guanethidine.,decrease,no risk
Diethylpropion,Guanfacine,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Guanfacine.,increase,risk
Diethylpropion,Guanoxan,Diethylpropion may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Diethylpropion,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Diethylpropion.,increase,risk
Diethylpropion,Haloperidol,The therapeutic efficacy of Diethylpropion can be decreased when used in combination with Haloperidol.,decrease,no risk
Diethylpropion,Halothane,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Halothane.,increase,risk
Diethylpropion,Hexafluronium,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Hexafluronium.,increase,risk
Diethylpropion,Hexocyclium,The risk or severity of Tachycardia can be increased when Diethylpropion is combined with Hexocyclium.,increase,risk
Diethylpropion,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Diethylpropion.,increase,risk
Diethylpropion,Hydralazine,Diethylpropion may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Diethylpropion,Hydrochlorothiazide,Diethylpropion may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Diethylpropion,Hydrocodone,Diethylpropion may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Diethylpropion,Hydroflumethiazide,Diethylpropion may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Diethylpropion,Hydromorphone,Diethylpropion may increase the analgesic activities of Hydromorphone.,increase,no risk
Diethylpropion,Hydrotalcite,The serum concentration of Diethylpropion can be increased when it is combined with Hydrotalcite.,increase,no risk
Diethylpropion,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Diethylpropion.,increase,no risk
Diethylpropion,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Diethylpropion.,increase,risk
Diethylpropion,Ketamine,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Ketamine.,increase,risk
Diethylpropion,Ketazolam,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Ketazolam.,increase,risk
Diethylpropion,Ketoprofen,The risk or severity of hypertension can be increased when Diethylpropion is combined with Ketoprofen.,increase,risk
Diethylpropion,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Diethylpropion.,increase,risk
Diethylpropion,Ketotifen,Diethylpropion may decrease the sedative activities of Ketotifen.,decrease,no risk
Diethylpropion,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Diethylpropion.,increase,no risk
Diethylpropion,Nabumetone,The risk or severity of hypertension can be increased when Nabumetone is combined with Diethylpropion.,increase,risk
Diethylpropion,Nadolol,The therapeutic efficacy of Nadolol can be decreased when used in combination with Diethylpropion.,decrease,no risk
Diethylpropion,Nalbuphine,Diethylpropion may increase the analgesic activities of Nalbuphine.,increase,no risk
Diethylpropion,Naloxegol,Diethylpropion may increase the analgesic activities of Naloxegol.,increase,no risk
Diethylpropion,Naltrexone,Diethylpropion may increase the analgesic activities of Naltrexone.,increase,no risk
Diethylpropion,Naphazoline,The risk or severity of hypertension can be increased when Diethylpropion is combined with Naphazoline.,increase,risk
Diethylpropion,Naproxen,The risk or severity of hypertension can be increased when Naproxen is combined with Diethylpropion.,increase,risk
Diethylpropion,Naratriptan,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Naratriptan.,increase,risk
Diethylpropion,Naxitamab,The risk or severity of hypertension can be increased when Diethylpropion is combined with Naxitamab.,increase,risk
Diethylpropion,Nebivolol,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Diethylpropion.,decrease,no risk
Diethylpropion,Nefazodone,The therapeutic efficacy of Nefazodone can be decreased when used in combination with Diethylpropion.,decrease,no risk
Diethylpropion,Niacinamide ascorbate,The serum concentration of Diethylpropion can be decreased when it is combined with Niacinamide ascorbate.,decrease,no risk
Diethylpropion,Nialamide,The risk or severity of adverse effects can be increased when Nialamide is combined with Diethylpropion.,increase,risk
Diethylpropion,Nicardipine,The therapeutic efficacy of Nicardipine can be decreased when used in combination with Diethylpropion.,decrease,no risk
Diethylpropion,Nicergoline,The therapeutic efficacy of Nicergoline can be decreased when used in combination with Diethylpropion.,decrease,no risk
Diethylpropion,Nicorandil,Diethylpropion may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Diethylpropion,Nicotine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Diethylpropion.,increase,risk
Diethylpropion,Nilvadipine,Diethylpropion may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Diethylpropion,Nimesulide,The risk or severity of hypertension can be increased when Diethylpropion is combined with Nimesulide.,increase,risk
Diethylpropion,Nimodipine,Diethylpropion may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Diethylpropion,Nisoldipine,Diethylpropion may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Diethylpropion,Nitrazepam,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Nitrazepam.,increase,risk
Diethylpropion,Nitrendipine,Diethylpropion may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Diethylpropion,Nitroglycerin,Diethylpropion may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Diethylpropion,Nitroprusside,Diethylpropion may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Diethylpropion,Nitrous oxide,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Nitrous oxide.,increase,risk
Diethylpropion,Nizatidine,Diethylpropion may decrease the sedative activities of Nizatidine.,decrease,no risk
Diethylpropion,Nomifensine,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Nomifensine.,increase,risk
Diethylpropion,Norepinephrine,The therapeutic efficacy of Diethylpropion can be increased when used in combination with Norepinephrine.,increase,no risk
Diethylpropion,Normethadone,Diethylpropion may increase the analgesic activities of Normethadone.,increase,no risk
Diethylpropion,Nortriptyline,Diethylpropion may decrease the sedative activities of Nortriptyline.,decrease,no risk
Diethylpropion,Nylidrin,The risk or severity of hypertension can be increased when Diethylpropion is combined with Nylidrin.,increase,risk
Diethylpropion,Olanzapine,Diethylpropion may decrease the sedative activities of Olanzapine.,decrease,no risk
Diethylpropion,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Diethylpropion is combined with Oliceridine.",increase,risk
Diethylpropion,Olmesartan,Diethylpropion may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Diethylpropion,Olodaterol,The risk or severity of hypertension can be increased when Diethylpropion is combined with Olodaterol.,increase,risk
Diethylpropion,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Diethylpropion.,increase,risk
Diethylpropion,Opium,Diethylpropion may increase the analgesic activities of Opium.,increase,no risk
Diethylpropion,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Diethylpropion.,increase,risk
Diethylpropion,Orphenadrine,Diethylpropion may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Diethylpropion,Oxaprozin,The risk or severity of hypertension can be increased when Diethylpropion is combined with Oxaprozin.,increase,risk
Diethylpropion,Oxatomide,Diethylpropion may decrease the sedative activities of Oxatomide.,decrease,no risk
Diethylpropion,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Diethylpropion.,increase,risk
Diethylpropion,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Diethylpropion.,increase,risk
Diethylpropion,Oxitriptan,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Oxitriptan.,increase,risk
Diethylpropion,Oxprenolol,The therapeutic efficacy of Oxprenolol can be decreased when used in combination with Diethylpropion.,decrease,no risk
Diethylpropion,Oxtriphylline,The risk or severity of adverse effects can be increased when Diethylpropion is combined with Oxtriphylline.,increase,risk
Diethylpropion,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Diethylpropion.,increase,risk
Diethylpropion,Oxybutynin,The risk or severity of Tachycardia can be increased when Diethylpropion is combined with Oxybutynin.,increase,risk
Diethylpropion,Oxycodone,Diethylpropion may increase the analgesic activities of Oxycodone.,increase,no risk
Diethylpropion,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Diethylpropion.,increase,risk
Diethylpropion,Oxymorphone,Diethylpropion may increase the analgesic activities of Oxymorphone.,increase,no risk
Diethylpropion,Oxyphenbutazone,The risk or severity of hypertension can be increased when Diethylpropion is combined with Oxyphenbutazone.,increase,risk
Diethylpropion,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Diethylpropion.,increase,risk
Diethylpropion,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Diethylpropion.,increase,risk
Diethylpropion,Quazepam,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Quazepam.,increase,risk
Diethylpropion,Quetiapine,Diethylpropion may decrease the sedative activities of Quetiapine.,decrease,no risk
Diethylpropion,Quinapril,Diethylpropion may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Diethylpropion,Quinidine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Diethylpropion.,decrease,no risk
Diethylpropion,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Diethylpropion.,increase,risk
Diethylpropion,Quinupramine,The therapeutic efficacy of Quinupramine can be increased when used in combination with Diethylpropion.,increase,no risk
Diethylpropion,Umeclidinium,The risk or severity of Tachycardia can be increased when Diethylpropion is combined with Umeclidinium.,increase,risk
Diethylpropion,Urethane,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Urethane.,increase,risk
Diethylpropion,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Diethylpropion.,increase,risk
Diethylpropion,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Diethylpropion is combined with Valproate bismuth.,increase,risk
Diethylpropion,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Diethylpropion.,increase,risk
Diethylpropion,Valsartan,Diethylpropion may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Diethylpropion,Vecuronium,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Vecuronium.,increase,risk
Diethylpropion,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Diethylpropion is combined with Venlafaxine.,increase,risk
Diethylpropion,Verapamil,The therapeutic efficacy of Verapamil can be decreased when used in combination with Diethylpropion.,decrease,no risk
Diethylpropion,Vigabatrin,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Vigabatrin.,increase,risk
Diethylpropion,Vilanterol,The risk or severity of hypertension can be increased when Diethylpropion is combined with Vilanterol.,increase,risk
Diethylpropion,Vilazodone,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Vilazodone.,increase,risk
Diethylpropion,Viloxazine,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Viloxazine.,increase,risk
Diethylpropion,Vortioxetine,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Vortioxetine.,increase,risk
Diethylpropion,Xamoterol,The risk or severity of hypertension can be increased when Diethylpropion is combined with Xamoterol.,increase,risk
Diethylpropion,Xylometazoline,The risk or severity of hypertension can be increased when Diethylpropion is combined with Xylometazoline.,increase,risk
Diethylpropion,Yohimbine,The therapeutic efficacy of Yohimbine can be decreased when used in combination with Diethylpropion.,decrease,no risk
Diethylpropion,Zaleplon,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Zaleplon.,increase,risk
Diethylpropion,Ziconotide,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Ziconotide.,increase,risk
Diethylpropion,Zimelidine,The risk or severity of adverse effects can be increased when Diethylpropion is combined with Zimelidine.,increase,risk
Diethylpropion,Zinc ascorbate,The serum concentration of Diethylpropion can be decreased when it is combined with Zinc ascorbate.,decrease,no risk
Diethylpropion,Ziprasidone,The risk or severity of adverse effects can be increased when Diethylpropion is combined with Ziprasidone.,increase,risk
Diethylpropion,Zofenopril,Diethylpropion may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Diethylpropion,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Diethylpropion.,increase,risk
Diethylpropion,Zolpidem,Diethylpropion may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Diethylpropion,Zonisamide,Zonisamide may decrease the excretion rate of Diethylpropion which could result in a higher serum level.,decrease,no risk
Diethylpropion,Zopiclone,The risk or severity of adverse effects can be increased when Diethylpropion is combined with Zopiclone.,increase,risk
Diethylpropion,Zotepine,Zotepine may decrease the stimulatory activities of Diethylpropion.,decrease,no risk
Diethylpropion,Zuclopenthixol,Diethylpropion may decrease the sedative activities of Zuclopenthixol.,decrease,no risk
Diethylpropion,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Diethylpropion.,increase,risk
Salmeterol,Bosentan,Salmeterol may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Salmeterol,Bretylium,Salmeterol may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Salmeterol,Brexpiprazole,The therapeutic efficacy of Salmeterol can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Salmeterol,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Bromocriptine,Bromocriptine may increase the hypertensive and vasoconstricting activities of Salmeterol.,increase,no risk
Salmeterol,Bromotheophylline,The risk or severity of hypokalemia can be increased when Bromotheophylline is combined with Salmeterol.,increase,risk
Salmeterol,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Salmeterol.,increase,risk
Salmeterol,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Salmeterol.,increase,risk
Salmeterol,Budesonide,The risk or severity of hypokalemia can be increased when Budesonide is combined with Salmeterol.,increase,risk
Salmeterol,Bumadizone,The risk or severity of hypertension can be increased when Salmeterol is combined with Bumadizone.,increase,risk
Salmeterol,Bumetanide,The risk or severity of hypokalemia can be increased when Salmeterol is combined with Bumetanide.,increase,risk
Salmeterol,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Buserelin,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Buserelin.,increase,risk
Salmeterol,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Salmeterol.,increase,risk
Salmeterol,Butriptyline,The risk or severity of hypertension can be increased when Butriptyline is combined with Salmeterol.,increase,risk
Salmeterol,Butylscopolamine,The risk or severity of Tachycardia can be increased when Salmeterol is combined with Butylscopolamine.,increase,risk
Salmeterol,Gadobenic acid,The metabolism of Salmeterol can be decreased when combined with Fusidic acid.,decrease,no risk
Salmeterol,Galantamine,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Gadobenic acid.,increase,risk
Salmeterol,Gallamine triethiodide,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Salmeterol.,increase,risk
Salmeterol,Ganciclovir,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Salmeterol.,increase,risk
Salmeterol,Gatifloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Salmeterol is combined with Ganciclovir.",increase,risk
Salmeterol,Gefitinib,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Gatifloxacin.,increase,risk
Salmeterol,Gemfibrozil,The metabolism of Salmeterol can be decreased when combined with Gefitinib.,decrease,no risk
Salmeterol,Gemifloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Salmeterol is combined with Gemfibrozil.",increase,risk
Salmeterol,Gentamicin,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Gemifloxacin.,increase,risk
Salmeterol,Gepirone,The serum concentration of Gentamicin can be increased when it is combined with Salmeterol.,increase,no risk
Salmeterol,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Salmeterol.,increase,risk
Salmeterol,Glasdegib,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Salmeterol.,increase,risk
Salmeterol,Glofitamab,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Glasdegib.,increase,risk
Salmeterol,Glyburide,The serum concentration of Salmeterol can be increased when it is combined with Glofitamab.,increase,no risk
Salmeterol,Glycopyrronium,The metabolism of Glyburide can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Golimumab,The risk or severity of Tachycardia can be increased when Salmeterol is combined with Glycopyrronium.,increase,risk
Salmeterol,Goserelin,The metabolism of Salmeterol can be increased when combined with Golimumab.,increase,no risk
Salmeterol,Granisetron,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Goserelin.,increase,risk
Salmeterol,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Granisetron.,increase,risk
Salmeterol,Guanabenz,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Grepafloxacin.,increase,risk
Salmeterol,Guanadrel,Salmeterol may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Salmeterol,Guanethidine,Salmeterol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Salmeterol,Guanfacine,Salmeterol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Salmeterol,Guanidine,The risk or severity of adverse effects can be increased when Salmeterol is combined with Guanfacine.,increase,risk
Salmeterol,Guanoxan,The risk or severity of adverse effects can be increased when Guanidine is combined with Salmeterol.,increase,risk
Salmeterol,Halofantrine,Salmeterol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Salmeterol,Haloperidol,The metabolism of Halofantrine can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Halothane,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Haloperidol.,increase,risk
Salmeterol,Hexocyclium,The risk or severity of hypertension can be increased when Salmeterol is combined with Halothane.,increase,risk
Salmeterol,Histamine,The risk or severity of Tachycardia can be increased when Salmeterol is combined with Hexocyclium.,increase,risk
Salmeterol,Histrelin,The serum concentration of Histamine can be increased when it is combined with Salmeterol.,increase,no risk
Salmeterol,Homatropine methylbromide,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Histrelin.,increase,risk
Salmeterol,Hydralazine,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Salmeterol.,increase,risk
Salmeterol,Hydrochlorothiazide,Salmeterol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Salmeterol,Hydrocortisone,The risk or severity of hypokalemia can be increased when Salmeterol is combined with Hydrochlorothiazide.,increase,risk
Salmeterol,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Salmeterol.,increase,risk
Salmeterol,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Salmeterol.,increase,risk
Salmeterol,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Salmeterol.,increase,risk
Salmeterol,Hydrocortisone phosphate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Salmeterol.,increase,risk
Salmeterol,Hydrocortisone succinate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Salmeterol.,increase,risk
Salmeterol,Hydroxychloroquine,The risk or severity of hypokalemia can be increased when Salmeterol is combined with Hydroflumethiazide.,increase,risk
Salmeterol,Hydroxyprogesterone caproate,The metabolism of Hydroxychloroquine can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Hydroxyzine,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Hydroxyzine.,increase,risk
Salmeterol,Ketamine,The metabolism of Salmeterol can be increased when combined with Ivosidenib.,increase,no risk
Salmeterol,Ketoconazole,The metabolism of Ketamine can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Ketoprofen,The metabolism of Salmeterol can be decreased when combined with Ketoconazole.,decrease,no risk
Salmeterol,Ketorolac,The risk or severity of hypertension can be increased when Salmeterol is combined with Ketoprofen.,increase,risk
Salmeterol,Nabilone,The metabolism of Mycophenolate mofetil can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Nabumetone,The risk or severity of Tachycardia can be increased when Nabilone is combined with Salmeterol.,increase,risk
Salmeterol,Nadolol,The risk or severity of hypertension can be increased when Nabumetone is combined with Salmeterol.,increase,risk
Salmeterol,Nafarelin,Nadolol may decrease the bronchodilatory activities of Salmeterol.,decrease,no risk
Salmeterol,Nalidixic acid,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Salmeterol.",increase,risk
Salmeterol,Naltrexone,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Nalidixic acid.,increase,risk
Salmeterol,Naphazoline,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Salmeterol.",increase,risk
Salmeterol,Naproxen,The risk or severity of hypertension can be increased when Salmeterol is combined with Naphazoline.,increase,risk
Salmeterol,Naratriptan,The metabolism of Naproxen can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Nateglinide,The risk or severity of hypertension can be increased when Salmeterol is combined with Naratriptan.,increase,risk
Salmeterol,Naxitamab,The metabolism of Salmeterol can be decreased when combined with Nateglinide.,decrease,no risk
Salmeterol,Nebivolol,The risk or severity of hypertension can be increased when Salmeterol is combined with Naxitamab.,increase,risk
Salmeterol,Nefazodone,The therapeutic efficacy of Salmeterol can be decreased when used in combination with Nebivolol.,decrease,no risk
Salmeterol,Nelfinavir,The metabolism of Salmeterol can be decreased when combined with Nefazodone.,decrease,no risk
Salmeterol,Netupitant,The metabolism of Salmeterol can be decreased when combined with Nelfinavir.,decrease,no risk
Salmeterol,Nevirapine,The metabolism of Salmeterol can be decreased when combined with Netupitant.,decrease,no risk
Salmeterol,Niacin,The risk or severity of adverse effects can be increased when Nevirapine is combined with Salmeterol.,increase,risk
Salmeterol,Nialamide,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Salmeterol.",increase,risk
Salmeterol,Nicardipine,The risk or severity of hypertension can be increased when Salmeterol is combined with Nialamide.,increase,risk
Salmeterol,Nicergoline,The metabolism of Nicardipine can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Nicorandil,Nicergoline may increase the hypertensive and vasoconstricting activities of Salmeterol.,increase,no risk
Salmeterol,Nicotine,Salmeterol may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
